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Summary
Air pollution is one of the most serious environmental health risks in developing 
countries. Epidemiologic studies have reported significant associations between urban 
concentrations of air pollution and mortality. Authorities are required to formulate and 
implement policies that aim to improve air quality, and cost-benefit analysis can be a 
useful tool to evaluate the environmental-policy options. The monetary valuation of the 
mortality impact is an essential input to such cost-benefit analysis since the mortality 
effects correspond to the major component of the benefits of policies that improve air 
quality.
This study aims to estimate the willingness to pay (WTP) to reduce risks of 
death associated with ‘typical’ air pollution policies and the value of a statistical life 
(VSL) in Sao Paulo, Brazil. It uses a methodology that has previously been tested in 
several industrialised countries, involving a computer-based contingent valuation 
survey. VSL in Sao Paulo ranged between US$0.77 and US$6.1 million, while our 
preferable estimates for policy analysis in Brazil are US$0.77 -  US$1.31 million. These 
numbers are higher than expected for a middle-income country like Brazil. It was 
identified a bias -  ‘yeah-saying’ behaviour -  and the results excluding those 
respondents ranged between US$0.41 and US$2.41 (preferable estimates US$0.41 -  
US$0.48) million.
No significant age, cancer, respiratory or cardiovascular disease effects on the 
WTP estimates were identified, whereas a positive effect of the physical function score 
was identified. WTP estimates for reduction in risk of dying in the future were 
consistent with theory only when individuals who inconsistently answered the WTP 
questions were removed. Benefit transfer, the most used alternative technique in 
developing countries to original valuation exercises, presented average transfer errors 
equal to 69%. Two case studies compared the results obtained by using benefit transfer 
with the results using our estimates, suggesting that benefit transfer can result in 
inaccurate policy analysis.
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Summary
Air pollution is one of the most serious environmental health risks in developing 
countries. Epidemiologic studies have reported significant associations between urban 
concentrations of air pollution and mortality. Authorities are required to formulate and 
implement policies that aim to improve air quality, and cost-benefit analysis can be a 
useful tool to evaluate the environmental-policy options. The monetary valuation of the 
mortality impact is an essential input to such cost-benefit analysis since the mortality 
effects correspond to the major component of the benefits of policies that improve air 
quality.
This study aims to estimate the willingness to pay (WTP) to reduce risks of 
death associated with ‘typical’ air pollution policies and the value of a statistical life 
(VSL) in Sao Paulo, Brazil. It uses a methodology that has previously been tested in 
several industrialised countries, involving a computer-based contingent valuation 
survey. VSL in Sao Paulo ranged between US$0.77 and US$6.1 million, while our 
preferable estimates for policy analysis in Brazil are US$0.77 -  US$1.31 million. These 
numbers are higher than expected for a middle-income country like Brazil. It was 
identified a bias -  ‘yeah-saying’ behaviour -  and the results excluding those 
respondents ranged between US$0.41 and US$2.41 (preferable estimates US$0.41 -  
US$0.48) million.
No significant age, cancer, respiratory or cardiovascular disease effects on the 
WTP estimates were identified, whereas a positive effect of the physical function score 
was identified. WTP estimates for reduction in risk of dying in the future were 
consistent with theory only when individuals who inconsistently answered the WTP 
questions were removed. Benefit transfer, the most used alternative technique in 
developing countries to original valuation exercises, presented average transfer errors 
equal to 69%. Two case studies compared the results obtained by using benefit transfer 




Ambient air pollution represents an important environmental health risk in the 
developing world, in particular in urban centres. Sao Paulo, the largest Brazilian 
metropolis, with significant regional, industrial and economic importance has, as a 
consequence of its economic dynamics and its high population density, more than 1 0  
million people living within its urban area (IBGE, 2000) and the population faces 
serious environmental problems. The concentration levels of air pollutants in Sao Paulo 
are among the highest in the world, the causes being linked to the great number of 
vehicles and the considerable concentration of industries. In addition, Sao Paulo 
presents geographic characteristics that contribute to eventual thermal inversions, which 
increase the accumulation of atmospheric pollutants.
The epidemiologic literature developed during the last twenty years provides 
strong evidence that exposure to outdoor air pollution in urban centres is positively 
associated with a range of acute and chronic health effects, ranging from minor effects 
such as physiological disturbances and eye irritation to death. In Brazil, studies 
associating air pollution with different health outcomes have been developed since the 
mid nineties; most of the studies were carried out in Sao Paulo. Some studies associated 
air pollution in Sao Paulo with different morbidity outcomes, for example, emergency 
room visits due to chronic lower respiratory diseases in the elderly and ischemic 
cardiovascular respiratory diseases in children, and hospital admissions due to 
respiratory problems in children and adolescents. Also, several studies have reported 
significant associations between urban concentrations of air pollution and “all-cause” 
mortality, cardiovascular mortality, and respiratory mortality, plus deaths due to more 
specific causes such as pneumonia and chronic obstructive pulmonary disease. These 
studies suggest that fine particulate matter (PMio) is the most harmful pollutant for 
human health, although other pollutants such as sulphur dioxide (SO2), nitrogen dioxide 
(NO2) and ozone (O3) have also been found to be related to health events.
In this context, the environmental authorities are constantly required to 
formulate and implement policies that aim to increase air quality, and consequently, to 
reduce the health impacts of air pollution in the exposed population. In order to evaluate 
such policies, cost-benefit analysis can be a useful tool in providing a means of 
comparison between policies and, above all, in evaluating whether the overall benefits 
associated with the policy are greater than its costs. Thus, the monetary evaluation of
13
the associated health impacts of the policies is an essential input to the cost-benefit 
analysis of any air-quality policy assessment. In addition, the health effects are likely to 
correspond to the major component of the benefits of policies to improve air quality, 
and reductions in the risk of premature death are widely believed to be the most 
important benefit underlying many environmental programmes, including those related 
to reduction of air pollution (Krupnick et al., 2002). It can be concluded that it is 
important to estimate in monetary terms the benefit of reducing risks of death when 
evaluating policies or environmental programmes that reduce air pollution.
It is important to discuss in advance eventual ethical concerns involving the 
process of establishing monetary values to reductions in risk of mortality and, 
consequently, to human lives. It is observed that reductions in risks to human lives are 
always related to costs incurred to achieve the risk change. For example, individuals 
purchase safety goods such as smoke detectors, visit a doctor or undertake clinical 
exams regularly, attitudes that can be associated with costs measured in terms of money 
and/or in terms of forgone utility. Consequently, mortality risk reductions are inevitably 
constrained by individuals’ income, imposing upon individuals the task of choosing 
which risks to incur. At the social level, “ ...the key issue is the risk reduction that is 
achievable for any given expenditure and the value society places on this risk reduction” 
(Viscusi, 1993). In the context of risks to death associated with air pollution, in which 
the most important benefit associated with policy making and regulation is the reduction 
in probabilities of premature death among the population exposed to pollutants, it is 
important to estimate how much the society evaluates the small mortality risk reductions 
associated with these policies, and to compare with their corresponding social costs. 
Because these small risk reductions are associated with an expected number of 
premature deaths avoided in a given period of time, it is said that the society’s total 
willingness to pay to avoid such deaths divided by the number of avoided deaths 
corresponds to the value of one statistical life. In summary, what is being valued is not a 
specific human life but small mortality risk reductions that correspond to a number of 
unknown lives saved, and “identifiable deaths are not the same as statistical deaths” 
(Keeney, 2004).
The economic problem associated with policy making on the grounds of air 
quality arises when it is recognised that life cannot be free of risk, and reducing one 
type of risk necessarily increases other mortality risks since everyone must die at some 
point of time. Therefore, policies aiming to reduce mortality risks may be associated
14
with other risks or with a transfer of risks from one social group to another. In other 
words, effective decisions about risks require trade-offs between objectives: “the 
question is whether the public should pay for very expensive risk-reduction programmes 
that would avert a few statistical deaths but result in considerably more deaths 
associated with reduced income” (Keeney, 2004).
Economists evaluate changes in risks of death using two general alternative 
approaches: the human capital approach and the willingness-to-pay approach. The first 
approach estimates the economic productivity of the individual whose life is at risk by 
using individuals’ discounted lifetime earnings as its measure of value, and assigning 
values in direct proportion to income. The willingness-to-pay approach assumes that the 
preferences of individuals can be characterised by substitutability between income and 
safety, that is, that individuals make trade-offs between the consumption of goods or 
services and the factors that increase the consumer’s safety. These trade-offs reveal the 
values individuals place on their safety or on the reduction on their risks of death. 
Several economic valuation methods comprise the willingness-to-pay approach. The 
valuation methods are in general divided in revealed preference techniques and stated 
preference techniques. Revealed preference techniques are those where individuals 
reveal their preferences in associated markets such as the labour market 
(‘compensating-wage’ method) and the housing market (hedonic-price models). 
Individuals that state their preference through questionnaires simulating contingent 
markets (contingent valuation method) or structured games (choice experiments) 
characterize stated preference techniques. Each approach and valuation method has its 
associated characteristics, advantages and disadvantages in dealing with the evaluation 
of small risk reductions to life.
The methodology used in this research involved the use of a contingent 
valuation computer-based survey instrument developed by Krupnick et al. (1998) 
specifically to fill some gaps in the contingent valuation literature concerning the 
elicitation of willingness to pay for reduction in risks of death. This survey instrument 
was adapted to the Brazilian context and used to elicit the willingness-to-pay measure 
related to reductions in risk of death in Sao Paulo, Brazil.
Epidemiologic studies also suggest that the short-term mortality impact of air 
pollution tends to be more significant among the elderly, children, and those individuals 
in poor health. Thus, when analysing the benefits of policies that aim to reduce air 
pollution, economists should initially consider that the willingness to pay for a reduction
15
in the risk of dying might differ between young and old individuals, and between 
healthy and impaired groups. Theory, however, is inconclusive about the role of age and 
health status in the willingness to pay for small reductions in probabilities of death and 
the value of a statistical life. For example, it can be initially expected that willingness to 
pay increases with the probability of dying during the following year (baseline risk), 
which increases with age. On the other hand, willingness to pay also depends on the 
marginal utility of future consumption, which is not clear whether and how it can be 
influenced by age (Alberini et al., 2004b). In other words, these issues have to be tested 
empirically, and it remains controversial in the literature whether willingness to pay for 
mortality risk reduction should vary with the age and health status of individuals whose 
lives are extended.
Other important issues are involved in the valuation of mortality risk reductions 
such as the effect of altruism -  the fact that individuals may be concerned not only 
about their own welfare but also about other individuals’ welfare -  and the latency 
period inherent to some diseases associated with air pollution (e.g. cancer). Theory 
predicts that the willingness to pay for a risk reduction happening in the future should 
be lower than the willingness to pay for an immediate risk reduction of the same size. 
This is because there are uncertainties about the future, both related to individuals 
surviving to the period they would enjoy the benefit and related to the individuals’ 
marginal utility of future consumption. The uncertainty in this case regards how 
different the immediate and latent estimates should be in order to proportionate accurate 
policy analysis.
The objective of this research is to estimate how much individuals in Sao Paulo 
are willing to pay to reduce their risk of dying from diseases related to air pollution. As 
a consequence, to estimate for the first time in Brazil the value of a Brazilian statistical 
life. The research questions investigated are: (i) how does the age of the respondents 
affect the willingness to pay for a contemporaneous mortality risk reduction? (ii) what is 
the impact, if  any, of the health status of the respondents? (iii) do the willingness-to-pay 
values for a reduction in mortality risks that happen in the future follow the economic 
theory’s prediction? The results of this research can provide policy makers in Brazil 
with an important statistic for policy assessment on the grounds of air pollution, and the 
empirical tests of the important issues involved can contribute to the sparse literature in 
the field. Finally, by comparing the results of this research with related studies
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conducted in developed countries, it can contribute towards future research and policy 
evaluation in Brazil and other developing countries.
This thesis is organised as follows. Chapter 2 reviews the epidemiologic 
literature associating air pollution with health outcomes, providing a general overview 
of the main air pollutants and their links with human health; the general methods used in 
epidemiologic studies; and the recent Brazilian epidemiologic studies, focusing on 
studies relating air pollution to mortality in Sao Paulo. Chapter 3 explores the different 
approaches economists use to establish appropriate economic values for changes in risk 
of death and to estimate the value of a statistical life. It discusses the adequacy of the 
willingness-to-pay approach and the contingent valuation method for the purposes of 
this research, and the economic models that provide the theoretical basis for 
willingness-to-pay measures for risk reductions. Chapter 4 reviews the main empirical 
studies that estimate willingness to pay to reduce risks of death and the value of a 
statistical life, focusing on ‘compensating-wage’ studies, contingent valuation studies, 
averting behaviour studies, and meta-analyses. It discusses some issues involved in 
valuations of risks to life including altruism, moral and ethical issues. In addition, it 
introduces some alternative metrics to the value of a statistical life commonly used in 
medical literature (health indices) and specifically in the context of air pollution (the 
value of a statistical life year).
Chapter 5 introduces the empirical work undertaken in Sao Paulo, Brazil, to 
estimate the willingness to pay for small mortality risk reductions and the value of a 
statistical life. The contingent valuation survey instrument is detailed and the data 
analysis is reported, including the analysis of the determinants of inconsistent 
willingness-to-pay responses and protest responses; non-parametric and parametric 
willingness-to-pay values for different risk reductions; the validity tests of willingness- 
to-pay values; and estimates of the value of a statistical life (year). Chapter 6  discusses 
the research questions regarding the role of age and health statuses in the willingness-to- 
pay values, and the willingness to pay for a risk reduction that happens in the future. It 
investigates whether willingness to pay for reduced future risk of death in Sao Paulo 
corresponds to expectations and theory. Finally, Chapter 7 discusses the relevance of the 
empirical results obtained in this study in terms of policy analysis in Brazil. Alternative 
approaches that can provide approximations of the value of a statistical life (year) are 
introduced and the Brazilian studies available are reviewed. In addition, it discusses the 
benefit transfer procedures that are, in general, the alternative procedures adopted in
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developing countries in the absence of resources for undertaking original revealed 
and/or stated preference studies. Benefit transfer validity tests are performed to estimate 
potential ‘errors’ of benefit transfer estimates when compared with willingness-to-pay 
estimates generated in this study. Finally, case studies of policy analysis in Brazil are 
presented to explore the implications for policy analysis of using benefit transfer 
estimates instead of the results provided in this study. Conclusions and discussions are 
drawn in Chapter 8 .
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2. Air pollution and risk to human health
It is widely accepted that exposure to outdoor air pollution is associated with a 
range of acute and chronic health effects, ranging from minor disturbances such as eye 
irritation to death from respiratory and cardiovascular disease (HEI, 2004). The 
evidence of this association is based on epidemiologic studies of disease occurrence in 
human populations, which relate changes in exposure to air pollution in space and time 
to health outcomes, and also from experimental studies of animals and humans. 
Epidemiologic studies on the health effects of air pollution provide estimates of the 
health effects of both short- and long-term exposure to a variety of air pollutants in 
human populations in many parts of the world. These estimates have been the scientific 
basis for air quality regulations for some pollutants, since they apply to humans living in 
real world conditions.
The limitations of observational epidemiology include the difficulty of 
accounting for potential confounders, i.e. risk factors other than exposure to air 
pollution, and the difficulty of estimating the toxicity of specific components of the 
urban air pollution mixture. In fact, separating the effects of one pollutant from the 
effects of other pollutants present in the ambient atmosphere is very difficult. For 
example, WHO (2003) recognised that ozone, nitrogen dioxide and particulate matter 
are linked by complex atmospheric chemistry and that effects attributed to each of these 
pollutants may be influenced by the underlying toxicity of the full mixture of all air 
pollutants. Epidemiologic studies are also not ideal for studying the mechanisms by 
which exposure to air pollution produces disease (pathophysiological pathway of 
disease).
Among the relevant results found in the epidemiologic literature, there is 
evidence of a relationship between ambient air pollution and an increase in the severity 
or duration of an already established respiratory disease. Also, mortality has long been a 
key health endpoint in epidemiologic studies. It is a distinct and discrete health 
outcome, and mortality data are routinely collected and readily available for 
epidemiologic analyses (HEI, 2003).
This chapter aims to review the epidemiologic literature associating air pollution 
and health outcomes. The following section provides a general overview of the main air 
pollutants and their possible links with human health. Section 2.2 describes the methods
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used in epidemiologic studies, while the main issues addressed in the international 
epidemiologic studies are detailed in section 2.3. The recent Brazilian epidemiologic 
studies are described in section 2.4, focusing on studies relating air pollution to 
mortality in Sao Paulo.
2.1. Main air pollutants
This section describes the main air pollutants, their characteristics, possible 
emission sources and health impacts. It is based on a number of similar reviews of the 
existing evidence such as Omarsal and Ganton (1997), HEI (2003, 2004), Harrison 
(2004), Kojima and Lovei (2001) and WHO (2003).
• Airborne particles - Particulate matter (TSP, P M jo, PM2.5)
According to Harrison (2004), airborne particles or particulate matter (PM) are 
microscopic pieces of solid material or liquid droplets, other than pure water, floating 
freely in the atmosphere. Various terms are used to describe particulate matter, some 
derived from and defined by sampling and/or analytic methods, e.g. suspended 
particulate matter, total suspended particulates (TSP) and black smoke. Others refer to 
the site of deposition in the respiratory tract, e.g. inhalable particles, which pass into the 
upper airways (nose and mouth), and thoracic particles, which deposit within the lower 
respiratory tract, and respirable particles, which penetrate to the gas-exchange region of 
the lungs. Other terms, such as PM10, have both physiological and sampling 
connotations (WHO, 2003).
These particles are observed in different sizes, ranging from a few nanometres 
(billionths of a metre) in diameter up to about 1 0 0  pm1 ( 1 0 0  millionths of a metre) 
(Harrison, 2004). According to Omarsal and Ganton (1997), total suspended particles 
are particles with an aerodynamic diameter of less than 70 pm. Particulate matter larger 
than 10  pm in diameter (PM10) results from physical actions such as wind erosion or 
grinding operations and tends to settle near its emission source. Particulate matter with 
an aerodynamic diameter of 2.5 pm (PM2.5) or less is defined as fine particles, while 
larger particulate matter is called coarse particles. Particles emitted directly from a 
source are named primary, while particles that are formed within the atmosphere, 
mainly from the chemical oxidation of atmospheric gases, are termed secondary
1 1 pm = 1 micrometer = 1 micron = 10'6 meter.
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(Kojima and Lovei, 2001). Particles greater than 10 pm in diameter are large enough to 
settle quickly from the atmosphere due to gravity, while particulate matter with an 
aerodynamic diameter of 1 0  pm or less remains in the atmosphere for longer -  hours or 
even days -  because of its low settling velocity. The smaller particles present the 
highest risk to the human health because they can penetrate deeply into the respiratory 
tract and cause respiratory illness (discussed below).
Because of the diversity of airborne particulate matter, there are different metrics 
of measurement, that is, different ways of assessing and expressing the magnitude of the 
pollutant load. In the past, measurements of airborne particles were made using the 
black smoke technique, which involves collecting particles by drawing air through a 
filter paper and then determining the blackening of the filter paper by the collected 
particles. Nowadays, the techniques used to measure particles are concerned with the 
particles mass rather than blackness, e.g. the use of Tapered Element Oscillating 
Microbalance (TEOM) instruments (Harrison, 2004).
Particulate matter originates from natural as well as anthropogenic sources. 
Natural sources include wind-blown soil dust, volcanic ash, forest fires, sea salt, and 
pollens or may be formed in the atmosphere through reactions with gaseous emissions, 
e.g. nitrogen and sulphur oxides react to form nitrates and sulphates respectively. 
Anthropogenic sources include thermal power plants, industries, commercial and 
residential facilities, and motor vehicles using fossil fuels (Omarsal and Ganton, 1997, 
HEI, 2004). The main anthropogenic source of airborne particles is incomplete 
combustion of fossil fuels and biomass, e.g. coal burning for cooking, heating or 
industrial use. The combustion of coal generates carbon as both elemental (graphitic) 
carbon and organic compounds absorbed on its surface. Coal also contains a substantial 
proportion of incombustible mineral material and trace elements, some of which enter 
the atmosphere with the smoke (Harrison, 2004). Road traffic is also an important 
source of airborne particles at ground level in urban areas. Nearly all particulate matter 
emitted by motor vehicles consists of fine particles and a large fraction of these particles 
has an aerodynamic diameter of less than 1 pm. Their small average size means that 
they are able to penetrate deep into the respiratory tract, especially into the alveolar 
regions of the lung, inducing inflammatory responses.
Various short-term and long-term epidemiologic studies published in the US and 
Europe have found associations of particulate matter with increased mortality (e.g. 
Schwartz and Dockery, 1992a and 1992b; Saldiva et al., 1994) and morbidity effects
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such as hospital admissions, emergency room visits, time off school or work, respiratory 
symptoms, exacerbation of asthma, and changes in lung function (e.g. Braga et al., 1999 
and 2001). Recent studies have begun to strengthen the understanding of the relation 
between exposure to particulate matter, morbidity and mortality (e.g. Pope et al., 2002). 
Some studies have suggested that ultra fine particles (PM o.i), particles containing metals 
such as iron, and other types of particles may be the most toxic components of the air 
pollution mixture (HEI, 2004). According to Omarsal and Ganton (1997), particulate 
matter greater than 1 0  pm in diameter is deposited in the extra-thoracic part of the 
respiratory tract, while PMio is deposited near the fine airways. PM2.5 is a larger health 
concern because it can evade the human body’s respiratory defence system and reach 
the lung tissue, where it can remain imbedded for years, or in the case of soluble 
particles, be absorbed into the bloodstream.
• Airborne toxics (hydrocarbons)
Hydrocarbon compounds (HC) are defined as compounds consisting of carbon 
and hydrogen. In air quality studies, however, the term hydrocarbon is often extended to 
include a variety of other volatile organic compounds (VOC) such as alcohols and 
aldehydes (Omarsal and Ganton, 1997). Another group of hydrocarbons of concern 
includes polycyclic aromatic hydrocarbons (PAH). Benzene is an aromatic volatile 
organic compound, which is a minor constituent of petrol. 1,3-butadiene is also a 
volatile organic compound, which is produced by the combustion of olefins and 
constitutes an important chemical in certain industrial processes, particularly the 
manufacture of synthetic rubber.
According to Omarsal and Ganton (1997), hydrocarbon compounds can be 
emitted from both natural and anthropogenic sources. Natural sources include anaerobic 
decomposition of plants in swamps and marshes, seepage from natural gas and oil 
fields, and emissions from trees. The first two sources produce methane (CH4), and the 
third source produces photochemical reactive hydrocarbon compounds. Anthropogenic 
emission sources include motor vehicles, gasoline and solvent storage tanks and transfer 
stations, petroleum refineries, and chemical and petrochemical plants. Motor engines -  
both combusting petrol and diesel -  emit toxic hydrocarbon compounds, including 
benzene, 1,3-butadiene, aldehydes and polycyclic aromatic hydrocarbons. They are 
released in vehicle exhaust gases either as unbumed fuels or as combustion products,
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and are emitted by the evaporation of solvents and motor fuels. Benzene is present in 
gasoline, while aldehydes and 1,3-butadiene are not present in gasoline, diesel fuel, 
ethanol, or methanol, but are present in their exhaust emissions as partial combustion 
products. Aldehydes are also formed in the atmosphere from other mobile source 
pollutants and have a high photochemical reactivity in ozone formation. The major 
types of aldehydes formed include formaldehyde and acetaldehyde (Omarsal and 
Ganton, 1997).
Most hydrocarbon compounds are not directly harmful to human health at the 
level of concentration found in ambient air. However, through chemical reactions in the 
lower atmosphere (troposphere) they play an important role in forming nitrogen dioxide 
(NO2) and in the photochemical formation of ozone (O3), which are health and 
environmental hazards. Methane (CH4) does not participate in these reactions. The 
remaining hydrocarbon compounds, non-methane hydrocarbon (NMHC), are the focus 
of air quality studies because they are reactive in forming secondary air pollutants 
(Omarsal and Ganton, 1997). Several aldehydes, such as formaldehyde and 
acetaldehyde, have also been designated probable human carcinogens. In addition, 
several of the aldehydes have been shown to induce acute respiratory effects such as 
shortness of breath, alteration in respiration and coughing (HEI, 2004). Other effects 
may include eye and nose irritation, irritation of mucous membranes and nausea. 
Benzene and especially 1,3-butadiene are of particular concern, as they are known to be 
potent human carcinogens (e.g. leukaemia). Benzene also has toxic effects that are 
associated with the central nervous system as well as the haematological and 
immunological systems. Occupational studies of exposure to high levels of benzene 
have found that it can damage the respiratory tract, lung tissue, and bone marrow and 
can cause death. Polycyclic aromatic hydrocarbons absorbed in the lungs and intestines 
and metabolised in the human body are carcinogenic, and associated with a 50% greater 
risk of bladder cancer among truck drivers and deliverymen exposed to diesel engine 
exhaust (Omarsal and Ganton, 1997).
• Carbon monoxide (CO)
Carbon monoxide is a colourless and odourless gas that is slightly denser than 
air. It is emitted by natural and anthropogenic sources. Anthropogenic sources form 
carbon monoxide from incomplete combustion of fossil fuels in motor vehicles, heating
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and industrial facilities, thermal power plants, and incinerators. Natural emission 
sources include the oxidation of hydrocarbons and other organic compounds. 
Conversion of carbon monoxide into carbon dioxide (CO2) in the atmosphere is slow 
and takes two to five months (Omarsal and Ganton, 1997).
Carbon monoxide inhibits the capacity of blood to carry oxygen to organs such 
as the heart and brain, and tissues. When inhaled, it replaces oxygen in the bloodstream 
by binding with haemoglobin (Hb) to form carboxyhaemoglobin (COHb), which lowers 
the oxygen level in the blood. Because more blood is needed to supply the same amount 
of oxygen, the heart must work harder. People with chronic heart disease may 
experience chest pains when carbon monoxide levels are high. At very high levels, 
carbon monoxide impairs vision, manual dexterity, and learning ability and can cause 
death (Kojima and Lovei, 2001; Omarsal and Ganton, 1997).
• Sulphur oxides (SOx)
Sulphur oxides are products of the combustion of sulphur-containing fossil fuels, 
including solid fuels (e.g. coal), liquid fuels (e.g. gasoline, diesel, and fuel oil), and 
natural gas. Sulphur dioxide (SO2), which is extremely soluble in water, is a stable, non­
flammable, non-explosive, colourless and corrosive acid gas that can be detected by 
taste at concentrations as low as 1 0 0 0  pm/m3 or by smell at concentrations above 1 0 0 0 0
3 • •pm/m . It combines with water vapour in the atmosphere to produce acid rain, which is 
a regional air pollution problem, and to the formation of secondary particulate matter.
Thermal power generation, heating, cooking, petroleum refining, ore smelting 
and transportation can produce SO2. In the atmosphere sulphur dioxide may be 
converted to sulphur trioxide (SO3) by reacting with oxygen. Both react with the 
moisture in air to form sulphurous (H2SO3) and sulphuric (H2SO4) acids, which may be 
transported by winds many kilometres before falling to earth as acid rain (Omarsal and 
Ganton, 1997). Where significantly elevated levels of ambient sulphur dioxide are 
found, it is more likely to have come from the combustion of coal than from other 
sources. In countries where coal is rarely used, the available data suggest that ambient 
sulphur dioxide concentrations tend to be low (Kojima and Lovei, 2001).
Adverse health effects of sulphur dioxide include coughing, phlegm, chest 
discomfort, and bronchitis. Additionally, it is believed that sulphur dioxide exacerbates 
the effects of particulate matter, and vice versa. Sulphur dioxide has been associated
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with reduced lung function in asthmatics -  exposure at levels as low as 0.25 ppm elicits 
increased bronco-constriction in people with asthma. Increased daily mortality and 
hospital admissions from respiratory and cardiovascular disease, even at low levels, are 
also associated with sulphur dioxide exposure (HEI, 2004).
• Nitrogen oxides (NOx)
Nitrogen oxides are formed during fossil fuel combustion processes as nitrogen 
in the air reacts at high temperatures with oxygen (oxidation). Nitrogen oxides include 
nitric oxide (NO), nitrogen dioxide (NO2), nitrous oxide (N2O), dinitrogen trioxide 
(N2O3), and nitrogen pentoxide (N2O5). The main source of nitrogen oxides is 
transportation (e.g. road traffic). Other important sources are thermal power stations, 
heating plants and industrial processes such as waste incineration. Nitrogen oxides are 
also produced by natural phenomena such as lightning, volcanic eruptions, and bacterial 
action in the soil.
Nitrogen dioxide has a variety of environmental and health impacts. In the 
atmosphere, it may be involved in a series of reactions (in the presence of ultra-violet 
radiation) that produce photochemical smog, reducing visibility. It may also react with 
moisture in the air to form nitric acid (HNO3) aerosols. In the lower atmosphere 
(troposphere), nitrogen dioxide forms ozone by reacting with hydrocarbon compounds. 
In the upper atmosphere (stratosphere) it reacts with chlorine nitrate, which releases 
ozone-destroying chlorine atoms upon reaction with hydrogen chloride (Omarsal and 
Ganton, 1997).
Nitrogen dioxide is relatively insoluble and is likely to deposit in the mucous 
membrane of the lower respiratory tract. The upper airways are less affected because 
nitrogen dioxide is not very soluble in aqueous surfaces. It has been associated with 
increased respiratory morbidity (e.g. asthma exacerbation and reduced lung function and 
rate of lung growth in children). Short-term exposure to nitrogen dioxide is associated 
with increased daily mortality and hospital admissions from respiratory and 
cardiovascular disease. Nitrogen dioxide, also an oxidant, has elicited inflammatory 
responses at levels as low as 1 mg/m in clinical experiments and increased 
responsiveness to ozone and certain allergens, although other studies have reported 
considerably variable responsiveness to nitrogen dioxide (HEI, 2004).
• Ozone (0^)
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Ozone is a colourless gas that occurs in two separate layers of the atmosphere. 
Ozone in the outer layer of the atmosphere (stratosphere) is generated by photolysis of 
oxygen or naturally occurring hydrocarbon, and protects the earth from ultra-violet rays. 
In the lower layer (troposphere), ground-level ozone is formed by the reaction of its 
precursor gases, volatile organic compounds and nitrogen oxides, with ambient oxygen 
in the presence of sunlight and high temperatures. Ground-level ozone is a major 
constituent of smog in urban areas (Omarsal and Ganton, 1997). Nitrogen oxides and 
volatile organic compounds, the main ozone precursors, are both emitted from industrial 
facilities and motor vehicles, the latter being the main anthropogenic emission source. 
Thermal inversions increase ground-level ozone concentrations.
Adverse health effects of ozone have been observed for exposure periods as 
short as five minutes. Ozone has been associated with transient effects on the human 
respiratory system; the most significant is decreased pulmonary function in individuals 
taking light to heavy exercise -  changes in pulmonary function have been reported for 
one- to three-hour exposures during exercise. Epidemiologic studies have found 
evidence of increased numbers of asthma attacks and hospitalisations related to 
increases in ambient ozone levels. Ozone may also increase the lung’s reaction to 
allergens and other pollutants, and cause severe damage to lung tissues and impair 
defences against bacteria and viruses (Omarsal and Ganton, 1997). Although some 
recent studies have found associations of daily increases in ozone with increased 
mortality, evidence that long-term exposure to ozone causes chronic health effects is 
limited. Some evidence suggests that the lung may develop tolerance to ozone after 
repeated short-term exposures (HEI, 2004). It can also irritate the eyes, nose and throat, 
causing breathing difficulties, and provoke thoracic pain, increased mucous production, 
chest tightness and nausea.
• Lead (heavy metals)
Lead is a non-ferrous metal that has a large number of industrial applications 
such as the manufacture of batteries, paints, tank lining and tank piping. Motor vehicles 
fuelled with leaded gasoline are the main source of lead in ambient air. According to 
Omarsal and Ganton (1997), tetraethyl lead is added to gasoline to increase the fuel’s 
octane number, which improves the antiknock characteristics of the fuel in spark- 
ignition engines. About 70 to 75 per cent of this lead is transformed into inorganic lead
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in vehicles’ engines upon combustion and emitted to the atmosphere through the 
exhaust pipe along with 1 percent of the organic lead that passes through the engine 
unchanged. The rest of the lead remains trapped within the exhaust system. Organic 
lead emissions usually occur as vapour, while inorganic lead is emitted as particulate 
matter, often less than 1 pm in size.
The main health effects of lead exposure have been observed in children, women 
of reproductive age, and male adults. Newborns and children younger than 6  years old 
are most vulnerable -  those with high levels of lead accumulated in their teeth 
experience lower intelligence quotients (IQ), short-term memory loss, reading and 
spelling underachievement, impairment of visual motor function, poor perception 
integration, disruptive classroom behaviour, and impaired reaction time (Omarsal and 
Ganton, 1997). Lead absorbed in the human body is distributed among bones, teeth, 
blood, and soft tissues. There is evidence that more lead is absorbed when dietary 
calcium intake is low, in cases of iron deficiency or diets with low levels of vitamin D 
and zinc. The amount of lead absorbed by the body increases significantly when the 
stomach is empty, and the rate of absorption is higher for children than for adults, which 
means that poor, malnourished children are even more susceptible to lead poisoning 
than other individuals (Kojima and Lovei, 2001).
2.2. The different types of epidemiologic studies
There are different sources of information about the health impacts of air 
pollutants. According to WHO (2003), the main sources are observational 
epidemiology, controlled human exposures to pollutants, animal toxicology, and in vitro 
mechanistic studies, each of them associated with strengths and weaknesses. 
Epidemiologic studies generally deal with the full spectrum of susceptibility in human 
populations (e.g. children, the elderly, and individuals with pre-existing diseases), and 
exposure occurs under real life conditions, which avoids extrapolation across species 
and different levels of exposure. These arguments seem to suggest that epidemiologic 
studies are the appropriate research method to investigate associations between air 
pollution exposure and different human health outcomes. “However, the exposures are 
complex in epidemiologic studies, unless it is a study in the workplace, inevitably 
includes mixtures of gases and particles” (WHO, 2003).
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Epidemiologic research in general focuses on the time or space dimensions of 
concentrations of outdoor air pollution, but usually not both within the same population. 
HEI (2004) argues that short-term temporal variation (over days and weeks) in air 
pollution concentrations has been used to estimate effects of daily morbidity and 
mortality, while spatial variation in long-term mean concentrations of air pollution has 
been the basis for cross-sectional and cohort studies of long-term exposure. Peters and 
Pope (2002) state that since the late 1980s, over 150 epidemiologic studies using 
advanced time-series statistical modelling and related techniques have reported 
associations between daily changes in particulate air pollution and daily changes in 
respiratory and cardiovascular mortality, hospitalisations, and related health endpoints. 
In addition, prospective cohort studies have reported that long-term exposure to fine 
particulate air pollution may have impacts on cardiopulmonary mortality.
This section aims to review the different types of study design that 
epidemiologists have been using to investigate the potential impacts of air pollution 
exposure on human health. Again, it is based on a number of similar works found in the 
literature.
• Time series studies
Time-series studies have been conducted to analyse daily rates of health events 
such as hospital admissions or deaths in one or more areas in relation to daily 
concentrations of air pollutants and other risk factors that vary over months or years 
(HEI, 2004). Daily time-series analysis is commonly used to evaluate short-term effects 
of air pollution on different health outcomes. Episodes in which levels of air pollution 
increased to high levels and remained elevated for some period provided some of the 
earliest epidemiologic evidence of the health effects of short-term exposure to air 
pollution (e.g. Schwartz and Dockery, 1992a and 1992b).
The associations between daily health outcomes and daily concentrations of air 
pollutants is investigated using regression techniques to estimate a coefficient that 
represents the relation between exposure to pollution and the health outcome. The most 
usual regression method found in the literature models the logarithm of the health 
outcome to estimate the relative risk, that is, the proportional change in the health 
outcome per increment of ambient pollutant concentration. In general, analysts assume 
that daily health outcomes -  and mainly deaths -  follow a Poisson distribution, since
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these are considered rare events in proportion to the population investigated. Indeed, 
HEI (2004) states that the primary statistical approach in time-series studies has been 
formal modelling of count data using a Poisson regression model. If the health outcome 
may be influenced by seasonal changes, weather, air pollution, or other variables, then 
the Poisson process will be non-stationary, that is, the underlying expected mean 
outcome count will change over time depending on these variables. HEI (2004) 
concludes that Poisson regression modelling provides a formal way to evaluate possible 
associations between daily health outcomes, especially mortality, and daily 
concentrations of air pollution while controlling for other variables.
One positive characteristic of time-series studies is that individual cofactors such 
as smoking habit, diet, and genetic characteristics are unlikely to be confounders 
because they are not generally associated day to day with daily concentrations of air 
pollution. In fact, “such an approach is quite sensitive in detecting acute effects of air 
pollution on health, as the corresponding estimates are less affected by confounding 
variables that may be present when data obtained during large periods of time are 
aggregated” (Conceicao et al., 2001). Recent work indicates that the magnitude of the 
relative risk estimates from time-series studies of daily mortality depend on the 
approach used to model both the temporal pattern of exposure and potential confounders 
that vary with time such as season and weather (HEI, 2004). In order to control for 
season and various potential time-dependent confounders, time-series studies of daily 
mortality eliminate the long-term temporal variability of exposure by using analytic 
approaches, such as filtering data or non-parametrically smoothing time (HEI, 2003).
Studies that use uniform methods for assembling and analysing data from 
multiple cities -  multi-city studies -  have also attempted to explain the differences 
among cities in relative risks associated with exposure to air pollution. For example, 
analysts found that the relative mortality risk of particulate matter was greater in cities 
with higher annual mean concentrations of nitrogen dioxide or PM io. Large multi-city 
studies also have the statistical power to explore more precisely the shape of the air 
pollution concentration-response function, the timing of effects related to air pollution, 
and the extent of life shortening (harvesting) due to air pollution (HEI, 2004). Study 
designs other than the time series have also been used to study acute health effects of 
short-term exposure to air pollution, such as panel studies and case-crossover studies.
• Panel studies
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HEI (2004) defines panel studies as those studies where small groups (or panels) 
of individuals are followed over short time intervals, during which health outcomes, 
exposure to air pollution, and potential confounders are obtained for each subject on one 
or more occasions. Panel studies have generally reported that exposure to outdoor air 
pollution is associated with increased upper and lower respiratory symptoms and 
increased rates of asthma attacks.
• Case-crossover studies
Case-crossover study design is characterised by the comparison of exposures of 
each case of health outcome in the study population among different periods near the 
time of the health outcome -  case period -  and one or more periods during which the 
health outcome did not occur -  control periods. The relative risk is then estimated using 
methods for matched case-control studies, a common epidemiologic design. Ideally, 
control periods are chosen so that there is no need to statistically adjust for factors such 
as seasonality, and long-term time trends in mortality. Although case-crossover studies 
of air pollution are few, they seem to provide results comparable to those of standard 
time-series analysis (HEI, 2004).
• Randomised (controlled) clinical trial
Randomised clinical trial design involves random assignment of the treatment of 
interest between control and experimental groups of the population. It has been applied 
at the community level to assess the impact of health interventions such as tobacco 
control programs. Because randomisation leads to statistical comparability of treatment 
and control groups, a key strength of the randomised clinical trial is the strength of its 
evidence in causal inference. The randomised clinical trial provides convincing 
evidence for causality and accountability for comparisons for which validity is protected 
by the randomisation of treatment. Such experiments are considered the gold standard in 
biomedical research if they have sufficiently large samples, highly structured protocols, 
and limited variation in participation and treatments (HEI, 2003).
According to HEI (2003), even when the mechanism of action is unknown and 
potential confounders are not measured, causality can be inferred because 
randomisation increases the probability that treated and comparison groups have 
comparable distributions of potential confounders. However, selection bias and lack of
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follow up can degrade the protection afforded by randomisation and increase 
vulnerability to biases that affect purely observational studies, particularly if the bias is 
dependent on exposure and susceptibility to the health outcome. The authors conclude 
that randomised interventions for ambient air pollution exposures at the population level 
are in general not possible. Studies of people moving to areas of higher or lower 
pollution, cohort studies, and time-series studies have only some required features. 
However, randomised studies in clinical and laboratory settings can be informative 
(HEI, 2003).
• Cohort studies
In parallel with time-series studies, which focus on the short-term health impacts 
of pollutants, prospective cohort studies investigate the long-term effects of exposure to 
air pollution. According to HEI (2004), cohort studies take advantage of spatial 
variation in air pollution concentrations to compare incidence of disease and death in 
populations exposed over the long term to differing levels of air pollution. By following 
large populations for many years, cohort studies estimate both numbers of deaths and, 
more importantly, mean reductions in life span attributable to air pollution. According 
to Maynard (2004), some prospective cohort studies show that inhabiting a relatively 
polluted area for a prolonged period of time leads to a shortening of life expectancy. 
Two approaches have been taken to represent this health effect: (i) estimating the 
number of non-expected deaths occurring by a given date in a population; or (ii) 
estimating the total loss of life expectancy by a population that eventually dies.
Cohort studies use regression analyses that adjust for the long-term effects of 
potential confounders, such as cigarette smoking, occupation, and prior medical history. 
However, measuring actual health benefits over the long term is a challenge. For 
example, pollution reductions are likely to be accomplished in small increments over a 
long time, and other factors affecting health (e.g. medical care) are likely to change over 
the same time frame (HEI, 2003).
2.3. Evidence of health impacts of air pollution
A number of health effects have been associated with different air pollutants in 
the epidemiologic literature. For example, air pollution can worsen the condition of 
those with heart or lung diseases, and can aggravate asthma. In addition, air pollution is
31
associated with a reduction in life expectancy, although the extent of this association is 
not fully known (COMEAP, 2001). It is understood that the severity of the effect on 
health is dependent on the concentration of the pollutants, the period of exposure to air 
pollutants and the health status of the exposed population (among other possible things). 
Epidemiologic studies associating air pollution with different health outcomes in the US 
and Europe have been developed since the air pollution disasters that happened in 
London in 1952, the Meuse valley in 1930 and Pennsylvania in 1948. These suggested 
that extremely high levels of particulate-based smog could produce increases in the 
daily mortality rate (Schwartz, 1994). To mention just a few examples relating 
particulate matter levels and mortality, Schwartz and Dockery (1992a; 1992b), Dockery 
and Pope (1993), and Pope et al. (1995) found a strong correlation between ambient 
particulate matter concentration and daily mortality in different North-American cities. 
Several other similar studies were undertaken in different regions worldwide and are 
summarised elsewhere (e.g. HEI, 2004; WHO, 2003), but there is still no evidence of a 
threshold level, beyond which no health effect is observed in humans (WHO, 2003). 
This section aims to review the epidemiologic literature that establishes the association 
between different health effects and the concentration of air pollutants, focusing on 
recent studies discussing relevant issues in the debate regarding air pollution and 
mortality events, such as harvesting2, potential confounders and possible mortality 
pathways.
Pope et al. (2004) analysed patterns of associations between particulate matter 
with specific causes of death that might provide guidance toward understanding general 
pathophysiological pathways linking particulate matter (PM2.5) and mortality. The 
authors argued that although epidemiologic observations provide compelling evidence 
of a link between particulate matter and cardiopulmonary morbidity and mortality, the 
understanding of the underlying biological mechanisms remains limited. Expected 
patterns of particulate matter mortality associations for specific causes of 
cardiopulmonary deaths were determined based on three hypothesised general 
pathophysiological pathways. The pathways assumed were (a) accelerated progression 
of chronic obstructive pulmonary disease (COPD); (b) inflammation/accelerated
2 The harvesting hypothesis refers to the death o f those individuals who were likely to die anyway in a 
short period o f time. “This could occur if air pollution hastened the deaths o f  persons who were extremely 
frail. I f  air pollution did not simultaneously increase the number o f  people who become frail, the size o f 
the frail pool would decrease after an air pollution episode. On subsequent days, a smaller frail pool 
would result in a reduction in daily deaths” (Zanobetti et a l ,  2003).
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arteriosclerosis; and (c) altered cardiac autonomic function. Specific causes of death 
included all cardiovascular diseases, ischemic heart disease, dysrhythmias, heart failure, 
cardiac arrest, hypertensive disease, other arteriosclerosis, aortic aneurysms, 
cerebrovascular disease, diabetes, all other cardiovascular diseases, diseases of the 
respiratory system, COPD and allied conditions, pneumonia and influenza, and all other 
respiratory diseases.
In order to test the hypothesised association pathway, Pope et a l (2004) 
analysed mortality data collected by the American Cancer Society (ACS) as part of the 
Cancer Prevention Study II (CPS-II), an ongoing prospective mortality study of 
approximately 1.2 million American adults interviewed since 1982. Participants 
completed a confidential questionnaire including questions about age, sex, weight, 
height, smoking history, alcohol use, occupational exposures, diet, education, marital 
status, and other characteristics. Reported deaths were verified with deaths certificates. 
The analysis was restricted to those participants who resided in U.S. metropolitan areas 
with available pollution data, resulting in three cohorts ranging from 319,000 to 500,000 
individuals according to three different levels of exposure.
Pope et al. (2004) estimated adjusted mortality relative-risk ratios using the 
standard Cox proportional hazards regression model, an approach that has been used in 
previous studies of pollution-related mortality. The models controlled for available 
individual co-risk factors. To control for age, sex, and race, the models were stratified 
by one-year age categories, sex and race, allowing each category to have its own 
baseline hazard. Both indicator and continuous variables were used to control for 
tobacco smoking, while indicator variables were used to represent drinking habits, 
education and occupational exposure to asbestos, chemicals, coal or stone dust, diesel 
engine exhaust, and formaldehyde. Models were estimated for each of the death cause 
categories using each of the particulate matter indices, and in stratified analysis of 
smokers, former smokers, and “never smokers”.
The authors found robust associations between PM2.5 and overall cardiovascular 
disease mortality. Predominant particulate matter mortality associations were with 
ischemic heart disease, but statistically significant associations were also observed with 
dysrhythmias, heart failure, and cardiac arrest. Statistically significant, positive 
associations were not consistently observed for other cardiovascular deaths or for 
respiratory disease deaths. COPD and related deaths were negatively associated with 
fine particulate air pollution exposure. Cigarette smoking was associated with far larger
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excess risks for both cardiovascular and respiratory disease mortality than air pollution. 
For example, for “never smokers”, the particulate matter mortality association with 
pneumonia and influenza was positive and statistically significant.
Pope et al. (2004) concluded that, first, although previous studies have observed 
that elevated exposures to particulate matter are associated with measures of lung 
function and prevalence of symptoms of obstructive airway disease, the pattern of 
particulate matter mortality associations analysed did not fit the a priori pattern 
presented for the accelerated progression of COPD hypothesis. Second, given the robust 
particulate matter association with ischemic heart disease, the empirical pattern of 
particulate matter mortality association is more consistent with the inflammation/ 
accelerated arteriosclerosis hypothesis. Third, the association between particulate matter 
and death attributable to dysrhythmias, heart failure, and cardiac arrest supports the 
altered cardiac autonomic function hypothesis. However, the authors argue that the 
likelihood of multiple mechanistic pathways with complex interdependencies must be 
considered when interpreting these results.
As discussed in section 2.2, time-series studies in general analyse the mortality 
effect of air pollutants in the very short-run, within days of exposure, while cohort 
studies in general deal with long-term (chronic) effects of air pollution. Zanobetti et al. 
(2003) analysed the effects of PMio on an intermediate time scale, and the potential for 
short-term mortality displacement. They assessed if deaths associated with particulate 
air pollution are advanced by a few days or can be advanced for weeks. The authors 
argued that most studies reporting association between daily deaths and pollution 
concentrations analysed lags up to two days before, which is a common source of 
criticism of short-term time-series studies. Some researchers speculate that air pollution 
kills those who would have died in a few days anyway (harvesting). In fact, some 
studies analysed this issue using different methodologies, all of them reporting 
increased, rather than decreased, effects when longer lags were examined (e.g. 
Schwartz, 2001).
The authors analysed daily counts of “all-cause” mortality, cardiovascular 
disease mortality and respiratory mortality from 10 cities across Europe and adjacent 
countries. Mortality data from 1990 to 1997 was divided into age groups: 15-65; 65-74; 
and older than 75 years. Air pollution data (PMio) were available as daily averages of 
different monitoring stations in each city. The statistical analyses involved the use of
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generalised additive regression models (GAM3) fitted for each of the ten cities, for 
respiratory and heart mortality first, then for “all-cause” and stratified respiratory and 
cardiovascular deaths by age groups. All models controlled for temperature and relative 
humidity on the same and up to three previous days using non-parametric smooth 
functions. To remove seasonal and long-term fluctuations, Zanobetti et al. (2003) used a 
smooth function of time. Seasonal patterns are controlled because there are unmeasured 
predictors of death that have long-term trends over time and vary seasonally, creating a 
potential for confounding factors. The authors cite diet as an example of such seasonal 
effect, although they recognise that daily fluctuations in diet are unlikely to be 
correlated with air pollution. Finally, the dependence of daily deaths on PMio of the 
present day and up to forty preceding days was examined using an unconstrained 
distributed lag model and a fourth-degree polynomial distributed lag model.
The harvesting effect would be confirmed if air pollution were negatively 
associated with deaths several days to weeks afterwards. According to the authors, this 
association can provide insight if the pollution-related deaths were took forward by a 
few days or few weeks. An increase of 4.2% in respiratory deaths for a lO-pm/m 
increase in PMio concentration was found using the unconstrained distributed lag 
model, and similar results were found with the polynomial distributed lag models. In 
contrast, the mean of PMio on the same and previous day was associated with a 0.74% 
increase in respiratory mortality. The authors found a 1.97% increase in deaths from 
cardiovascular diseases using the unconstrained distributed lag model and similar results 
using the polynomial distributed lag models. The study showed that the effect size 
estimate for airborne particles doubles for cardiovascular deaths when the first forty 
days after exposure is observed, and increases five times for respiratory deaths. A 
different pattern of mortality risk over time was found for cardiovascular and respiratory 
deaths, with the elevation in risk of death after exposure declining more slowly over 
time for respiratory than cardiovascular deaths. The results suggest that the adverse 
response to pollution persists for a month or longer after exposure not only for total 
mortality but also for respiratory and cardiovascular mortality.
Schwartz (2001) developed an analytical framework for examining the 
harvesting hypothesis, testing if most of the particulate-related events are only being
3 In this model the mortality outcome is assumed to depend on the sum o f non-parametric smooth 
functions for each variable, allowing the analyst to better model the non-linear dependence o f daily deaths 
on weather and season (Zanobetti et al., 2003).
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advanced by a short period of time. It is claimed that if  particulate air pollution is only 
advancing the date of adverse events by few days than it is a less serious public health 
concern. The proposed approach, which localises the harvesting period in time and 
examines the association between daily health outcomes and air pollution outside that 
time scale, was applied to data on respirable particles (PM io) and daily mortality and 
daily hospital admissions for heart and lung disease in Chicago. An alternative approach 
to examine harvesting was also proposed, which included analysing separately deaths 
that occurred inside and outside of hospitals. Schwartz (2001) argued that if the deaths 
caused by particulate air pollution are primarily in very ill subjects who would die 
within a few days in any event, those subjects are more likely to die in the hospital than 
individuals whose condition was not critical and who might have well recovered. 
Looking at the relative impact of air pollution on deaths by location of death is 
supposed to be an indirect test of how much of the air pollution-related deaths are only 
being brought forward by a few days.
Daily death counts were obtained for years 1988 to 1993 for “all-cause” 
mortality inside and outside hospitals; daily counts of hospital admissions of individuals 
aged 65 or more for heart disease, pneumonia, and COPD were obtained, along with 
weather and air pollution data. Long-term trends and seasonal variations were filtered 
out of the data to avoid confounding by omitted factors, such as smoking habits or 
respiratory epidemics. These factors may have long-term trends or seasonal patterns that 
coincide with those of air pollution, but whose short-term fluctuations are unlikely to be 
correlated with air pollution (Schwartz, 2001). The statistical analysis involved 
regressing (G A M  models using loess smooth functions4 of the variables) the death 
counts or hospital admissions on PM io concentrations controlling for time trends, 
weekday effects, temperature and humidity. The author also used a seasonal and trend 
decomposition program to decompose the mortality and hospital admission data into 
different time scales. This method decomposes a single time series into a number of 
independent time series representing the daily fluctuations that is due to patterns with 
different time scales. To examine harvesting on different time scales, these seasonally 
detrended data were smoothed using different windows of 15, 30, 45, and 60 days,
4 Loess smoothing is a curve-fitting technique, which “estimates a smoothing function by fitting a 
weighted regression within a moving window, and the weights are close to one in the central third o f the 
window, declining rapidly to zero outside that range, allowing a more flexible control o f the variables in a 
given model” (Sharovsky et al., 2004).
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allowing the examination of the association between PMIO and health outcome net of 
progressively longer displacement of the events.
Schwartz (2001) concluded that the effect-size estimate for deaths outside of the 
hospital is larger than for deaths inside the hospital, which means that deaths in the 
hospital, where short-term harvesting is most likely, are less sensitive to air pollution 
than are deaths outside of the hospital. The result for hospital admissions showed no 
evidence that most of the effect is short-term harvesting. These results support the 
finding that when short-term rebound effects are averaged out, the effect size for 
particulate air pollution increases rather than decreases. Although these results indicate 
that the deaths and hospital admissions are on average being brought forward by a non­
trivial amount of time, they cannot specify what that time is.
Braga et al. (2000) investigated the potential confounding effect of respiratory 
epidemics in the association between air pollution and daily deaths. The authors argued 
that previous studies that controlled for influenza epidemics using an indicator (dummy) 
variable for epidemic periods did not provide a systematic analysis to assess whether a 
control for epidemics changes the air pollution association with mortality in a 
meaningful way, and did not adequately control for respiratory epidemics. Influenza is 
not the only pathogen that can produce pneumonia, which suggests that controlling for 
influenza outbreaks alone may miss some episodes. Braga et al. (2000) proposed to 
model the rise and fall of each respiratory epidemic separately, including those not due 
to influenza, and check if this changed the associations between air pollution and daily 
deaths.
Air pollution data were obtained for five U.S. cities with daily PMio monitoring, 
while “all-cause” mortality data and weather data were provided by official sources. For 
each city, a generalised additive Poisson regression was fitted, modelling the logarithm 
of the expected number of daily deaths as equal to the sum of the (loess) smooth 
functions of the covariates -  air pollution, temperature, dew point and barometric 
pressure on the same day, the previous day’s ambient temperature and the day of the 
week. In order to characterise epidemic periods, the authors used pneumonia hospital 
admission data for individuals aged 65 or older, including pneumonia caused by 
pathogens other than influenza and omitting influenza outbreaks that did not produce 
much life-threatening illness. An epidemic period was defined as the period of 10 days 
or more of epidemic days, which were defined as those days on which the 3-day moving 
average of pneumonia hospital admissions was above its 90 percentile.
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Braga et a l (2000) concluded that, overall, the estimated effect of PMio 
concentration was reduced by 8 % after controlling for respiratory epidemics, the 
decrease ranging from 3% in Minneapolis to 15% in Seattle. However, the authors 
argued that these decreases did not modify significantly the association previously 
observed between air pollution concentration and daily deaths, confirming the strength 
of the association and supporting causality in this relationship. The study showed that 
the association between air pollution and the number of daily deaths is robust enough to 
support controlling for respiratory epidemics, an issue that has been attracting attention 
among researchers.
Pope et al. (2002) assessed the relationship between long-term exposure to fine 
particulate air pollution and “all-cause”, lung cancer and cardiopulmonary mortality, 
using the same database described before -  the American Cancer Society prospective 
mortality study. The risk factor data for approximately 500,000 adults were linked with 
air pollution data for several metropolitan areas throughout the United States and 
combined with socio-economic data, health status, and cause of death data. The authors 
concluded that long-term exposure to combustion-related fine particulate air pollution is 
an important environmental risk factor for cardiopulmonary and lung cancer mortality.
"X • *Each 10-pm/m elevation in fine particulate air pollution was associated with 
approximately a 4%, 6 %, and 8% increased risk of “all-cause”, cardiopulmonary, and 
lung cancer mortality, respectively.
2.4. Evidence of health impacts of air pollution in Brazil
Epidemiologic studies in Brazil associating air pollution with different health 
outcomes have been widely developed since the mid nineties, although the literature 
records that similar studies had been developed since the early seventies (Ribeiro and 
Cardoso, 2003). Most of the studies were carried out in Sao Paulo since air pollution is 
more significant in that metropolis than any other city in Brazil. Furthermore, given its 
geographic characteristics, Sao Paulo is subject to frequent thermal inversions that can 
lead to a substantial accumulation of atmospheric pollution (Saldiva et a l, 1995). Some 
studies have related air pollution in Sao Paulo to different morbidity outcomes, for 
example, emergency room visits due to chronic lower respiratory diseases in the elderly 
(Martins et a l, 2002), respiratory symptoms in children aged 11 to 13 years of age 
(Ribeiro and Cardoso, 2003), ischemic cardiovascular emergency room visits (Lin et a l ,
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2003) and hospital admissions due to respiratory diseases in children (Gouveia and 
Fletcher, 2000a). Also, Braga et a l (1999; 2001) and Lin et a l (1999) found a strong 
association between air pollution and hospital admissions due to respiratory problems 
for children and adolescents aged 13 years or younger. However, throughout this section 
attention will be given specifically to the studies relating air pollution in Sao Paulo to 
mortality effects.
Saldiva et a l (1995) analysed the relationship between the daily mortality of 
elderly people and air pollution in the metropolitan area of Sao Paulo during 1990-1991. 
Data were obtained with the Municipal Government Obituary -  daily records of deaths 
from natural causes of individuals aged 65 or more that lived within the metropolitan 
area -  and the State Environment Agency -  daily measures of relative humidity, daily 
low temperature, and daily concentrations of sulphur dioxide (measured by coulometry), 
carbon monoxide (measured by non-dispersive infrared), PMio (measured by beta 
gauge), ozone (measured by chemiluminescence). The concentrations of the pollutants 
were estimated as the twenty-four-hour average of available measurements from the ten 
most centrally located monitoring stations, out of twelve stations distributed in the city 
of Sao Paulo.
The authors used time series regression models to estimate the association 
between daily mortality and air pollution, controlling for season (month of year and day 
of week), weather (e.g. temperature and relative humidity), and other factors. Gaussian 
regression models were used for the basic analysis, although daily mortality counts are 
in general modelled with the Poisson distribution5. The authors claimed that this 
procedure was possible given the sufficiently large mean daily mortality observed in 
Sao Paulo. Models were estimated using lagged moving averages of the air pollution 
concentrations, and re-estimated observing first-order autocorrelation of the residuals. 
Measures of individual air pollutants were included in the models altogether and 
separately. The authors tried various approaches to evaluate the sensitivity of the results 
to model specification, outliers, or potential confounding of temporal, seasonal, or 
weather-related factors.
Mortality was associated with suspended particles (PM io), nitrogen oxides, 
sulphur dioxide, and carbon monoxide. According to the authors, the association with 
PMio was the most statistically significant, robust and independent of the other
5 Daily mortality data are in general a count o f very rare events, which can be modelled as a Poisson 
process.
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pollutants. An increase in PMio equal to 100 pg/m3 was associated with an increase in 
overall mortality equal to approximately 13%. The authors argued that this association 
was consistent across different model specifications and estimation techniques 
(Gaussian and Poisson models). Another conclusion of the study was that the dose- 
response relationship between mortality and respirable particulate pollution was almost 
linear, with no evidence of a safe threshold level. Poisson regression techniques showed 
that the relative risk of mortality for a 100mg/m3 increase in PM io was equal to 1.13 
(1.07-1.18 -  95%CI). Saldiva et a l (1995) concluded that the close interdependence 
among the levels of pollutants, mainly PM io, nitrogen oxides and sulphur dioxide, 
suggests that some caution has to be taken when excluding the participation of any 
specific pollutants in the process of mortality. Nevertheless, multiple regression models 
including the mentioned pollutants simultaneously attributed the association with 
mortality to PM io.
Gouveia and Fletcher (2000b) investigated the association between outdoor air 
pollution and “all-cause”, respiratory and cardiovascular mortality in Sao Paulo, and 
analysed the role of age and socio-economic status in modifying the association 
between air pollution and mortality. Daily mortality for age groups was explored during 
1991 to 1993, but with an emphasis on children under five years and the elderly. The 
study was conducted in the city of Sao Paulo instead of the whole metropolitan area 
surrounding the municipality of Sao Paulo.
According to the authors, data on mortality were provided by the city’s mortality 
information system -  PRO-AIM - , which is based on death certificates and assigned by 
medically qualified personnel to ensure high quality data. Socio-economic data were 
obtained from the 1991 census. Five socio-economic variables were used to generate a 
composite index of socio-economic status for each of the 58 administrative districts of 
Sao Paulo. For each of the socio-economic variables a value was assigned from zero to 
one in a comparative analysis -  from the worst conditions to the best conditions. The 
composite index was estimated as the mean of these five values for each district. The 
socio-economic conditions of each subject were characterised based on their district of 
residence. The local environmental agency -  CETESB -  provided daily levels of 
sulphur dioxide measured by colorimetry, PMio measured by a gauge aerosol method, 
carbon oxide measured by non-dispersive infrared, and ozone and nitrogen dioxide 
measured by chemoluminescence. For each pollutant, daily levels were calculated by 
averaging all available data across all monitoring stations in the city of Sao Paulo. The
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University of Sao Paulo provided daily data on meteorological variables -  temperature, 
humidity, atmospheric pressure, rainfall, wind speed and direction.
Gouveia and Fletcher (2000b) used Poisson regression models to investigate the 
association between air pollution and mortality, adjusting for potential confounding 
factors, initially allowing for longer-term patterns in the data (time trend), then for 
seasonal and cyclical variations, for short-term systematic (calendar effects) and non- 
systematic (meteorological) effects. To model the temperature effect, the authors 
produced correlation functions to characterise at which delay the effect of temperature 
was greatest on each health outcome. After identifying the best lags, the authors plotted 
the residuals of the outcomes against the measures of daily temperature at the chosen 
lags to help determine the shape of the exposure-response relation. Functions with 
different shapes were tested, including linear, quadratic, two-piece linear, three-piece 
linear, and non-linear. The effect of each pollutant was investigated on the same day and 
lagged by one and two days as these were the lags commonly used in similar studies in 
the literature. Poisson regressions were used to estimate the coefficients of the air 
pollution variables for different mortality outcomes and age groups. The authors 
estimated relative risks of death in relation to a change from the 10th to the 90th 
percentile in levels of each air pollutant.
The authors concluded that “all-cause” “all-age” mortality showed smaller 
associations with air pollution than mortality for specific causes and age groups. For 
example, a 3-4% increase in daily deaths of elderly people for all causes and for 
cardiovascular diseases was associated with an increase in fine particulate matter and 
sulphur dioxide. For respiratory deaths the increase in mortality was higher -  6 % -  
while cardiovascular deaths were also associated with levels of carbon monoxide, 
representing a 4% increase in daily deaths. Other conclusions involve associations 
between air pollutants and mortality in children under 5 years old, which were not 
statistically significant, and the significant increase in risk of death according to age 
with effects being more evident in individuals older than 65. Gouveia and Fletcher 
(2 0 0 0 b) concluded that older age groups seem to be at a higher risk of mortality 
associated with air pollution in Sao Paulo.
Conceicao et a l (2001) evaluated the association between child mortality and air 
pollution in the city of Sao Paulo from January 1994 to December 1997. Daily records 
of mortality in children under 5 years of age were obtained from the municipality 
information programme (PRO-AIM). Pollution data were obtained from the records of
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eleven monitoring stations of the state agency (CETESB), and weather data (humidity 
and temperature) were provided by the Institute of Astronomy and Geophysics of the 
University of Sao Paulo. The authors used generalised additive models in the statistical 
analysis. According to the authors, such models consider non-parametric smooth 
functions of the explanatory variables, a Poisson distribution, and a log link. Several 
models for different sets of explanatory variables were used to evaluate the sensitivity 
of the pollutant concentration coefficients. The results suggest a significant association 
between respiratory mortality in children and daily levels of carbon oxide, sulphur 
dioxide, and PMio in Sao Paulo. The associations with these pollutants were significant 
even after terms for seasonal variation and weather were included or autocorrelation 
was considered. This conclusion was coherent with previous child mortality data 
(Saldiva et al., 1994), and indicates that air pollution in Sao Paulo represents a serious 
threat to children’s health.
Sharovsky et al. (2004) analysed the independent effects of environmental 
variables on daily counts of death from myocardial infarction in Sao Paulo, where 
12,007 fatal events were observed from 1996 to 1998. According to the authors, 
exposure to cold temperatures can increase blood pressure, sympathetic nervous 
activity, and platelet aggregation in humans, while pollution levels are associated with 
changes in blood viscosity, heart rate variability, ischemic threshold, and occurrence of 
life-threatening arrhythmias. All these symptoms are associated with myocardial 
infarction.
The authors used the Poisson regression in a generalised additive model (GAM) 
to investigate associations between weather (temperature, humidity, and barometric 
pressure), air pollution (sulphur dioxide, carbon monoxide, and PM io), and the daily 
death counts attributed to myocardial infarction. Mortality data were obtained from 
death certificates provided by the municipal obituary registry and listing myocardial 
infarction as a primary cause. Daily mean concentration of sulphur dioxide (pg/m3), 
measured by coulometry, carbon oxide (ppm), measured by non-dispersive infrared, and 
PMio (pg/m ), measured with a beta gauge, were provided by CETESB. A loess smooth 
function was included in the GAM model to control for non-linearity in the dependence 
of mortality on seasonal trend and temperature. An alternative model was used 
including ten categories (deciles) for daily temperatures, instead of loess smoothing 
functions. Similar procedures involved the use of quintiles of relative humidity and 
sulphur dioxide.
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Sharovsky et a l (2004) concluded that there is a significant association of daily 
temperature with deaths due to myocardial infarction, with the lowest mortality being 
observed at temperatures between 21.6 and 22.6 Celsius. Sulphur dioxide 
concentrations correlated linearly with myocardial infarction deaths, increasing the 
number of fatal events by 3.4% for each 10-pg/m3 increase. Carbon monoxide and 
particulate matter did not have significant effects on mortality either individually or 
when analysed with sulphur dioxide in the final model. The authors argued that their 
study provides evidence of important associations between daily temperature, air 
pollution and mortality from myocardial infarction in Sao Paulo, even after a 
comprehensive control for confounding factors.
Lin et a l , (2004) assessed the impact of daily changes in air pollutants (nitrogen 
dioxide, sulphur dioxide, carbon oxide, ozone, and PM io) on total number of daily
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neonatal deaths (those that occur between the first and the 28 days of life) in Sao 
Paulo, from January 1998 to December 2000. The study used pollutant levels obtained 
at various stations, and the daily averages were considered to be indicative of the 
pollution level in the whole city. Information on daily minimum temperature and 
relative humidity was also obtained. Statistical modelling was done using Poisson 
regression techniques in generalized additive models, using a locally weighted 
smoothing process to control for time (long-term trend), temperature, humidity, and 
days of the week. Autoregressive terms were included in the models when the analysis 
of the autocorrelation plots indicated the necessity of minimising the autocorrelation of 
the residuals. The effect of air pollutants was estimated using the air pollutant levels on 
the concurrent day and moving averages from two to seven days in single-pollutant 
models. Pollutants that presented a positive and statistically significant association with 
the outcome in single-pollutant models were analysed together -  an index of air 
pollution was created with the pollutants included in the co-pollutant models. The 
authors concluded that primary pollutants correlated strongly with each other and PMio 
presented the highest correlations. Ozone presented a negative correlation with carbon 
monoxide but low and positive correlations with the other primary pollutants. Humidity 
was correlated inversely with all pollutants, while, as expected, minimum temperature 
was negatively correlated with primary pollutants but not with ozone. The study 
reported adverse health effects attributed to the exposure to the air pollutants such as 
increases in neonatal deaths, which are events correlated with perinatal assistance more
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than with environmental factors in Brazil. PMio and sulphur dioxide were found to have 
consistent associations with daily neonatal deaths in a short time lag.
Martins et al. (2004) evaluated if the effects of PMio on respiratory mortality of 
elderly people in Sao Paulo are linked with socio-economic status. The authors 
undertook a time-series study using data from January 1997 to December 1999. The 
daily number of elderly respiratory deaths was modelled in generalised linear Poisson 
regression models controlling for long-term trend, weather, and day of the week, in six 
different regions of Sao Paulo City. Three socio-economic indicators were used: college 
education, monthly income, and housing. Martins et al. (2004) concluded that for a 10- 
pg/m increase in PM io, the percentage increase in respiratory mortality varied from 
1.4% to 14.2%. The overall percentage increase in the six regions was 5.4%. The effect 
of PM io was negatively correlated with both the percentage of people with college 
education, and with those on a high family income. It was positively associated with the 
percentage of people living in slums. “These results suggest that socio-economic 
deprivation represents an effect modifier of the association between air pollution and 
respiratory deaths” (Martins et al., 2004).
2.5. Conclusions
The adverse health effects of air pollution seem to be widely accepted among 
researchers nowadays. A number of studies have been developed in the past twenty 
years suggesting that short-term and long-term exposure to different levels of several air 
pollutants can be associated with various morbidity effects and mortality. This chapter 
described the main air pollutants associated with adverse health effects to humans, their 
characterisations and potential emission sources. In addition, a summary of the different 
methodologies commonly used in the epidemiologic literature was presented, describing 
their main features, strength and weaknesses. Finally, a review of the main issues 
discussed in the international epidemiologic research community was introduced, as 
well as the recent studies developed in Brazil, especially in Sao Paulo, associating air 
pollution with mortality trends.
44
3. Justification of approach and theoretical literature review
This chapter explores the different perspectives to establish appropriate 
economic values for changes in risks of death. It begins with a description of the 
approaches that economists use to value changes in risks of human death and, therefore, 
to estimate the value of a statistical life (VSL). The human capital approach is reviewed 
in terms of its characteristics and weaknesses. The willingness-to-pay (WTP) approach 
is then discussed and some of its empirical variations are presented, like the averting 
behaviour method, the ‘compensating-wage’ method, the hedonic property value 
method and the contingent valuation method (CVM or CV). Finally, the adequacy of the 
willingness-to-pay approach and the contingent valuation method for the purposes of 
this research are discussed.
In section 3.2 a literature review of economic models is conducted in order to 
provide the theoretical basis for the willingness-to-pay measures for reduced 
contemporaneous risks of death, as well as the willingness to pay to reduce future risks. 
The life-cycle consumption-saving model with uncertain lifetime, the general life-cycle 
model of consumption, and the Cropper-Sussman model are described and analysed. 
Finally, some conclusions are presented.
3.1. Different approaches to estimate the value of mortality risk reductions
The purpose of estimating the value of a statistical life is to provide the basis for 
policy-making involving social decisions. The value of a statistical life is a convenient 
metric for evaluating policies that reduce risk of death and is represented as the total 
willingness to pay for the policy that results in one less death in the population. 
Johansson (1995) defines the value of a statistical life as the aggregate willingness to 
pay for a measure saving a number of lives divided by the number of lives saved. The 
appropriate measure of the value of a statistical life from the point of view of 
government policy is society’s willingness to pay for the risk reduction. It is expected 
that the value of a statistical life may vary with the type of the risk involved in the 
analysis -  if voluntary or involuntary, the initial risk level, the size of the risk change, 
age and income (e.g. Freeman, 2003 and US EPA, 2000).
Willingness to pay (WTP) in the context of risks to life is defined as “the 
breakeven payment, per unit reduction in the probability of death, that leaves an
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individual’s overall expected utility unchanged” (Shepard and Zeckhauser, 1982). In a 
more general context, the willingness to pay for a specific good or service is the sum of 
the amounts of money individuals spend on the good or service plus the consumer 
surplus measure associated with the consumption of this good or service. The consumer 
surplus concept, as introduced by Marshall (1920), is measured as an area to the left of 
an ordinary or Marshallian demand curve and above the actual price paid by the 
consumer. The Hicksian or income-compensated consumer surplus is measured as an 
area to the left o f a compensated or Hicksian demand curve, where the individual is held 
at a certain level of utility through adjustments in his or her income6.
Researchers have identified two alternative general approaches for valuing the 
benefits of lifesaving activities, including those associated with environmental 
programmes: the Human Capital approach and the Willingness-to-Pay approach 
(Cropper and Freeman, 1991; Shepard and Zeckhauser, 1982; Berger et a l 1994; 
Johansson, 1995). The first approach, based on human capital, estimates the economic 
productivity of the individual whose life is at risk. It uses an individual’s discounted 
lifetime earnings as its measure of value, assigning valuations in direct proportion to 
income. The willingness-to-pay approach assumes that the preferences of individuals 
can be characterised by substitutability between income and safety, that is, individuals 
make trade-offs between consumption of goods or services and factors that increase the 
consumer’s safety. These trade-offs reveal the values individuals place on their safety or 
on the reduction on the risks of death.
3.1.1. The human capital approach
The human capital measure is based on the assumption that the value of an 
individual alive is what this individual produces, and his or her earnings accurately 
measure that productivity. Alternatively, this approach assumes that the cost to society 
of a human death is the impact that such death has on national income or output, so that 
the value of a statistical life is measured in terms of its contribution to national income. 
This means that the value of preventing someone’s death is equal to the gain in the
6 Freeman (2003), chapter 3, provides a discussion on how the Marshallian consumer surplus compares 
with the Hicksian welfare measures, such as the compensating variation (CV) -  the compensating 
payment necessary to make the individual indifferent between the original situation and the new price set 
-  and the equivalent variation (EV) -  the change in income (given the original prices) that would lead to 
the same utility change as the change in prices. The CV measure defines the WTP in case o f price 
decrease, and the willingness to accept (WTA) otherwise. Similarly, EV defines a WTA measure for a 
price decrease and WTP in case o f price increase.
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present value of his or her future earnings. According to Kuchler and Golan (1999), the 
use of forgone earnings to measure the value of health and life depends on two 
assertions; that changes in health status are reflected in earnings and that national 
income is a reasonable measure of social welfare.
Freeman (2003) formalised the human capital approach and discussed its 
implementation, although the author clearly stated that this approach is inappropriate for 
valuing reductions in the risk of death. According to the author, the value of preventing 
the death of an individual of age (t) is the discounted present value of that individual’s 
earnings over his or her remainder expected life:
Value (1)
m (1 + r)‘
where:
7Ct+t is the probability of the individual surviving from age (/) to age (t+i);
E t+i are the expected earnings at age (t+i);
r represents the discount rate;
T is the age at retirement from the labour force.
The human capital approach has the appeal of being easy to use, but some
ethical issues make it debatable, with several other issues arising when implementing
this simple approach to value an individual’s risks of death. The most important 
concerns the choice of a discount rate to calculate the present value of an individual’s 
future earnings. The human capital value of young people would be particularly 
sensitive to the discount rate utilised. Because of discounting and the time lag before 
children become productive participants in the labour market, the human capital 
approach places a much lower value on saving children’s lives compared with saving 
the lives of adults who are in the labour force. Furthermore, all the differences in the 
labour market structure are reflected in the human capital approach: because of earning 
differences among individuals of different gender and race, the human capital approach 
values saving the lives of women and non-whites less than saving the lives of adult 
white males. Also, this approach assigns no value to retired or totally disabled people’s 
lives.
Cropper and Freeman (1991) provide some criticism of the human capital 
approach as provider of an approximation for the willingness-to-pay measures for small 
reductions in risk of death. The first comment concerns the role of non-market
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production in the measure of productivity, like homemakers and housekeepers. Even 
when adjustments are made for home production, the method tends to favour males over 
females, workers over retirees, and higher-paid over lower paid people. The second 
issue relates to the inclusion (or not) of individuals’ own consumption on the measure of 
his or her productivity. The authors argue that excluding individuals’ consumption 
leaves a measure of the individual’s worth, as a producing asset to the rest of society, 
but this measure is the antithesis of the individualistic premise of conventional welfare 
economics. Cropper and Freeman (1991) argue that the most important criticism of the 
human capital approach is the inconsistency with the premises of welfare economics: it 
is each individual’s own preference that counts for establishing the economic values 
used in cost-benefit analysis.
All the above issues suggest that human capital measures are poor proxies for 
the willingness-to-pay measure for small changes in the risk of death. It does not reflect 
the probabilistic nature of death and individuals’ different attitudes towards risks.
3.1.2. The willingness-to-pay approach
The willingness-to-pay approach has its basis in the premise that changes in 
individuals’ economic welfare can be valued according to what they are willing (and 
able) to pay to achieve that change7. According to this assumption, individuals treat 
longevity like a special consumption good and reveal their preferences through the 
choices that involve changes in the risk of death and the consumption of other economic 
goods whose values can be measured in monetary terms. That is, in many situations 
individuals act as if their preference functions include life expectancy or the probability 
of death as arguments, and make a variety of choices that involve trading off changes in 
their risk of death for other economic goods. When what is being changed can be 
measured in monetary terms, the individual willingness to pay is revealed by these 
choices, which are the basis of the economic value of reductions in the risk of death.
The focus of the willingness-to-pay approach relies on the individualistic 
dimension of human behaviour, which means that the expressed willingness to pay to 
reduce the probability of death refers to the individual’s own risk. The underlying 
assumption is that individuals are the best judge of their own welfare and that even in
7 An alternative value measure based on the assumption o f substitutability in preferences is the 
willingness to accept (WTA), which can be defined as the minimum amount o f money the individual 
would require to voluntarily forgo an improvement that otherwise would be experienced (Freeman, 2003).
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matters involving life and death individual preferences must be considered. Thus, the 
willingness-to-pay measure can be seen to be a reasonable one for use in cost-benefit 
analysis. However, because the probability of surviving is a normal good, income 
differences rather than preferences can explain some of the variance in willingness-to- 
pay estimates.
In health economics literature, some methods for empirical estimation of 
willingness-to-pay measures have been utilised, each providing a means to derive 
Hicksian measures for individuals making trade-offs between risks to life and health and 
other consumption goods and services. These methods are the ‘compensating-wage’ 
method, the contingent valuation method, the hedonic price (or hedonic property value), 
and the averting behaviour method.
• ‘Compensating-wage’ method
According to Kuchler and Golan (1999), the ‘compensating-wage’ method was 
the predominant empirical approach to assess willingness to pay for risk reductions until 
the late nineties. It uses the labour market data on wage differentials for jobs with 
different levels of health risks, assuming that workers understand the workplace risk 
involved, and that the additional wage that workers receive when they undertake risky 
positions reflects risk choice. In other words, the ‘compensating-wage’ approach relies 
on the assumption that workers will accept exposure to some level of risk in return for 
some compensation. In general, a hedonic-wage function is estimated where wages are 
specified as a function of personal characteristics of the worker -  income, age, sex, 
education, and health status - and the characteristics of the job. Among the latter, the 
fatality risk level of the job, benefits paid in case of injury on the job and benefits in the 
event of a fatal accident can be cited as examples.
Formally, Freeman (2003) supposes that each individual chooses a job so as to 
maximise the expected utility from consumption of the numeraire, (A), and from the 
vector of job characteristics (J). Additionally, each job is characterised by its risk of 
accidental death, (<$), where (?) indices jobs. Individuals face a hedonic wage function 
that is the locus of points at which firms’ marginal wage equals workers’ marginal 
acceptance:
Pw = Pw(8> *0 > (2)
where (pw) is the weekly or monthly wage. The individual chooses job (/) to maximise 
expected utility subject to the wage constraint:
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Max E(u) = tt.u ( X ,  J)  + X.(p*(S, J ) - X ) 9 (3)
where (X) is the marginal (expected) utility of income and (71) is the probability of 
surviving the period and being able to consume (X). In wage-risk studies it is risk of
death, (S), rather than survival probability, (tt) that is observed. The relationship 
between them is given by (n  = [1-6]-[I-#]), where (<f>) is the probability of dying from a 
non-work related cause. Since (</>) is usually small, (/z) is approximately equal to (1-6). 
The first order conditions governing the choices of (X) and job risk are:
for all job (/') characteristics (Jj).
From equation (4), (X) is the expected marginal utility of consumption, which is
price. Equation (5) also implies that wages must be lower for jobs that are safer, that is, 
the marginal implicit price of an increase in (nt)  is a decrease in the wage rate. Equation 
(6) requires that the marginal willingness to pay for each job characteristic equal its 
marginal implicit price. In summary, the risk premium associated with a higher risk job 
must be equal to the individual’s marginal willingness to accept compensation for risk.
According to Viscusi (1993), the main empirical approach to assess risk trade­
offs in the labour market has utilised hedonic-wage equations. Controlling for other 
aspects of the job, it estimates the wage premium workers receive for risk, which is the 
interaction of labour demand by firms and labour supply decisions by workers. 
Assuming that a greater workplace safety would increase firm’s costs, to maintain the 
same level of profits along some isoprofit curve the firm would pay lower wage rates to 
compensate for the cost of providing a safer work environment. As a consequence, the 
firm’s wages offer curve would be an increasing function of risk.
The supply side of the labour market is characterised by several restrictions on 
worker’s preferences. Viscusi (1993) considered an expected utility model with state- 
dependent utilities, where U(w) denoted the utility of being healthy and V(w) denoted
(4)
u(X,J )  _ dpw
(5)X d&
(6)X dJj ’
by assumption positive. According to equation (5), the marginal willingness to pay for 
an increase in the probability of surviving the job risk must equal its marginal implicit
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the utility of being injured. The only critical assumptions required for workers to 
demand compensating differentials for risk are that the worker would rather be healthy 
than injured (U(w)>V(w)), and the marginal utility of income is positive (U ’(w) >0, 
V’(w)>0). It is not necessary to assume that individuals are risk averse in their attitude 
toward financial gambles {U”<0, V”<0), workers would select the available wage-risk 
combination that maximises their expected utility. Wage-risk combinations that 
maintain an expected utility level (Z) constant are given by:
Z = (1 -  p).U  O )  + p V  O ) , (7)
where, (w) is the wage and (p) represents the risk involved. The wage-risk tradeoff 
along this curve is given by:
—  = - I * .  = t/(w)-K(w) > 0
dp Z „ (\-p).U'(w) + py'{w)  
which means that the required wage rate increases with the risk level.
The observable points in the labour market are, in fact, particular wage-risk 
choices of different workers at points of tangency with the market opportunity curve. 
The econometric task of the hedonic wage methodology is estimating the locus of these 
wage-risk trade-offs for the entire market. The estimated rate of trade-off (dw/dp) 
provides a local measure of the wage-risk trade-off for marginal changes in risk. For 
any given worker located along the hedonic wage curve, “the estimated slope 
simultaneously reflects the marginal willingness to accept risk and the marginal 
willingness to pay for greater safety. The points on this curve also represent the points 
of tangency of firms’ offer curves with workers’ constant expected utility loci. The 
slope for the firm reflects both the marginal cost of greater safety and the marginal cost 
reductions from an incremental increase in risk. The slope at any point (dw/dpi) 
consequently represents the marginal supply price as well as the marginal demand price 
of risk for both the worker and firm located at that point” (Viscusi, 1993).
‘Compensating-wage’ models are consistent with the willingness-to-pay 
approach in the sense that they recognise that individuals have unique preferences over 
risky alternatives and that they have opportunities to reduce risks, depending on their 
labour skills. These models postulate that part of the differences in risk preferences is 
systematic and depends on objective and measurable individual characteristics.
Contingent valuation method (CVM)
51
Contingent valuation is a survey method in which respondents are asked to state 
their preferences in hypothetical or contingent markets, allowing analysts to estimate 
demands for goods or services that are not traded in markets. In general, the survey 
draws on a sample of individuals who are asked to imagine that there is a market where 
they can buy the goods or service evaluated. Individuals state their maximum 
willingness to pay for a change in the provision of the goods or service, or their 
minimum compensation (willingness to accept) if the change is not carried out. Socio­
economic characteristics of the respondents such as gender, age, income, education, and 
demographic information are also obtained. If it can be shown that individuals’ 
preferences are not random, but that instead they vary systematically and are 
conditioned to some observable demographic characteristics, then population 
information can be used to forecast the aggregate willingness to pay for the goods or 
service evaluated. The contingent valuation method has been widely used for estimating 
environmental benefits in particular.
There is a large body of literature on the advantages and disadvantages of the 
contingent valuation method (Mitchell and Carson, 1989; Bateman et al., 2002). The 
central problem in a contingent valuation study is to make the scenario sufficiently 
understandable, clear and meaningful to respondents, who must understand clearly the 
changes in characteristics of the goods or service he or she is being asked to value. The 
mechanism for providing the goods or service must also seem plausible in order to 
avoid scepticism that the goods or service will be provided, or the changes in 
characteristics will occur. Table 1 provides a summary of the main biases that, 
according to Mitchell and Carson (1989), can be generated in a contingent valuation 
study.
The most serious problem related to contingent valuation studies may be the fact 
that the method provides hypothetical answers to hypothetical questions, which means 
no real payment is undertaken. This fact may induce the respondent to overlook his or 
her budget constraint, consequently overestimating his or her stated willingness to pay. 
Another criticism refers to the fact that researchers cannot know for sure that 
individuals would behave in the same way in a real situation as they do in a hypothetical 
exercise.
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Table 1: Typology of potential response effect biases in contingent valuation______
1) Incentives to misrepresent responses
Biases in this class occur when a respondent misrepresents his or her true willingness to pay (WTP)
A Strategic bias', where a respondent gives a WTP amount that differs from his or her true WTP amount 
(conditional on the perceived information) in an attempt to influence the provision o f the good and/or 
the respondent’s level o f payment for the good.
B Compliance bias
i Sponsor bias: where a respondent gives a WTP amount that differs from his or her true WTP amount in
an attempt to comply with the presumed expectations o f the (assumed) sponsor.
ii Interviewer bias', where a respondent gives a WTP amount that differs from his or her true WTP
amount in an attempt to either please or gain status in the eyes o f a particular interviewer.
2) Implied value cues
These biases occur when respondents treat elements o f the contingent market as providing Information 
about the ‘correct’ value for the good.
A Starting point bias: where the elicitation method or payment vehicle directly or indirectly introduces a 
potential WTP amount that influences the WTP amount given by a respondent
B Range bias: where the elicitation method presents a range o f potential WTP amounts that influences a 
respondent’s WTP amount.
C Relational bias: where the description o f the good presents information about its relationship to other 
public or private commodities that influences a respondent’s WTP amount.
D Importance bias: where the act o f being interviewed or some feature o f the instrument suggests to the 
respondent that one or more levels o f the amenity has value.
3) Scenario misspecification
Biases in this category occur when a respondent does not respond to the correct contingent scenario. 
Except in A, in the outline that follows it is presumed that the intended scenario is correct and that the 
errors occur because the respondent does not understand the scenario as the researcher intends to be 
understood.
A Theoretical misspecification bias: where the scenario specified by the researcher is incorrect in terms o f 
economic theory or the major policy elements.
B Amenity misspecification bias: where the perceived good being valued differs from the intended one.
i Symbolic: where a respondent values a symbolic entity instead o f the researcher’s intended good.
ii Part-whole: where a respondent values a larger or a smaller entity than the researcher’s intended 
good.
a Geographical part-whole: where a respondent values a good whose spatial attributes are larger or 
smaller than the spatial attributes o f  the researcher’s intended good.
b Benefit part-whole: where respondent includes a broader or a narrower range o f benefits in valuing 
a good than intended by the researcher.
c Policy package part-whole: where a respondent values a broader or narrower policy package than 
the one intended by the researcher.
iii Metric: where a respondent values the amenity on a different (and usually less precise) metric scale 
than the one intended by the researcher.
iv Probability o f  provision: where a respondent values a good whose probability o f provision differs 
from that intended by the researcher.
C Context misspecification: where the perceived context o f the market differs from the intended context.
i Payment vehicle: where the payment vehicle is either misperceived or is itself valued in a way not 
intended by the researcher.
ii Property right: where the property right perceived for the good differs from that intended by the
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researcher.
iii Method o f  provision : where the intended method o f provision is either misperceived or is itself 
valued in a way not intended by the researcher.
iv Budget constraint: where the perceived budget constraint differs from the budget constraint the 
researcher intended to invoke.
v Elicitation question: where the perceived elicitation question fails to convey a request for a firm 
commitment to pay the highest amount the respondent will realistically pay before preferring to do 
without the amenity.
vi Instrument context: where the intended context or reference ffame conveyed by the preliminary non­
scenario material differs from that perceived by the respondent.
vii Question order: where a sequence o f questions, which should not have an effect, does have an effect 
on a respondent’s WTP amount.
Source: Mitchell and Carson (1989) and Johansson (1995).
In the context of risk and safety, the contingent valuation method involves 
asking members of a representative sample of the population-at-risk about their 
willingness to pay for a small hypothetical improvement in their safety. According to 
Beattie et al. (1998), people’s ex-ante willingness to pay to reduce risk will tend to vary 
with their perceptions of the attitudes towards the characteristics of different hazards. 
For example, the extent to which the hazard analysed is seen to be voluntarily assumed, 
under the potential victims’ own control. The authors argue that there is evidence of 
apparent anomalies and inconsistencies in responses to willingness-to-pay questions in 
the safety and environmental fields. The most common inconsistencies involve 
embedding (Table 1, item 3-B-ii), scope (Table 1, item 3-B-iii) and sequencing effects 
(Table 1, item 3-C-vii). The first two effects refer to the tendency of many contingent 
valuation respondents to report the same willingness to pay for a comprehensive bundle
Q 9
of safety or environmental good as for a proper subset of the bundle . Sequencing 
effects reflect a tendency for the order in which a sequence of contingent valuation 
questions is presented to respondents to have a significant impact on the willingness-to- 
pay responses.
8 Kahneman and Knetch (1992) questioned the validity o f the contingent valuation method for evaluating 
public goods based on an experimental investigation: “ ...the assessed value o f a public good is 
demonstrably arbitrary, because willingness to pay for the same good can vary over a wide range 
depending on whether the good is assessed on its own or embedded as part o f  a more inclusive 
package...contingent valuation responses reflect the willingness to pay for the moral satisfaction o f 
contributing to public goods, not the economic value o f these goods” (Kahneman and Knetch, 1992). 
However, Smith (1992) argued that Kahneman and Knetch (1992) failed to specify correctly the nature o f 
the issues involved in their experiment, and demonstrated that the ‘regular’ type o f  embedding -  the type 
characterised by the embedding o f substitute goods under an umbrella good (Bennet et al., 1998) -  in fact 
is to be expected under conventional (neo-classical) economic assumptions. A second type o f embedding, 
referred to as ‘perfect’ embedding or ‘part-whole’ problem, can be explained by factors that include lack 
o f familiarity regarding the good being valued or the inability o f respondents in distinguishing between 
small changes in the good (Bennet et al., 1998). I return to this discussion in the next section.
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• The hedonic price or property value method
The hedonic price model provides the basis for deriving welfare measures from 
observed differences in properties’ prices. The method is based on the assumption that 
house characteristics yielding differences in health risks across houses are reflected in 
property value differentials. Just as wages are higher in risky occupations to compensate 
workers for their increased risks to life, property values may be lower in areas where 
lives are at risk, to compensate residents for those increased risks. The property market 
is then used to infer the willingness to pay to reduce risk of death, through a hedonic 
price function.
Freeman (2003) provided a basic model for the hedonic property value method 
used to value environmental amenities. The author assumed that each individual’s utility 
is a function of: the individual’s consumption of a composite commodity (X); a vector 
of location-specific environmental amenities (0 ; a vector of the structural 
characteristics of the house the individual occupies9, (S); and a vector of the 
characteristics of the neighbourhood in which the house is located10 (N). An important 
assumption of the hedonic technique is that the urban area as a whole can be treated as a 
single market for housing services, and individuals should have information on all 
alternatives and must be free to choose a house anywhere else in the urban market.
Once the interest was in the values of characteristics to buyers of houses, 
Freeman (2003) argued that there was no need to model formally the supply side of the 
property market. The author simply assumed that the housing market was in 
equilibrium, that is, that all individuals have made their utility-maximising residential 
choices given the prices of alternative housing locations, and that these prices just 
cleared the market given the existing stock of houses and its characteristics. Given these 
assumptions, the price of the (fth) residential location can be taken to be a function of 
the structural, neighbourhood, and environmental characteristics of the location:
Ph = Ph(Si,Nt,Qi) (9)
Equation (9), when considering the individuals and their choices observed in the 
housing market, is called the hedonic price function of properties and can be 
econometrically estimated. The coefficient relative to the environmental amenity gives 
the marginal change in house prices given a marginal change in the environmental
9 Characteristics like size, number o f rooms, age, and type o f construction.
10 For example, quality o f local schools, accessibility to parks, stores, and work place, and crime rates.
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amenity. This coefficient reflects how individuals value changes in environmental 
amenities in the housing market. The same approach can be used to estimate how 
individuals value changes in their risk of death in the housing market.
Freeman (2003) concluded that the major limitation of the hedonic price model 
is the assumption that consumers are able to select their most preferred bundle of house 
characteristics from a complete range of levels of all characteristics. Also, the derivation 
of welfare measures for changes in the levels of environmental amenities is especially 
difficult for non-marginal amenity changes. Values for marginal changes in amenity 
levels can be estimated by adding up the observed marginal willingness to pay for all 
affected individuals. However, for non-marginal changes, welfare measurement requires 
knowledge of the inverse demand function or the income-compensated bid function for 
the amenity.
• The averting behaviour method
This method assumes that individuals spend some of their money on activities 
that reduce their risk of death, such as buying smoke detectors, and that these activities 
are pursued to the point where their marginal cost equals their marginal value of 
reduced risk of death. The marginal costs incurred by individuals to reduce their 
probability of death are used to evaluate individuals’ willingness to pay to reduce their 
risk of death. Given individual data on the marginal costs of an averting good, which is 
likely to vary among individuals, and data on the effect of the averting good on the 
probability of death, the individual’s willingness to pay can be estimated. The most 
relevant measure of the effect of the averting behaviour on risk of death is, according to 
Cropper and Freeman (1991), the individual’s perception of this risk reduction. 
Although relevant, these perceptions are difficult to be observed and in general no data 
are available.
The key criticism of the averting behaviour method is that the actual activities 
used in most studies, such as wearing seatbelts or purchasing smoke detectors, are 
yes/no decisions. This means that the consumer decides or not to buy the averting good 
provided his or her marginal benefit is not less than the marginal cost of purchasing the 
good. The marginal cost equals the marginal benefit only for the last person to purchase 
the averting good, for all other consumers, the willingness to pay exceeds the marginal 
cost of a reduction in the conditional probability of death. To overcome this problem, 
the general procedure for estimating the willingness to pay to reduce risk of death
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requires data on the cost of the averting activity and data on its effects on reducing the 
risk of death for a cross-section of individuals. If both the marginal costs and the 
probabilities of death vary among individuals then it is possible to estimate the average 
willingness to pay using a probit or logit model of averting behaviour.
Another problem with the averting behaviour method arises when the averting 
activity produces joint benefits, such as when it reduces the risk of injury or property 
damage as well as the risk of death. In practice, researchers deal with this problem 
either by treating the value of joint products as zero, and then obtaining an upper bound 
to willingness to pay, or by assuming that the value of injury is some fraction of the 
value of a statistical life. Cropper and Freeman (1991) conclude that because of the 
problems cited above, especially the discreteness of the averting activity, the estimates 
of the value of a statistical life obtained from the averting behaviour method are lower 
than estimates obtained from other valuation methods.
3.1.3. The adequacy of the willingness-to-pay approach and the contingent 
valuation method for this study
The different approaches discussed in the previous sections are all associated 
with important advantages and disadvantages. The human capital approach fails to be 
consistent with the premises of welfare economics, where the individual’s own 
preferences are what count for establishing the economic values used in cost-benefit 
analysis. This feature of the human capital approach indicates that the willingness-to- 
pay approach might be the best alternative to estimate the benefits of life saving 
programmes, the objective of which include reducing the probabilities of death.
Given that the willingness-to-pay approach seems to be the appropriate approach 
for the purposes of this research, the next step involves the choice of an adequate 
valuation method. As argued by Viscusi (1992): “adopting the willingness-to-pay 
approach and establishing empirical estimates considerably simplify the task of 
addressing value-of-life issues in policy contexts. For private decisions the dominant 
concern will be the private willingness-to-pay amount. For public choices it will be 
society’s overall willingness to pay for the risk reduction. One would expect that the 
greatest benefit from a life-extension policy would be that received by the individual 
whose life is directly affected, so private valuations provide a good starting point for 
assessing the value of life” (Viscusi, 1992).
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The major problem of the indirect methods, those where individuals reveal their 
preferences through market decisions, is to isolate the risk-income trade-off from other 
factors and to take into account the institutional restrictions of the observed markets 
(labour and property markets, for instance). Also, the application of these methods is 
limited to those risks that are traded in markets, when the need of information about the 
value of changes in probabilities of death is greater in areas where no market exists, like 
health and environmental areas.
In particular, the ‘compensating-wage’ method estimates the value of a 
statistical life based on information of the labour market, where older people are 
generally absent. Since older people have fewer life-years remaining than young people 
the compensation received in labour market studies may overstate the value of risk 
reductions to old people. In addition, “much of the criticism of the ‘compensating-wage’ 
approach centres on its assumptions concerning the labour market. Many critics argue 
that the actual labour market bears little resemblance to the labour market described in 
‘compensating-wage’ models. The ‘compensating-wage’ approach assumes that 
workers are fully cognisant of the extent and consequences of the on-the-job risks they 
face, that labour market is strictly competitive, and that insurance markets are 
actuarially correct, with premiums and payouts matched to accurately assessed risks” 
(Kuchler and Golan, 1999).
While the contingent valuation method overcomes the problems of the 
‘compensating-wage’ method, its disadvantage is the fact that little is known about the 
extent to which answers to hypothetical questions actually represent the respondent’s 
behaviour or preferences. It has become an important tool for evaluating changes in
probabilities of death caused by public policies focused on safety, health or
environmental expenditures. It is particularly attractive in situations where changes in 
death risks are not readily estimated using revealed preference techniques. In the 
particular context of this research, the contingent valuation method seems to be 
adequate for the purposes of the study. First, because the objective of the study is to
estimate the main benefit of air pollution reduction programmes, the reduction in
probabilities of death of the population, and second, the limitations of other methods 
based on the willingness-to-pay approach seem to confirm that the contingent valuation 
method is appropriate.
As noted in Section 3.1.2, a point to be observed when using the contingent 
valuation method for eliciting the willingness to pay for a reduction in probabilities of
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death is how sensitive the estimates are to changes in risk. Economic theory suggests 
that willingness to pay to reduce small probabilities of death should increase with the 
magnitude of risk reduction, and approximately proportional to this magnitude, 
assuming that risk reduction is a desired good. For example, if a reduction in annual 
mortality risk is valued at a certain amount of money, then a larger reduction in risk 
should be valued at a larger amount of money. In addition, the difference between the 
values should be proportional to the difference in risks, ignoring the income effect.
Hammitt and Graham (1999) discuss some reasons why stated willingness to 
pay is frequently not sensitive to variation in risk magnitude. One possible reason, they 
argue based on the review of several studies, is that respondents might not understand 
probabilities, or lack intuition for the changes in small probabilities of death risk. 
Another possibility involves the fact that respondents might not treat the given 
probabilities as applying to them. In that case, willingness to pay would not be 
proportionate to the amount of risk reduction given to respondents, but proportionate to 
changes in perceived risk. Finally, it is possible that respondents might not value 
changes in risk levels in a manner that is consistent with expected utility theory (section 
3.2).
In summary, in a reliable contingent valuation study involving small changes in 
probabilities of death, tests should be performed to evaluate how sensitive willingness- 
to-pay estimates are to changes in risks. An ‘internal’ test of sensitivity to magnitude, 
the one performed within one sample, occurs when the respondent informs different 
willingness to pay for different changes in risk in the same questionnaire. An ‘external’ 
test of sensitivity to magnitude occurs when different samples are used to compare the 
willingness-to-pay estimates, meaning that different respondents are asked about their 
willingness to pay for different risk reductions and there is no possibility of co­
ordinating their responses. Internal tests are more likely to be successful because 
respondents in general base their responses to willingness-to-pay questions about one 
risk reduction on their answers to previous questions about a different risk change, 
anchoring their answers on their previous responses, which enforces some degree of 
consistency.
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3.2. Theoretical literature review
The theoretical framework that has been used to develop the economic models 
that define willingness to pay for a change in health risks is based on economic models 
of individual choice that focus on the conditional probability of death under an 
uncertain lifetime. Such models are based on the interplay between the ‘impatience’ to 
consume and the productivity of resources. The models offer insight into consumption, 
saving, investment, portfolio selection and purchase of life insurance and annuities 
(Shepard and Zeckhauser, 1982). They are based on the assumption that individuals 
maximise their expected utility by choosing among alternatives, some of which change 
their risk of dying11 (as in the discussion on the compensating-wage method, section 
3.1.2, equation (3)). Thus, the willingness to pay for a reduction in the risk of death is 
the maximum amount that can be taken from the individual without reducing his or her 
expected utility. They also generate predictions about how willingness to pay varies 
with age and lifetime earnings, providing the theoretical basis for many empirical 
studies of willingness to pay for reduction in health risks.
The main models that provide the theoretical foundation for studies of 
willingness to pay for health risk reduction are presented below.
3.2.1. The life-cycle consumption-saving model with uncertain lifetime: the 
Fisher-Yaari framework
In the 1930s, Fisher (1930) developed a general framework to analyse the 
allocation of consumption over an individual’s lifetime. He was aware of the 
uncertainty of an individual’s survival, but did not explore how the consumer might be 
expected to behave rationally under this uncertainty.
Yaari (1965) concentrated his discussion entirely on the uncertainty of lifetime 
and ignored the other uncertainties that a consumer generally faces. He started the
11 Kahneman and Tversky (1979) presented a critique o f expected utility theory as a descriptive model o f 
decision-making under risk, and developed an alternative model named Prospect Theory. The authors, 
both psychologists, described several classes o f choice problems in which individuals’ preferences seem 
to violate the axioms o f  expected utility theory, and concluded that individuals are highly sensitive to how 
choices are presented to them (framing o f  the alternatives involving risk). For example, individuals are 
risk-averse when offered a choice formulated in one way, but are risk-taker when offered the same choice 
formulated or framed in a different way. Another important conclusion o f Kahneman and Tversky (1979) 
refers to the subjective assessments o f probabilities that individuals seem to assume when deciding 
between choices under risk, which may differ from the actual probabilities involved. One possible 
implication o f these results for the validity o f contingent valuation results has already been discussed in 
footnote 8.
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discussion with the “Fisher-type” analysis of allocation over time, supposing that the 
consumer’s preferences are represented by a utility function (V), the Fisher utility 
function:
V(c) = \a(t).g[c(t)]dt (10)
0
V(c) is the utility of the consumption plan (c);
T  corresponds to years that a consumer expects to live;
c is an arbitrary consumption plan. A real valued function defined on the interval
[0,7];
c(t) is the rate of expenditure on consumption that takes place at time (t) if the plan
(c) is adopted;
a  is a subjective discount function; a non-negative real valued function defined on
the interval [0,7];
g  is the utility associated with the rate of consumption at every moment of time. A
concave real valued function defined on the interval [0,oo);
Equation (10) has an implicit assumption that the consumer’s preferences are 
independent over time, which is a strong but necessary assumption to make the problem 
manageable. The objective is to maximise (V(c)) subject to a wealth constraint, for
which the author assumes the possibility of unrestricted borrowing, the existence of a
single interest bearing asset and the re-contracting of all outstanding loans at every 
moment of time. It is also assumed that the consumer’s initial asset is zero. Thus, the 
consumer’s net assets at time (t) are:
t t
S(t)=  J{exp ^j{x)dx}.{m {r)-cir)}dt (11)
0 T
S(t) is the consumer’s net asset at time (f);
j ( t)  is the rate of interest which is expected to prevail at time (r);
m(r) is the rate of earnings (other than interest) at time (r);
The wealth constraint is given by the inequality:
S(T) > 0 (12)
A consumption plan would be admissible if the following three conditions hold: 
(c) is bounded and measurable;




The Fisher problem, that is, to find an admissible plan of consumption (c*) such 
that \V(c) > V(c)\ for all admissible plans (c), does not always have a solution. But if  it 
does have a solution, then the following statements are true: the optimal plan (c )  is
continuous on the interval [0, 7], it is differentiable wherever it is positive, and
decreasing wherever the rate of subjective discount is greater than the rate of interest.
Now Yaari (1965) leaves the Fisher problem under complete certainty related to 
(T) and supposes that (7) is now a random variable with a known probability
likely to be different for each value of the random variable (7). To overcome this 
problem the author utilises the expected utility hypothesis, in which the consumer will 
select a consumption plan that maximises the expected value of (V).
The same difficulty happens with the wealth constraint, that also depends on (7), 
so that a given consumption plan may be admissible for one value of (7) but 
inadmissible for other values (feasibility problem). To overcome the feasibility problem, 
Yaari considers two procedures suitable to the context of the study: the chance- 
constrained programming procedure and the penalty function procedure (or loss- 
fimction procedure). The first approach requires that the wealth constraint be met with 
probability (A) or more, where (A) is a number fixed in advance. Thus, what the chance- 
constrained programming procedure does is replace the deterministic constraint (1 2 ) by 
the probabilistic constraint:
wherever (c*) is positive it satisfies the following fundamental differential equation:
(13)
The quantity can be regarded as the consumer’s subjective rate of
a(t)
1 *7discount . Thus, equation (13) says that the optimal consumption plan increases 
wherever the rate of interest is greater than the rate of subjective discount, and it is
distribution, and so is the Fisher utility function (V). One problem arises because it is 
meaningless to speak about maximisation of a random variable (V), since its value is
12 For example, if  a ( t) = e h c8{t) = — — = — k.e ^ => — -
d{t)
the differentiation with respect to (t) o f  the discount function, a ( t ) .
c%t) . e h „ = k. —— = k , where dS{t) is
a(t) e
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prob{S{T) >0}> X. (14)
It is of interest to examine what the consumer’s optimal plan looks like given 
that the wealth constraint (12) must hold with probability equal to one. This is due to the 
idea that the institutional framework of modem society makes it virtually impossible for 
an individual to die with a negative net worth.
The other approach to cope with the feasibility problem, penalty function or 
loss-function procedure, charges the consumers themselves with protecting the wealth 
constraint by assuming that a violation of the constraint implies a loss of utility. Thus, 
the total utility of a consumption plan (c) for a lifetime of length (7) is given by 
(V{c) + (p[S(T)W where {(p) is a non-decreasing concave real function defined on (-
oo, oo) that describes a penalty for violation of the wealth constraint. Since (cp) is non­
decreasing, a positive (S(I)) increases utility and a negative one decreases utility, but 
only the latter possibility represents a loss of utility. Then, one further condition must be 
imposed:
<p(x) = 0  for x > 0  and
q>(x) < 0 for x < 0 (15)
The new utility function (U) is defined in (16) and it is assumed that the
consumer attempts to find the consumption plan, which maximises the expected utility 
without any constraints.
U(c) = )a(t).g[c(l)]dt + rfS(r)] (16)
0
Yaari (1965) still considers the bequest size and time problems, which are the 
importance the consumer gives to the size of his or her wealth at the moment of his or 
her death and to the time at which it is made. To accommodate this possibility, the
1 Tauthor introduces a subjective weighting function for bequests (JJ) into the Marshallian 
utility function (U):
U(c) = )a(l).g[c(t)]dt + f)(T).<p[S(T)] (17)
0
In summary, two alternatives were formulated by Yaari (1965) to describe the 
consumer’s behaviour when faced with the uncertainty of lifetime. The first, (Case A), 
sees the consumer as attempting to maximise the expected value of a Fisher utility
13 Reference to Alfred Marshall who “gave particular emphasis to family affections as a motive for 
saving.” (Yaari, 1965)
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function, subject to a non-negative net asset at the moment of his or her death with 
probability equal to one. The second, (Case B), considers the consumer maximising a 
Marshallian utility function, subject to no constraints, since the loss for negative 
bequests is incorporated in the utility function. The solutions to both cases are then 
described and analysed, starting with Case A.
Equation (10) gives the Fisher utility function for a fixed lifetime (7), which is 
assumed to be a random variable in the interval [0, T  ] with probability density function 
(n):
n{t) > 0  for all t and
f
JW(r)<A = l (1 8 )
0
The probability that the consumer will be alive at time (t), (O(t)), and the value 
of the conditional density of (7), at moment (r), (nt (t)), are given by:
f
Q(t) = \x(T)dT , 0 < t< T  (19)
................................  t .................................
and m{r) = ,  0 < t < r < T , t * T  (20)
0 ( 0
Then, the expected utility ( V (c)) of the plan (c) is given by:
_  ^ '
V(c) = EV(c) = \7i(t).\a(T).g[c{r)]dT.dt (21)
o o
By a change in the order of integration in (21) 14 and using (19):
f
V(c) = \CL(().a(t)g{c(t)]dt (22)
0
||t
The problem in Case A is to find an admissible consumption plan (c ) such that 
(V(c*)>V  (c) ), for all admissible plans (c). A plan is considered to be admissible if it 
is bounded, measurable, non-negative and satisfies the wealth constraint ( 12) with 
probability one. If such a plan does exist then its properties can be obtained by using 
standard calculus of variation technique.
Under the assumption that (;r(0  > 0) for 0 < t < T , the constraint:
prob{S(T) > 0} = 1 (23)
Is equivalent to
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S(T)>  0 for all t (24)
Now for (t = T ), (24) will hold with equality for sure, but for other values of (t) 
it is convenient to convert the constraint (24) to:
§{t) > 0 whenever S(t) = 0 (25)
From the definition of (5) (equation (11)):
= + (26)
Thus, what the requirement (25) says is that (c(t) <m(t)) whenever (S(t)=0). The 
problem becomes:
Maximise
\n { t)a ( t)  g[c(t)]dt = \ m a ( t )  g W )  -  f i t )  + j(t).S(t)]dt (27)
0 0
subject to: (i) c(t) > 0 for all t\
(ii) c(t) <m(t) whenever S(t)=0;
(iii) S (T ) = 0 .
In general, the solution (c*) will be composed of three segments: the first one, in 
which {c*(t)-0\ constraint (i) being effective (bounded solution); the second, when 
constraint (ii) is effective, (c*(t) = m(t)); and finally, the interior solution in which 
neither constraint is effective. Whenever (c*) is interior, it must satisfy the differential 
equation:
= - I  j (  0  + —  -  sift)}- , (28)
r '  a{t) I g"[c (f)]
where =
The interesting result that emerge when equation (28) is compared to equation 
(13), the analogous result in the absence of uncertainty related to the time of death, is 




that is always greater than the consumer’s subjective rate of discount with certainty
14 This is possible because c is assumed to be bounded and measurable.
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In summary, the future is discounted heavily because of the uncertainty of
a(t) 
survival.
Analysing Case B, where the consumer is concerned with his or her bequest at 
time of death, the problem becomes one of maximising the expected value of (17), 
subject to no wealth constraints, since the loss for negative bequests is incorporated in 
the utility function15. Writing the expected value of the Marshallian utility function and 
changing the order of integration:
U(c) = EU(c) = j{C2(/).a(0.g[c(/)] + }dt (30)
0
The result of the maximisation problem above produces the optimal 
consumption plan (c*) and the corresponding asset function (S*)\
= (3D
V w  «(/> Jg " [c (01 «(o *"[c(o]
Writing the first equation in (31) slightly differently, it is possible to interpret 
the role of the consumer’s bequest to dependants:
&(t) = J  m  g ’[c(Q] [ m(t) a{t).g'[c" (t)] -  fi(t ).p[S‘ (t)] ]
1 «(0jV'[c‘(/>] 1«(0 g"[c'(0] J
The first term on the right hand side of (32) is equal to the equation without 
uncertainty about (7), equation (13). The second term, however, if negative, implies that 
lifetime uncertainty makes the consumer more impatient, and if the second right hand 
side of (32) is positive then lifetime uncertainty makes him less impatient.16 The author 
concludes: “from this it follows that lifetime uncertainty increases impatience at time (t) 
if (cc(t).g'[c*(t)]> J3(t).(p'[S*(t)]) and decreases it if the reverse inequality holds. In 
other words, impatience is greater than it would be with no uncertainty if the marginal 
utility of consumption exceeds the marginal utility of bequests, and it is less than it 
would be under no uncertainty if the marginal utility of bequests exceeds that of 
consumption” Yaari (1965).
15 But subject to the constraint c > 0.
16 Reference to Irving Fisher’s term: “Uncertainty o f human life increases the rate o f preference for 
present over future income for many people, although for those with loved dependants it may decrease 
impatience.” (I. Fisher, 1930, The Theory o f  Interest, p.216)
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The author explores the cases analysed before, A and B, but now in the presence 
of a life insurance market (cases C and D). The conclusions are presented here but the 
algebra is suppressed because it shows no additional insights to the analysis. Case C 
considers that the consumer has no bequest concerns but he or she is constrained by the 
requirement that his or her transferable assets at time of death should be non-negative 
with probability equal to one. It is concluded that the introduction of insurance is 
equivalent to the removal of uncertainty from the problem of consumption allocation. 
Case D, in which the consumer may have assets or liabilities both in the form of regular 
notes and in the form of actuarial notes, also has the same solution that holds in the 
absence of any uncertainty. Another important conclusion states that when the insurance 
market is available the consumer can separate the consumption decision from the 
bequest decision.
Yaari’s model was innovative while introducing uncertainty to the classical 
problem of consumption allocation during the consumer’s lifetime. However, it does not 
address directly some concerns of this research, which are the role of age and health 
status in individual’s willingness to pay for a reduction in his or her risk of death. 
Nevertheless, it is the conceptual basis of further models that explicitly introduces the 
problem, such as the general life-cycle model of consumption.
3.2.2. The general life-cycle model of consumption: the Shepard- 
Zeckhauser model
The general life-cycle consumption model explicitly introduced life-risk- 
mitigating goods or services among the consumption possibilities of individuals faced 
with the uncertain lifetime consumption modelled by Yaari (1965). That is, in this 
model the consumer devotes his or her resources either to purchasing reductions in his 
or her probability of death, or general consuming, constrained by income. By doing this 
Shepard and Zeckhauser (1982) focused on the way some age-related attributes (mainly 
income and consumption) could be introduced into a utility function for life. This 
characteristic allowed the analysis of how individual willingness to pay for a mortality 
risk reduction relates to individuals’ age and income, an important issue for the 
purposes of this study. Like Yaari (1965), the authors also analysed lifetime 
consumption under uncertainty in the presence of insurance and capital markets.
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Shepard and Zeckhauser (1982) addressed the question of how economists 
should think about individual purchases of survival, purchases defined as actions or 
goods to reduce risks of death. In other words, they addressed how to value reductions 
in risk. The authors suggested three justifications for examining the approaches to this 
problem:
(i) Economists may better understand the decisions that individuals make when 
choosing occupations and lifestyle;
(ii) Economists can help people assess their probabilities and value structures in 
order to make better choices;
(iii) Economists can improve public policies that affect probabilities of death.
They focused their model on the last justification because educating 
policymakers would provide greater immediate social returns than educating 
individuals. The individual analysed in Shepard and Zeckhauser’s model spends income 
to purchase probabilities of survival and consumption goods. Many goods, such as food, 
serve both functions. However, the central concept considered is the willingness to pay 
for increased survival probability. That is, “how much would an individual threatened 
with risk of losing his life at some age be willing to pay to reduce the probability of 
loss? ... Anyone engaged in lifetime consumption allocations must first be concerned 
with what capital and insurance markets are available for trade. Can he [the average 
individual] borrow at fair17 rates against future use? Can he use his wealth to purchase 
annuities that will guarantee a given consumption level over an unexpectedly long life?” 
(Shepard and Zeckhauser, 1982)
The authors presented a model to suggest how a rational individual would 
allocate his or her wealth between buying survival or consumption. In order to facilitate 
the analysis, they considered three cases; the first two are extreme cases and the third 
one captures some of the elements of social insurance schemes and, therefore, seems to 
be more realistic about modem individuals’ behaviour:
(i) The “Robinson Crusoe” case in which there are no (insurance) markets on which 
the individual can trade;
(ii) The case of perfect markets, where individuals can trade across time periods and 
insure against variability in length of life;
17 An annuity o f  one pound is fair when it is expected to have a payoff o f  (1+r) pounds, where (r) is the 
risk less rate o f  interest.
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(iii) The pensioner situation, which assumes that the individual has a certain level of 
consumption that is purchased (per period) at a price guaranteed by the 
government, and that the price does not vary with his or her survival portfolio 
over productive and non-productive years. One possible interpretation of the 
pensioner case would be that all individuals are identical, and that the total 
product of society is divided among its members. When buying survival, each 
individual ignores the effect his or her survival will have on the overall level of 
resources.
The Life Cycle Consumption-Allocation model derives a value function for lives 
saved as a function of age, giving the value of a life at one age compared with the value 
at another age, and the trade-off between improved survival and enhanced consumption. 
The model explicitly treats the dependence of earning rates on age, and treats 
individual’s life cycle savings and consumption as endogenous variables. An important 
assumption states that an individual’s utility over life spans of different lengths can be 
represented as a weighted sum of period utilities.
Thus, a theoretical limitation emerges from this approach: the value function, 
which is defined as a weighted sum of period utility functions, is itself a utility function 
only for small perturbations in the survival function. The reason for the limitation is that 
decisions must be made before the uncertainty is resolved, so the utility of an attribute 
in one period depends on the probability distribution of the likely amount of that 
attribute in a future period.
The authors assume that a consumer maximises his or her expected utility of 
consumption over an uncertain lifetime subject to wealth and solvency constraints. An 
individual’s lifetime utility is an additive function of his or her period utility functions, 
referred to by Yaari (1965) as the ‘Fisher problem’. The individual’s period utility 
function depends on whether he or she is alive and on his or her rate of consumption in 
that period, conditional on being alive. This function is scaled so that the period utility 
of being dead is zero and the utility of consumption is non-negative, monotonically 
increasing, and risk averse over relevant values of consumption. Like Yaari (1965), 
section 3.2.1, the period utility function is assumed to remain the same over all periods.
An individual’s utility at time t of his or her remaining life after age (f) is given 
by the expected discounted utility of consumption for each year in which he or she is 
alive and from time (t) on. Say:
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y(t) = J X(r).«[c(r)]^-r(r-')r fr , (33)
t
where:
yft) is the utility of survival at age (/), not conditional on survival at age (f);
r, t represents the time in individual’s life from 0 to (7) ;
l(t) is the actuarial survival function that gives the probability of being alive
at time (/), (1(0) = 1 and 0  < I ft) < 1); 
eft) is the rate of consumption at time (/);
uft) is the period utility function at time (/);
Other notations used below are:
to is the time at which individual first begins to save (accumulate wealth);
w(t) represents the level of wealth at time (t);
w(t) > 0  is the solvency constraint;
m(t) is the rate of earnings at time (t);
v(t) is the value of remaining life at age (f), not conditional on survival at age
(0;
is the marginal change in optimal (v(t)) per unit reduction in the force of 
mortality at time (t);
is the discounted expected remaining years of life following age (/) (not 
conditional on survival at age (/));
constant rate of consumption (in perfect market and pensioners case); 
is the scaling factor for utility function; 
is the net amount received by annuitant alive at age (t); 
corresponds to discounted expected earnings following age (/), 
discounted to age (t) and conditional on survival at age (/); 
equals to discounted expected consumption following age (f), discounted 
to age ( 0  and conditional on survival at age (t);
An important special case, (y(0)), gives the utility from the initial age onward, 
indicating that (33) is a joint utility function for a consumption trajectory and a survival 
function. Implicit in (33) are some strong assumptions about the multi-period utility 
function (uft)):
(i) Death has zero utility relative to the utility for being alive with consumption (c). 








utility function, this assumption is relatively benign. Its effect is to require that 
death cannot have a period utility of negative infinity. That is, this model would 
not apply if a person would trade off an infinite amount of money for a 
probabilistic improvement for just an instant more of life.
(ii) The utility of consumption at one time is independent of past consumption 
(marginality assumption). This assumption implies the additive (integral) form 
for total expected utility.
(iii) The consumer is assumed to be indifferent to remaining wealth at the time of 
death (no bequest). This assumption, necessary to keep the mathematics 
manageable, is plausible under the conditions that the consumer has no 
economic dependants, or he or she has purchased life insurance to cover the 
basic needs of the dependants.
The objective is to maximise (y(0)) in (33), subject a to feasible trajectory on 
consumption, which is constrained by non-negativity,
c( t )>0  for all. (34)
Shepard and Zeckhauser (1982) started solving the maximisation problem and 
analysing the first extreme case formulated, namely, the “Robinson Crusoe” case. In 
this one, the individual cannot borrow against future earnings and no insurance markets 
are available. Then, the individual faces a solvency constraint on wealth:
w( 0  > 0  for all t, (35)
and an initial condition,
w(0) = wo (36)
It is assumed that when an individual is first able to allocate consumption over 
his or her lifetime, there is no accumulated wealth (w(0)=0). Wealth is related to 
consumption by:
lS(t) = r.w{t) + m{t) -  c(t) (37)
In this model, the level of earnings (m(t)) depends only on whether the 
individual is alive at the time (t). Equation (37) says that the rate of change in wealth is 
equal to the interest at rate (r) earned on that wealth (assumed to equal the discount rate 
for future utility) plus earnings less consumption. From the perspective of time zero, the 
problem comes in maximising (y(0)), defined by (33), and subject to (34) and (37).
Assuming that the individual is strongly risk-averse on consumption near zero, 
the consumer’s preferences will keep (c) positive and (34) becomes redundant. Two
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situations are possible: those intervals where the debt constraint is binding (w(t)=0) and 
those in which it is not (w(t)>0). The dividing point between these cases is the time (to) 
at which solvency ceases to bind:
to = minft such that w(t)>0}, t in (0, T) (38)
The first situation, where (w(t)=0) applies for (f) between 0  and (to). To 
maximise (33), consumption must be raised up to the limit allowed by the solvency 
constraint, so that (w(t)= 0) and ( dk(x) = 0) between ( 0 ,  to). Substituting into (37):
c(t) = m(z) when w(r)= 0 (39)
The second case, where the solvency constraint is not binding (w(t)>0), holds 
for ( t  > to). Solving it is the equivalent to maximising (y(to)) subject to (37). The 
Hamiltonian formed is:
H(c , w, X, r) = e~r(r_'o)./ (r).w[c(r)] + X(t). [r.w(r) + m(r) -  c(r)] ( 4 0 )
Setting the first partial derivative with respect to the control variable of the 
Hamiltonian to zero:
—  = 1(t).u'[c(t)} -  X(t) = 0
dc
Solving for the optimal consumption trajectory (c (i)):
d u . .  A ( r ) / {M0)
  c (r) =  — — ------------------------------------ ( 4 1 )
dc 1(t)
To find (X(tJ), the partial derivative related to the wealth constraint is needed:
dw dr
Solving the ordinary differential equation:
X(t) =  X(to).e~r(T-t0) ( 4 2 )
One interpretation of (X(r)) is the marginal utility at time (to) of wealth at time 
( t). Equation ( 4 2 )  indicates that this value is higher in (to) and declines from there on at 
the discount rate. Then, the marginal utility of a unit of wealth at time (t) is proportional 
to its present value at time (/).
Substituting ( 4 2 )  in ( 4 1 ) ,  for non-binding cases (c(t)) must satisfy:
« '[c '(r)] = 4 7 T  (43)/(r)
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As equation (43) shows, the marginal utility of consumption is inversely 
proportional to the probability of being alive, resulting in earlier consumption by the 
individuals, since consumption in a later period involves a greater risk.
Another important result in the “Robinson Crusoe” case emerges when (43) is 
multiplied by (l(r)) on both sides:
u'[c(T)]l(x) = X(t*)9
The result states that the expected marginal utility of consumption is constant for 
all ages at which the individual is not close to insolvency.
In order to solve (43) for the actual level of consumption, it is necessary to 
determine the constant (X(to)). It depends on earnings possibilities and is found by the 
constraints in wealth, (35) and (36). To use these constraints, the ordinary linear non- 
homogeneous differential equation (37) is solved and the result is:
t
w(t) = ert. fe~rr.[m{r) - c (r) ]dr , (44)
to
which is the future value at time (f) of the difference between earnings and consumption 
under the optimal path from time (to) to time (t). Since it is not optimal to keep wealth 
remaining at the maximum possible age, (7), a transversality condition is imposed, 
(w(T) = 0 ), so that18:
T
je"r(r"r).[m(r)- c (r)]c/r = 0.
to
The value of the remaining life at age (/), (v(t)), is necessary to assess the utility 
of reductions in the probability of death at age (t). The authors show that this value is 
the same as the utility at age (t) of remaining life beyond age (t) conditional on survival 
at age (t) for an individual following the optimal consumption pattern. Furthermore, 
they showed that (v(t)) based on the optimal consumption pattern behaves like a utility 
function for small changes in survival probabilities, (l(t)).
In order to formalise the notion of the utility of remaining life, it is important to 
recall that (y(t) for t^O) in (33) is the utility at age (t) of all expected years of life beyond 
age (t). It does not consider the possibility of the individual being dead at age (t). 
Defining the utility of life following age (t), conditional on survival at age (f), by 
dividing (y(t)) by the probability of survival to age (f), yields:
18 Remember that one o f the (strong) implicit assumptions o f this model is that no legacies or bequests 
values are considered.
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v(0 = ^  (45)
m
{ j  \
The probability of death is defined as H(x) = -  —  log l(x) . Suppose there is a 
dx )
small reduction in the probability of mortality at age (/), that is, (<dju(t) < 0). It lowers 
(jjl(x)) for (x=t), but leaves (jjl(x)) unchanged for other values of (r). The new survival 
function (lA(tj) is:
l(x) for x < t
l \ x )  = f  > t (46) and (47)
e W}.I(x) for x > t
For small (dju(t)), (47) is approximately [1 + dju(t)]J(x) . (48)
The marginal utility at time (t), conditional on survival at that time, per unit 
reduction in the probability of death at time (/), is then defined as (R(t)). In other words, 
for a perturbation (d/i(t)), the change in utility is (R(t).dju(t)). Furthermore, Shepard and 
Zeckhauser (1982) prove that, in the “Robinson Crusoe” case, the marginal utility of 
survival probability is equal to the value of remaining life:
(R(t)=v(t)\ (49)
Willingness-to-pay (WTP) measures how much an individual will sacrifice one 
desired attribute, wealth for future consumption, in order to obtain improved survival, 
another desired attribute. A major advantage of Shepard and Zeckhauser’s model is that 
it yields estimates of willingness to pay for marginal changes in the probability of death. 
To calculate willingness to pay, let (djd) denote a marginal change in the probability of 
death and (dw) 19 denote the marginal change in wealth that an individual will accept as 
compensation to leave his or her overall conditional utility at age (t) constant. In other 
words, (dw) is the willingness to pay for a reduction (d/J) in the probability of death.
Willingness to pay is determined by the indifference relation that the total 
differential of (v(t)) is zero:
dv dv .dv = — du +— dw = 0  
dju dw
Using the fact that, in the “Robinson Crusoe” case, the marginal utility of 
survival probability is equal to the value of remaining life (49) and some substitutions, 
yields:




.dw = 0 (50)
The term (R(t).dju) measures the marginal utility at age (t) of the change in 
survival, (dp), conditional on survival to that age, and the second term is the marginal 
conditional utility of the change in wealth. The marginal willingness to pay (MWTP) is:
M W T P = dw = m m  (51)
dju X(t).e
In the case where the solvency constraint is not binding, substituting (42) for 
WO) in (51):
Wtp  = RW ( f )  (52)
A(fo)
Solving (43) for (A(to)) and substituting the result into (52) yields:
WTP = R[^  (53)
u'[c (r)]
Equation (53) states that willingness to pay is proportional to the expected utility 
of remaining life at age (t), conditional on survival at that age, and inversely 
proportional to the marginal utility of consumption at age (t).
When the solvency constraint is binding, payments to reduce the probability of 
death must come out of immediate consumption. The indifference relation for 
willingness to pay is:
-  R(t).dfj, + u'(c).dc = 0 (54)
Then, marginal willingness to pay becomes:
WTP = —  = R(l  ^ (55)
dju u'[c(t)]
Again, willingness to pay is inversely proportional to the marginal utility of 
consumption on the optimal trajectory, and proportional to the expected utility of 
remaining life at age (/), conditional on survival at that age. The difference is that in 
(53) the consumption level is an internal optimum, while in (55) it is determined by the 
solvency constraint and is equal to earnings, (m(t)). This is the main conclusion of the 
“Robinson Crusoe” case.
Shepard and Zeckhauser (1982) then analysed the second case, namely, the 
perfect market case. The principal characteristic of the case is the availability of 
insurance annuities, which offer protection to individuals. Payments are made according
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to some specified schedule during certain years and the insurer promises to pay some 
stated income beginning at a specified age and continuing indefinitely. Annuities 
increase the range of consumption allocations available to individuals and thereby 
increase their expected utilities of living to any age, and of their remaining life beyond 
any age.
In terms of the formal model, the availability of annuities replaces the wealth 
equation (37) by:
t) = r.w(t) + m(t) -  c(t) + f { t ) , (56)
where (f(t)) is the net amount received by the annuitant at age (t). It is assumed that the 
annuity is of a type that does not require prepayment; it includes borrowing with a life 
insured loan; that is, borrowing against human capital during years with low earnings 
and no wealth. Thus, the assumption of actuarial fairness implies:
T
Je-" ./(r)./(r)rfr = 0 (57)
0
To maximise (y(0)) in (33) subject to (34), (35), and (56), the Hamiltonian is 
formed as in (40), but with the right-hand side of (56) substituting the last term in 
brackets. The solution involves an optimal consumption path that is a constant rate 
regardless of age ( c ). It is not optimal to hold positive wealth at any age, because the 
possibility of death means that wealth would become worthless, that is, it is always 
better to invest the remaining wealth in annuities that would provide a higher 
consumption rate in case of survival.
With perfect markets, an individual should exchange his or her lifetime wealth 
for a level lifetime annuity. Consequently, the solvency constraint is binding at every 
age (/), so that (w(t)=0 for all t). Solving (56) for (f(t))\
f ( t )  = c - m ( t ) .  (58)
Thus, the level of the annuity is the deficit in earnings below the constant level 
of consumption. The authors defined (E(t)) as the discounted life expectancy at age (f), 
conditional on survival at age (t):
E(t) = - ^ . f e - r(^ J (T )d T .  (59)
They defined (N(t)) as the discounted expected earnings following age (t), 
discounted to age (t) and conditional on survival to age (t):
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1 T
N(t) = - ^ . ^ ' r(r-,)./(r).w(r)^r (60)




Equation (61) states that discounted expected lifetime consumption equals 
discounted expected earnings. Substituting (59) and solving for (c  ):
-  N (°)c = —— , (62)
£ ( 0 )
which says that the maximum level of consumption is the ratio of discounted lifetime 
earnings to discounted life expectancy.
Substituting (62) and (33) into (45):
v(0 = u(c).E(t) (63)
Thus, in the case of perfect markets, the utility of remaining life is equal to the 
utility of consumption per year times discounted life expectancy.
As in the “Robinson Crusoe” case, Shepard and Zeckhauser (1982) proved that, 
in the perfect market case, the marginal utility of survival probability (R(t)) is the sum 
of a financial surplus term (a financial effect of a reduction in the probability of death) 
and a direct utility-gain effect (the pleasure of additional life with quality held fixed):
/?(0(anmiities) = m'(c).[A(/) -  C.E(t)\ + u(c).E(t) (64)
To evaluate willingness to pay in the perfect market case, it is noted that the 
solvency constraint on wealth is always binding, that is, the individual always spends 
his or her entire wealth on actuarially fair annuities. Thus, the compensating variations 
that define willingness to pay are given by (54) and the definition of willingness to pay 
given in (55). Substituting (64) for (R(t))9 its value for the perfect market case is:
WTP = [N (t) -  c.E(t)} + ^ - . E ( t )  (65)
u'(c)
The first term is the impact on net lifetime income of improved survival, and the 
second term is willingness to pay for remaining life at a constant level of consumption. 
For (t=0), the term in brackets vanishes and willingness to pay equals the total lifetime 
utility of consumption divided by the marginal utility of consumption.
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For a more meaningful result, the authors defined the amount of consumption 
equivalent to the consumer’s surplus from being alive in any year with that consumption 
level as:
-  w ( ^ )  -Cs = _ -  c (66)
u'(c)
Substituting (6 6 ) into (65) yields:
WTP = N(t) + cs.E(t) (67)
The first term in equation (67) is discounted expected additional earnings 
conditional on survival at age (t). The second one is the surplus consumption multiplied 
by the discounted life expectancy. Thus, livelihood provides a lower bound on 
willingness to pay, and there is also a consumer surplus from being alive, which is 
valued by the individual.
Shepard and Zeckhauser (1982) finally turned to the pensioner case, in which 
readjustments in the rate of consumption are ignored, that is, annuities could not be
readjusted. To value the marginal reduction in the probability of death at age (t) in the
pensioner case, it is necessary to ignore the first term in (64). Thus,
7? ( / )  (ignoring readjustments) =  u { c  ) .7 T ( / )  =  v ( ^ )  ( 6 8 )
Willingness to pay is obtained by dividing the utility of remaining life at age (t)
by the marginal utility of income. Thus,
WTP = (69)
k '(c )
Substituting (6 6 ) into (69) yields:
WTP = cs.E(t) + c.E(t)  (70)
In the pensioner case, willingness to pay is the sum of annual consumer surplus
(ics) multiplied by the discounted life expectancy plus average consumption (c )
multiplied by the discounted life expectancy, that is, willingness to pay is the lifetime 
consumer surplus from being alive plus the discounted consumption.
A major advantage of Shepard and Zeckhauser’s model is that it yields estimates 
of willingness to pay for marginal changes in the probability of death. It provides a 
mechanism for valuing small changes in risk levels to individuals of various ages, who 
have particular preferences and earnings opportunities. This mechanism allows analysts 
to compute the value of individuals’ benefits derived from public programmes.
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Furthermore, it provides the theoretical basis for many empirical estimates of the value 
of risk reduction described in the empirical literature review.
• The role of age in willingness-to-pay measures
Epidemiologic studies suggest that most of the statistical lives saved by 
reductions in air pollution levels are those of old people and those with chronically 
impaired health (e.g. Schwartz, 1994, 2001; Saldiva et a l , 1995; Martins et a l , 2002; 
Martins et a l , 2004). For this reason, when evaluating the costs and benefits of policies 
that aim to reduce air pollution, economists must consider how respondents’ age and 
health status affect willingness-to-pay measures.
Concerning the role of age in willingness to pay for improvements in survival, 
Shepard and Zeckhauser (1982) concluded that it follows an inverted-U pattern related 
to age. At lower ages, willingness to pay is low because of low earnings and the 
discounting of years of higher earnings. At older ages, willingness to pay is reduced 
because of shorter remaining life, since willingness to pay is proportional to the 
expected utility of remaining life at age (0, conditional on survival at that age. In the 
case where there was no insurance market, the willingness-to-pay curve followed a 
pronounced inverted-U, peaking at about age 40, falling by about 50% by the age of 60. 
With a perfect life insurance market the curve was much flatter but still had a decline of 
more than 50% between the ages of 40 and 70. It has to be observed that these results 
were obtained under restrictive assumptions, as described below.
To illustrate their theoretical development, Shepard and Zeckhauser (1982) 
provided a numerical calculation for a financially self-sufficient individual of 20. They 
assumed surviving probabilities based on the U.S. male life table, an interest rate equal 
to 5 per cent, and earnings equal to the average profile from a sample of Social Security 
enrolees, supposing that earnings ceased at the retirement age of 65. They utilised a
“JOconstant proportional risk aversion period utility function , and empirically observed 
survival and earning functions for the two polar cases considered in their study: the 
Robinson Crusoe case and the perfect market case.
In the Robinson Crusoe case, the optimal consumption pattern was identical to 
the earnings curve from age 20 to 35. Beyond 35 years savings began to accumulate as 
consumption dropped below earnings. Wealth was equal to zero up to age 35, when it
20 u(c) = c‘'m , where (c) is the consumption and (m) the risk aversion parameter, being valued equal 0,8. 
With this utility function, the utility o f  zero consumption is set equal to the utility o f  not being alive.
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gradually increased, reaching a maximum at age 65 when earnings ceased. After 65, 
wealth declined as it started to be depleted by consumption. After some considerations 
about the discounted remaining consumption function and the remaining lifetime utility, 
Shepard and Zeckhauser (1982) presented the numerical values for the willingness to 
pay for reductions in the probability of death. For ages less than 40, willingness to pay 
was given as equation (55), and for ages beyond age 40 willingness to pay was given as 
equation (53). In the latter case, the authors found the marginal utility of wealth at age 
40 equalled 0.203 by equating (43) and the aversion period utility function. Figure 1 
shows the willingness-to-pay estimates as a function of age produced by Shepard and 
Zeckhauser (1982), for the Robinson Crusoe case.
In the perfect market case, when annuities are considered available, the optimal
consumption function was a constant. Since the rate of consumption was constant at all
ages, the marginal utility per unit of reduction was the constant multiple, u ’(c), times
willingness to pay. The authors concluded that annuities made willingness to pay flatter
as a function of age. Annuities raised willingness to pay considerably before age 33 and
after age 55, but depressed willingness to pay within this high earning interval. Table 2
shows the estimates for selected ages. The results indicate that the availability of perfect
markets had different effects on willingness to pay, depending on age. At young ages,
when consumers would be limited to their current income, and at advanced ages, when
consumers would have very little assets left, perfect markets increase willingness to pay.
For mid ages willingness to pay was less because peak consumption was lower.
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Table 2: Valuations of life at various ages derived from willingness to pay for
males with 1978 average income profile -  US$ million





Source: Shepard and Zeckhauser (1982).
3.2.3. Future risks to life: the Cropper-Sussman model
It is widely argued that exposure to air pollution affects human health and can 
lead to premature death, as summarised in the epidemiologic literature review. The time 
series medical literature has found a correlation between short-term increases in 
pollution and specific causes of death, including heart attack, emphysema, and chronic 
bronchitis (Carrothers et a l , 1999). Also, cohort or panel studies suggest that some 
diseases related to air pollution can cause an increase in probabilities of death in the 
future, i.e. there may be a time lag between exposure to air pollution and the occurrence 
of the health effects (latency period). The main examples are carcinogens with a latency 
period, and the case of pollutants whose effects depend on cumulative exposure, such as 
particulate matter (Dockery and Pope, 1993; Pope et al, 1995).
Hence environmental economists, when estimating the benefits related to air 
pollution control programmes, are faced with the task of valuing improvements in 
exposure to pollutants today that do not reduce risk of death until the latency period. In 
other words, the benefits in lives saved are not realised at the time that actions are taken. 
“The benefits of reducing chronic exposure to particulate matter may not be felt 
immediately, just as the benefits of reducing exposure to carcinogens will not be 
realised until the end of the latency period” (Cropper, 2000).
The economic literature identifies two approaches to estimating individuals’ 
willingness to pay today for a reduction in risk of dying in the future. The first approach 
involves asking people directly, through a contingent valuation survey, how much they 
would pay to reduce their probability of death in a certain point in the future (Krupnick 
et a l , 2000; Alberini et a l , 2001; Krupnick et a l , 1998). The difficulty with this 
approach is that considerable resources would be required to obtain reliable willingness- 
to-pay values for all relevant ages. The second approach involves discounting 
willingness to pay over the latency period, using an appropriate discount rate (Cropper 
and Sussman, 1990; Cropper and Freeman, 1991). It relies on obtaining accurate values
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for willingness to pay at different ages and discounting these estimates back to the 
present. “The advantage of this approach is that the analyst can use discount rates 
compatible with other parts of the benefit-cost analysis being performed” (Cropper,
This section describes the model that Cropper and Sussman (1990) used to 
demonstrate that individuals discount future risks to themselves at the consumption rate 
of interest, which equals the market rate of interest in the case of perfect capital 
markets. Like Shepard and Zeckhauser (1982), the ‘life cycle utility model’ (Cropper 
and Sussman, 1990) was developed using the framework of the ‘life cycle consumption 
saving model with uncertain lifetime’ (Yaari, 1965). The main differences between 
Cropper and Sussman’s model and that developed by Shepard and Zeckhauser are: (i) 
Cropper and Sussman analysed changes in future risks of death while Shepard and 
Zeckhauser investigated current risk of death over the life cycle; (ii) Cropper and 
Sussman presented a discrete-time version of the life cycle model. Both models 
investigated willingness to pay for reductions in risk of death with and without the 
presence of capital and insurance markets.
Cropper and Sussman (1990) assumed that the individual has a probability 
distribution over the date of his or her death. The expected lifetime utility at age (/), (VJ), 
is the sum of the utility of living exactly ( t - j )  more years multiplied by the probability of 








is the expected lifetime utility at age (/);
represents the individual’s current age;
equal to the oldest age to which the individual can survive;
is the the probability that the individual at age (/) dies at age (t), just
before he or she completes age (t+1). It follows that
f  T  ^
(pj,t> 0, t = j ,j  + l,...,T) and = 1 ;
\ t=J J
U(ct)
is the utility of consumption in years (j) to (t);
is the period utility of consumption, assumed to be increasing in (ct), 
strictly concave, and bounded from below;
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It is assumed that the utility of consumption is additively separable, implying 
that equation (71) may be written as:
V1 = Y j (\ + p y - ‘.q1,,Ul(c ) ,  (72)
‘=j
where:
p is the discount rate;
qjit is the probability that the individual survives to age (t), given that he or
she is alive at age (/). This is equal to the probability that the individual
(  t
dies at age (t) or later:
Equation (72) assumes that the utility of living depends only on consumption 
and not on length of life, and that survival probabilities are exogenous to the individual. 
The individual faces the problem of maximising his or her expected lifetime utility from 
age (/) until (7) by choosing his or her consumption at each age, given his or her initial 
wealth, (Wj), annual earnings, (yt, t = j, j + l,...,T), and capital market opportunities. It 
is assumed, initially, that the individual can save by purchasing actuarially fair annuities 
and borrow via life insurance loans. These assumptions are relaxed later in order to 
evaluate how the capital market imperfections affect the discount rates at which 
willingness to pay for a future risk must be discounted to the present.
>  Actuarially Fair Annuities Case
In the presence of fair annuities, an individual who invests (57) at the beginning 
of his or her (/th) year will receive (5(7 +Rj)) at the end of the year with probability (7- 
Dj) and nothing with probability ( D j ) .  For the annuity to be fair (RJ) must satisfy:
(l + R j).(\-D /) = \ + r ,  (73)
where
Dt is the conditional probability of dying at age (t). Follows that (Dt=1);
1-D( is the probability that the individual survives to age (t+1), given that he
is alive at age (t), that is,
v j
(r) represents the risk-less rate of interest. Since ( R j  > r), an individual who
can save via fair annuities will prefer to do so. It is assumed that the individual can also 
borrow at the actuarial rate of interest. The individual’s budget constraint requires that
83
the present value of borrowing, discounted at the actuarial rate of interest, equals the 
value of initial wealth:
= (77)
Fla+&r‘
t= j  L imJ
Equation (74) is equivalent to requiring that the present value of expected 
consumption equals the present value of lifetime earnings plus initial wealth:
f i qj,,(l + rY -.c , =j?qt,l.(l + r)J-'.yl + Wj (75)
‘=j t=j
The pattern of consumption over the lifetime is determined by maximising (72) 
subject to (75). The correspondent Lagrangian function is:
L M )  = £ ( 1  + p )J-,qj,i.U(ci) - 1  + r)1" .a  -j^qj.-.Q  + r)H .y, -  Wj} (76)
t=j t=j t=j
The first order condition states that:
8L(c'’h )  = (1 + p y - ‘.qj, (c,) -  h-qj, <.(1 + r)H  = 0 , or
OCt
(1 + r)H
( \ + Py
Using equation (77) and assuming ( t = j ) ,  it is observed that the marginal utility 
of consumption at age (j) equals the marginal utility of income in year (/), that is, 
U'{cj) = Aj. Combining these results, the optimal path of consumption must satisfy:
U \c,) = U'(c,).f  + r y ' t = j + l ,. ..T  (78)
(1 + p Y '
Cropper and Sussman (1990) then analysed how government regulation affects 
individuals’ lifetime utility, by assuming that a government regulation alters the 
probability that a person dies in any year, given that this person is alive at the beginning 
of that year. That is, government regulation alters the conditional probability of dying at 
age (k), (Dk). The authors emphasise that when the conditional probability of death is 
altered at age (k), it affects the probability of surviving to ages (k+1) and 
beyond: qJ,k + \i q j ,k  + 2, . That follows from the repeated use of the definition of
(A):
q j , k = (1 -  -  Dj + i)...(l - D k - 1) (79)
Formally, the individual’s willingness to pay at age (/') for a change in (Dk), 
(WTPjk), is the wealth that must be taken from him or her at age (/) to compensate him
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or her for a reduction on the conditional probability of dying at age (k), (Dk), and keep 
his or her expected utility constant. That is:
dVj
WTPj,k = -t% -d D k  (80)dVj
~dWj
The first term in the right hand side of (80) is the rate at which the individual is 
willing to substitute wealth for risk. Using the Envelop Theorem in the Lagrangian 
function (76) yielded by the maximisation of (72) subject to (75), (WTPjtk) can be 
represented:
T
WTPj,k = dDk (81)(l-D *)-' £<,y,4 (l + p y -'.t /(c ,H -1 +(l + ry-'.0*-c,)]
f=*+l
That is, “willingness to pay at age (j) for a change in the conditional probability 
of death at age (£) equals the loss in expected utility from age (k+1) onward, converted 
to dollars by dividing by the marginal utility of income in year (j), (Xj). Added to this is 
the effect of a change in (Dk) on the budget constraint. A reduction in (Dk) makes the 
individual wealthier by increasing the present value of his expected lifetime earnings 
from age (k+1) onward. An increase in survival probabilities, however, decreases the 
consumption that the person can afford in years (k+1) through (T), and his or her 
willingness to pay is reduced by the present value of this amount” (Cropper and 
Sussman, 1990).
Equation (81) is then used to investigate the relationship between willingness to 
pay at age (f=20) for a change in probability of death at age (k=40) and willingness to 
pay at age (j=40) for the same reduction. The authors found that (WTP2o,4o) was equal to 
(WTP40jo) discounted to age (j=20), where the rate of discount in each year (/) is the 
rate at which the individual is willing to trade consumption in year (t) for consumption 
in year (t+1):
WTPj,k = Tj,kWTPk,k, (82)
k-1
where the discount factor equals r M = n a + * < r ’ (83>
t=j
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and U R  WTPj + i,k U \cj)
1 WTPj.k U '(cj*1)
Equations (82) to (84) suggest that, if estimates of willingness to pay for a 
change in conditional probability of death in the future (WTP^k) can be extrapolated 
using labour market or contingent valuation data, then they can be discounted to 
estimate willingness to pay today for future risks changes (WTPjjt).
>  No Net-Borrowing Case
Cropper and Sussman (1990) also considered the possibility that actuarially fair 
annuities are not available, in order to investigate how it would affect the rate at which 
willingness to pay for a future risk is discounted to the present. The result that 
willingness to pay for a future risk is discounted at the consumption rate of interest, 
(84), defined as the marginal rate of substitution between (ct+j) and (ct) minus one, still 
holds. The consumption rate of interest, however, exceeds the market rate of interest if 
the individual’s consumption is constrained by income (early lifetime). Supposing that 
the individual can borrow and lend at the risk-less rate, (r), but constrained by no non­
negative wealth at the beginning of each period, implies that the present discounted 
value of (Wt) must be non-negative for each (/):
t
Wi + £ 0 * - a ) . ( 1 + r)hk £ 0  j < t < T (85)
k=j
The correspondent Lagrangian function is:
T t
L(c,,X,) = £  (1 + p)<-'.q,.,U(a) + A.,.{Wj + £ .(1  + r)'-* .(>* -  a)} (86)
t=j
The first order conditions state that:
8L(-C'’^  = ( i + Py - ‘.qi,,.u'(c,) -  4 .(1 + ry -  = o ,
8L(c,,X,) ^ .  = 0 , ^  > 0 and (U) + V .(1 + r)J' k.(> » -c*)}> 0  (87)
^ 2 ja *  ’ ' f t
Then, (88)
21 This can be shown by substituting equation (84) in the optimal path o f consumption (89) and assuming 
Ct=j+l).
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and {Wj + j ]  .(1 + r)J k .(yk -  Ck)} = 0 when Af > 0
k=j
Using equation (88) and assuming ( t = j ) ,  it is observed that the marginal utility
22of income in year (j) equals the marginal utility of consumption, that is, U'(cj) = A/ . 
Combining these results, the optimal path of consumption must satisfy:
t = j + l,. ..T  (89)
q,., (1 + p y
The resulting willingness to pay for future risk in the no-net-borrowing case is:
i + a = wI L p  - . o - d jY ' -a+ p ) (90)WTPj,k U(cj + i)
In the case where the wealth constraint is not binding, the consumption rate of 
interest equals the market rate of interest (St = r) and the discount factor, (/],*)> can be 
estimated from market interest rates. However, if the wealth constraint is binding, then 
to obtain discount rates (<$) by age is more complicated.
Cropper and Sussman (1990) conducted an empirical simulation using US data 
on earnings and mortality rates and solving the model for an isoelastic utility function . 
Table 3 shows the authors’ estimates of the rates at which future willingness to pay 
would be discounted back to age (18), under different assumptions about individuals’ 
borrowing opportunities and different ages. These discount factors assume a market rate 
of interest of (0.05) and the US mortality rates for white males.
The authors also inferred the magnitude of (WTP/$ *) from previous willingness- 
to-pay estimates to reduce current risk of death by people of different ages obtained by 
Jones-Lee et al. (1985) in a survey conducted in the United Kingdom. The resulting 
(WTPi8,k) was obtained by multiplying (WTPk,k) by the appropriate discount factor from 
Table 3. The results shown in Table 4 suggest that, with these assumptions, the 
willingness to pay at age (18) for a reduced probability of death at age (60), (WTPis,6o) 
is approximately one-twentieth of (WTP6o,6o\ the willingness to pay at age (60) for a 
reduced probability of death at age (60) discounted to age (18).
22 In fact, U' (Cj).qj, j  =  Aj . But (qjj = 1) since, by definition, (qjj) is the probability that the individual 
survives to his (jth) birthday, given that he or she is alive at age (j).
23 U(c) = c02
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(«> ( /« * )
Not binding 
(J l+r / " “ )
18 0.124 1.000 1.000 1.000
20 0.119 0.793 0.907 0.904
25 0.106 0.462 0.711 0.701
30 0.093 0.286 0.557 0.545
35 0.082 0.187 0.436 0.424
40 0.050 0.136 0.342 0.328
45 0.050 0.107 0.268 0.253
50 0.050 0.084 0.210 0.193
55 0.050 0.066 0.164 0.144
60 0.050 0.051 0.129 0.105
65 0.050 0.040 0.101 0.074
Source: Cropper and Sussman (1990) -  Assuming p  = r = 5%.
Notes: (p) is the individuals’ rate o f time preference; (4 )  is the consumption rate o f interest; (r) is the 
market rate o f interest; and (/}«,*) is the discount factor applied to WTP for a current risk reduction to 
estimate WTP for a risk reduction in the future.
Table 4: Willingness to pay at age 18 for a reduction in risk of death at Age k  - the
UK survey (Million 1985 US$)
(*) (H T P u M JS S
CO**)








Source: Cropper and Sussman (1990)
Note: WTPk, k is age-dependent WTP for current risk reduction provided by Jones-Lee et al. (1985), 
converted to dollars using 1985 exchange rate (£1 = $1.30). W TP18jk was obtained by
multiplying WTP^ k by the appropriate discount factor from Table 3.
3.3. Conclusions
A theoretical literature review was undertaken in this chapter, exploring the 
different perspectives to establish appropriate economic values for changes in risks of 
death. The main approaches used to estimate the value of a statistical life were 
described, namely the human capital approach and the willingness-to-pay approach. 
Their weaknesses and strengths were discussed and the relevant empirical methods were 
formalised -  the averting behaviour, the ‘compensating-wage’, the hedonic property 
value, and the contingent valuation methods.
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This chapter provided the basis for the empirical work in Sao Paulo, Brazil, 
undertaken to estimate the value of a statistical life and the value of a life year lost in 
Brazil as well as the willingness to pay for a reduction in individuals’ risk of death and 
the impact of age and health status in willingness-to-pay estimates. This empirical 
study, described in Chapter 5, used the willingness-to-pay approach, the contingent 
valuation method, and the willingness-to-pay metric. Additionally, most of the issues 
discussed in this literature review, which are related to the willingness-to-pay approach 
and the contingent valuation method, were considered in the empirical work (Chapter 5) 
and also in the discussion of the research questions (Chapter 6).
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4. Literature review of empirical studies
Following the theoretical literature review presented in Chapter 3, this Chapter 
provides a review of the main empirical studies that have estimated the willingness to 
pay to reduce risks of death or the willingness to accept higher risks and, therefore, the 
value of a statistical life. This empirical literature review focuses on ‘compensating- 
wage’ studies (section 4.1), contingent valuation studies (section 4.2), as well as 
averting behaviour studies (section 4.3). Section 4.4 discusses some issues involved in 
risks to life valuations, starting with issues related to the ‘compensating-wage’ method 
and then those specific issues regarding the contingent valuation method. The following 
are discussed: moral and ethical issues involved in risk to death valuation, and how 
economists deal with altruism when estimating willingness-to-pay measures, a common 
concern in the air pollution context. Section 4.5 introduces alternative metrics to the 
value of a statistical life commonly discussed in the medical literature (health indices) 
and specifically in the context of air pollution (the value of a statistical life year - 
VSLY). Finally, some conclusions are presented.
4.1. ‘Compensating-wage’ studies
This section discusses the studies that have used the ‘compensating-wage’ 
method and benefits from detailed literature reviews performed by Viscusi and Aldy 
(2003), Neumann et a l (2001), Mrozek and Taylor (2002), Day (1999), and Black et a l 
(2003). Neumann et a l (2001) argue that existing literature reviews of the value of a 
statistical life can be divided in two categories: narrative literature reviews and meta­
analyses. The first category involves discussion and synthesis of the trends, arguments, 
and uncertainties within the literature (e.g. Fisher et a l  1989; Miller, 1990, Viscusi, 
1993), which consists primarily of a qualitative analysis of the studies, although 
summary statistics of the value of a statistical life are in general presented. Meta­
analysis includes both a narrative discussion of the literature and a quantitative analysis 
of the value of statistical life estimates, where the value of a statistical life is regressed 
(dependent variable) against variables that describe the data set analysed and relevant 
aspects of each study (Neumann et a l (2001). Some relevant meta-analysis studies are 
reviewed below, given that this category of the value of a statistical life literature review 
is more detailed than narrative studies.
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Viscusi and Aldy (2003) have identified more than thirty studies of 
compensating differentials for risk in the US labour market and another twenty-two 
outside the US, which included studies of wage-risk trade-offs in labour markets in 
Australia, Austria, Canada, Japan, and the United Kingdom. In developing countries, 
the studies focused on Asia: Hong Kong, India, South Korea, and Taiwan. The studies 
were evaluated according to the sample data used and the risk variable evaluated. The 
results were summarised by non-US and US-based studies (Table 5).
Regarding the US studies, the authors observed that some of them evaluated the 
wage-risk trade-off for the entire labour force while others focused on sub-samples for 
specific occupations, for example police officers (Low and McPheters, 1983). Also, 
studies were carried out for specific States (South Carolina in Butler, 1983); blue-collar 
workers only (Dorman and Hagstrom, 1998 and Fairris, 1989); males only (Berger and 
Gabriel, 1991); and union members only (Dillingham and Smith 1984).
Half of the studies of the US labour market reviewed by Viscusi and Aldy 
(2003) revealed a value of a statistical life range from US$5 million to US$12 million 
(2000 dollars). Estimates below the US$5 million value were most frequent among 
studies that used the Society of Actuaries data24, which includes workers who have self­
selected themselves into jobs that are an order of magnitude riskier than the average 
(across 37 occupations included in the Society of Actuaries data set, the annual risk 
averaged approximately 1 in 1000). Studies producing estimates beyond US$12 million 
used structural methods that did not estimate the wage-risk trade-off directly, or were 
derived from studies in which the authors reported unstable estimates of the value of a 
statistical life (Viscusi and Aldy, 2003). The authors estimated that the median value of 
a statistical life in the US was about US$7 million, which was in line with the estimates 
from the reviewed studies that they regarded as the most reliable.
Viscusi and Aldy (2003) argued that a relevant research issue of policy 
importance is the effect of income levels on the wage-risk trade-off. According to the 
authors, Hamermesh (1999) noted that as wage inequality has increased over time, on- 
the-job mortality risks have diverged. Hamermesh (1999) concluded that workplace 
safety is highly income-elastic, which is in line with the findings of Viscusi (1978b) that 
the value of a statistical life increases with the wealth of the worker. Similarly, Viscusi 
and Evans (1990) estimated the income elasticity of the value of statistical job injury
24 The Society o f Actuaries data set provides fatality risk data for 37 occupations for 1967.
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risks to be 0.6 to 1.0 in the US. Using meta-analysis of several ‘compensating-wage’ 
studies in several countries, Viscusi and Aldy (2003) concluded that income elasticity of 
the value of a statistical life ranged between 0.5 and 0.6. However, Day (1999) 
suggested different figures using similar meta-analysis, although the author highlights 
that his results are dependent on the specification of the meta-analysis model. The 
figures ranged between 0.36 and 0.55 using a log model -  the dependent variable was 
the natural log of the value of a statistical life, and between 2.65 and 3.56 using a linear 
model. Neumann et al. (2001) suggested in their meta-analysis an income elasticity of 
the value of a statistical life ranging between 0.86 and 1.3, depending on model 
specification.
Another point raised by Viscusi and Aldy (2003) was that some studies 
attempted to explore the effect of occupational diseases, instead of focusing on the risk 
of accidental death or injuries. For example, Lott and Manning (2000) evaluated the 
effect of workers’ exposure to carcinogen on their wages. Also, Viscusi and Aldy 
(2003) observed that several early papers in the literature did not find statistically 
significant compensating differentials for on-the-job mortality risk. As an example, the 
authors mentioned Leigh (1981), who estimated a risk premium for injuries but not for 
fatalities; Dorsey (1983) who did not find a mortality-based risk premium; and more 
recent papers by Leigh (1995) and Dorman and Hagstrom (1998) who also did not find 
compensating differentials in many model specifications.
According to Viscusi and Aldy (2003), Marin and Psacharopoulos (1982) 
undertook the first hedonic labour market analysis of job risks outside of the United 
States in their study of the UK labour market. Based on wage and risk data from the 
1970s, Marin and Psacharopoulos (1982) estimated a value of a statistical life of about 
US$3.5 million. Arabsheibani and Marin (2000) replicated the same analysis for the 
United Kingdom by employing a similar methodology and more recent wage and risk 
data from the same sources as in the original study. Arabsheibani and Marin (2000) 
estimated a higher value of a statistical life than did Marin and Psacharopoulos (1982). 
While the evaluation of the whole UK labour force yielded a relatively large value of a 
statistical life of about US$18 million, sub-samples of non-manual workers resulted in 
the value of a statistical life ranging up to US$68 million. Viscusi and Aldy (2003) 
concluded that the results from several studies in the UK revealed compensating 
differentials in the order of 10% of total worker wage income, which are substantially 
larger than in other developed countries and can be attributed to the correlation between
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the risk measure and other unobservable variables that may yield important returns to 
the worker (the issue of unobservables is discussed in Section 4.4.1).
Canadian studies produced compensating differentials more in line with the US 
experience than with the evidence from the UK labour market (Viscusi and Aldy, 2003). 
Most Canadian labour market values of a statistical life fell within the range of US$3 -  
US$6 million. The authors show that with the exception of some UK studies, the 
compensating differentials estimated in developed country analyses found risk 
premiums ranging between 1 and 2 per cent of labour income , which is a result 
consistent with the findings of Duncan and Holmlund (1983). These authors estimated a 
positive wage differential for dangerous jobs on the order of about 2 per cent of wages 
in Sweden.
Viscusi and Aldy (2003) listed studies in some of the newly industrialised 
countries of Asia, like Hong Kong, South Korea, and Taiwan. The authors noted that 
these countries had on-the-job mortality risks three to five times greater than the 
average in Australia, the US, and the UK. Additionally, the average worker earnings in 
these Asian countries were two to four times lower than labour earnings in developed 
countries. For example, Kim and Fishback (1999) studied the South Korean labour 
market over the 1984 -  1990 period using the unit of observation at the industry level, 
unlike the studies in the developed countries, which employed worker-level data. Kim 
and Fishback (1999) estimated the value of a statistical life as approximately US$0.5 
million in South Korea, about 94 times the average annual earnings of workers. 
Similarly, Siebert and Wei (1998) estimated a value of a statistical life for Hong Kong 
that was even larger than the Korean estimate, and the ratio of value of a statistical life 
to average annual earnings for Hong Kong was about 150. Viscusi and Aldy (2003) 
concluded that these estimates are of the same order of magnitude as the ratio observed 
in the US labour market.
Other studies in Asian countries included Liu, Hammitt, and Liu (1997) and Liu 
and Hammitt (1999), which estimated the wage-risk trade-off in Taiwan. The first study 
focused on all non-agricultural workers while the second based their analysis on in- 
person surveys of petrochemical workers. According to Viscusi and Aldy (2003), 
workers’ risk perceptions in the petrochemical industry yielded a mortality risk rate 
about 35 per cent greater than the rate published by the Taiwan Labour Insurance
25 Mean risk levels between 1 in 10,000 and 3 in 10,000 (Table 5).
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Agency, the data source used by Liu, Hammitt, and Liu (1997). In addition, 
petrochemical workers faced higher average mortality risks (perceived and measured) 
than the average non-agricultural workers in Taiwan. However, the higher wages and 
income associated with petrochemical workers in 1995 relative to the broader workforce 
in the early to mid 1980s possibly explains why Liu and Hammitt (1999) estimated the 
value of a statistical life at about twice the one estimated by Liu, Hammitt, and Liu
(1997).
Finally, Viscusi and Aldy (2003) argue that estimates for the Indian labour 
market produced a value of a statistical life greater than figures for other developing 
countries despite the fact that per capita, income in India was an order of magnitude 
smaller than in other developing countries. Shanmugam (1996, 1997, 2000, 2001) 
estimated the wage-risk trade-off using survey data of manufacturing workers in 
Madras, India, in 1990. The estimates of the value of a statistical life from these studies 
in India were very different, even though they reflected the same wage and risk data, 
which can illustrate how value of a statistical life estimates can be sensitive to different 
econometric specifications, Viscusi and Aldy (2003) concluded. Table 5 summarises the 
findings of Viscusi and Aldy (2003).
Table 5: Summary of Labour Market Studies of the Value of a Statistical Life





Smith (1974) Current Population Survey 
(CPS) 1967, Census o f 
Manufacturers 1963, US 
Census 1960,Employment 
and Earnings 1963.
Bureau o f Labour 
Statistics (BLS) 1966, 
67
0.000125 9.2
Thaler and Rosen 
(1975)
Survey o f Economic 
Opportunity 1967
Society o f Actuaries 
1967
0.001 1.0
Smith (1976) CPS 1967,1973 BLS 1966, 67, 70 0.0001 5.9
Viscusi
(1978,1979)
Survey o f Working 
Conditions (SWC), 1969- 
1970
BLS 1969, subjective 
risk o f job (SWC)
0.0001 5.3
Brown (1980) National Longitudinal 
Survey o f Young Men 1966- 
71, 1973
Society o f Actuaries 
1967
0.002 1.9
Viscusi (1981) Panel Study o f Income 
Dynamics (PSID) 1976
BLS 1973-76 0.0001 8.3
Olson (1981) CPS 1978 BLS 1973 0.0001 6.7
Arnould and 
Nichols (1983)
US Census 1970 Society o f Actuaries 
1967
0.001 0.5-1.3











1976 (police officer wages)
Constructed a risk 
measure from DOJ/FBI 
police officers killed 
data for 72 cities
0.0003 1.4
Dorsey and Walzer 
(1983)
CPS May 1978 BLS 1976 0.000052 11.8,12.3
Leigh and Folsom 
(1984)
PSID 1974; Quality o f 
Employment Survey (QES) 
1977
BLS 0.0001 10.1-13.3
Smith and Gilbert 
(1984, 1985)
CPS 1978 BLS 1975 Na 0.9
Dillingham and 
Smith (1984)
CPS May 1979 BLS industry data 
1976, 79; NY Workers’ 
Comp Data 1970
0.000082 4.1-8.3







Leigh (1987) QES 1977; CPS 1977 BLS Na 13.3
Moore and Viscusi 
(1988)









Moore and Viscusi 
(1988)
QES 1977 BLS, discounted 
expected life years lost; 
subjective risk o f job 
(QES)
0.00006 9.7
Garen (1988) PSID 1981-1982 BLS 1980, 81 0.000108 17.3
Viscusi and Moore 
(1989)






US Census 1970 BLS 1969 0.000097 11.7
Moore and Viscusi 
(1990)




Kniesner and Leeth 
(1991)





Author’s mail survey 1984 Workers’ assessed 
fatality risk at work 
1984
0.0009 2.1
Leigh (1991) QES 1972-73, QES 1977, 
PSID 1974, 81, Longitudinal 
QES 1973-1977, CPS 1977
BLS 1979, Workers’ 
Compensation data 
from 11 states 1977-80
0.000134 7.1-15.3
Berger and Gabriel 
(1991)
US Census 1980 BLS 1979 0.00008-
0.000097
8.6-10.9
Leigh (1995) PSID 1981, CPS 1977, QES 
1977







PSID 1982 BLS 1979-81, 1983, 





Lott and Manning 
(2000)


















Weiss, Meier and 
Gerking (1986) 
Austria
Austrian Microcensus File 
o f Central Bureau o f 
Statistics 1981
Austrian Social 
Insurance Data on Job- 





National Survey of Class 
Structure and Labour 
Process 1981
Labour Canada and 
Quebec Occupational 
Health and Safety 
Board 1981
0.00019 3.9-4.7
Meng and Smith 
(1990)
Canada
National Election Study 
1984
Labour Canada and 
Quebec Occupational 
Health and Safety 
Board 1981-83
0.00012 6.5-10.3





Yearbook o f Labour 
Statistics (Japan)
0.00003 9.7










and Girrard (1992) 
Canada








Labour Market Activity 
Survey 1986
Labour Canada and 
Statistics Canada 1986
0.00025 2.2-6.8
Kim and Fishback 
(1993)
South Korea
Ministry o f Labour’s Report 
on Monthly Labour Survey 
and Survey on Basic 
Statistics for the Wage 
Structures
Ministry o f Labour’s 
Analysis for Industrial 
Accidents
0.000485 0.8
Siebert and Wei 
(1994)
UK
General Household Survey 
1983
Health and Safety 
Executive (HSE) 1986- 
88
0.000038 9.4-11.5
Lanoie, Pedro and 
Latour (1995) 
Canada
Authors, in-person survey 
1990




Sandy and Elliot 
(1996)
UK
Social Change and 










Authors’ survey o f blue 
collar manufacturing 
workers, Madras, India 1990
Administrative Report 
o f Factories Act 1987- 
90
0.000104 1.2-1.5
Liu, Hammitt and 
Liu (1997) 
Taiwan








Miller, Mulvey and 
Norris (1997) 
Australia
Australian Census of 




Health and Safety 
Commission 1992-93
0.000068 11.3-19.1
Siebert and Wei 
(1998)
Hong Kong
Hong Kong Census 1991 Labour Department 0.000139 1.7
Liu and Hammitt 
(1999)
Taiwan
Authors’ survey of 
petrochemical workers 1995
Workers’ assessed 




Meng and Smith 
(1999)
Canada
















Author’s survey o f blue 
collar manufacturing 
workers, Madras, India 1990
Administrative report 





Author’s survey o f  blue 
collar manufacturing 
workers, Madras, India 1990
Administrative report 




Siebert and Wei 
(2001)
UK





Source: Viscusi and Aldy (2003)
Other meta-analysis studies also investigated a range of ‘compensating-wages’ 
estimates of the value of a statistical life, associating these estimates with the 
characteristics of each particular ‘compensating-wages’ study to propose a range of 
estimates based on ‘good practices’. For example, Mrozek and Taylor (2002) obtained 
data on 203 estimates of the value of a statistical life from 33 different ‘compensating- 
wage’ studies. As a result of the meta-analysis, the authors considered a number of 
‘best-practice’ assumptions regarding methodologies and datasets to recommend a value 
of a statistical life ranging between US$1.5 and US$2.5 million. Mrozek and Taylor 
(2002) claimed that an advantage of their value of a statistical life figures is that they 
were developed using the evidence from the entire literature, not only a few preferred 
studies or estimates.
In contrast to Mrozek and Taylor (2002), Neumann et a l (2001) meta-analysis 
considered not only the ‘compensating-wage’ studies, but all legitimate values of a 
statistical life study identified, including ‘compensating-wage’, contingent valuation and 
consumer (averting) behaviour studies based on individual willingness to pay. The 
authors claimed that by doing so they allowed the statistical analysis to reveal any 
systematic effects on the value of a statistical life estimates due to inappropriate 
methodologies or datasets rather than completely eliminating such studies. Another 
difference of Neumann et a l (2001) meta-analysis regards the use of only one value of a 
statistical life per study, that is, the authors’ preferred ones. When the author of a 
specific study recommended a range of values Neumann et a l (2001) used the interval 
midpoint, resulting in 60 estimates/studies considered suitable for the meta-analysis. 
Neumann et a l (2001) predicted mean values of a statistical life under various
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assumptions regarding income levels and study type (‘compensating-wage’, contingent 
valuation and averting behaviour). The estimates ranged between US$3.4 and US$4.7 
million (2001) for consumer market studies; between US$5.6 and US$7.8 million for 
contingent valuation studies; and between US$7.0 and US$9.7 million for 
‘compensating-wage’ studies.
Day (1999) also performed a meta-analysis of 60 estimates of the value of a 
statistical life reported in 16 different ‘compensating-wage’ studies. Using the results of 
this meta-analysis (a meta-regression), and assuming a preferred specification of the 
model (assuming a log distribution of the estimates of the value of a statistical life and 
excluding baseline risk as a covariate) and different ‘best-values’ for the covariates, Day 
(1999) presented a ‘best’ estimate of the value of a statistical life. The estimate, 
US$5.63 million, was lower than the value of a statistical life estimated at the mean 
values of the data (US$9.12 million), which lead the author to conclude that the net 
effect of the biases identified in the estimation of the wage-risk equations was to 
increase the value of a statistical life. Table 6 summarises the results of meta-analysis 
studies that suggested values of statistical lives.
Table 6:Summary of meta-analysis studies on the value of a statistical life (US$
million)
Author (year) Study type used in meta-analysis VSL (year)
N e u m a n n s  al. (2001)
Averting behaviour 3 .4 -4 .7  (2001)
Contingent valuation 5 .6 -7 .8  (2001)
‘Compensating-wage’ 7 .0 -9 .7 (2 0 0 1 )
Mrozek and Taylor (2002) ‘Compensating-wage’ 1 .5 -2 .5  (2001)
Day (1999) ‘Compensating-wage ’ 5.6 (1996)
4.2. Contingent valuation studies
Hammitt and Graham (1999) conducted a literature search of willingness-to-pay 
studies published since 1980. They focused on studies that (i) addressed an intervention 
designed to protect or enhance human health or safety, (ii) reported willingness-to-pay 
information elicited using survey methods, and (iii) attempted to link willingness-to-pay 
responses to specific changes in probability of death, illness, and/or non-fatal injury. 
The studies reviewed dealt with a large range of risks, from medical treatments to 
hazardous waste management, the most frequent topic involving traffic safety. None of 
these studies regarded air pollution reduction programmes and consequent changes in 
risks of death.
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In the context of mortality risk associated with air pollution, some recent studies 
have used the contingent valuation framework to elicit willingness to pay data for a 
reduction in risks of death (Krupnick et a l 1998, 1999, 2002; Alberini et al. 1997, 
2001; Cifuentes et al. 1999; NewExt, 2002). The common feature of these studies is that 
they all reject ‘compensating-wages’ estimates of the value of a statistical life for 
evaluating risk changes produced by air pollution reduction programmes. The main 
reason they give is that ‘compensating-wage’ estimates are measures of compensation 
received by working-aged individuals for immediate risk reductions whilst, according to 
the epidemiologic literature, the significant correlation between air pollutants and deaths 
occurs among people over the age of 65 (Pope et al. 1995; Schwartz, 1991, 1993; 
Schwartz and Dockery, 1992a, 1992b; Gouveia and Fletcher, 2000; Saldiva et al., 
1995).
Krupnick et a l (1998) presented the preliminary results of a survey instrument 
developed to fill some gaps in the contingent valuation literature concerning the 
elicitation of willingness to pay data for a reduction in risk of death. The gaps are 
related to the internal inconsistency (also cited by Hammitt and Graham, 1999), that is, 
the way individuals misperceive small changes in their risk of death. The authors 
believed that part of this misperception is due to the way changes in risk are presented 
to the respondents, and attempted to develop a survey instrument that introduced basic 
concepts of probabilities. The first section of this instrument also proposed simple 
practice questions to familiarise the respondents with the probability concepts 
introduced. The second section presented leading-age and gender-specific causes of 
death and introduced common risk-mitigating behaviours, and the third section educated 
the respondents about the costs associated with risk-mitigating behaviours. The final 
section elicited information about the willingness to pay for risk reductions of a given 
magnitude that occur at a specified time.
The willingness-to-pay section of the instrument presented by Krupnick et al
(1998) started by introducing a baseline risk specific for the respondents’ age and 
gender. The respondent was then asked to consider two risk reductions occurring over 
the next ten years: the first risk reduction reduces the baseline risk by 5 in 1,000, while 
the second change reduces the baseline risk by 1 in 1000. The willingness-to-pay 
questions were then presented to the respondents for each baseline risk reduction, and 
finally another willingness-to-pay question was introduced concerning future risk 
reductions. This last question is specifically important for valuing environmental
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improvements related to conventional air pollutants and carcinogens, given that the 
benefits related to the risk reduction involved occurs in the future while the costs of 
implementing such improvements are incurred in the present (Section 4.4, Future Risks 
to Life).
The results of the questionnaire pre-tests conducted by Krupnick et a l (1998) 
indicated that individuals were able to distinguish between different magnitudes of 
small probabilities and also were able to make judgements about future risks. This 
instrument, or related variations of it, was used to elicit willingness to pay for risk 
reductions and, consequently, to estimate the value of a statistical life in Canada, Japan, 
United States of America, Chile, United Kingdom, France, Italy and Spain.
Before describing the study cases, it is worth highlighting the fact that the 
general models discussed in Chapter 3 provide the theoretical basis for the basic 
contingent valuation instrument described above; supporting the willingness-to-pay 
values estimated in the study cases. Specifically, the General Life Cycle model of 
consumption (Shepard and Zeckhauser, 1982) provides the theoretical arguments 
involved in the empirical tests of how willingness-to-pay measures for reductions in 
risks of death vary with age, a common concern of the studies discussed below. 
Furthermore, the Life Cycle Utility Model (Cropper and Sussman, 1990) is the 
theoretical reference for the estimation of willingness to pay for a fatal risk reduction at 
some point in the future.
• Japan
Krupnick et a l (1999) reported the results of a pilot survey conducted in Tokyo, 
Japan. Although based on the instrument mentioned in Krupnick et a l (1998), this 
survey instrument incorporated some important improvements. It (i) targeted the 45-75 
year old population, (ii) discussed mortality risks in ten-year intervals, (iii) change in 
risk corresponded to annual risk changes, and (iv) considered the risk reduction as a 
private good. The first was appropriate considering that the goal of the survey was to 
discuss reductions in mortality risks in the context of environmental policy, and it is 
only in middle age that risks of death from cancer, cardiovascular and respiratory 
diseases become significant. The use of ten-year intervals was important because it 
allowed risks to be represented in terms of chances per 1000, which can be represented 
graphically, facilitating the respondents’ comprehension of risk concepts. Also, it 
allowed the assessment of a risk of magnitude similar to that related to air pollution
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reductions (1 in 10000) in annual risk reductions of 1 in 1000. This increased the 
general understanding of the risk changes being valued. Finally, the authors considered 
the method of delivering risk reductions as a private good, that is, not covered by health 
insurance nor delivered by environmental programmes, which reduced the risk of death 
for the whole population, not only for the respondent. This feature could make the 
respondents think of their own risk and avoids the free-rider behaviour .
The survey was conducted during February and March 1998 for a total of 316 
respondents. Although focused on individuals from 45-75 years, the survey included 
some individuals as young as 30. The sample selection involved recruiting employees in 
different companies in Tokyo, and also random selection through telephone calls. 
Respondents were assigned to two different sub samples, the first one receiving first the 
willingness-to-pay question related to the 5-in-1000 risk reduction and a subsequent 
question related to the 1-in-1000 risk reduction; the second sub sample receiving the 
willingness-to-pay questions in an inverted order. Both groups received a third 
willingness-to-pay question for a risk reduction occurring between 70-80 years. The 
willingness-to-pay questions observed the dichotomous choice format with two follow- 
up questions, and three initial values (bids).
The estimation process of median and mean willingness-to-pay measures 
combined the responses to the initial and follow-up questions to obtain the lower and 
upper bounds of the interval of the respondent’s willingness to pay. The authors 
considered that the willingness to pay followed different distributions, such as ‘F’, 
Weibull, lognormal, exponential, logistic and log logistic, and estimated the parameters 
of a maximum likelihood function .
26 Free-rider behaviour arises when individuals misrepresent their true marginal utility for the provision of 
a public good. In other words, as the public good will benefit all individuals, the respondent declines a 
payment considering he or she can free ride on other individuals’ payments.
For definitions and details o f  these distributions, refer for example to Greene (1998). In short, the ratio 
x \ /
has ‘F ’ distribution with nj and n2 degrees o f freedom, assuming that X] and x2 are
X 2 /
/  m
two independent chi-squared variables with degrees o f freedom parameters equal to n] and n2. The
1 -V Q hx- ^ / ) 2
lognormal distribution is defined as L N (jli , <j 2) =  f  (x )  =  —j = —  £  ; the logistic
V2;rox
distribution as F ( x ) = ------- — ; the Weibull density function is defined as
l + e x
101
The results of the Japanese study case were obtained assuming the Weibull 
distribution of willingness to pay. The authors claimed that their willingness-to-pay 
measures implied values of a statistical life far lower than those reported by labour 
market studies, which average around US$5 million. Furthermore, a series of tests were 
developed to determine the relationship between the willingness-to-pay estimates and 
different baseline risks, and also between willingness-to-pay measures and other 
regressors, like dummies indicating whether the respondent took into account altruism 
when answering the willingness-to-pay questions. Although the authors could not 
explain it, respondents who took into account effects on other individuals reported 
lower willingness to pay for a reduction in risk of death. The age effect was consistently 
positive, which means that older people were willing to pay more for a given risk 
reduction than younger people.
The main feature of the Japanese study was the improvement made in the survey 
instrument in order to overcome common problems in contingent valuation studies 
related to environmental risk reductions, such as future risks to life and communication 
of small risk changes. The authors developed a survey instrument that focused on 
mortality risk realised in the future and the questionnaire was administered face to face 
with extensive use of visual aids, with some cognition tests included in the instrument. 
The results demonstrated that the instrument was successful in the way that individuals 
were able to distinguish between different magnitudes of small changes in mortality 
risks, and between the same changes in risks occurring at different times.
• Canada
The Canadian study case had as its main objectives the estimation of what older 
people were willing to pay to reduce their risk of dying and the examination of the 
impact of age and current health status on willingness to pay. Krupnick et al. (2002) 
argued that the majority of statistical lives saved by environmental programmes are 
lives of old people and those with chronically impaired health. Respondents were asked 
whether they had ever been diagnosed as suffering from several diseases, like cancer 
and chronic heart or lung diseases. In addition, respondents were asked to complete a
6xd~l x e~(x~M)/p
f { x ) = — — exp(—(—)e) ; the exponential is f i x ) = ----------- ; and log-logistic is
P P P
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detailed health questionnaire28 in order to capture the severity of the disease and other 
chronic health conditions, physical and psychological. From this questionnaire it is 
possible to construct physical health scores, such as energy/vitality and general health, 
and a mental score, which measures symptoms of psychological distress.
The survey targeted people 40 to 75 years old in Hamilton, Ontario, Canada. It 
was self-administered using a computer by 930 respondents, with the help of audio and 
visual aids to communicate specific baseline risks of death and the changes in risk. 
Krupnick et al. (2002) used graphs containing 1000 squares to explain probabilities of 
death, where white squares denoted chances of surviving, red squares represented 
chances of dying, and blue squares showed reductions in the risk of dying. Also, graphs 
were used to illustrate the different timing of payments and risk reduction periods. Like 
in the Japanese case study, a ten-year risk reduction period was used and information 
was given to respondents about quantitative risk reduction associated with some 
medical and non-medical procedures, and their relative costs, before asking the 
willingness-to-pay questions. Respondents were asked if they were willing to pay for an 
abstract product that would reduce their own probabilities of death during the following 
ten years, which means that risk reductions were considered a private good.
Median and mean willingness-to-pay estimates were US$253 and US$466, 
respectively, for the 5-in-1000 risk reduction, and US$131 and US$370 for the 1-in- 
1000 risk reduction. The results presented by Krupnick et al. (2002) indicate that, 
regarding tests of risk comprehension, 11.5% of the sample gave wrong answers when 
asked which person had the higher risk of death, after different risks being represented 
using the visual aid. Also, 13% of the sample gave wrong answers when choosing 
which person they would rather be, the one with lower risks or the other, and 2.6% of 
the sample gave wrong answers to both questions. Concerning the understanding and 
acceptance of the proposed scenario, 20% of the sample did not think that the baseline 
risk of death given in the survey applied to them. Although 31% of the sample did not 
believe the abstract product proposed to reduce risks would work, only 20% said this 
fact affected their willingness to pay.
(1 + *)2
28 Short Form 36, or SF-36. Ware, J.E.Jr., Kosinski, M. and Keller, S. (1997). SF-36 Physical and Mental 
Health Summary Scales: a user’s guide manual. Lincoln: RI Quality Metric.
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Concerning the willingness-to-pay estimation process, Krupnick et a l (2002) 
used a statistical framework to model willingness to pay based on an interval- 
data/continuous-data variant of the Tobit29 model, known as the Spike30 model. It was 
justified because of the significant number of zero responses in the sample. The authors 
assumed a normal distribution for willingness to pay and adapted the Spike model to the 
sample, which included a mix of zero willingness to pay, continuous observations, and 
interval data. They also estimated a probit model trying to identify reasons for zero 
responses to willingness-to-pay questions, but there was no particular association 
between zero responses and individual characteristics, with the exception of the mental 
health score. The results showed that people with lower mental health scores were more 
likely to answer zero to willingness-to-pay questions for the risk reductions.
The authors performed a Wald test to show that mean willingness to pay for a 5- 
in-1000 risk reduction was statistically greater than the mean willingness to pay for a 1- 
in-1000 risk reduction, which means that their estimates passed the internal scope test. 
However, willingness to pay was not proportional to the size of the risk reduction. The 
respective values of a statistical life were below or equal to the age-adjusted figures 
commonly used by Health Canada and bellow the official figure used by USEPA.
One interesting result of the Canadian study regards the fact that age had no 
effect on willingness to pay until the age of 70. That means that mean willingness-to- 
pay estimates were similar across age groups up to 70 years and were about 30% lower 
for the group aged 70 or older. Another important result concerns the role of physical 
health on willingness-to-pay values, which was not significant, with the exception of 
cancer. However, this last result was based on a small sample and its credibility is 
supposed to be low. Regarding the role of the mental health score, Krupnick et a l 
(2002) concluded that people with fewer symptoms of psychological distress were 
willing to pay significantly more to reduce their chance of dying.
• United States of America
The results and specifications of the American study case are given in a 
reference paper comparing the Canadian and American results (Alberini et a l , 2001). 
From this paper, it can be concluded that the survey instrument used to elicit willingness
29 Tobin, J. (1958) “Estimation o f Relationships for Limited Dependent Variables” Econometrica, 26, 
p.24-36.
0 Kristrom, B. (1997) “Spike Models in Contingent Valuation” American Journal o f  Agricultural 
Economics, 79, p. 1013-1023.
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to pay was identical to that used in the Canadian study, which means that the 
questionnaire was self-administered on a computer, avoiding possible interviewer bias 
and allowing the use of individual-specific baseline risks. Furthermore, the same audio 
and voice aids used in the Canadian study were available in the American study to 
increase comprehension of risk changes and introduce simple probability concepts. 
Other similarities involved the use of risk reductions as a private good -  an abstract 
product that reduces each respondent’s own risk of death -  and the willingness-to-pay 
elicitation mechanism being a combination of dichotomous choice payment questions 
with follow-ups, and open-ended questions.
The sample was nationally representative of the US population for gender, age, 
race and income, recruited through a technology called Web-TV, which involves 
attaching a special device to individuals’ television sets. The respondent could use a 
remote control device or a keyboard to access the Internet using the television as a 
monitor. A firm recruited individuals to participate as panel members in exchange for 
the technology and free Internet access. The original contact and recruitment were done 
by telephone through random-digit dialling, and 1800 individuals were contacted. 
Approximately 1200 actually completed the survey. Because respondents in this study 
participated from their homes, instead of having to travel to a centralised facility like in 
other studies, it allowed the inclusion of less healthy individuals and people with 
impaired mobility.
Alberini et a l (2001) reported median and mean willingness-to-pay estimates of 
US$ 350 and US$ 770 respectively for the 5-in-1000 risk reduction; and US$ 111 and 
US$ 483 for the 1-in-1000 risk reduction. Values of a statistical life results ranged from 
US$ 700,000 to US$ 4,830,000. The statistical model of willingness to pay used to 
estimate mean values was an interval-data model based on the Weibull distribution and 
was estimated using the maximum likelihood method. The mean willingness to pay for 
the 5-in-1000 risk reduction was statistically different (Wald test) from the mean 
willingness to pay for the 1-in-1000 risk change. However, the null hypothesis of 
proportionality of mean willingness to pay with the size of the risk reduction was 
rejected, again through a Wald test.
One surprising result refers to high mental scores being positively related to the 
likelihood of having zero willingness to pay for a given risk reduction. The general 
notion is that increasing one’s chance of survival is highly valued when an individual 
has a positive view of life. The result is surprising because higher mental health scores
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imply respondents with less psychological distress, thus it would be expected that 
individuals with higher mental health scores would have a higher probability of stating a 
positive willingness to pay. Regarding respondents’ physical health, although people 
with a cancer history were numerous, their willingness-to-pay value was not statistically 
different from that of other respondents. Instead, chronic lung disease and high blood 
pressure occurrences had a statistically significant effect on willingness-to-pay values. 
Another important result refers to the absence of an age effect in willingness-to-pay 
measures. The median willingness to pay for US respondents aged 70 years or older was 
only 20% lower than that for the younger age group. However, this difference was not 
statistically significant, contributing to the authors’ conclusion that the impact of age on 
willingness to pay was modest.
• United Kingdom
Markandya et al. (2003) adapted the computerised survey instrument developed 
by Krupnick et a l (1999, 2002) to estimate the willingness to pay for mortality risk 
reductions in the UK. A pre-test of the survey instrument was conducted to identify the 
best way to adapt the survey instrument to the UK context while maintaining its 
comparability with the other European country studies and those undertaken in Canada 
and the US. The UK development work consisted initially of a series of ten in-depth 
interviews with individuals of age 40 and above, and an equal gender split. The original 
survey instrument was tested and issues of comprehension were identified. A similar 
procedure was followed in a series of three focus groups comprising eight participants 
in each group.
The final survey was conducted in 2002 in Bath where thirty-three groups of ten 
individuals answered the computerised survey instrument, constituting a total sample 
size of 330 individuals. The survey respondents were recruited by a professional 
recruitment company and were offered the equivalent of €25 incentive payment for 
their attendance. The company had the remit to recruit on a stratified random basis a 
sample that closely matched the socio-economic characteristics of the UK population, 
the area of recruitment being a 35-km radius around the city of Bath. The company used 
a mix of recruitment techniques including random digit dialling, in-street recruiting and 
snowballing. Out of 1350 eligible respondents contacted, 355 were co-operative, and 
330 actually attended. Of the 995 that were not co-operative, 560 were not able to travel 
to the survey centre and 435 did not find the incentive high enough.
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The authors claimed that the sample was not fully representative of the
population of the UK, however, descriptive analysis showed that the sample had some
similar statistics when compared with census data on the UK population. For example,
the composition of the sample is relatively even in terms of gender, the median
household income was €42,400, the mean household income was almost €44,000, and
the respondents had on average 14 years of schooling. Approximately 34 per cent of the
sample had (private) health insurance. Virtually all respondents identified themselves as
white-Caucasian; thus, no race variables were used in this study. The minimum age of
respondents was 40 and the oldest individual in the sample was 77 years old (average
*11
age was 58 years). Roughly 45 per cent of the sample was of age 60 or older .
Estimates of mean and median willingness to pay were based on a fully 
parametric model that assumed that willingness to pay follows the Weibull distribution. 
The willingness-to-pay elicitation format used was the dichotomous choice format with 
follow-up question, which allows the formation of intervals around the respondent’s 
true willingness-to-pay amount by using the responses to the initial and first follow-up 
questions. The mean willingness to pay for a 5-in-1000 immediate risk reduction was 
€736.3, while the median estimate was €387.6. These figures implied a value of a 
statistical life in the range €772,000-1,472,640.
The validity test performed in the willingness-to-pay regressions examined the 
effect of various factors on willingness to pay. Focussing on the effect of age on 
willingness to pay for the 5-in-1000 risk reduction, different functional forms were 
tried, but no meaningful association between respondent age and willingness to pay was 
detected. The authors checked if willingness to pay depended on the expected remaining 
life, and found that the coefficient of the expected remaining life was positive but 
insignificant. Possible associations between willingness to pay and baseline risk were 
checked but neither absolute nor proportional baseline risk was significantly associated 
with willingness to pay, and the coefficient on the former of the wrong sign (negative).
In a specification where age was controlled using age dummies, and individual 
characteristics of the respondent were added, higher education levels were associated 
with lower willingness-to-pay amounts. This effect was also observed in the Canadian 
and US studies, although it was not statistically significant. Income per household
31 According to the UK Office for National Statistic (Focus on People and Migration, June 2004), the age 
structure in England in 2002 was as follows: 20% between 0 and 15 years old; 64% aged between 16 and 
64, and 16% older than 65 years.
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member was positively and significantly associated with willingness to pay. In general, 
the health status did not matter, although the coefficient of the dummy variable 
indicating the presence of chronic illness was positive and significant at the 5% level. 
The coefficient of this dummy was 0.18, implying that suffering from any of the 
cardiovascular, lung or blood-pressure illness, or having had a stroke, tends to raise 
willingness to pay by about 20 per cent in the UK.
Regarding willingness to pay for a future risk reduction, the authors found that it 
tended to increase with the (log) chance of surviving to age 70 and to decrease if the 
individual thought his or her health would be worse in the future. Other variables did 
not matter, with the only exception of the presence of chronic illness among relatives.
• France
Desaigues et a l (2003) described the application of the questionnaire of 
Krupnick et a l (1998, 2000) in France. The original questionnaire was administered to 
299 individuals, but in contrast to the UK and Italy, an open question was added after 
each set of bids; at the end of the questionnaire the willingness-to-pay values were 
recalled to give the respondents the opportunity to correct their values. In addition 
several variants were tested on samples of about 50 each, in particular variants phrased 
in terms of life expectancy gain. From the total sample, 151 answered the sequence SI 
(first 5-in-1000 then 1-in-1000 risk reduction) and 148 answered the sequence S2 (first 
1-in-1000 then 5-in-1000).
Interviewees were recruited by a private marketing firm, using the French quota 
system to be representative, in age, sex and income, of the population of Strasbourg. 
They were paid €20 to attend the interview. It was observed that 269 individuals (90%) 
had private health insurance to supplement the social security system. 51% of the 
sample thought that their health was comparable to the rest of their age group, 38% that 
it was better than the rest of their age group, and 11% that it was worse. The authors 
claimed that the respondents had trouble understanding probabilities (23% failed the 
first probability test, 22% chose the wrong person in the second probability test and the 
wrong person in probability choice) but learnt fast to correct their answer. 18% of the 
respondents acknowledged a poor comprehension of probabilities.
Regarding the different sequences of risk reduction presented to respondents, S1 
and S2, the authors concluded that the second wave showed a higher number of zeros. 
This suggests that the mental exercise seems to be more difficult. The starting
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probability reduction (1 in 1000) was perceived as too low; respondents who stated a 
positive willingness to pay could not increase their willingness to pay for a 5-in-1000 
risk reduction, correcting more often the first stated value. The ratio (willingness to pay 
for 5-in-1000)/(willingness to pay for 1-in-1000) was 1.6 for SI, and 1.2 for S2. The 
starting risk reduction also had a large impact on willingness-to-pay estimates, on 
average the positive willingness to pay were FF 1022 larger when the starting risk 
reduction was 5-in-1000 rather than 1-in-1000.
To test the sensitivity of the results to the commodity proposed, to the elicitation 
question, and to the risk reduction, the authors carried out several variants on samples of 
about 50 individuals each. Variant 1 treated the air pollution problem as a public good, 
that is, the good to be valued was described as a public health policy instead of a 
product (or treatment). Only one bid was offered (1000 FF) in this variant due to the 
small size of the sample (52 individuals), followed by an open question. The payment 
vehicle was an increase of the social security contribution, which is deducted from the 
salary and collected and administered by a public agency. Mean willingness to pay was 
lower than that for the original questionnaire, by a factor of about 2. However, the 
credibility of the scenario was enhanced. For example, only 17% of the respondents 
doubted the effectiveness of the public policy (compared to 37 % for the product), and 
90% took into account their budget constraint (compared to 76 % for the product). The 
number of zero willingness to pay was lower - 12 % (8% in S2 and 15% in SI), but 
60% thought of other benefits (mostly for society in general), compared to 26 % for the 
product.
Variant 2 tested the open question elicitation format without previous offered 
bids. This version was applied to a sample of 50 individuals answering the S2 sequence 
(l-in-1000 followed by 5-in-1000). Variant 3 used life expectancy instead of risk 
reduction as the good being valued. This variant was tested in three versions. First, only 
a gain in life expectancy was stated (an indefinite extension of life), with a proposed bid 
of FF 1000 (59 individuals). Second, a further variant asked 61 respondents to give their 
willingness to pay for an increase in life expectancy of 1 month, 3 months, and 12 
months. Third, the risk reduction was stated as in the original questionnaire and then 
translated to the individual life expectancy gain (calculated by the computer in response 
to the age and gender of the individual). The results of the last 2 versions are not 
comparable because the life expectancy gain was put into perspective by telling each
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respondent his or her life expectancy, without any reference to the corresponding risk 
reduction.
The authors concluded that the better the scenario was understood and accepted, 
the lower was the highest individual willingness to pay. In the original version the 
highest willingness to pay for the open question and the 5-in-1000 risk reduction was 
about FF 6000. When the bids were removed and only the open question was asked, the 
highest willingness to pay was FF 3650. In the life expectancy variants it fell to FF 1800 
for version (i) and FF 1500 for version (iii). For version (ii), willingness to pay 
increased with life expectancy: FF 140 for 1 month, FF 234 for 3 months, FF 377 for 12 
months. Finally, the authors recommended a range of value of a statistical life ranging
T9from €0.5-3 million from the French survey, with a central value of €1 million .
• Italy
Alberini and Scarpa (2003) summarised the results of a contingent valuation 
survey eliciting willingness to pay for reductions in individuals’ own risk of death. The 
survey was self-administered using the computer to a sample of respondents recruited at 
various locations in Italy. Again, the original questionnaire was that developed by 
Krupnick et a l (1998, 2000) and was translated into Italian. The objectives of the study 
included investigating if the willingness to pay for a reduction in the risk of dying 
depended on age. Also, testing if willingness to pay was influenced by a person’s health 
status, and testing if it was possible to elicit meaningful willingness-to-pay figures for a 
latent risk reduction. Finally, exploring the issue of transferability of willingness to pay 
figures from one country to another, by comparing obtained results with the UK and 
French results.
Respondents were selected among participants in computer classes at the 
Fundazione Eni Enrico Matei - FEEM’s Multimedia Library in Venice, Milan, Turin 
and Genoa, and from workers of the Milan area for a total of 292 completed interviews. 
The objective of the sampling was to obtain a random sample stratified by age and 
gender. The age brackets were 40-50, 51-60 and above 60. Approximately one third of 
the sample was assigned to each stratum with an even split between men and women. 
Sampling took place in two waves. The first wave involved the collection of the first 
155 completed surveys and took place in different cities (Venice, Milan, Genoa and 
Naples). The sampling method was based on convenience sampling as people who took
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part into information technology priming classes were asked to fill in the survey in 
various centres. The second wave was designed to complement the first in terms of 
achieving the target numbers in each age/gender category, and was carried out in Milan 
and surrounding areas by enumerators that carried out surveys on laptops.
As in the UK and French contingent valuation studies, respondents were asked 
to think about a product that would deliver the stated risk reduction, and were asked 
whether they would buy the product at the stated price, with payments to be made every 
year for 10 years, beginning immediately. The risk reductions to be valued by the 
respondent were private, and the elicitation technique was dichotomous choice with one 
dichotomous-choice follow-up question. Respondents were asked several questions 
about their own health status. For example, how they would rate their health, relative to 
others of the same age. About 42 per cent of the sample rated their health as excellent or 
very good when compared with others the same age. This figure is comparable to the 
corresponding proportion in the French study, but is much lower than the corresponding 
statistics for the UK, Canada, and the US.
Respondents were also asked whether they suffered from various chronic 
ailments. The authors founded that about 15% had heart disease, 13% had a chronic 
respiratory illness, 33% had high blood pressure, and less than 7% had or have had 
cancer. In the survey, respondents were told the risk of dying over ten years for the 
average person of their age and gender. The average baseline risk in the sample was 
about 50 per 1000, and was much lower than the baseline risks for the UK, France, the 
US and Canada.
Finally, mean willingness to pay for the 5-in-1000 risk reduction was about 
twice the mean willingness to pay for the 1-in-1000 risk reduction. Median willingness 
to pay for the 5-in-1000 risk reduction was 2.34 times the median willingness to pay for 
the 1-in-1000 risk reduction. To compute the value of a statistical life implied by the 
willingness to pay figures, the authors divided willingness to pay by the annual risk 
reduction, assuming that the risk reduction over the course of 10 years would be accrued 
uniformly. A total of four possible values were produced, one for each of mean and 
median willingness to pay, and one for each of the two risk reductions. The value of a 
statistical life ranged from €1,448,000 to €2,896,000. The mean willingness to pay for a
32 FF1 = €0.15 (Desaigues et al., 2003)
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risk reduction of 5-in-1000 at age 70 was estimated at €557.63, and median willingness 
to pay for the same risk reduction was €225.95.
The authors concluded that the Italian data satisfied the internal scope test and 
indicated that willingness to pay depended on gender and income. Additionally, at least 
when the willingness-to-pay responses for the 5-in-1000 and 1-in-1000 risk reductions 
were pooled to increase the sample size, willingness-to pay estimates suggested that the 
relationship between age and log willingness to pay was an inverted-U.
• Europe (Pooled data the UK, France and Italy)
Alberini et a l (2004a) and EC NewExt (2003) estimated willingness to pay and 
value of a statistical life for Europe obtained by using the pooled data of the three 
studies described before -  the UK, France and Italy. The authors used the responses to 
the willingness to pay questions about the immediate risk reduction to estimate the 
value of a statistical life. They showed that the estimates of the value of a statistical life 
were within (and on the lower end of) the range recommended by DG Environment and 
US EPA, but did not find any evidence that willingness to pay and value of a statistical 
life were lower for older individuals. Willingness to pay showed good internal validity 
in the sense that it depended on income and on the fact that the respondent had been 
admitted to the hospital or had visited an emergency room for cardiovascular or 
respiratory illnesses in the last five years, among other things.
The average age of the respondent was 55 to 58, depending on the country. The 
samples were relatively well balanced in terms of gender, with only a slight prevalence 
of women over men. The average number of years of schooling ranged from 11 (for the 
French study) to about 14 (for the UK sample). The percentage of the sample that rated 
their own health as good or excellent relative to others of the same age varied across the 
three countries. In Italy, only 38 per cent of the respondents described their health as 
very good or excellent, against 61 per cent of the British sample. The percentages of 
respondents who failed the probability tests or otherwise reported having problems 
understanding the concept of risk were similar across the three countries. These 
percentages were low, suggesting that most people were able to answer the questions 
meaningfully in the survey.
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The unconditional willingness-to-pay model implied a mean willingness to pay 
US$1,230 (€1,129)33 per year for the three European countries, and median willingness 
to pay US$573 (€526) for a 5-in-1000 risk reduction. This implied the value of a 
statistical life ranging between US$2,460 (€2,258) and US$1,146 (€1,052) million, 
respectively34. The validity test of willingness-to-pay estimates was performed with the 
usual socio-economic variables. Willingness to pay declined only for the oldest 
respondents in the sample, who held willingness-to-pay amounts that were 
approximately 25% lower than those of the other respondents. However, the coefficient 
on the dummy for a respondent who is 70 or older was not significant at the 
conventional levels, a similar result found in Canada and US studies (Krupnick et al 
2001 and 2002). Men had slightly lower willingness to pay and so did people with 
higher levels of education, although these effects were not significant at the 
conventional levels. The presence of cancer and chronic illnesses did not influence 
willingness to pay, but individuals who had been hospitalised for cardiovascular or 
respiratory illnesses over the previous 5 years had willingness-to-pay amounts that were 
over twice as large as those of all others.
The authors also used the responses to the willingness-to-pay questions, 
combined with the extension in life expectancy implied by the 5-in-1000 risk reduction, 
to estimate the value of a gain in remaining life expectancy. They used two alternative 
approaches. The first approach regressed willingness to pay on the gain in the life 
expectancy based on population life-tables; that is, the baseline life expectancy was the
c
population’s life expectancy based on age and gender . This approach resulted in no 
statistically significant association between willingness to pay and the change in life 
expectancy. As an alternative, the authors divided willingness to pay by the life 
expectancy extension to obtain willingness to pay for each month of life expectancy 
extension. This resulted in mean willingness to pay at US$1,146 (€1,052) per year for 
each month of additional life expectancy, and median willingness to pay at US$506 
(€465) per year. The implied values of a statistical life year (VSLY, discussed in section 
4.5) were US$136,438 (€125,250) and US$60,784 (€55,800), respectively. Regarding 
the effect of age, willingness to pay per month of life expectancy gain was higher
33 US$ 1 = € 0.918 (Alberini et a l , 2004a).
34 VSL = mean or median WTP / risk reduction.
35 The 5 in 1000 over the next 10 years risk reduction equals from 0.64 to 2.02 months life expectancy 
extension, depending on the person’s age and gender, and averaged 1.23 months for the sample.
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among older persons, which suggested that the marginal utility of life expectancy 
extensions increased with age.
The second approach used the “gain in life expectancy” as the respondent’s own 
estimate of life expectancy (respondent’s subjective remaining life years). Willingness 
to pay increased significantly with subjective life expectancy gains, and this increase 
was less than proportional to such gains. Regarding the possible effect of age, there was 
little evidence that willingness to pay varies with age, but the regression results 
suggested a possible inverted-U shaped-relationship. As before, while the presence of 
chronic illnesses did not affect willingness to pay, having been to the hospital for 
cardiovascular or respiratory illnesses in the previous 5 years raised the willingness to 
pay significantly. Willingness to pay for a month of subjective life expectancy gain was 
US$1,289 (€1,183) and median willingness to pay was US$528 (€485) per year, which 
resulted in VSLY estimates equal to US$154,684 (€142,000) and US$63,399 (€58,200), 
respectively.
The authors concluded arguing that their results for extensions in life expectancy 
should be interpreted with care since their respondents were not asked directly to value 
a gain in life expectancy. In contrast, it has been indirectly inferred the value of such a 
life expectancy extension from respondents’ willingness to pay for a reduction in their 
risk of dying.
• China36
Zhang (2002) reported the results of a survey with Beijing residents and workers 
in 1999. The objective of the survey was to estimate individuals’ willingness to pay for 
a reduction in their risk of dying. The questionnaire was divided into four parts. Part I 
asked about the major environmental factors affecting the respondent’s health, and 
occurrence of diseases in the past year. Part II asked if the respondent had health 
insurance and, if so, which type of health insurance. The respondent was asked to 
indicate, in case of a job change, his or her preference between a high-risk-highly paid 
job and, alternatively, a job with low risk and low wage. Part III elicited willingness to 
pay for risk reductions of a given magnitude, either 2-in-10000 or 27-in-100000. Part IV 
elicited personal information, including age, gender, education, and income.
36 Another study is currently being undertaken in China using the Krupnick et al. (1998) methodology and 
supported by the World Bank; no results were available to be included in this literature review. In 
addition, similar study was carried out in South Korea but no publication was available to provide details 
o f this study.
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Over 95% of the respondents were young -  i.e. aged less than 45 years. Almost 
all respondents (99%) had graduated from high school, and had stayed in school at least 
11 years. Most of the respondents were teachers (28.5%) or managers (19.6%). Over 
30% of the respondents’ incomes were greater than 1,000 RMB yuan per month, and 
over 93% of the respondents’ incomes were greater than 500 yuan per month, while 
average wage in Beijing was approximately 700 yuan per month according to official 
data. 53% of the respondents or their family members suffered from respiratory or heart 
diseases. About 70% of the respondents reported having health insurance.
The author estimated parametric and non-parametric mean willingness-to-pay 
estimates. For a 2-in-10000 risk-reduction, it ranged between 109 and 186 yuan (1999 
RMB) and for 27-in-100000 the range was between 261 and 459 yuan (1999 RMB). 
The corresponding value of a statistical life in Beijing was between 0.5 million yuan to 
1.7 million yuan (1999 RMB yuan), equivalent to US$60,000 - US$200,000. To analyse 
the relationship between income, age, gender, education and willingness to pay Zhang
(2002) estimated several models in which willingness to pay was regressed on these 
socio-economic variables.
Zhang (2002) acknowledged several limitations in his study. First, the sample 
was not representative of Beijing residents -  the results referred to young people in 
Beijing, the survey just focused on lower income individuals, the respondents had 
intermediate education backgrounds. Second, the survey did not use audio-visual aids to 
communicate baseline risk of death and risk change, as suggested in previous studies 
(Krupnick et a l 1999; Alberini et a l 2001). Baseline risk was explained in a sentence in 
the questionnaire. The author concluded that some individuals might find it easier to 
think about mortality risk reduction in terms of increases in life expectancy rather than 
as small reductions in mortality risks.
• Chile
Cifuentes et a l (1999) estimated the value of a statistical life for Chile using the 
contingent valuation method in order to provide the government agencies with a more 
accurate value than that commonly used in Chile (US$60,000). This commonly used 
value was estimated using the human capital approach, which underestimates the value 
of a statistical life by not considering the individual’s wellbeing. The main motivation 
of the study was the observed big difference between the Chilean value of a statistical 
life and the American commonly used values (US$450,000 -  US$5,000,000). The
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difference persists even after taking into account the differences in per capita income 
between the countries and the increasing importance of the value of a statistical life in 
public policy decision-making.
The survey instrument used in the Chilean study was based on the instrument 
developed by Krupnick et al. (1998), although adapted for Santiago, Chile. The 
respondents were first informed of the average mortality rates of Santiago, showing 
them the mortality risks for the following ten years according to their gender and age 
group. They were asked if they believed that the risk of death showed to them could 
reasonably be their own, and were given the opportunity to correct it. Respondents were 
then asked the willingness-to-pay question for a reduction in risk by 1-in-1000. The 
process was repeated for a different change in risk (5-in-1000) and for a change in risk 
in the future.
A pilot survey and a pre-test were conducted with 25 and 28 respondents, 
respectively, all of them final year students of Civil Engineering in the Catholic 
University of Chile. The pilot survey objective was to test different payment vehicles; 
annual and monthly payments. The argument was that most payments in Chile are 
expressed monthly and it would be easier for Chileans to think on the values they would 
pay for a risk reduction. Most of the surveys reported in the literature, the authors 
argued, use annual payment. The objective of this test was to validate the instrument 
and obtain the range of values for the dichotomous choice questions.
The results of the pilot survey showed, according to the authors, that willingness 
to pay obtained by monthly payment had less dispersion than that obtained with annual 
payments. The implied value of a statistical life based on median willingness-to-pay 
estimates ranged between USS310,277 (5-in-1000 risk reduction) and US$413,703 (1- 
in-1000 risk reduction). Although the preliminary results of the pre-test presented by 
Cifuentes et a l (1999) were based on a sample of only 28 individuals, the authors 
highlighted some important conclusions. The first one relates to the fact that people 
were able to identify the difference between the two risk reductions, although the 
difference was small. The second conclusion was that the estimated value of a statistical 




Chilton et a l (2004) estimated the willingness to pay for health benefits 
associated with reductions in air pollution in the UK. The study aimed to generate a 
range of monetary values for various key benefits associated with reductions in air 
pollution levels. The study focused on two types of mortality effects -  chronic (loss of 
life expectancy in normal health) and acute (loss of life expectancy when elderly and in 
poor health). It focused on two types of morbidity effects; a hospital admission with 
breathing difficulties, and breathing discomfort on 2 or 3 days every year.
The authors used a contingent valuation survey to elicit the various willingness- 
to-pay estimates. The principal research tool was a questionnaire administered to a 
representative sample of the general population. According to the authors, a substantial 
period of time was spent developing and piloting the questionnaire in collaboration with 
specialists. The pilot involved conducting a large-scale field test of the questionnaire 
and happened in Edinburgh and Norwich. The main survey aimed to interview a larger, 
representative sample of the UK population. It was conducted in 41 different postcode 
sectors in England, Scotland and Wales. The study used a random probability sampling 
method involving 2 stages. After stratifying by region and socio-economic status, 41 
postcode sectors were randomly selected, and later 35 addresses were randomly selected 
within each sector, totalling 1435 addresses in the UK. Within each selected household, 
an individual aged 18 or more was randomly selected. The final sample had 665 
interviews.
Interviews were conducted on a one-to-one basis in respondents’ own homes, by 
a team of 48 experienced interviewers using a structured interactive programme on 
laptops with interviews lasting, on average, 29 minutes. The initial stage of the 
questionnaire asked respondents general questions about their household. In one of the 
opening questions, respondents were asked to consider a wide range of different public 
health risks (of which air pollution was just one) and were asked to consider the three 
biggest threats to their own health. The reason for this approach was to investigate to 
what extent respondents identified air pollution as a high priority concern for them, and 
to put air pollution in some context. The following section of the interview asked the 
respondent to consider various ways that air pollution might affect people’s health, 
including the impacts on mortality (chronic and acute) and morbidity (respiratory
'xnhospital admissions and days of breathing difficulties) .
37 Descriptions o f the health impacts were developed in consultation with the Department o f Health, UK 
to provide a brief description as accurate as possible based on current epidemiologic evidence.
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The remaining set of questions focused on eliciting willingness to pay for four 
possible benefits associated with reducing air pollution. Chronic mortality (N) -  X 
months more life in normal health; acute mortality (P) -  X months more life in poor 
health; respiratory hospital admission (H) -  avoiding an admission to hospital with 
breathing difficulties; and days of breathing discomfort (D) -  avoiding 2 or 3 days of 
breathing discomfort every year. In the case of N (X months more life in normal health) 
and P (X months more life in poor health when elderly) the value of X was randomly set 
at either 1, 3 or 6 months. Varying the length of the gain in life expectancy provided the 
possibility of testing sensitivity to scope.
Before getting to the willingness-to-pay questions respondents were encouraged 
to think about their budget constraint and disposable income. They were told to focus 
just on the benefits to them personally and the other named members of their household 
and not to answer on behalf of anyone else. Respondents then embarked on a random 
card sorting procedure to help them identify the most they would be willing to pay each 
year for the rest of their lives to get all four of the benefits. This procedure involved the 
interviewer shuffling a pack of 12 cards showing different amounts. The cards were 
turned over one at a time and for each in turn, the respondent was asked whether or not 
it would be worth paying that amount every year for the rest of their life for all four 
benefits. Each time a card was shown the interviewer provided the respondent with an 
estimate of how much it would add up over the rest of their life based on the average for 
someone of their age and gender. Respondents were then asked to divide this maximum 
total willingness-to-pay amount among the four benefits.
148 respondents were excluded because of protest behaviour or declining to 
state a willingness to pay. Another 46 respondents gave zero willingness-to pay 
responses for non-protest reasons. Chilton et a l (2004) concluded that chronic mortality 
was the most valued of the four benefits with, on average, 44.9% of the total 
willingness-to-pay amount allocated to this benefit, with only 17.4% of respondents 
assigning no value to this benefit. This contrasted with acute mortality, which was the 
least valued of the four benefits, with respondents allocating an average of 10.1% of 
their total willingness-to-pay amount, and more than half of them (52.8%) assigning no 
value to it at all. The other two benefits, hospital admission and days of breathing 
difficulties, were allocated intermediate proportions of the total (23.0% and 22.5%, 
respectively) and were assigned no value by about a third of respondents (31.3% and 
36.0%).
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The authors claimed that, when allocating their willingness-to-pay amounts 
between the four benefits, respondents were sensitive to the nature and the quality of the 
good being valued. In particular, they valued a gain of life expectancy in normal health 
more highly than a gain of life expectancy in poor health. However, there was no great 
difference between mean values for willingness to pay for chronic mortality for 1, 3 and 
6 months. Parametric estimation of willingness to pay for 1, 3 and 6 months was, 
respectively, £23.30, £29.61 and £34.40. These values were smaller than the trimmed 
mean willingness-to-pay values (£60.15, £67.72 and £80.87). However, the authors 
claimed that the purpose of the regression analysis was principally to examine whether 
responses moved in the direction suggested by economic theory, and suggested using 
the trimmed mean willingness-to-pay estimates. The authors’ best estimate of the value 
of a statistical life year (VSLY), based on life extension in normal health, ranged 
between £31,200 (US$50,856)38 and £8,000 (US$13,040). In the case of willingness to 
pay for acute mortality, neither the number of months nor the level of income had any 
significant impact. The authors argue that there was considerable ambivalence about 
whether this was considered as a ‘good’. For willingness to pay for hospital admission it 
seems to present an inverse relationship with age.
• Other studies
Other contingent valuation studies estimated the value of a statistical life in a 
number of circumstances. For example, Johannesson and Johansson (1997) attempted to 
measure the value that adult Swedes place on an increased survival probability at high 
ages. They estimated the willingness to pay for a programme that would increase the 
expected length of life by one year, conditional on having survived until the age of 75 
years. The authors provided a rough estimate of the value of a statistical life by 
multiplying the willingness to pay for an extra year of life by the expected duration of a 
life. It ranged between US$70,000 and US$130,000 (1995). Also, Buzby et a l (1995) 
estimated the value of a statistical life (US$4.1 million 1993) from the willingness to 
pay for a reduction in risk of cancer from pesticides. Hammitt and Graham (1999) 
conducted telephone surveys to elicit the willingness to pay for a risk reduction of dying 
in a car crash. The implied value of a statistical life ranged between US$0.8 and US$2.1 
million (1999).
38 £ 1= US$ 1.63 in June 2003 (www.xrates.com).
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• Summary
Table 7 summarises the results of the contingent valuation studies using the 
Krupnick et al. (1998, 1999, 2002) methodology, which aims to facilitate comparison 
with the figures obtained in the empirical study in Brazil.
Table 7: Summary of annual willingness to pay (WTP) for an immediate risk 
________ reduction and the implied value of a statistical life (VSL) -  US$
Country ($year)
Risk reduction




Mean WTP Median Mean
US ($2000) 55,000 53,000
5-in-1000 350 770 700,000 1,540,000
1-in-1000 111 483 1,110,000 4,830,000
Canada ($2000) 50,000 46,800
5-in-1000 253 466 506,000 933,000
1-in-1000 131 370 1,312,000 3,704,000
UK ($2002) 42,146 43,677
5-in-1000 422 802 844,000 1,604,000
1-in-1000 96 360 960,000 3,600,000
France($2002) 34,872 35,061
5-in-1000 522 — 1,043,573 —
1-in-1000 — — — —
Italy ($2002) 27,233 43,698
5-in-1000 788 1,577 1,576,000 3,154,000
1-in-1000 336 760 3,360,000 7,600,000
E urope($2002) NA NA
5-in-1000 573 1,230 1,146,000 2,460,000
1-in-1000 — — — —
Japan00 ($1999) 51,855 63,000
5-in-1000 113 323 193,000 551,000




5-in-1000 — 310,277 —
1-in-1000 413(b) — 413,703 —
China ($1999) NA NA
2-in-10000 — 22 — 110,000
27-in-100000 — 54 — 200,000
Notes: Adapted from Alberini et al. (2004a,b); (a) Krupnick et al. (1999); (b) Present value o f monthly
payments;
As can be seen in Table 7, the estimates of the value of a statistical life vary 
substantially between North American and European countries -  the very small sample 
sizes in Japan, Chile and China suggest that these estimates are not representative and 
cannot be compared. For example, the value of a statistical life based on median 
willingness-to-pay values range between US$506,000 in Canada and US$1,576,000 in 
Italy, which can be regarded as unexpected given that the median income in the Italian 
sample was approximately half that observed in the Canadian sample. The same 
happens when estimates using mean willingness-to-pay values or the smaller risk
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reduction are used. If the Italian results, which seem not to be in line with the results 
obtained in other developed countries, are not considered, the figures seem to suggest 
that the value of a statistical life in developed countries -  as estimated by the Krupnick 
et a l methodology for a 5-in-1000 risk reduction -  ranges approximately between 
US$1.0 and US$2,5 million.
4.3. Averting behaviour studies
Some authors derived values of a statistical life from observations of the 
consumption of risk-mitigating goods. For example, Blomquist (1979) analysed how 
individuals value small changes in their probability of survival, through the analysis of 
automobile seatbelt use. Dardis (1980) investigated voluntary purchases of smoke 
detectors to estimate consumers’ willingness to pay for risk reduction, while Jenkins et 
al., (2001) analysed the purchase of helmets by bicycle users. Averting behaviour 
studies are not found easily in the literature when compared with compensating-wage 
and contingent valuation studies, possibly because of their characteristics and 
limitations that tend to be reflected in lower values of a statistical life. These limitations 
refer mainly to the discreteness of consumption (‘yes/no’ decision), and averting goods 
likely to generate joint benefits. However, the averting behaviour method is a revealed 
preference method that uses the willingness-to-pay approach, enabling analysts to 
derive willingness-to-pay estimates and the value of a statistical life for specific groups, 
that is, those consumers of the good being analysed. Some studies are reviewed below.
Blomquist (1979) developed a model of individual life-saving activity to show 
how the value of life saving is implied by observable behaviour, and estimated a value 
of a statistical life, based on the premium individuals pay in seatbelt use in order to 
reduce their risk of death. The framework presented, a two-period life cycle model with 
partly endogenous risk of death, explained the demand for life-saving activity and 
implied a necessary relation among the productivity and costs of the life-saving activity, 
and the value of a statistical life. The theoretical model will not be detailed here; 
instead, emphasis will be given on the empirical estimation of the value of a statistical 
life, which is demonstrated to correspond to the value of a unit change in the probability 
of survival and equal to the monetary worth to the individual of his or her future utility 
of consumption.
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Empirically, in the case of seatbelt users, the value of a statistical life should be 
considered as money costs plus disutility costs less morbidity benefits, all divided by 
the change in the probability of survival. Seatbelt-use money costs would include time 
costs, such as installation of seatbelts and buckling, and disutility costs would consist of 
discomfort of using belts, distastefulness of buckling and unbuckling, and resistance to 
use due to habit. The author assumed disutility costs equal to zero given the difficulty in 
observing such data and, therefore, estimated lower-bound values of a statistical life. 
The data set used to estimate the value of a statistical life was the Panel Study of 
Income Dynamics, 1968-197439, which provided detailed information on seatbelt user 
characteristics. It is a nationwide (US) survey of 5,517 households followed throughout 
seven years, with approximately 500 variables for each household. The seatbelt use 
variable was equal to 1 if the driver claimed to use seatbelts all times and 0 if he or she 
claimed to use them none of the time. Passenger use and part-time use of seatbelts were 
not considered. Also, the sample was constrained to drivers whose cars had seatbelts 
installed in them to avoid the problem associated with the costs of purchasing a car with 
seatbelts or with having seatbelts installed. Another sample characteristic consisted in 
limiting the survey to drivers who were working in 1972 in order to avoid the problem 
of estimating the drivers’ shadow wage rates.
Blomquist (1979) used probit analysis to determine the seatbelt productivity 
variables (those that determine the use of seatbelts) and concluded that (i) the age of 
driver, (ii) male gender and (iii) rural speed limit were the most important. The 
explanations were that (i) older drivers are more likely to be involved in an injury 
accident; (ii) women tend to drive under safer conditions than men; and (iii) high-speed 
driving is relatively dangerous. Other (cost) variables found to be important were the 
driver’s wage rate (high-wage users face higher time costs); length of work- 
commutation trip and length of vacation (because longer trips relates to less fastening 
and unfastening); married driver and number of children; and education.
The time cost of seatbelt use was determined from estimates of the time required 
and the wage rate of the driver. The average time per one-way trip spent to use seatbelts 
was estimated to equal 8 seconds -  the sum of 5 seconds for finding and fastening, 1 
second for adjustment, and 2 seconds for unfastening. This average time, multiplied by 
the number of one-way trips per year produces the average annual time expenditure on
39 Survey Research Center, 1972,1973,1974.
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seatbelt use. The Probit coefficient of the wage-rate variable was then used to determine 
the standard deviation of net benefits (average annual time expenditure times the value 
of time in a vehicle relevant to the valuation of benefits of time-saving projects divided 
by wage-rate coefficient equals to US$16.79). The author weighted results from 
different studies to assume the effectiveness of seatbelt use with respect to fatalities 
equal to 0.50, while effectiveness with respect to non-fatal injuries was assumed equal 
to 0.25. Thus, based on accident and driver data, the estimate of the probability of death 
in a car accident was 3.027 x 10‘4, and while using seatbelts it was 1.514 x 10'4. The 
average non-fatal injury loss that can be avoided by seatbelts was obtained in the traffic 
safety literature and assumed to equal US$95040. With these estimates and assuming 
that all drivers would use seatbelts if all costs, disutility and time were zero, the value of 
a statistical life was estimated to equal US$368,000 in 1978 dollars. This value depends 
on the point estimate of several terms as well as the value chosen for the value of the 
probit equation when all individuals use seatbelts, which determines disutility costs, 
according to the Blomquist (1979) model. The author provided a sensitivity analysis of 
each of these parameters, generating values ranging between US$229,000 and 
US$820,000.
The Blomquist (1979) study was original when using seatbelts as a life-saving 
good. It benefited from the fact that only 23% of US drivers used seatbelts at the 
beginning of the seventies, which enabled the use of probit analysis to estimate the 
value of life for the typical driver who did not use seatbelts. As the author stated, the 
value of life was inputted using the theory about seatbelt-use time costs, information on 
these costs, and the coefficient of wage rate to convert standardised into actual costs. 
Such a study would not be possible nowadays, since the use of seatbelts is mandatory in 
most countries.
Dardis (1980) used smoke detectors as the life saving good of analysis to 
estimate consumer’s willingness to pay for risk reduction and, consequently, the value 
of a statistical life. It was assumed that smoke detectors have to be replaced after ten 
years and that the average household with smoke detectors owned 1.5 of them. Cost of 
using smoke detectors included purchase (market) price and annual replacement cost of 
batteries. Two discount rates were used to estimate annualised costs (5% and 10%),
40 It consists o f labour productivity loss ($850) plus an admittedly arbitrary amount for pain and suffering 
($100). Costs o f property damage and insurance administration are excluded since these are costs that are 
not avoided by using seatbelts.
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reflecting the consumers’ subjective opportunity cost of saving or borrowing. The 
author used a range of weighting schemes to account for uncertainty concerning the 
relative importance attached by households to the probabilities of death or injury. The 
first scheme assigns that consumers consider that 50% of the value of using smoke 
detectors regards injury; while the last scheme means that the individual attaches no 
value (0%) to the reduction in the probability of injury and is only concerned with a 
reduction in the probability of death. The author claimed that the latter weighting 
scheme is considered to be the most realistic for smoke detectors since educational 
campaigns have focused on their life saving role.
The change in probabilities of death and injury was estimated based on the 
number of residential fire deaths and injuries, operating rates for smoke detectors and 
the degree of protection provided by smoke detectors. Dardis (1980) estimated that (i) 
13% of households were equipped with smoke detectors in 1976; (ii) only 80% of 
installed smoke detectors were operational at one point in time; (iii) when combining 
household usage or saturation rate with operating rate yielded an effective saturation 
rate of 10% for all households; and (iv) smoke detectors only provide 45% protection 
against death and 30% protection against injury, based on a number of factors including 
inability to escape, inability to respond to an alarm, and failure to respond correctly. 
Combining these estimates with the number of residential-fire deaths in 1976 
(approximately 6,200) resulted in 6,492 deaths in the absence of smoke detectors. 
Provision of smoke detectors in all households would have resulted in the avoidance of 
2,337 deaths, corresponding to a probability of death reduction of 3.16 x 10'5 when 
combining death avoidance with the number of households in the US. This estimate was 
based on the assumption that residential fires involve one death only.
Dardis (1980) combined annualised costs of smoke detectors with weighted 
probability reductions to produce estimates of the value of life to purchasing households 
from 1974 to 1978. The resulting estimates were combined with sales of smoke 
detectors to yield the value of life to the total population. The annualised value of life 
for smoke detector users ranged between US$606,013 and US$676,266 in 1974 and 
US$137,342 and US$153,797 in 1979. The value of life for each period was multiplied 
by the relative importance of sales in each time period to produce the weighted value of 
a life to consumers -  US$256,652 and US$294,96841. However, the author claims that
41 Using weighting scheme 3 -  mortality effect is the only concern o f smoke detector uses. Different 
estimates are due to different discount rates used -  5% and 10%.
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these estimates represent an overestimate of the value of life to the whole population at 
risk, since not all individuals bought smoke detectors. Upper bound values were inferred 
for non-users from 1979 data and assuming that the non-user population was informed 
of the risks from household fires. The values ranged between US$137,342 and 
US$153,797.
Jenkins et al., (2001) studied the market for bicycle safety helmets to estimate 
the value of a statistical life for different age groups, including children. This is a major 
contribution of this study given the uncertainties involving child mortality valuation42. 
By using the same methodology and data to estimate values for both children and adults 
the authors provided a set of values for reduced mortality risks that are directly 
comparable across child and adult age categories. Another important feature of the 
Jenkins et a l , (2001) study is that bicycle helmets provide protection to a single 
member of a household, in contrast with smoke detectors (e.g. Dardis, 1980) that protect 
the entire household as well as material goods. Also, bicycle helmets do not generate 
any positive effect other than safety improvement, as can be expected to happen with 
other safety-related good, such as automobile size that proportionates additional comfort 
to car users (e.g. Atkinson and Halvorsen, 1990).
The assumption underlying the valuation exercise is that consumers (cyclists) 
purchase a helmet if their value for the reduced risk of head injury (whether resulting in 
death or not) is greater than the cost of the helmet, including the purchase, time and 
disutility costs. This means that the value of a statistical life is greater than the 
annualised cost of a helmet divided by the change in the probability of death due to the 
purchase and use of the helmet. In other words, this study generated lower bound 
estimates of the value of a statistical life for helmet purchasers43 and, by implication, an 
upper bound estimate of the value of a statistical life for cyclists who do not purchase 
helmets.
The annualised cost of a bicycle safety helmet was estimated using average 
market prices, a replacement period of four years, and zero value for time 
(fastening/unfastening) and disutility (discomfort) costs for children and adults, given 
the difficult to obtain such data. The reduction in the probability of head-injury death 
was estimated as follows: an estimate was made of the number of bicycle trips by age
42 There is growing concern about child mortality valuation issues, which is the subject o f specific 
projects currently undertaken by US EPA and OECD. For example, how to treat parent’s altruism since 
children do not take economic decisions.
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group using results of a national survey; the number of deaths due to head injury from 
bicycle accidents; and the effectiveness of bicycle helmets at reducing mortality risk. 
This latter estimate combined the results of the survey (percentage of cyclists that wore 
helmets by age groups) and the percentage of reduction in severe brain damage from 
bicycle accidents by using helmets. The authors estimated that 79.83 head-related 
deaths occurred in 1997 among children aged 5 to 9 in the absence of helmets, and that 
63.06 of those could have been avoided if helmets were used. Combining with the 
number of 5 to 9 years old children using bicycles produced a probability reduction of 
4.41 x 10‘6.
The value of a statistical life for helmet users varied between US$1.3 and 
US$2.7 million (5 to 9 years); US$1.1 and US$2.6 million (10 to 14) years; and US$2.0 
and US$4.0 million (20 to 59 years), according to different assumptions on the length of 
time using helmets and equal concern between death and injury. Table 8 summarises the 
value of a statistical life estimates generated in averting behaviour studies in the US.
Tabie 8; Summary of averting behaviour studies








Blomquist (1979) Automobile death 
risks, 1972
Estimated disutility o f 
seatbelts
38,395 1.0
Dardis (1980) Fire fatality risks 
without smoke 
detectors, 1974-1979
Purchase price and 
maintenance costs o f 
smoke detectors
NA 0.77
Garbacz (1989) Fire fatality risks 
without smoke 
detectors, 1968-1985
Purchase prices o f smoke 
detectors
NA 2.56
Carlin and Sandy 
(1991)
Fatality risks with use 
o f children’s car seats, 
1988
Purchase prices o f car 
seats plus time to buckle 
children
24,737 0.84
Jenkins et al. 
(2001)
Bicycle-related fatal 
head injury risks, 1997
Purchase prices o f 
bicycle helmets
NA
1 .4 -2 .9  
(5-9 years) 
1 .2 -2 .8  
(10-14 years) 
2 .1 -4 .3  
(20-59 years)
Source: Adapted from Viscusi and Aldy (2003)
As can be seen in Table 8, none of the averting behaviour studies refer to risk 
reduction in the context of air pollution. It can be argued that this is difficult to identify 
an averting good or service that clearly reduces the consumers’ risk of dying from 
diseases associated with air pollution and, in addition, data regarding its consumption
43 This is a theoretical limitation o f the averting behaviour method that was discussed in Chapter 2.
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and risk reduction can be easily obtained. For example, car catalyst can be regarded as a 
potential averting good related to air pollution but in most markets its use is already 
compulsory (consumers do not have choice about consuming or not), a characteristic 
that makes car catalysts not useful for an averting behaviour study. Another example 
can be the masks used by cyclists and pedestrians in most urban centres in Asia, but in 
this case the difficulty is to estimate the risk reduction associated with the use of these 
masks.
4.4. Other issues in valuation of risk changes
This section discusses some further practical issues involved in estimating 
willingness-to-pay measures for risk reduction and the value of a statistical life. It starts 
with a review of the issues related to the ‘compensating-wage’ method, once again 
mostly based on a recent study of Viscusi and Aldy (2003), and finishes with a 
discussion of other contingent valuation issues.
4.4.1. ‘Compensating-wage’ studies
The ‘compensating-wage’, or hedonic wage method, empirically estimates 
work-related values of a statistical life, using the wage-risk trade-offs (and other factors 
that affect wages) to estimate wage differentials related to different mortality risks. 
However, there are a number of difficulties associated with the estimation of the value 
of statistical life using this method. For example, Viscusi and Aldy (2003) detailed the 
econometrics and data issues in hedonic labour market analysis, such as: risk data 
measuring; omitted-variable bias and endogeneity; wages measuring and related data; 
the choice of a functional form for the hedonic equation; identifying inter-industry wage 
differentials; and the effect of union affiliation on the value of a statistical life. Black et 
a l (2003) used three different US data sets to estimate the price of risk44 and matched 
these data to two sources of job risk data45. The main findings were that the estimates 
were quite unstable, and that this instability seems not to be due to specification error. 
Small changes in the specification of explanatory variables or the risk measured used 
resulted in large variations in the estimated price of risk. In addition, various estimates
44 The Outgoing Rotation Groups o f the Current Population Survey, the March Annual Demographic 
Supplement o f  the Current Population Survey, and the National Longitudinal Survey o f  Youth (1979)
45 The Bureau o f Labour Statistics estimates from their Survey o f Working Conditions, and the National 
Institute o f Occupational Safety and Health estimates from their National Traumatic Occupational 
Fatality survey.
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indicated that the price of risk was negative, which is contrary to the theoretical 
framework used. These findings lead the authors to have doubts about the usefulness of 
existing value-of-a-statistical-life estimates to guide public policy. “These estimates are 
so highly sensitive to the risk measure used and the specification of the wage equation 
that the selection of any particular value of the price of risk seems arbitrary” (Black et 
a l 2003).
• Risk and wage data
Viscusi and Aldy (2003) argued that an ideal measure of job-related fatality and 
injury risk would reflect both the worker’s and the firm’s perception of the risk. Such 
data on perceived risks is generally not available and the standard approach is to use 
industry-specific or occupation-specific risk measures reflecting an average of 
observations of fatalities during a period of time. Measures of job-related fatality and 
injury in general includes self-reported risks based on worker surveys and objective risk 
measures derived from actuarial tables, workers’ compensation records, and death 
certificates (Viscusi and Aldy, 2003).
According to Viscusi and Aldy (2003), the choice of the measure of fatality risk 
can significantly influence the magnitude of the risk premium estimated through 
regression analysis, a similar conclusion of Black et a l (2003). Viscusi and Aldy (2003) 
cited several early papers on compensating differentials that used the University of 
Michigan Survey of Working Conditions and Quality of Employment Survey data that 
included qualitative measures of job-related risk, which are generated using direct 
surveys of workers and their perceptions of their work environment. Other studies in the 
US used actuarial data and employed a job-related risk measure based on data collected 
by the Society of Actuaries for 1967. The majority of the studies of the US labour 
market used data collected by the US Department of Labour Bureau of Labour Statistics 
(BLS), which has maintained industry-specific fatality and injury risk data since the late 
1960s. Finally, the National Institute of Occupational Safety and Health (NIOSH) has 
also collected information on fatal occupational injuries through its National Traumatic 
Occupational Fatalities surveillance system (NTOF) since 1980, using official death 
certificates.
Viscusi and Aldy (2003) concluded that most of the risk variables used in non- 
US studies were based on job-related accident and mortality data collected by official 
sources (government-reported); few of these studies indicated whether the mortality risk
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data were derived from samples or censuses of job-related deaths. For example, the data 
sets used in studies in India (Shanmugam, 1996; 1997; 2000; 2001) were from the 
Office of the Chief Inspector of Factories in Madras. Many studies in the UK employed 
data provided by the Office of Population Censuses and Surveys (Marin and 
Psacharopoulos, 1982; Arabsheibani and Marin, 2000), while others used unpublished 
data from the UK Health and Safety Executive (Siebert and Wei, 1994). In South Korea, 
accident data were obtained from the Ministry of Labour (Kim and Fishback, 1999). 
Additionally, the authors claim that while a large number of studies of labour markets 
around the world evaluated the compensating differential for a job-related death and 
injury, very few attempted to account for the risk of occupational disease such as 
cancer.
Finally, a common source of bias of ‘compensating-wage’ studies refers to using 
industry-based risk measures to reflect individuals’ risk measure, which is likely to 
introduce a measurement error. According to Viscusi and Aldy (2003), applying 
industry averages to individuals may result in errors associated with matching workers 
to industry due to response error in worker surveys, or the possibility of some 
occupations within the industry facing risks that differ from their industry’s average. As 
a result, this type of measurement error tends to have a downward effect on the risk 
coefficient.
Other necessary data in ‘compensating-wage’ studies are the wage data, 
characteristics of workers, and employment. Viscusi and Aldy (2003) observed that in 
some cases a survey asks workers directly to collect more reliable information (e.g. 
Lanoie et al., 1995; Liu and Hammitt, 1999). In the US, the most used datasets are the 
Survey of Working Conditions (SWC); the Quality of Employment Survey (QES), the 
Current Population Survey (CPS) and the Panel Study of Income Dynamics (PSID). 
Black et a l , (2003) also mentions the Outgoing Rotation Groups of the Current 
Population Survey (ORG-CPS) and the National Longitudinal Survey of Youths 
(NLSY).
The dependent variable in a hedonic wage function in general is a measure of the 
hourly wage. However, Viscusi and Aldy (2003) argued that in some cases researchers 
have to construct the wage measure from weekly or annual labour earnings data. When 
the regression model includes workers’ compensation benefits, then both the wage and 
the benefits should be expressed in comparable terms, in terms of tax deduction, to 
ensure proper evaluation of the impacts of the benefits on wages. According to Viscusi
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and Aldy (2003), researchers in general match a given year’s survey data on wages and 
worker and employment characteristics with risk data for the same year or the average 
of earnings over a recent period.
• Specification of the hedonic wage function
A number of hedonic wage specification problems are well documented in the 
literature. These specification problems may include the functional form of the 
dependent variable; unobservable factors that may affect earnings; and the (non) 
inclusion of non-fatal risks. Regarding the functional form of the hedonic function, 
Viscusi and Aldy (2003) claim that this is an issue that cannot be determined on 
theoretical grounds. In general, two functional forms of the dependent variable are used, 
the linear and semi-logarithmic specifications (wage x log [wage] forms). Moore and 
Viscusi (1988a) employed a flexible functional form (the Box-Cox transformation) to 
identify the specification with greatest explanatory power. This approach presumes that 
a parameter exists such that when this parameter equals zero the model represents the 
semi-logarithmic functional form. When the parameter equals 1 then the model 
represents the linear functional form. Using maximum likelihood methods, Moore and 
Viscusi (1988a) estimated this parameter equal to 0.3 for their data, a result that is more 
consistent with a semi-logarithmic form than a linear form. Moore and Viscusi (1988a), 
however, rejected both specifications based on a likelihood ratio test and estimated 
similar values of a statistical life based on the Box-Cox transformed regression model 
and the semi-logarithm specification (Viscusi and Aldy, 2003).
Black et a l (2003) also tested a number of functional forms for the hedonic 
wage function as well as a non-parametric technique (propensity score matching) to 
produce estimates of the relationship between job risk and wages. In line with the 
conclusions of Viscusi and Aldy (2003), Black et a l (2003) concluded that the 
instability of the parametric estimates did not appear to be the result of the 
misspecification of the functional form of the regression function. The authors did not 
advocate in favour of any specific functional form, but used non-parametric estimates to 
conclude that the results continue instable.
Omitted variables bias is another source of specification problem raised by 
Viscusi and Aldy (2003). When possible determinants of a worker’s wage are not 
specified in a hedonic wage equation this may introduce a bias, if  the unobserved 
variables (confounders) are correlated with the observed variables. Viscusi and Aldy
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(2003) argue that dangerous jobs are often unpleasant in other respects, such as 
environmental factors like noise, heat, or odour, which might be correlated with the risk 
measure. In fact, Black et al. (2003) investigated the possibility that unobservable 
factors were correlated with the risk measure and affecting earnings by using the NLSY 
data, which contains workers’ characteristics not commonly available in labour 
economic data sets, such as illegal drug use and test scores for Armed Force 
qualifications. The authors found that job risk varies inversely with the Armed Force 
Qualification Test scores and varies positively with illegal (declared) drug use. In 
addition, individuals may systematically differ in unobserved characteristics, which 
affect their productivity and earnings in dangerous jobs, and so these unobservable 
factors will affect their choice of job risk46. Studies reviewed by Viscusi and Aldy
(2003) indicate that models that fail to account for heterogeneity in unobserved 
productivity may bias estimates of the risk premium by about 50%.
In addition to unobserved factors, omitting injury risk can affect the estimation 
of mortality risk measures and represents another type of specification problem. Viscusi 
(1981) showed that a positive bias in the mortality risk coefficient is introduced when 
the wage equation omits injury risk. However, Day (1999) cited that a study by 
Martinello and Meng (1992) found that the inclusion of non-fatal risk measures in some 
specification models reduced the estimates of the value of a statistical life, while in 
other specifications the value of a statistical life increased. Viscusi and Aldy (2003) 
argued that the high correlation between injury and mortality risks is likely to introduce 
an econometric problem (colinearity) when analysts introduce both measures in the 
specification model.
Also, endogeneity is a common problem of ‘compensating-wages’ studies since 
the dependent variable (wage) is explained by, among others, the risk variable, which 
simultaneously depends on wage. Day (1999) claims that ignoring this issue may bias 
the estimates of the value of a statistical life downward since it is likely that those who 
are less risk averse, consequently requiring less compensation to accept risky positions, 
choose more dangerous jobs. In general, many of the estimates of the value of a 
statistical life accounting for endogeneity are two to three times as large as those 
estimated with risk as an exogenous variable (Day, 1999).
46 Garen, J.E. (1988) “Compensating-wage Differentials and the Endogeneity o f Job Riskiness”, Review 
o f  Economics and Statistics, 73(4).
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• Union effect
Regarding the effects of union affiliation on the value of a statistical life, Viscusi 
and Aldy (2003) argue that the relationship between union affiliation and the wage-risk 
trade-off has received substantial attention in the literature. Initially, it is believed that 
workers in union jobs receive greater premiums for facing risks than those workers in 
non-union jobs because if  a worker lacks adequate information about the risks at the 
workplace, then this worker may underestimate the actual risks faced, and may demand 
lower wages than if this worker were aware of the risks. Unions potentially provide 
workers with more accurate information about their job-related risks and might also 
negotiate for mechanisms that increase worker exposure to safety information. 
However, the empirical tests cannot provide a conclusion about the union effect on 
wage-risk trade-offs. Most studies of the US labour market found that union affiliation 
is positively correlated with a greater wage-risk trade-off, while the international 
evidence is more mixed (Viscusi and Aldy, 2003).
Marin and Psacharopoulos (1982) conducted an analysis of compensating 
differentials for risk in the UK and found that union affiliation had an insignificant 
impact on the risk premium, the same result as in Arabsheibani and Marin (2000). In 
contrast, Siebert and Wei (1994) found higher union risk premiums, and Sandy and 
Elliott (1996) estimated larger compensating differentials for risk for non-union 
members. According to Viscusi and Aldy (2003), a follow-up study, Sandy et a l 
(2001), concluded that non-union workers enjoy greater risk premiums in the UK. In 
Canada, several analyses have found little support for a positive impact of union 
affiliation on compensating differentials for risk (e.g. Meng 1989; Martinello and Meng, 
1992). In developing countries studies have also found mixed effects of union affiliation 
on a worker’s risk premium. For example, Shanmugam (1996-7) included a union x 
fatality risk interaction term, and found that union members enjoy a positive 
compensating differential for risk in India. In South Korea, Kim and Fishback (1999) 
could not statistically identify compensating differentials for risk between union and 
non-union workers (Viscusi and Aldy, 2003).
4.4.2. Contingent valuation studies
Some issues are commonly discussed in the valuation of mortality 
environmental risk reduction literature as being important for the correct estimation of
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the benefits for the purpose of policymaking. It is argued that the economic theory is not 
conclusive about how these issues can be addressed. Those related to how the 
willingness-to-pay measure is dependent on respondents’ age, and how future risks to 
human life can be valued in the present have been addressed in the theoretical literature 
review. In addition, there are ethical and moral issues involved in valuing statistical 
lives, and how altruistic individuals incorporate in their willingness to pay the concern 
with other individuals’ lives. These important issues are discussed below.
• Ethical and moral issues
The value of a statistical life, defined as the aggregate willingness to pay for a 
measure saving a number of lives divided by the number of lives saved, is commonly 
referred to as the value of life and the value of preserving life. One of the most 
controversial aspects of valuing the benefits of reducing death risks is the pricing or 
placing of a monetary value on human life. For non-economists, this idea seems 
insensitive or inhuman. Perhaps, the idea becomes acceptable when individuals 
recognise that what is actually being valued is not life per se, but small changes in the 
probability of death.
Cropper and Freeman (1991) suggest that another way to characterise the 
economic approach when valuing changes in probabilities of death is by saying that the 
economic value is derived by focusing on choices ex-ante, before the uncertainty about 
whether or not the individual will die is resolved. However, this uncertainty about one’s 
death is resolved at some point in time, which means that each individual at some point 
will know if he or she will die or will live a bit longer. From this ex-post perspective, 
the individual who will die would be willing to pay their total wealth to change the 
outcome or may require an infinite amount to compensate him or her to accept the 
death. According to some critics of the economic perspective, this difference in 
perspective can have no ethical or moral significance, meaning that neither willingness 
to pay nor compensation measures based on the ex-ante perspective are morally 
acceptable.
Cropper and Freeman (1991) argue that one defence of the economic perspective 
is based on the observation that people appear to be willing to make ex-ante trade-offs 
involving risks of death. Considering that individuals are rational and their preferences 
are the basis of economic value measures, then their willingness to consent to ex-ante 
trade-offs must have some ethical significance. In addition, for many of the public
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policy issues in which value of risk reduction information is used, it will never be 
known ex-post whose deaths were caused by failure to adopt a policy or whose lives 
were prolonged by a policy to reduce risks of death. The authors conclude with the 
argument that “ ...it is consent, and the veil of ignorance over who dies and who is 
saved, that legitimises the ex-ante perspective and its focus on the value of changes in 
risks rather than on the value of life versus death” (Cropper and Freeman, 1991).
• Altruism
Individuals may be concerned not only about their own welfare but also about 
other individuals’ welfare. It is said that those individuals who are concerned about 
others’ welfare express altruistic concerns, even when the good or service being 
evaluated does not personally affect them. These altruistic concerns are usually not 
observed on markets, making it difficult to estimate from market data (indirect methods) 
the total monetary value individuals place on mortality risk changes. It is said that 
benevolent altruism occurs when the individual cares about others’ utility, and 
paternalistic altruism occurs when an individual cares about others’ consumption. In 
general, it is assumed that individuals view people who are not in their family with 
benevolent altruism and view their families with paternalistic altruism.
In the context of risk reduction activities, the total benefit of a determined policy 
should be assessed by the society’s total willingness to pay for the reduced risk. This 
willingness to pay would consist of two components: the private valuation consumers 
attach to their own risks change (pure self-interest), plus the altruistic valuation that 
other members of society place on their risks changes (Viscusi et al, 1988).
Jones-Lee (1992) argues that under the willingness-to-pay approach, the value of 
a statistical life for a society of purely self-interested individuals is given by the 
population mean marginal rate of substitution of their own wealth for their own 
reduction in probabilities of death. In addition, if individuals are not purely self- 
interested but are also concerned for others’ safety -  and then willing to pay an amount 
for the reduction in probabilities of death -  then the value of a statistical life should be 
augmented by an amount reflecting this additional willingness to pay. Furthermore, the 
author claims that it is appropriate to include the amount of individuals’ willingness to 
pay for others’ safety in the definition of the value of a statistical life if and only if 
altruism is exclusively safety-focused. That is because while an individual may be 
concerned and hence willing to pay for another individual’s safety, the former
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individual is completely indifferent to the other determinants of the latter individual’s 
wellbeing.
Finally, Jones-Lee (1992) concludes that the value of a statistical life for a 
‘caring’ society would be 10% - 40% larger than the value that would be appropriate for 
a society of purely self-interested individuals. This conclusion is based on assumptions 
concerning the properties of the distribution of altruistic concern across the UK 
population (English households tend to the purely paternalistic form of altruism).
4.5. Alternative metrics for evaluating risk reductions associated with health
This section discusses the alternative metrics to the willingness-to-pay approach 
when used for valuing reductions in health risks, including fatal risks. Hammitt (2003) 
justifies the need of an alternative metric to the willingness to pay by arguing that 
individuals and societies make decisions that affect their exposure to a wide variety of 
health risks and some choices can have both beneficial and adverse effects for the same 
person. Making decisions about health risks, continues the author, is difficult and 
confusing; leading to situations where individuals can make choices that may conflict 
with their judgements. For example, individuals may be poor at understanding 
probabilities, especially the small ones that are relevant to health choices, and choose 
alternatives that in fact have greater health risks associated with them. For this reason, 
concludes the author, individuals may have difficulties in stating their willingness to 
pay for changes in their health risks.
This section briefly describes the concept of quality-adjusted life years (QALY), 
which evaluates interventions in terms of their cost-effectiveness—the cost per QALY 
gained. It is compared with the more usual willingness-to-pay metric, which is used in 
cost-benefit analysis to compare the value of health benefits with the cost of producing 
them. The relevance of this discussion is that the “US Office of Management and 
Budget, which oversees federal regulation, has recently proposed that regulatory 
agencies use both cost-effectiveness analysis (using QALY or other health measures) 
and cost-benefit analysis (using WTP) to evaluate rules intended to promote health and 
safety” (Hammitt, 2003). Both measures can be justified as measures of individual 
preferences over health risks.
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Additionally, this section discusses the appropriateness of the value of a 
statistical life year (VSLY or VOLY), which is defined and compared with the value of 
a statistical life, when analysing mortality risks.
• Quality-Adjusted Life Years (QALY)
According to Krupnick (2004), the QALY measure uses the quality of a life year 
as the basic unit of account and aggregation, and is based on the product of the duration 
of a health state and a score (or weight) reflecting the quality of the health state47. 
Hammitt (2003) argues that QALY is used to measure an individual’s future longevity 
and the quality of the individual’s health during that time. In general, a score equal to 
zero represents death, and perfect health has a score equal to one. Thus, numeric values 
can be assigned to different health states so that morbidity effects can be combined with 
mortality effects to develop an aggregated measure of health outcomes. Another 
characteristic of the QALY approach is that life years are treated equally for all 
individuals, that is, the score attributed to perfect health, for example, carries the same 
value for all individuals regardless of any socio-economic characteristics such as age 
and income (Krupnick, 2004).
QALY measures are calculated by weighting the amount of time an individual 
will spend in each future health state by an index or score that measures the health- 
related quality of life in that state. If a person will live for (7) more years in a given state 
of health, the total QALY he or she will experience is equal to (q x  7), where (q) is the 
health-related quality of life associated with his or her health state (0 > q > 1). Health 
states perceived as worse than dead can be accommodated by using negative values of 
(iq) (Hammitt, 2003).
Krupnick (2004) identifies several approaches for deriving scores or weights for 
the health index, including (i) rating scales (RS); (ii) time trade-off (TTO); (iii) person- 
trade-off (PTO); and (iv) standard gamble (SG). These approaches estimate the 
population’s (or experts’) average preferences for health states and derive weights for 
these states, bearing in mind that these approaches are not perfect substitutes. The rating 
scale, the simplest method for estimating weights or scores, involves giving individuals
47 Other health indices found in the literature share this characteristic. For example, the Health Utilities 
Index (HUI), EuroQol or EQ-5D, the Functional Capacity Index, the disability-adjusted life years 
(DALYs) index, the Years o f Healthy Life Scale. The variations in these indices have to do with the 
methods used to elicit the weights to be assigned to various health states and the specifications o f the 
domains underlying the health states (Krupnick, 2004).
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a description of a health state and asking them to rate it on a numeric scale. It is an 
example of a psychometric approach to determine preferences (Krupnick, 2004). It does 
not involve trade-offs or decisions under uncertainty.
In the time-trade-off approach respondents are asked to make trade-offs between 
outcomes that occur with certainty. For example, respondents are asked how many 
healthy years of life they would like to give up in order to forgo specific symptoms. 
Krupnick (2004) argues that it seems to be a consensus among analysts that both 
approaches -  the rating scale and time trade-off -  are better suited for the evaluation of 
chronic symptoms than acute ones.
The person trade-off approach asks respondents to choose between helping a 
number of individuals in a certain health state and a different number of individuals in 
another health state (Krupnick, 2004). The objective is to vary the number of 
individuals in one of the classes and elicit the number of individuals that makes the 
respondent indifferent between the two alternatives being offered, deriving a score from 
this point. It is appropriate for analyses at the social level, rather than the individual 
level. Finally, the standard gamble approach incorporates both trade-offs and 
uncertainty over health states. According to Krupnick (2004), it is based on expected 
utility theory because respondents are asked to make choices under uncertainty. In 
general, continues the author, respondents are asked the probability of death that would 
make them indifferent to experience the described condition.
Krupnick (2004) compared willingness-to-pay and quality-adjusted-life-year 
measures according to a list of attributes identified as desirable. The criteria for judging 
these measures included different types of validity48, comprehensiveness, ease of 
application, costs of developing estimates, how well uncertainty is addressed, whether 
averting behaviour is captured, whether qualitative risk attributes are included, and 
whether these measures bias choices towards certain groups. The main conclusions are 
summarised in Table 9. Regarding the criterion validity criteria, the author concluded 
that tested against conditions for preferences to represent utility49, the literature seems to
48 C riterion validity - the degree to which it measures the theoretical construct under investigation or the 
true measure. C ontext validity -  how close does the construction o f the measure mirror the context for 
public policymaking. C onvergent validity -  if  the measurement in question compares with some other 
measurement by a different approach. C onstruct validity -  if the estimate has properties that are 
consistent with the theory underlying the construction o f the measure. C ontent validity - if  the design 
and execution o f the study yielding the estimate conform to the generally accepted best practice.
49 Mutual utility independence; constant proportional trade-off o f longevity for health; risk neutrality over 
life span; additive independence o f  utility for health states across time periods; and income independence 
(Krupnick, 2004).
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indicate that QALY fails for a given individual, although there is evidence that once 
aggregated for many individuals, some of these violations of assumptions cancel out. 
Willingness-to-pay measures, on the other hand, are derived from a theory that is utility 
based. With respect to context validity, Krupnick (2004) concludes that the willingness- 
to-pay metric in general fits the policy context better than the QALY metric, but both 
pay little attention to estimating preferences for community health improvements. 
QALY does better than willingness-to-pay estimates according to the convergent 
validity criteria, because the weights are confined to the [0,1] interval for QALY and are 
not so constrained for willingness to pay.
Another criticism of QALY as a measure is formalised by Doctor et al. (2004): 
“QALYs are computed by adjusting each year of life by the quality of life in which it is 
spent. They are intuitively appealing, i.e. easy to explain to doctors and policy makers, 
and are tractable for decision modelling, which explains their popularity in practical 
research. A disadvantage of QALY model is that it represents individual preferences for 
health only under restrictive assumptions. Empirical tests of the QALY assumptions 
have generally yielded negative results. These findings undermine the credibility of 
economic evaluations based on QALYs and may call into question the validity of some 
clinical and health policy decision models” (Doctor et al. 2004).
Hammitt (2003) argues that because QALYs describe preferences only with 
respect to longevity and health, they do not answer the question of whether the health 
benefits of a policy justify its cost. In this sense, the trade-off between health and other 
goals should be set outside the QALY framework, often by comparing the cost per 
QALY gained by the policy under consideration with the cost effectiveness of other 
interventions. In addition, the author argues that the QALY and willingness-to-pay 
metrics offer sharply conflicting perspectives about the relative importance of reducing 
mortality risk to different people, and these differences can matter when comparing 
programs that disproportionately affect different sub-populations. For example, 
reducing the risk of automobile crashes, which most affects young adults, or reducing 
levels of air pollution, which most affects elderly people with chronic heart and lung 
disease. Under the QALY metrics, the value of reducing current mortality risk to a 
person is proportional to the person’s life expectancy and to the health-related quality of 
life the individual will experience. In other words, the QALY measure implies that it is 
more important to reduce mortality risk to people having a higher life expectancy and to 
those who will be healthier. Under the willingness-to-pay metric, the relative value of
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reducing mortality risk is less sensitive to life expectancy and health prospects, but is 
sensitive to wealth and income.
Hammitt (2003) concludes that health metrics should ideally rank changes in 
health risk in the same order that individuals would rank them for themselves, and that 
society would rank them across individuals. If the individual and social rankings differ, 
it is theoretically possible that every individual would prefer the health risks he or she 
faces under policy A to those he or she faces under policy B, even though policy B 
scores better on the social ranking. There is some conflict between the goals of 
consistency with individual and with social preferences, and willingness to pay and 
QALYs differ in their emphasis on satisfying each of them. Empirically, neither QALYs 
nor willingness to pay is measured with great precision, and the differences in how the 
two metrics rank different policies may not be as sharp in practice as they are in theory. 
Evaluating policies from both perspectives may help to develop greater insight about the 
difficult health choices that societies must make (Hammitt, 2003).
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Table 9: Comparisons of Health Valuation Measures for Technical Attributes






Key assumptions violated by 
individuals, but may perform better in 
the aggregate.
Performs well.
Comparison to actual 
choices
Standard gamble (SG) scores predict 
treatment choices
Concern over hypothetical bias for 
stated preference (SP) studies; difficult 
to make head-to-head comparisons of 
SP with actual choices
Context Validity SG does fairly well in invoking trade­
offs, but not in context o f reduced 
health risks; person trade-off (PTO) 
reflects community-level choices; 
health domains/states defined on 
medical interventions may not match 
health outcomes relevant for policy 
interventions.
Performs well; however, most health 
valuation studies are for individual 
preferences rather than community 
preferences.
Convergent Validity Differences in preference weights by 
approach; SG is the only utility- 
consistent approach and depends on 
cardinal utility assumption, but is 
insensitive to changes in health status.
Differences in revealed preference 
(RP) and stated preference (SP); SP 
has potential to better match choice 
context.
Construct Validity Focus is more on testing validity o f 
indices than validity o f weights. 
Weights are sensitive to duration o f 
effect, violating independence 
assumption. Difficult for people to 
make SG trade-offs. Duration estimates 
often unreliable or ad hoc. Yet, QALY 
indices can predict medical 
consumption.
Performs well, except proportionality 
to scope/scale for contingent valuation 
method (CVM).
Content Validity Critics charge little attention given to 
“weights” surveys except in the 
construction o f health state 
descriptions. Proponents say there is 
extensive work on this topic.
Major thrust o f SP literature
Comprehensiveness More comprehensive than WTP, but 
for health only. Combines mortality 
and morbidity.
Less comprehensive than QALYs, but 
covers more than health; doesn’t 
combine mortality and morbidity.
Ease o f  Application Easy Easy
Cost Cheap to apply, but getting weights is 
expensive (though only a one-time 
effort).
Cheap to apply, but getting unit values 
is more expensive per endpoint than 
QALYs. Presumption is that measures 
have to be estimated for each health 
effect-duration combination and by 






Relatively little attention here, only in 
sensitivity analysis. Uncertainty in 





Inclusion o f  
Qualitative Elements 
o f Risk
Embedded in preferences to unknown 
degree.
Embedded in preferences to unknown 




• Value of a Statistical Life (VSL) x Value of a Statistical Life-Year (VSLY)
A pertinent discussion in the context of mortality risks related to air pollution 
regards the use of the value of a statistical life for every case of mortality. The argument 
is that many people whose deaths are associated with air pollution may have had a short 
life expectancy even in the absence of air pollution (harvesting problem, discussed in 
the epidemiologic literature review -  Chapter 2). In this case, it seems unreasonable to 
value a death of someone with a short period to live the same value as the death of 
someone with many years of remaining life expectancy. For example, according to IVM 
(2000), the ExtemE project suggested that value of a statistical life estimates should be 
restricted to valuing fatal accidents, mortality impacts in climate change modelling and 
similar cases where the impact is sudden; and when the affected population is similar to 
the general population for which the value of a statistical life applies. The view of the 
ExtemE project team was that the value of a statistical life should not be used in cases 
where the hazard has a significant latency period before impact, nor when the 
probability of survival after exposure is altered over a prolonged period, or where the 
life shortening is very limited. In such cases the years of life lost (YOLL) approach is 
recommended, and value of a statistical life year (VLYL, VSLY or VOLY)50 estimates 
should be used.
The value of a statistical life is a risk-based unit of measurement while the value 
of a statistical life year is considered to be a life-span-based unit. VSLY should reflect 
the willingness to pay for an extended period of an individual’s life expectancy in a 
given health state, this period of time in general being one year. The main difficulty in 
adopting the VSLY as the metric in a stated preference study is that the willingness-to- 
pay value may be expected to be contingent on the health state in which the respondent 
expects to be at the time when he or she benefits from the extension in life.
An alternative procedure to stated preference methods that directly elicits 
individuals’ willingness-to-pay for an extended period of life is to derive the VSLY 
from value-of-a-statistical-life estimates, where the observed value of a statistical life is 
the discounted present value of future years, allowing for the survival probabilities. 
However, the main argument used against adopting this procedure is that there are other
50 VLYL -  value o f a life year lost; VSLY -  value o f a statistical life year; and VOLY -  value o f a life 
year. These are commonly used terms to designate the same concept.
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significant factors51 that determine individuals’ willingness to pay for mortality risk 
changes in addition to life span. As a result, the conversion of a pre-determined value of 
a statistical life into a time-stream of VSLY is arbitrary, since the value of a statistical 
life itself appears not to be the result of individual thought processes involving the 
discounting of such a time-stream (EC NewExt, 2003).
The value of a life statistical year has been suggested in some specific contexts 
on the basis that it explicitly allows for differences in length of lost life from different 
environmental impacts to be taken into account in environmental damage estimation. 
According to EC NewExt (2003), the context of air pollution may be expected to 
produce changes in life expectancy that are measured in terms of days or weeks rather 
than years. This study outlines the main issues that should be considered in selecting the 
appropriate metric in the context of air pollution. Investigations were carried out on: (i) 
theoretical issues, (ii) construction of the utility function, (iii) applied issues, (iv) 
measurement of the willingness to pay, (v) comprehension of the unit by user 
community, and (vi) complementarity with measurement of physical units of 
environmental damage. The study concluded that epidemiologic studies seem to suggest 
that the VSLY should be used in the context of air pollution since it is only possible to 
estimate total years of life lost from air pollution, and not the number of deaths.
EC NewExt (2003) argued that one justification for adopting the VSLY metric is 
that it more easily resonates with users of the QALY metric, since they are both based 
on the implicit assumption that there is a positive relationship between utility and life 
expectancy. However, the different theoretical foundations underlying QALY and 
VSLY make them not directly comparable. For example, QALY assumes that 
preferences over health and life expectancy depend only on health consequences, whilst 
VSLY allows for the possibility that preferences over health outcomes depend on 
individual characteristics such as wealth52 as well as on the nature of the cause of 
impact (involuntariness).
In a context where the average age of the victim or the normal life expectancy 
within the relevant population are not known, the use of the value of a statistical life 
metric is recommended. However, in the context of air pollution, “the number of deaths
51 For example, the emotional and personal costs to those who would be affected, which might be 
expected to peak in middle age when there are most likely to be young and/or old dependants.
52 One argument used to justify the use o f the non-monetary QALY measure is because it cannot be 
skewed by individuals’ wealth or income; it may be seen as more equitable since everyone is assumed to 
have the same life expectancy.
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that can be attributed to air pollution is only observable in mortality statistics when the 
effect is sufficiently instantaneous that the initial increase in death rate is not obscured 
by the subsequent depletion of the population who would otherwise die later” (EC 
NewExt, 2003). The authors argue that the usual case is that the impact of air pollution 
is not instantaneous but the cumulative result after years of exposure, so that the number 
of deaths is not observable. As a result, it is impossible to tell whether a given exposure 
has resulted in a small number of people losing a large amount of life expectancy or 
many people losing a small amount of life expectancy. In this case only the average 
number of years of life lost are calculable and this makes a case for the use of VSLY in 
the context of air pollution.
It seems that eliciting the VSLY directly by asking individuals how much they 
would be willing to pay for an extension in their life expectancy is, however, a difficult 
task. There are not many studies in the literature, which makes it difficult to evaluate 
precisely the caveats involved in a contingent valuation study designed for that purpose. 
Johannesson and Johansson (1997) undertook such an analysis in Sweden by asking 
respondents their willingness to pay for a programme increasing their life expectancy by 
one year, conditional on having survived until the age of 75 years. The authors also 
asked respondents to state their expected quality of life using a rating scale from zero 
(worst possible quality of life) to ten (best possible quality of life). It was shown to be a 
strong positive correlation of the expected quality of life at an advanced age and the 
willingness to pay for a one-year life extension, which suggests that the willingness to 
pay is highly sensitive to the size of health gain (scope). As a consequence of this strong 
link between quality of life in the future and the willingness to pay for a life extension 
in the future, the willingness to pay was very low -  ranging between US$700 and 
US$1,300, since individuals expect a low quality of life at old ages. The authors 
concluded that to value a conditional increase in life expectancy is a difficult cognitive 
task.
4.6. Conclusions
An empirical literature review was undertaken in this chapter with focus on the 
main willingness-to-pay-based methods used to estimate the value of a statistical life. 
The review of the ‘compensating-wage’ studies, based on findings of recent meta­
analysis studies (e.g. Viscusi and Aldy, 2003), presented values of a statistical life
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ranging between US$0.5 and US$20.8 million in US and US$0.2 (Taiwan) and 74.0 
(UK) million elsewhere. The review of contingent valuation studies focused on those 
using the Krupnick et a l (1998, 1999) methodology. In this case the value of a 
statistical life did not vary as much as in the case of ‘compensating-wage’ studies. 
Instead, the estimates seem to range between US$0.5 million (Canada) and US$7.6 
million (Italy). Averting behaviour studies, although not as frequent in the literature as 
other willingness to pay methods, also presented a wide range of estimates -  US$0.77 
and US$4.3 million. Also, some meta-analyses of studies estimating the value of a 
statistical life were undertaken in an attempt to provide best-practice estimates. The 
proposed value of a statistical life ranged between US$1.5 and US$5.6 million. It can be 
concluded that the value of a statistical life estimates can be very sensitive to the 
method, data, assumptions and statistical methods used in the valuation exercise.
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5. Estimating the willingness to pay for mortality risk reduction in Sao Paulo, 
Brazil
The previous chapters introduced the air pollution problem in Brazil and its 
impact on human health. An extensive literature review indicated the theoretical 
background and the main issues related to policymaking in air quality matters. The 
main objective of this chapter is to estimate the willingness to pay for small mortality 
risk reductions in Sao Paulo, Brazil, which enables the estimation of the value of a 
statistical life. This latter estimate, along with the value of a statistical life year, and 
their dependence on specific individual characteristics, are the relevant statistics 
involved in policy assessment in the context of air pollution.
This chapter is organised as follows. First, a description of the survey 
assumptions and elicitation instrument is provided in section 5.1. A descriptive analysis 
of the samples is presented in section 5.2, while section 5.3 shows the investigation of 
the determinants of inconsistent willingness-to-pay responses. Section 5.4 investigates 
the determinants of protest responses regarding the hypothetical payment for risk 
reductions. Regarding the estimation of willingness-to-pay values for small risk 
reductions, the section follows the recent literature on the economic valuation with 
stated preference techniques (Bateman et al., 2002), which suggests the following 
procedure, described in sections 5.5, 5.6 and 5.7, respectively:
(i) To estimate non-parametric willingness-to-pay values for different 
risk reductions;
(ii) To estimate parametric willingness-to-pay values for different risk 
reductions using the constant-only bid function approach;
(iii) To test the consistency of estimates with the economic theory using 
parametric models with covariates.
The value of a statistical life and value of a statistical life year estimates are 
presented in section 5.8 and the summary of results and conclusions are in section 5.9.
5.1. The survey
As described in the empirical literature review, Krupnick et a l (1998) first 
presented this computer-based survey instrument (questionnaire) which had been 
developed to fill some gaps in the contingent valuation literature concerning the 
elicitation of willingness to pay for reduction in risks of death. This survey instrument
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was adapted to the Brazilian context53 54 and used to elicit the willingness-to-pay
measure related to reductions in risk of death in Brazil. First, a brief introduction
regarding the computer-based survey informed the respondents that it was part of a 
strictly academic, non-commercial, research, followed by a statement of its general 
objectives. The structure of the survey instrument is as follows55:
(i) Details of the samples
The surveys -  pilot and final -  were conducted in Sao Paulo, Brazil, in October- 
November 2002 and March 2003, respectively. At the outset of the pilot survey a series 
of institutions that work with the elderly in Sao Paulo were contacted. As a result, four 
universities and a bank agreed for the survey to be conducted on their 
students/employees56. The bank’s employees were highly skilled professionals such as 
software analysts or developers, A class individuals and relatively wealthy people in 
Brazil. The surveys in the universities involved mainly classes B and C, i.e. upper and 
lower middle classes.
Previous information about the social characteristics of the students and 
employees involved in the mentioned groups did not exist. During the initial phase of 
the survey there were no specific sample selection criteria apart from the age of the 
respondents being between 40 and 75 years, and that the respondents should be resident 
in Sao Paulo. All members of the computer skill classes for the Third age (in general, 
women in the 50s to 70s), and all available and co-operative IT employees were 
interviewed. Given an observed initial gender and age bias, the next procedure was to 
contract professional assistance for the sample selection of extra interviews. The 
objective was to obtain a socio-economic and demographic respondent profile as close 
as possible to that observed for the population of Sao Paulo -  a similar distribution of 
the different age groups, gender and income.
53 A especial acknowledgement here is devoted to Mrs Brigitte Desaigues, Laboratoire de Strategic 
Industrielle -  University de Paris 6 Sorbonne, and Mr. Kene Bounmy, BETA - University de Strasbourg, 
who developed and provided the survey software adapted for the Brazilian case.
54 For example, the baseline risks per age and gender were estimated from official Brazilian life tables; 
the main causes o f  death presented to respondents were based on official statistics; questions relating to 
race were removed from the questionnaire for legal reasons and because there are no mortality statistics in 
Brazil disaggregated by race; and questions related to religious matters were not specific to any religion, 
given the multitude o f  religions and sects in Brazil.
The description o f  the questionnaire is based on EC NewExt (2003) and Krupnick et al., (1997).
56 Thanks for the invaluable collaboration o f Romenio das Neves Catharino (UNIBANCO); Prof. Antonio 
Jordao Neto (PUC-SP and Universidade Santo Amaro); Prof. Antonio Simoes Ferreira Filho e Profas. 
Mariuza Pelloso Lima e Sandra Maria Valeria Patriani (Fundacao Institute Tecnologico de Osasco); Prof. 
Joao Carlos Schimitz and Maria Julia Nogueira Amaro (Universidade Anhembi Morumbi).
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The professional contracted for the sample selection was responsible for renting 
the computer laboratories as well as for the sample selection, observing the desired 
percentages among the different social classes, gender and age groups. Two different 
labs were used, one in a very popular region in central Sao Paulo and another in a 
sophisticated region, in an attempt to capture members of the socio-economic class A. 
In addition, two rounds of interviews were contracted. The first one achieved 156 
interviews during three days in November 2002 and another round was performed in 
one day in December, achieving an extra 34 interviews. The pilot sample totalled 309 
interviews.
The statistics of the pilot survey are in Section 5.2, providing evidence that 
adjustments would be necessary for the final survey, especially involving the high 
percentage of ‘yes’ responses to all offered bids. After increasing the bid values, a 
second round of the survey (Final) was conducted in March 2003, using only the 
professional sample selection, an experienced professional firm that had its own 
recruiting database, consisting of the addresses, contact numbers and socio-economic 
profile of thousands of residents in Sao Paulo. The individuals filtered from this 
database were contacted by telephone and invited to attend an interview in a computer 
lab at an agreed date and time57. An average of 70 interviews were conducted per day 
and ten computers were used simultaneously from 9:00-19:00 daily. The criteria used in 
the sample selection involved residents in Sao Paulo, aged 40-75 (percentages per age 
intervals reflecting the city population profile), belonging to social classes A, B and C 
(percentages reflecting the population statistics), and not having participated in the pilot 
survey (November-December, 2002). A total of 287 individuals were interviewed for 
the final sample58.
The reason for not including classes D and E was the high level of illiteracy that 
exists in these groups and the potential for misunderstanding the probability concept 
within the questionnaire. Thus, given the limited financial resources for the research, it 
was decided to concentrate the research effort on those classes more likely to be able to
57 Initially, one can point out a possible bias referring to the fact that all respondents must have had a 
telephone to be invited for the interviews. But a quite usual procedure in Brazil involves those who 
cannot buy a telephone: they use someone else’s numbers for an initial contact and then reply the call. In 
general, even in very poor communities some kind of public communal number is available.
Initially, a total o f 300 individuals were contacted to attend the lab and answer the questionnaire, but 
heavy rains and a strike in the public transport system in Sao Paulo contributed to a large number of 
absentees. Also, budget constraints and the collaboration o f different institutions during the pilot survey 
contributed for the pilot sample size being larger than the final sample size.
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respond cogently to the survey. According to the last Brazilian official Census (IBGE, 
2000), the population living in Sao Paulo had the following characteristics:
Table 10: Statistics of the population of Sao Paulo -  aged between 40 and 75 years
Social Group % Gender % Age group %
A 7 Male 47.7 40-49 45.1
B 26 Female 52.3 50-59 29.3
C 36 60-69 19.2
D and E 31 70-75 6.4
40-64 85.2
65-75 14.8
Source: Fundacao Seade (www.seade.gov.br)
It is important to emphasize that both samples cannot be claimed as fully 
representative of the population of Sao Paulo (10 millions inhabitants). Both samples 
were obtained observing the same gender and age distribution as those observed in 
Table 10, which was an attempt to minimise the consequences of a non-representative 
sample and the small sample size. The targeted sample size was 300 due to budget 
constraint. The survey design implied the payment in cash of an incentive for the 
respondent to attend the computer labs and cover his or her travel expenses. The amount 
paid for each respondent equalled RS25,00 (approximately US$7.50), which 
corresponds to a total cost of US$1,420 for the pilot sample (190 times US$7.50) and 
US$2,152 (287 times US$7.50)59.
(ii) Targeting the 40-75 years old population
This feature was judged appropriate given that the aim of the survey was to 
discuss reductions in mortality risks in the context of environmental policy, particularly 
air pollution. Arguably, it is likely that the risk of death from air pollution related 
diseases -  cancer, cardiovascular and respiratory diseases -  becomes significant only in 
middle age (e.g. Saldiva etal., 1995).
(iii) Presenting mortality risks in annual risk changes over ten-year intervals
The use of ten-year intervals allowed representing risk and risking changes in 
terms of chances per 1000, which could be represented graphically, thereby facilitating 
the respondents’ comprehension of risk concepts. Graphs were used to explain 
probabilities of death that contained 1000 squares, where white squares denoted chances 
of surviving, red squares represented chances of dying, and blue squares showed
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reductions in the risk of dying. This characteristic of the survey instrument was adopted 
following extensive tests in North America that concluded that the use of grids with 
more than 1000 squares (i.e. 10,000 or 100,000) results in reduced cognition and a 
tendency to ignore small risk changes as being significant (Alberini et a l , 2004b). 
Because annual risk changes associated with air pollution policy are smaller than 1-in- 
1000, the risk change was expressed as change over 10 years. Baseline risks and 
payment schedules were also put in 10-year terms. The use of this mechanism was 
important to help individuals differentiate a 5-in-1000 risk reduction from a 1-in-1000 
risk reduction and, consequently, to reduce potential scope problems, i.e. the tendency 
of contingent valuation respondents to report the same willingness to pay for a bundle of 
goods as for a subset of the bundle.
(iv) Providing general baseline risk per age and gender
After obtaining the respondent’s age and gender within the survey, the Brazilian 
life table was used to provide the risk of death of an average individual of the same age 
and gender. The purpose of this was to help respondents better appreciate the context of 
mortality risks and to show them the effect of age on baseline risks in ten-year 
increments. The respondents were presented a grid with red squares representing their 
10-year average baseline risks. This procedure, along with other specific features within 
the study, was intended to ensure that hypothetical bias was reduced. Hypothetical bias 
refers to the fact that respondents provide hypothetical answers to hypothetical 
questions, which may not be the same answers they would give in a real situation.
(v) Examples of life-saving activities
Examples of risk reducing activities, such as visiting a doctor and taking 
medication, were provided along with a reminder that these activities involve some cost, 
although no specific cost was suggested in the survey. The purpose of these 
explanations was to illustrate that in everyday life respondents do pay small amounts of 
money to reduce their mortality risks. Also, the reason for not providing the actual cost 
estimates was to avoid the possibility of these costs anchoring later willingness-to-pay 
responses. Further information was presented on leading causes of death according to 
age and gender and common risk-mitigating activities, both medical and non-medical.
59 The targeted sample size followed similar surveys carried out in the UK, France and Italy, as can be 
seen in section 6.4. The North American surveys used samples three times larger, but no information is 
available regarding the costs o f sampling in those studies.
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(vi) Illustrating the concept of probabilities and test of comprehension
The survey instrument introduced the concept of probabilities to the respondent, 
and specifically the probability risks of death, testing for comprehension of the concept. 
The examples used included flipping coins and the throw of a dice. The comprehension 
test was performed by describing two hypothetical people identical in every way, apart 
form the fact that one had a 5-in-1000 chance of dying over the next 10 years while the 
other had a 10 in 1000 chance of dying over the next 10 years. The respondents were 
shown side-by-side grids of the risks for both people and asked to select which person 
had the largest chance of dying. In case of a wrong answer, an explanation was provided 
and another test was performed. Even if respondents could distinguish these risks, they 
might not feel that the difference in risk was significant. Therefore, the survey asked 
which of these two people they would rather be or if  they were indifferent.
(vii) The mortality risk as context free and the risk reduction as a private good
Willingness to pay for different risk reductions was obtained in a general 
context, i.e. not specifically in the air pollution context. Past observations during focus 
groups in the US and Japan indicated that individuals tend to lose the dimension of the 
risk size when the risk is presented relating to air pollution. Also, the method of 
delivering risk reductions was treated as a private good rather than as a public good. 
That is, the risk reduction was presented as being covered by health insurance nor 
delivered by environmental programmes that reduce the risk of death for the entire 
population, but being applied only to the respondent. This feature is designed to make 
the respondent think about his or her own risks, thereby avoiding free-rider behaviour. 
The link with the air pollution context comes from the risk sizes evaluated: “we ask 
respondents to value annual risk reductions on the order of 10'4. For instance, the Pope 
et a l (1995) study predicts that a 10 pg/m3 change in PMio results in an annual average 
change in risk of death of 2.4 in 10,000, while studies based on time series generally 
predict that the same change in pollution levels results in a 0.8 in 10,000 risk change” 
(Krupnick et al., 2002).
(viii) Respondents’ health status
Respondents were asked whether they had ever been diagnosed as suffering 
from various diseases, including cancer and chronic heart or lung diseases. The same 
questions were posed about respondents’ relatives. Individuals were asked to respond to
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a series of questions in order to capture the severity of any physical and psychological 
health condition. One purpose of these questions was to encourage the respondents to 
think about their health before responding to the willingness-to-pay questions. From the 
answers, it was possible to construct physical health scores, for example, an 
energy/vitality and general health score, and a mental score. The latter measured 
symptoms of psychological distress60. In addition, the respondents were asked to rate 
their current health relative to others of their age and gender, and to rate their expected 
health in ten years relative to their health today. They were also asked to rate their 
expected health at age 70 relative to their expected health in 10 years.
(ix) The willingness-to-pav questions
The respondents were asked to consider two risk reductions occurring over the 
following ten years. The first risk reduction was of 5 in 1000 from the baseline risk, 
while the second was of 1 in 1000. The willingness-to-pay question was presented to the 
respondents for each baseline risk reduction, and another willingness-to-pay question 
was introduced regarding future risk reductions (asked only for individuals aged 60 or 
less). This last question is particularly important for valuing environmental 
improvements related to conventional air pollutants and carcinogens, given that the 
benefits related to the risk reduction involved occur in the future while the costs of 
implementing such improvements are incurred in the present. The respondents were 
reminded that there is a chance they may not live to the age 70, making a payment today 
useless. A screen to elicit the strength of respondents’ conviction in their willingness-to- 
pay responses followed each question.
The willingness-to-pay question format used in the surveys was the closed- 
ended or dichotomous choice format, with a follow-up question. In the present study, 
this format therefore involved offering a value (bid value) to the respondents and asking 
if they would be willing to pay that amount of money to buy a product that would 
reduce their probability of death in the following ten years:
“Suppose that the Health Ministry had approved a new product that, when 
used over the next ten years, would reduce your chance o f  dying from a 
disease or illness. This product would reduce your total chance o f  dying 
over the next ten years from X  to Y. I f  you were to take this product you
60 Short Form 36, or SF-36. Ware, J.E.Jr., Kosinski, M. and Keller, S. (1997). SF-36 Physical and Mental 
Health Summary Scales: a user’s guide manual. Lincoln: RI Quality Metric. For details about the health
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would have to pay the fu ll amount o f  the cost out o f  your own pocket each 
year fo r  the next ten years. For the product to have its fu ll effect, you would 
need to use it every year for all ten years. In answering the next questions, 
please assume that the product has been demonstrated to be safe and 
effective in tests required by the Government. Keeping in mind that you 
would have less money to spend on other things, would you be willing to pay 
R$ X  per year for the next ten years (totalling R$ I OX) to buy this product?”
Depending on the respondent’s answer, another dichotomous choice question 
was posed with a greater bid value if the response to the initial question was affirmative 
or a lower bid value if the initial response was negative. Following these questions a 
final (open-ended) question asked what would be the maximum value the respondent 
would be willing to pay for the product.
The dichotomous choice elicitation method is intended to reduce the possibility 
of strategic bias, whilst follow-up questions are used to allow the researcher to improve 
the statistical efficiency of the willingness-to-pay estimates obtained. According to 
Haab and McConnell (2002), double-bounded models increase efficiency over single 
dichotomous choice models in three ways. First, answer sequences ‘yes-no’ and ‘no- 
yes’ yield clear bounds on willingness to pay. For the ‘no-no’ and ‘yes-yes’ pairs, there 
are also efficiency gains due to additional questions, even when they do not bound 
willingness to pay completely, since they further constrain the part of the distribution 
where the respondent’s willingness to pay can lie. Finally, the number of responses is 
increased, so that a given function is fitted with more observations, although statistically 
the number of observations is not doubled, since there is correlation between responses 
from a single individual (Haab and McConnell, 2002).
(x) Debriefing questions
The debriefing questions were intended to elicit the respondent’s perceptions 
regarding aspects of the survey, such as the payment instrument. Answers to these 
questions were used to explain variation in stated willingness to pay.
status indices refer to Krupnick et al. (2002).
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5.2. Descriptive analysis
5.2.1. The pilot survey
As described in section 5.1, the pilot survey was initially conducted among 
students of Universities of Third Age in Sao Paulo and employees of a bank. After 
initial statistics were produced, a professional service was contracted to help obtain a 
socio-economic and demographic respondent profile as similar as possible to that 
observed for the population of Sao Paulo. Table 11 shows how the questionnaires were 
obtained.
Table 11: Origin of the questionnaire -  pilot sample
Universities o f Third Age Less than 65 65 and over Total
ANH 11 12 23
FITO 19 9 28
PUC 22 12 34
SAN 8 11 19
Subtotals 60 44 104
Institutions
Bank 10 0 10
Private Lab 1 59 14 73
Private Lab 2 90 27 117
Subtotals 159 41 200
Own Laptop 4 1 5
Total 223 86 309
Initially, a series of tests were performed on the data collected, assessing the risk 
comprehension and the willingness-to-pay values provided by the respondents. Two 
particularly important tests were those that identified individuals who had poor 
understanding of the probability concept (Flag4) or were not consistent when stating the 
willingness-to-pay responses (FlagO). The purpose was to investigate whether excluding 
those individuals from the sample would significantly modify the estimates. For 
comparison, different sub-samples were used during all analyses: a full sample (total 
sample) and two ‘cleaned’ sub-samples (using FlagO and Flag4).
Flag 0 indicates respondents who reported inconsistent values in both risk 
reduction willingness-to-pay questions. It means, for example, that the individual 
reported a maximum willingness to pay (using the open question format) lower than the 
bid he or she had already accepted to pay, or stated a maximum willingness to pay 
greater than an amount he or she had refused before. This would indicate that the 
respondent was not considering the bid values offered or was not paying sufficient 
attention while responding to the questionnaire. Flag 4 refers to individuals who
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answered both probability tests in the questionnaire wrongly. The first test was 
performed after providing a series of explanations and examples of the concept of 
probability for all respondents. In case of a wrong answer, a second test was performed. 
If the respondent gave a wrong answer again, indicating a poor comprehension of the 
probability concept, then this respondent was given Flag 4 equal to 1. Table 12 indicates 
the percentage of the sample for selected debriefing questions.
Table 12: Debriefs in the sample -  risk comprehension -  pilot sample
Flag Description N %
FlagO Inconsistent WTP values for both risk reductions valued 52 16.8
Flagl Wrong answer in the first probability test AND shows preference for 
having the higher risk o f death
11 3.6
Flag2 Wrong answer in the first probability test AND initially shows 
preference for having the higher risk o f death, but changed preference 
when asked to confirm
8 2.6
Flag3 Shows preference for having the higher risk o f death 53 17.2
Flag4 Wrong answer in both probability tests 20 6.5
Flag5 Shows preference for having the higher risk o f death and confirmed 14 4.5
Flag6 Respondent states that had not understood probability well 26 8.4
Table 13 introduces selected descriptive statistics of the sample. Although only 
class A, B and C were interviewed, which means rich, upper and lower middle class, 
respectively, the average income level is around R$ 2.500 a month (less than US$ 
10,000 annual income). It has to be observed that the bank employees, highly skilled 
professionals and A-class individuals, given the high inequality levels observed in 
Brazil, certainly have lifted the income average considerably.
Table 13: Descriptive statistics of the respondents -  pilot samp e
Variable Total sample Without FlagO = 1 Without Flag4 = 1
Observations (n) 309 257 289
% o f male 44.3 44.8 43.9
Age -  mean (stdev) 57.3 (10.3) 57.4(10.3) 57.0(10.3)
Household monthly 















Years o f  education 9.2 (4.5) 9.5 (4.6) 9.3 (4.5)
% with health insurance 66.3 71.2 66.8
US$ 1 = R $ 3 .5 3  during tlie survey period (Oct-Nov/2002).
Table 14 gives the gender distribution by age groups. Comparing the gender 
distribution in the sample with the same figures for Sao Paulo, it can be observed that 
the survey sample contains slightly more women (55.7% for the total sample) than the 
census data for Sao Paulo (52.3%). The age group distributions in the survey sample 
diverted from the populations’ statistics, although the age group (51 to 60) figure was
154
very similar between the survey sample (30.1%) and the population (29.3%). The 
differences can be explained by the fact that only two thirds of the sample had some 
selection control, whilst the other third, which had no control at all, was strongly biased 
towards older women.
Table 14: Frequency by gender and age groups -  pilot sample
Age Groups
4 0 - 4 9 5 0 - 5 9 6 0 -6 9 7 0 -7 5 4 0 - 6 4 6 5 - 7 5
Total
sample
Men 46 40 32 19 103 34
Women 42 44 60 26 120 52
Both 88 84 92 45 223 86
Without
Flag0=l
Men 37 36 27 15 87 28
Women 33 36 50 23 100 42
Both 70 72 77 38 187 70
Without
Flag4=l
Men 46 36 28 17 98 29
Women 41 39 59 23 113 49
Both 87 75 87 40 211 78
The scenario-acceptance figures, expressed in Table 15, are similar among the 
different types of samples - total and cleaned samples, suggesting that those respondents 
who answered incorrectly to the probability tests and those who stated inconsistent 
maximum willingness-to-pay values had on average the same perceptions of the survey 
scenario. The relatively high percentage of respondents that had doubts about the 
product’s effectiveness may have influenced negatively the willingness-to-pay 
estimates, suggesting that these scenario-acceptance variables have to be tested in all 
parametric estimations of willingness to pay to verify their effects on the estimates.
Table 15: Scenario acceptance -  pilot sample






Did not believe the stated risks applied to them 18.8 18.3 19.0
Had doubts about the product’s effectiveness 37.5 36.2 37.7
Had doubts about the product’s effectiveness and stated that 
doubts affected WTP
18.8 18.3 20.1
Thought product might have side effects 34.0 33.9 33.9
Thought about other benefits o f the product 48.2 49.0 49.5
Said other benefits influenced WTP 12.9 14.0 12.5
Did not understand the payment scheme 8.4 7.4 8.7
Did not consider whether they could afford the payment 22.3 22.6 22.8
Regarding the objective and perceived risks, the figures in Table 16 indicate 
small differences among the different samples. Approximately 40% of the sample (aged 
60 or less) thought that they would live up to 70 years, which indicates some optimism 
among the respondents.
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Baseline risk o f  dying over the next 10 years (objective 
measure, assigned based on age and gender)
242 (185) 242 (183) 237(183)
Chance o f surviving until age 70 (subjective measure, ranges 
from 0 to 100%)
40.3 (38.7) 41.9 (39.1) 39.9 (38.3)







Any o f coronary, angina, heart attack, or other heart disease 24.3 24.1 23.9
Any o f  emphysema, chronic bronchitis or asthma 13.6 12.8 14.5
High blood pressure 31.4 30.7 31.8
Any o f the above (heart, lungs or high blood pressure 
occurrences)
48.2 47.9 48.8
Has been diagnosed with cancer 9.7 10.1 10.0
Has visited emergency room or has been hospitalised in the last 
5 years for respiratory or heart problems
15.9 15.6 15.2
Judges his/her health to be very good or excellent relative to 
others o f the same age
81.5 80.9 81.3
Table 17 shows the general health status of respondents, whilst Table 18 
indicates the medical literature based standard form (SF36) indices. Both results suggest 
a relatively healthy -  physically and mentally -  set of individuals, also confident about 
their health status when compared to other people of the same age.
Table 18: Additional index scores from SF-36 -  mean (standard deviation) -  pilot
sample






Role-physical score -  measures the extent o f disability in 
everyday activities due to physical problems
81.4 (35.1) 84.8 (32.2) 81.1 (35.1)
Bodily pain score -  measures the severity o f  bodily pain and 
resulting limitations in activities
83.9(19.8) 84.7(19.7) 83.5(19.9)
General health score -  measures respondent’s perceived 
general health
70.2(15.5) 70.6(15.8) 70.1 (15.3)
Vitality score -  measures energy level and fatigue 63.3(16.1) 63.3 (15.6) 63.1 (15.9)
Social functioning score -  measures the impact o f either 
physical or emotional problems on the quantity and quality o f 
social activities
76.3 (15.7) 77.1 (14.7) 76.0(15.9)
Role-emotional score -  measures the extent o f disability in 
everyday activities due to emotional problems
81.6 (32.3) 82.7 (32.3) 80.6 (33.0)
Mental health score -  measures respondent’s perceived mental 
health (happiness and peace o f mind)
67.8(18.6) 68.6(17.6) 67.4(18.5)
Physical functioning score -  measures the extent o f disability 
in everyday activities due to general health problems
78.1 (25.7) 80.4 (23.6) 78.3 (25.7)
Table 19 illustrates the offered values (bids) used in all dichotomous format 
willingness-to-pay questions -  immediate 5-in-1000 risk reduction, immediate 1-in- 
1000 risk reduction and future 5-in-1000 risk reduction.
156
Table 19: Bid structure (R$ 2002) -  pilot sample








1 60 120 30
2 120 400 60
3 400 600 120
4 600 800 400
US$ 1 = R $ 3 .5 3  during tlle survey period (Oct-Nov/2002).
A reason for concern is the high percentage of ‘yes’ responses for all bid values, 
especially for the immediate 5-in-1000 risk reduction (Table 20). Two possibilities may 
be considered, the bid values offered were too low or individuals did not consider their 
income constraint when stating their preferences. The first hypothesis was adopted and 
the bid values were increased for the second and final round of the survey.
Table 21 shows the percentage of respondents who stated zero willingness to 
pay for a given risk reduction. The general increase in percentages has to be observed 
when comparing the initial risk reduction -  immediate 5-in-1000 -  with the second 
suggested risk reduction -  immediate 1-in-1000 risk reduction.
Table 20: Percentage of ‘yes’ responses to the initial payment question -  pilot 
_________sample________ ___________ _________________________________
Initial Bid (Brazilian Reais - R$)
60 120 400 600
5-in-1000 risk reduction over 10 
years starting now
Total sample 85.1 88.5 76.0 75.6
Without 
FlagO = 1
84.4 87.9 73.0 70.3
Without 
Flag4 = 1
84.9 87.8 76.1 76.0
1-in-1000 risk reduction over 10 
years starting now
Total sample 79.7 74.4 64.9 52.4
Without 
FlagO = 1
79.7 74.2 62.9 43.8
Without 
Flag4 = 1
80.8 73.0 65.2 53.3
5-in-1000 risk reduction over 10 
years starting at age 70
Total sample 65.1 66.7 69.6 53.9
Without 
FlagO = 1
73.0 69.1 68.4 45.2
Without 
Flag4 = 1
65.1 64.4 71.4 54.2
Table 21: Respondents who reported willingness to pay equal to zero (%) -  pilot 
_________sample________________________________________________________
5-in-l000 risk reduction over 10 
starting now
1-in-1000 risk reduction over 10 
starting now
5-in-l000 risk reduction over 10 



















12.9 13.6 13.2 24.7 25.7 24.2 16.8 17.5 16.9
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5.2.2. The final survey
The final survey, as described in section 5.1, was fully conducted by a 
professional firm specialising in market surveys, with substantial experience in Sao 
Paulo. This firm selected respondents from its database of residents in Sao Paulo 
according to previously given desired statistics of the sample. It adopted the same 
approach as before to separate the sample in total and cleaned sub-samples. Table 22 
presents the results, which indicate an increase in all percentages regarding the pilot 
survey, especially those figures referring to flags 0 and 4. The observed lower average 
education level and income (Table 23 and Table 13) may possibly explain this increase 
in the number of inconsistent answers and mistakes regarding the probability tests.
Table 22: Debriefs in the sample -  risk comprehension -  final sample
Flag Description Occurrences
N




FlagO Inconsistent WTP values for both risk reductions valued 81 28.6
Flagl Wrong answer in the first probability test AND shows 
preference for having the higher risk o f death
15 5.3
Flag2 Wrong answer in the first probability test AND initially shows 
preference for having the higher risk o f death, but changed 
preference when asked to confirm
10 3.5
Flag3 Shows preference for having the higher risk o f death 72 25.4
Flag4 Wrong answer in both probability tests 32 11.3
Flag5 Shows preference for having the higher risk o f death and 
confirmed
28 9.9
Flag6 Respondent states that had not understood probability well 38 13.4
Table 23: Descriptive statistics of the respondents -  final samp
Variable Total sample Without FlagO = 1 Without Flag4 = 1
Observations (n) 283 202 251
% o f  male 44.9 45.5 45.0
Age -  mean (stdev) 56 (9.46) 56 (9.46) 55 (9.3)
Household monthly R$ 1,185 R$ 1,277 R$ 1,230
income -  mean (stdev) (R$ 1,590) (R$ 1,710) (R$ 1,664)
Individual monthly R$ 844 R$ 912 R$ 872
income -  mean (stdev) (R$ 1,140) (R$ 1,273) (R$ 1,197)
Years o f education 7.6 (4.2) 7.9 (4.2) 7.8 (4.1)
%  has health insurance 43.8 41.6 42.6
US$ 1 = R$ 3.40 during the survey period (March/2003).
Table 24 presents the occurrences of men and women by age group in the final 
sample. Comparing the figures for the total sample (not cleaned) with those presented in 
Table 10 for the population of Sao Paulo, it can be observed that 78.1% of the final 
survey sample is aged between 40-64 while the corresponding percentage for the whole
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population is 85.2%. Along with other figures, such as those regarding the sub-group 
aged between 40 and 49 years, this may suggest that the average age of respondents in 
the sample is higher than it would be expected if this has to present similar figures than 
the population of Sao Paulo.
Table 24: Frequency by gender and age groups -  final sample
Age Groups
4 0 - 4 9 5 0 - 5 9 6 0 - 6 9 7 0 - 7 5 4 0 - 6 4 6 5 - 7 5
Total
sample
Men 37 40 40 10 101 26
Women 46 46 48 16 120 36
Both 83 86 88 26 221 62





45.1 29.3 19.2 6.4 85.2 14.8
Without
Flag0=l
Men 29 27 30 6 73 19
Women 30 35 33 12 85 25
Both 59 62 63 18 158 44
Without
Flag4=l
Men 32 35 38 8 90 23
Women 46 40 41 11 110 28
Both 78 75 79 19 200 51
Table 25 shows the percentage of respondents who accepted specific features of 
the scenario presented. In general, the figures are similar to those observed in the pilot 
sample, and also there are no significant differences among the sub-samples. The 
percentages are very high, indicating that respondents might not find the scenario 
credible. However, the same sort of problem was observed in previous studies (e.g. 
Canada), suggesting that it can be a problem in the valuation of health in contingent 
valuation studies.
Table 25: Scenario acceptance -  final sample







Did not believe the stated risks applied to them 22.3 23.8 20.7 19.7
Had doubts about the product’s effectiveness 36.4 35.6 36.2 30.6
Had doubts about the product’s effectiveness and stated that 
doubts affected WTP
12.7 11.9 12.3 19.7
Thought product might have side effects 36.4 35.6 35.1 25.0
Thought about other benefits o f the product 48.4 46.5 50.2 48.7
Said other benefits influenced WTP 8.1 7.4 7.6 20
Did not understand the payment scheme 11.7 13.4 11.9 13
Did not consider whether they could afford the payment 24.7 27.3 25.5 26
The following tables show the objective and subjective measures of risk faced 
by individuals in the final sample, as well as the health profile of the sample.
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Baseline risk o f  dying over the next 10 years (objective 







Chance o f  surviving until age 70 (subjective measure, ranges 
from 0 to 100%)
40.0 (37.9) 40.7 (37.4) 40.9 (37.8)







Any o f  coronary, angina, heart attack, or other heart disease 23.0 20.8 23.1
Any o f emphysema, chronic bronchitis or asthma 16.2 15.8 16.7
High blood pressure 34.6 32.7 33.1
Any o f the above (heart, lungs or high blood pressure occurrences) 50.9 49.0 50.6
Has been diagnosed with cancer 9.5 7.9 8.4
Has visited emergency room or has been hospitalised in the last 5 
years for respiratory or heart problems
20.5 19.3 19.9
Judges his/her health to be very good or excellent relative to others 
o f the same age
81.6 83.2 81.3
Table 28: Additional index scores from SF-36 -  mean (standard deviation) -  final
sample






Role-physical score -  measures the extent o f disability in 
everyday activities due to physical problems
77.0 (37.0) 80.4 (34.9) 79.5 (35.3)
Bodily pain score -  measures the severity o f bodily pain and 
resulting limitations in activities
82.3 (20.1) 83.5(18.9) 83.5 (19.4)
General health score -  measures respondent’s perceived 
general health
67.5 (15.9) 68.2(15.3) 68.2(15.7)
Vitality score -  measures energy level and fatigue 62.6(15.8) 62.8(15.5) 63.5(15.5)
Social functioning score -  measures the impact o f either 
physical or emotional problems on the quantity and quality of 
social activities
74.7 (17.6) 76.0(15.9) 75.6(17.0)
Role-emotional score -  measures the extent o f disability in 
everyday activities due to emotional problems
76.3 (34.3) 78.5 (32.3) 78.1 (33.0)
Mental health score -  measures respondent’s perceived mental 
health (happiness and peace o f mind)
65.8(17.5) 66.0(16.7) 67.4(17.1)
Physical functioning score -  measures the extent o f disability 
in everyday activities due to general health problems
72.2 (27.4) 76.1 (25.4) 74.4 (26.2)
Table 29 shows the bid values offered in the willingness-to-pay questions in the 
dichotomous choice format, whilst Table 30 presents the percentage of ‘yes’ responses 
for each risk reduction evaluated. A high percentage of ‘yes’ responses even for the 
highest bid value can still can be observed, although they have fallen for the immediate 
5-in-1000 risk reduction, suggesting that the bid values were still too low or that 
individuals did not consider their income constraint when stating their preferences. The 
latter alternative is now more plausible, given, for example, the income differentials 
between Brazil and the US. In the US study the bid values corresponded to US$70-150-
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500-725, almost similar to those used in the final sample. However, official data reports: 
“real average income from main job, received monthly by individuals more than 10 
years old, occupied during the reference week”, for the metropolitan region of Sao 
Paulo in March 2003 equal to R$ 1,055 (US$310), or approximately R$ 12,665 
(US$3,725) per year (www.sidra.ibge.gov.br/bda/tabela/), almost ten times lower than 
the US average61.
Table 29: Bid structure (R$ 2003) -  final sample








1 240 (US$70) 600 120
2 600 (US$176) 1,800 240
3 1,800 (US$530) 2,700 600
4 2,700 (US$795) 3,600 1,800
US$ 1 = R$ 3.40 during the survey period (March/2003).
Table 30: Percentage of ‘yes’ responses to the initial payment question -  final 
_________sample________ ___________ _________________________________
Initial Bid (Brazilian R$
240 600 1,800 2,700
5-in-l000 risk reduction over 10 
starting now
Total sample 77.8 68.2 67.1 59.7
Without 
FlagO = 1
75.9 64.6 59.6 50.0
Without 
Flag4 = 1
78.1 67.2 65.6 63.1
1-in-1000 risk reduction over 10 
starting now
Total sample 70.8 51.5 43.8 54.2
Without 
FlagO = 1
66.7 37.5 26.9 39.6
Without 
Flag4 = 1
68.7 53.4 45.3 58.5
5-in-l000 risk reduction over 10 
starting at age 70
Total sample 71.1 61.0 57.1 54.9
Without 
FlagO = 1
65.7 46.4 48.3 54.0
Without 
Flag4 = 1
72.5 64.9 62.2 58.3
Table 31: Respondents who reported willingness to pay equal to zero (% )- final 
_________sample_______________________________________________________
5-in-l000 risk reduction over 10 
years starting now
1-in-1000 risk reduction over 10 
years starting now
5-in-1000 risk reduction over 10 



















25.5 32.1 23.9 32.9 42.6 30.7 17.7 21.3 16.3
A correlation analysis was performed among all variables available in an attempt 
to anticipate any autocorrelation problems in the econometric estimations due to the use
61 At this point o f the research the possibility o f a potential ‘yeah-saying’ bias started to be considered. It 
did not occur to me the possibility o f  such bias during the pre-test and pilot phases; when some debriefing 
questions could have been introduced in order to confirm the existence o f the bias and to help reducing it.
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of two or more eventual regressors linearly correlated. No statistically significant results 
indicated such linear correlations, apart from those expected, for example, variable ‘age’ 
with variable ‘risk 10’, which indicates the baseline risk presented to the respondent 
according to their gender and age.
5.3. Determinants of inconsistent willingness-to-pay responses
The samples obtained from the two surveys -  pilot and final -  have been treated 
in three different ways during the descriptive analysis: without ‘cleaning’, excluding 
respondents who failed in both probability tests (flag4=l), and eliminating respondents 
who reported inconsistent maximum willingness to pay to both immediate risk 
reductions (flag0=l). This section provides an attempt to identify the main determinants 
of both inconsistent willingness-to-pay responses and failure in responding correctly to 
the probability tests performed during the survey. The objective is to obtain some 
insights about possible (if any) common factors among those specific groups of 
respondents, and to facilitate the econometric analyses. For example, initially, it might 
be reasonable to consider education level as a potential determinant for the 
understanding of the concept of probability and for providing consistent answers. The 
common socio-economic variables were tested along with some attitudinal variables. 
The answers to the 5-in-1000 immediate risk reduction (the first question) were used for 
all tests. Table 32 shows the final results.





Constant 1.36293 3.23075 —
Age -0.02127 0.11139 -0.00690
Age square 0.00005 0.00099 0.00002
Gender 0.06078 0.18109 0.01972
Years o f Education -0.01471 0.02358 -0.00477
Income (individual) -0.00011 0.00010 -0.00004
Has visited an emergency room during the past 5 years? -0.76106 0.28992 -0.24691
Self assessed comprehension o f the concept o f probabilities -0.17713 (” } 0.06929 -0.05747
If respondent smokes 0.33242 0.20110 0.10785
If considered payment every year 0.71765 n 0.24977 0.19422
Initial bid value 0.00016 0.00009 0.00005
Mental health score 0.01121 0.00531 0.00364




Notes: Dependent variable is FlagO = Inconsistent maximum willingness-to-pay responses for both
immediate risk reductions.
(*) Significant at 1% - (**) significant at 10%.
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Regarding the determinants of inconsistent maximum willingness to pay for 
immediate risk reductions (flagO), the respondents’ age and education level were not, as 
expected, significant determinants. Instead, the respondents’ self-assessed 
comprehension of the concept of probability was significant, and the negative sign 
indicates that the higher the understanding of probabilities, the lower the likelihood of 
an inconsistent willingness-to-pay response. Other statistically significant determinants 
were the physical function score, whether or not respondents smoke and the dummy 
variable that indicates whether the respondents have visited an emergency room during 
the last five years. All of these are difficult to interpret. The physical function score 
indicates how the respondents rate their physical health to perform the daily activities. 
The negative sign suggests that the more physically healthy the respondents were, the 
lower the probability of stating an inconsistent willingness to pay. The mental health 
score is a significant variable in explaining inconsistent willingness-to-pay responses, 
although the positive sign of the parameter is unexpected. It would be expected that the 
higher the mental health score the lower the probability of an inconsistent answer. The 
initial bid offered to the respondent was also an important determinant of inconsistent 
responses and the positive sign indicates that respondents facing higher bids gave more 
inconsistent answers. This result may suggest lack of attention in responding to the 
questionnaire.





Constant -0.27662 4.45902 —
Age 0.00821 0.15472 0.0009
Age square 0.00035 0.00133 0.00004
Gender -0.48795 (*¥) 0.25998 -0.05349
Years o f Education 0.02784 0.03255 0.00305
Income (individual) -0.00007 0.00016 -7.57e-06
If  married -0.59971(" ) 0.25061 -0.07737
If  cardiac disease diagnosed in family and/or respondent 0.58891(" ; 0.28294 0.05807
Subjective health status in 10 years time -0.24906(" ) 0.12183 -0.02730
If  considered baseline risk as its own 0.44486(" J 0.25980 0.04877
If  considered health status when 70 years old 0 .7 0 9 0 7 ^ 0.34348 0.08483
Mental health score -0.02504r) 0.00761 -0.00274




Notes: Dependent variable is Flag4 = Wrong answer to both probability tests.
(*) Significant at 1% - (**) significant at 10%.
163
The statistically significant determinants of wrong responses to both probability 
tests (flag4) were the respondents’ gender, mental health score, physical function score 
and some attitudinal variables. Men had more difficulty understanding the concept of 
probability, a result that confirms initial observation during the application of the 
questionnaires. Both mental health and physical function scores had the same expected 
negative effect over wrong answers. The weaker the health score the higher the 
probability of mistakes, the marginal effect of the mental health score being greater than 
the physical function score. The influence of the attitudinal variables, as well as the 
marital status of the respondents, is difficult to interpret.
It can be concluded that both the physical function and mental health scores 
would be important determinants of inconsistent willingness-to-pay responses and 
incorrect answers to the probability tests. However, as concluded in section 5.2, the 
general statistics of the original sample were similar to those of the ‘cleaned’ samples, 
which excluded respondents who stated inconsistent willingness-to-pay responses 
(flagO=l), and those respondents who failed in the probability tests (flag4=0). It may 
suggest that the econometric results might not be substantially different between the 
samples. The econometric analyses consider the different sub-samples and compare the 
results of the two sub-samples with the complete (total) sample.
5.4. Determinants of protest responses
It was identified in Table 31 that a high percentage of respondents stated a zero 
willingness to pay for a given risk reduction. As described before, after the double 
bound dichotomous choice questions, another (open) question asked the respondents to 
state their maximum willingness to pay. In case of ‘no-no’ answers to the bids offered, 
it was asked if  the respondents would be willing to pay anything at all for the good 
being valued. It was considered a protest response when the respondents stated that they 
were not willing to pay any amount for the good being valued and stated that they did 
not consider their finances when answering the willingness-to-pay questions (a ‘protest’ 
dummy was created). This section attempts to identify possible common factors that 
determine the protest responses. The sample without any exclusion (total sample) and 
the responses to the first willingness-to-pay question posed (5-in-1000 risk reduction) 
were used.
As can be seen in Table 34 the statistically significant factors affecting the 
decision of protest are gender and income. The positive sign of the coefficient for
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income suggests that those richer individuals in Sao Paulo tend to protest, possibly 
because these are the individuals who already have a considerable tax burden in Brazil. 
The same result was observed in other contingent valuation studies in Brazil . Women 
tend to protest less than men in Sao Paulo, according to the negative sign of the variable 
gender. No other socio-economic variable was statistically significant in determining 
protest responses. As expected, the initial bid value offered to the respondents had no 
effect on the respondents’ decision to avoid payment.




Constant -8.97368 5.74768 —
Age 0.22422 0.19208 0.02072
Age square -0.00183 0.00167 -0.00017
Gender -0.45929(*’} 0.28421 -0.04245
Years o f Education 0.00569 0.03444 0.00052
Income (individual) 0.00027 (**} 0.00011 0.00002
If  respondent has private health insurance -0.08123 0.26937 -0.00751
If  married -0.02197 0.29681 -0.00204
Has visited an emergency room during the past 5 years? 0.70486 0.66439 0.06514
Degree o f faith in religion -0.11353 0.17215 -0.01049




Notes: Dependent variable is a dummy Protest = refuse to pay anything and did not consider the budget 
when stating willingness-to-pay values.
(*) significant at 1%; (**) significant at 10%.
5.5. Non-parametric willingness-to-pay estimates
Contingent valuation models with discrete choice questions allow the use of 
non-parametric distribution-free estimators of willingness-to-pay measures. When the 
pattern of willingness-to-pay responses is well behaved (i.e. decreasing acceptance of 
bid values as these values increase) the estimates of willingness to pay are not sensitive 
to the choice of distribution for the unobserved random component of individuals’ 
preferences, or to the functional form of the preference function. However, when the 
distribution or the functional form might have some effect on the estimates of 
willingness to pay, the Turnbull non-parametric distribution-free estimator (Turnbull,
62 For example, Ortiz et al. (2003) “Investigating Selection Bias in Contingent Valuation Studies: the case 
o f censoring protest responses for preservation of a rain forest area in Brazil” Paper presented at the I 
Congreso LatinoAmericano y del Caribe de Economistas Ambientales, Cartagena, Colombia, July 2003.
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1976) can provide the basis for comparison of the parametric estimates of willingness to 
pay (Haab and McConnell, 2002).
Responses to discrete choice contingent valuation questions offer the researcher 
only limited information regarding each respondent’s true willingness to pay. If the 
respondent says ‘yes’ then willingness to pay is greater or equal to the bid offered, 
whilst if the answer is ‘no’, willingness to pay is less than the bid. According to Haab 
and McConnell (2002), consider a random sample of (7) respondents, each offered one 
of (M )  distinct prices (tj, j  = 1, 2 , M)  for a project. Let (W TPt) be individual (j)’s true 
willingness to pay for the project. If the individual responds ‘yes’ to the question ‘Are 
you willing to pay (tj) for the project?’, then (W TPt > tj), if ‘no’, (W TPj < tj). Since 
(W TP)  is unobservable to the researcher, it can be taken as a random variable with a 
cumulative distribution function (F w (W )\  the probability that willingness to pay is less 
than (W). Thus, the probability of a randomly chosen respondent having willingness to 
pay less than (tj) is:
PvQVTPi < tj)  =  Fw(tj) = F j . (91)
That is, (Fj) represents the probability that the respondent will say ‘no’ to a price 
(tj) . Hence, the (M )  offered prices divide the full sample (T)  in a vector of (M )  sub­
samples ( T  = {Ti, where (Tj) is the number of respondents who faced the
M
offered price ( t j )  so that ( ^ Tj = T ). Similarly, the number of ‘yes’ (F) and ‘no’ (N)
responses can be indexed according to the offered price, that is, (Y  = {Yj, j  = 7, 2,..., 
M })  and (N = {Nj, j  = 1, 2 ,..., M }). When the offered prices are assigned randomly to 
the full sample, the (M )  sub-samples can be treated as independent samples from the full 
population (7), each receiving a bid or price (tj).
In order to derive an estimate of (F w(tj)), it is defined a response variable (Iy = 
1) if individual (/) responds ‘yes’ to the offered price (tj), and ( I y  = 0) if individual (/) 
responds ‘no’. The unknown probability of observing ( I y )  is:
Pr(Ij\Fw(tj),Tj) = Fw(tjf~UJ .(1 -  Fw(tj))"J (92)
For a given sample of (Tj) independent and identical individuals each offered the 
same price (tj), the probability of observing the set of sample ‘yes’/’no’ response (Ij = 
{Iij, I2j, ..., h jj})  is:
63 Initially, it is assumed that this probability is equal for different individuals.
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T, ±x-uj f >
Vrd\Fw{tj),Tj) = X \F »(t,)'-'“.(\-  Fw(tj))''1 = Fw(tj)‘-' .(1 -F w itj))1" (93)
;=1
If the sample is chosen randomly and the prices are assigned randomly as well, 
then the individual responses to each price can be interpreted as the outcome of 
individual Bernoulli trials with probability of success equal to (1-Fw(tjj). Since the 
individuals are randomly chosen and their responses are independent, the probability of 
observing a given number of ‘yes’ responses to offered price (tj), (Yj), from a sub­
sample (Tj), is the probability of (Yj) successes in (Tj) independent Bernoulli trials with
Tj
probability of success (l-F w (tj)). Defining (Yj = ^ L j )  as the number of ‘yes’ responses
/= i
to (tj), and (Nj  = Tj - Y j )  as the number of ‘no’ responses, the probability of observing 
the exact sample of responses to (tj) becomes:
Pr(K|Fw(tl) J j )  = [  j  "  FwW > V ’ (94)
\ I j \ \ l j  ~  Ij)\)
where the term in brackets represents the number of combinations of ‘yes’ responses 
that can occur in a random sample of (Tj) individuals.
Haab and McConnell (2002) demonstrated that assuming (Fw(tj)) as an unknown 
parameter, denoted (Fj), the probability of observing (Yj) ‘yes’ responses from (Tj) 
independent respondents becomes a function of (Fj). The authors argued that the 
maximum likelihood estimator for (Fj) could be found from equation (94), which 
represents the likelihood of observing (Yj) ‘yes’ responses from (Tj) respondents. 
Solving the first order conditions of the log-likelihood maximisation problem for (Fj)
(  N j \produced the maximum likelihood estimate of (F) Fj = —  . Intuitively, the maximum
V Tj  J
likelihood estimate of the probability that a randomly chosen respondent will not be 
willing to pay (tj) is equal to the sample proportion of individuals that respond ‘no’ to
ft).
When the offered or bid price increases, it is expected that the distribution 
function monotonically converges to one for large samples, that is, as the offered prices 
increase, the proportion of ‘no’ responses to each bid should increase. Alternatively, as 
the bid prices increase the percentage of ‘yes’ responses should decrease. However, as 
shown in Table 20 and Table 30, because of random sampling it is not rare to observe 
non-monotonic empirical distribution functions for some of the offered prices, that is,
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( f j  >  F j + 7) .  In such cases, Haab and McConnell (2002) suggest two options, relying on 
the asymptotic properties of a distribution-free estimator and accepting the small sample 
monotonicity problems, or imposing a monotonicity restriction on the distribution-free 
estimator. The second approach is known as the Turnbull distribution-free estimator 
(Turnbull, 1976).
If a monotonically increasing distribution function is to be guaranteed, a 
monotonicity restriction (Fj < Fj + 1, V/) must be imposed and the set of (Fj) must be 
estimated simultaneously, that is, the sub-samples can no longer be treated as 
independent. The log-likelihood function maximisation problem to estimate ( F j ,  j  = 1, 2, 
... M) subject to the monotonicity restriction is:
M
max ^  [Nj.ln(F}) + Yj.ln(l -  Fj)] subject to Fj < Fj  +1, V /. (95)
7=1
For convenience, this problem can be written in terms of the probability mass 
points f j u + i )  rather than the distribution function (Fj, F 2, ... Fm), where ( f j  =
Fj -  Fj.j)  is the weight of the distribution falling between price (j) and the previous 
price. In this form, the vector of probabilities i f = f i , f 2,  • • • , / m ,  / m + i )  represents a discrete 
form of the density function. Rewriting the likelihood function in terms of the unknown 





subject to f  < 0, V/ (96);Vj.ln(£/*) + r y .ln ( l-2 > )
*=1 Jt=l
The solution to the above likelihood maximisation problem involves recursively 
finding the set of first order conditions. Haab and McConnell (2002) showed that if the 
proportion of ‘no’ responses to each successive offered price monotonically decreases, 
then the distribution-free maximum likelihood estimate of the density point at price (j) 
is the observed proportion of ‘no’ responses to price (j) less the sum of the density
function estimates for all previous prices f  = —  = —  ~ ^
Tj k=] Tj Tj-i
The intuitive
interpretation of these maximum likelihood estimates is that the best estimate of the 
probability of a ‘no’ response to price (j) is the sample proportion of ‘no’ responses to 
that price. The maximum-likelihood estimates for the probability that the willingness to 
pay falls between two prices is therefore just the difference in the ‘no’ proportions
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between those prices, provided the response ‘no’ proportions are monotonically 
increasing.
In the case of non-monotonicity of empirical distribution function from (tj) to 
(tj+j), Haab and McConnell (2002) showed that the solution involves combining (jth) 
and (j+ lth) sub-samples into one group and dropping the (j+ lth) price producing
Ni j - 2
Yj +Nj *-i j
where the (*) denotes the Turnbull estimates. Once the estimates of the distribution 
function are pooled to guarantee monotonicity, the Turnbull estimates of the cumulative 
distribution function can be interpreted as unrestricted maximum likelihood estimates of 
the empirical distribution function.
A lower bound Turnbull estimate for willingness to pay can be derived 
considering the expected value of the random variable (WTP), assumed to be distributed 
between zero and the upper bound on the range of (WTP), namely (U). The expected 
value can be written as
/  u  \
E(WTP) = \wJFwQV)
0
Dividing the range of willingness to pay in (M+l) sub-ranges (0 -  ti, tj -  t2 ... fji/- U), 





j lV  .dFwQV)
. %
where (to = 0) and (tM+i = U)- Because (Fw(W)) is an increasing function, it can be
assumed that
t^j+i tj+1
\w .dF tv(W ) > \t,.dFw(W )
tj tj
. Assuming that (Fw(0) = 0) and (Fw(U) =
1), it can be written that
M











This lower bound estimate of willingness to pay offers a conservative estimate 
of willingness to pay for all non-negative distributions of (WTP), regardless of the true 
underlying distribution. The estimate produced from (97) represents the minimum 
expected willingness to pay for all distributions of (WTP) defined from zero to infinity,
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since (ElbO^TP)) will always bound expected willingness to pay from below as long as 
the true distribution is defined only over the non-negative range.
The Turnbull estimation technique was used to compute distribution-free and 
conservative estimates of mean willingness to pay to reduce risks of death in Sao Paulo, 
Brazil. This procedure involves using the responses to the initial (dichotomous choice) 
payment questions, ignoring the responses to the follow-up questions, to compute the 
relative frequencies of the given willingness-to-pay intervals64. Table 35 reports the 
produced estimates for the final survey.
Table 35: Non-parametric (lower-bound) Turnbull estimation of annual 
________ willingness to pay (US$ 2003)______________________________
5-in-1000 risk reduction over 10 years 
starting now














Mean 522.09 464.74 524.93 277.36 203.24 288.43
Estimates are distribution-free and conservative.
US$ 1 = R$ 3.40 during the survey period (March/2003).
Table 35 shows that the lower bound mean willingness-to-pay estimates are 
lower when individuals who gave inconsistent answers are removed from the sample 
(FlagO). The observed decrease in mean willingness to pay was around 11% in the case 
of the 5-in-l000 immediate risk reduction, and approximately 26% for the 1-in-1000 
immediate risk reduction. However, those estimates are higher when respondents that 
presented poor understanding of the concept of probability are removed (Flag4). 
Comparing the figures for different immediate risk reductions, it is observed that the 
lower bound mean willingness-to-pay estimates are consistently lower -  approximately 
50% - when the risk reduction being valued is lower (1-in-1000). This is an expected 
result, since the good being valued is a normal good. However, these results only 
represent the lower bound estimates of the true willingness to pay. It is interesting to 
observe the parametric results and perform the internal validity test to check the 
proportionality of willingness-to-pay estimates.
5.6. Parametric willingness-to-pay estimates
According to Bateman et a l (2002), the bid function explains the variation in 
willingness-to-pay response based on the change in the characteristics of non-market 
good, prices of market goods, income and other socio-economic characteristics of the
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respondents. The theoretical background relies on an indirect utility function (v()), that 
describes the maximum amount of utility a respondent can derive from his or her 
income, (y), given the prices of goods, (p), and the level of provision of the non-market 
good, (q). Thus individual utility function is assumed to be dependent on other 
demographic and economic factors, ( 5 ) .  A quantity (c) is defined as the maximum 
monetary payment that would ensure that the respondent’s well being with the higher 
level of provision of the non-market good is equal to his or her well-being at the lower 
level of provision. In other words, (c) represents the compensating variation measure of 
a change in welfare, that is, the respondent’s maximum willingness to pay to achieve the 
increase in provision of a non-market good. In a mathematical form:
v(y, p , s, q°) = v(y -  c, p, s, q l) (98)
The bid function can be written in a general form as:
c = c (q ° ,q \y ,p ,s ,e )  = WTP < y , (99)
where (e) is assumed to be the part of willingness to pay that is determined by the 
unobservable tastes of the respondent for the non-market good.
The simplest specification for the bid function is given by the constant-only bid 
function model, and is of great importance in deriving estimates of the mean and 
median willingness to pay of a survey sample. It is specified as:
c -  a + e and 0 < c < y ,  (100)
where (a) represents the location parameter of the assumed probability distribution, or 
the measure of central tendency of willingness to pay and corresponds to the ‘average’ 
willingness to pay of respondents in the sample65. It is recommended that the constant- 
only bid function estimation be used when the objective is to estimate mean and median 
willingness-to-pay values. In such situations, it is not important to determine whether 
willingness to pay is systematically influenced by the respondents’ characteristics. That 
is, it is desired that the (a) parameter be not represented as a function of covariates.
With this theoretical background in mind, the mean and median willingness-to- 
pay values were estimated for the interval data model, which can be generated from the 
referendum or dichotomous-choice with follow-up question format.
64 The non-parametric estimation using responses for the follow-up questions is presented in Annex 10.3.
65 The majority o f probability distributions assumed in contingent valuation studies are based on the 
parameters representing (i) central tendency (location parameter) and (ii) the spread o f willingness to pay 
values (scale parameter) around the central tendency parameter.
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The responses for willingness-to-pay and follow-up questions were combined to 
generate intervals in which the unobservable respondents’ willingness to pay are to be 
found. This model offers the greatest increase in efficiency of willingness-to-pay 
estimates because it allows the analyst to identify smaller intervals where the 
unobserved true willingness to pay is. By combining the respondents’ answers to both 
willingness-to-pay questions, more information on the distribution of willingness to pay 
is obtained and this information lowers the variance of the mean and median 
willingness-to-pay estimates (Haab and McConnell, 2002).
It was assumed that the respondents’ true willingness to pay is bound by their 
(disposable) income. That is, to generate intervals for willingness to pay given the 
answers to the dichotomous questions, the bound interval [0, annual income/2]66 was 
assumed when the respondent answered ‘no-no’ and ‘yes-yes’, respectively. Bounding 
willingness to pay is consistent with economic theory and leads to more reliable and 
plausible willingness-to-pay estimates (Haab and McConnell, 2002, pp 106).
Different probability distributions were assumed for the random variable 
willingness to pay, with emphasis on the non-negative distributions, including the 
Weibull, exponential, lognormal and log-logistic distributions. Non-negative 
distributions do not admit negative values for willingness to pay, which is a desired 
characteristic in this study since respondents should state a non-negative amount for the 
reduction in his or her risk of death. In order to select the appropriate probability 
distribution, that is, the one that best fits the sample data, the Akaike information 
criteria (AIC) was used. Akaike (1974) proposed comparing each log-likelihood 
adjusted by the specific number of parameters being estimated in a particular model. 
That is:
AIC  = -2(log likelihood) + 2(c + p  + 1)), (101)
where (c) is the number of model covariates (in the case of this study c=0 for all 
distributions), and (p) is the number of model-specific ancillary parameters. Although 
the best-fitting model is the one with the largest log likelihood, the preferred model is 
the one with the smallest information criteria value. Table 36 shows the relevant figures:
66 This ad-hoc procedure assumes that half o f individuals’ annual income equals their disposable income. 
Income tax in Brazil is payable in two levels, 10% and 27.5%, according to earnings. Other cumulative
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Table 36: Goodness of fit of different non-negative willingness to pay probability 
________ distributions -  Akaike procedure_____ ______________ _____________
Weibull Exponential Log-logistic
Ancillary parameters 1 0 1
5-in-1000 immediate risk reduction
Log likelihood -404.57076 -412.72118 -386.82943
Akaike criteria 813 827 778
1-in-1000 immediate risk reduction
Log likelihood -266.02575 -273.87937 -255.97043
Akaike criteria 536 550 516
Although the log-logistic probability distribution presented the best goodness- 
of-fit indicator according to the Akaike method, the Weibull distribution was assumed 
in this study for two reasons. First, and most important, the Weibull distribution is 
assumed in the majority of similar studies in the literature (e.g. Markandya et a l , 2003; 
Alberini et al., 2004b), which facilitates the comparison among the estimates. Second, 
the log-logistic and Weibull models have similar goodness-of-fit indicators with the 
sample data, which supports the choice of the Weibull probability distribution.
The statistical willingness-to-pay model using the Weibull distribution is 
estimated using the method of maximum likelihood (Alberini et al., 2004b). The log 
likelihood function of the responses is defined as:
lo g i = £  \0 %[f{wTP,u ; <?; c t)- F{WTP,L;6;o)\, (102)
i
where (WTP1) and (WTPU) are the lower and upper bounds of the interval around the 
respondent’s true willingness-to-pay value and (F(WTP; 6; a)) is the cumulative density 
function of the Weibull distribution with shape parameter (6) and scale parameter (er), 
defined as:
F(z\0\<j ) = 1-exp (103)






taxes, such as the compulsory contribution to social security, plus the high cost o f living in Sao Paulo 
(e.g. housing) seem to suggest that this is a conservative assumption.
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Table 37: Weibull accelerated failure-time model













5-in-1000 immec iate risk reduction
Constant 7 .61154^ 0.08311 7.67814(¥) 0.10103 7.60078r) 0.08997
Shape
parameter 0.83644 0.03642 0.81270 0.04066 0.82200 0.03736
Log
likelihood -404.57076 -295.59862 -361.84367
N 240 172 213
1-in-1000 immec iate risk reduction
Constant 7.52176r j 0.08489 7.45842(¥) 0.09790 7.53810n 0.09251
Shape
parameter 0.81076 0.03391 0.80993 0.04049 0.79450 0.03451
Log
likelihood -420.68683 -317.18323 -373.77635
N 245 185 215
Notes: FlagO = Inconsistent maximum willingness-to-pay responses for both immediate risk reductions. 
Flag4 = Wrong answer to both probability tests.
(*) significant at 1%; (**) significant at 10%.
According to Bateman et a l (2002, pp 244), the mean and median values for the 
Weibull distribution can be estimated as:
mean = exp(a)r(l + cr) and median = exp(a + ln(- ln(0.5))er), (104)
where (a) represents the location parameter of the Weibull probability distribution and 
(T(n)=(n-1)!) is the gamma function.
Table 38: Parametric estimation of mean and median annual willingness to pay 
________ (US$ 2003) -  Weibull distribution (95% Cl)67______________________
5-in-1000 risk reduction over 10 years 
starting now















(528.06 -  
817.37)
712.06 






(490.33 -  
766.80)
572.95 
(444.85 -  
749.06)
629.02 
(495.97 -  
807.12)
Median 383.59
(3 3 7 .8 2 -
434.17)
404.79
(3 4 6 .3 6 -
471.03)
376.58 
(327.93 -  
430.92)
345.82
(3 0 3 .4 2 -
392.96)
324.45 
(279.35 -  
375.19)
348.28
(3 0 1 .6 7 -
400.75)
US$ 1 = R$ 3.40 during the survey period (March/2003).
67 Mean and median annual willingness to pay using gross income (no disposable income adjustment)
5-in-1000 risk reduction over 10 years 
starting now














Mean 970.80 986.82 966.75 834.21 740.61 866.03
Median 572.61 570.16 567.46 483.38 422.34 499.39
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• /COThe mean and median willingness-to-pay estimates shown in Table 38 are 
consistent with the following criteria. First, the mean values are all greater than the non- 
parametric mean values (Table 35), which are supposed to be lower-bound estimates of 
mean willingness to pay. Second, lower values for the smaller risk reductions are 
observed in all estimates. However, willingness-to-pay estimates for different risk 
reductions are not proportional to the reduction in risk, i.e. the willingness to pay for a 
5-in-1000 risk reduction is not five times larger than the willingness to pay for a 1-in- 
1000 risk reduction.
Table 39: Internal scope test: are willingness-to-pay values proportional to the risk
reduction?
Ratio 5-in-1000 / ] -in-1000 risk reduction over 10 years starting now
Total sample Without FlagO =1 Without Flag4 =1
Mean 1.0713 1.2428 1.0396
Median 1.1092 1.2476 1.0813
As can be seen in Table 39, neither mean willingness-to-pay estimates nor 
median values increase in proportion to the size of the risk reduction, although median 
willingness-to-pay estimates present a little more sensitivity to the size of risk reduction. 
Interestingly, the ratio is higher for both mean and median estimates when the sub­
sample cleaned using FlagO is chosen. This result would be also expected when the sub­
sample cleaned using Flag4 was used. Although the ratios suggest that the estimates fail 
the internal scope test, this failure is common to other results in the literature. For 
example, the ratios observed in similar tests in the US and Canada were 1.9 and 3.2 
(median values), and 1.3 and 1.6 (mean values), respectively (Alberini et a l , 2004b).
As mentioned in the empirical literature review of contingent valuation studies, 
Hammitt and Graham (1999) discussed some reasons why stated willingness to pay are 
not sensitive to variation in risk magnitude. One possible reason, they argued based on 
the review of several studies, is that respondents might not understand probabilities, or 
lack intuition for the changes in small probabilities of death risk. Another possibility 
involves the fact that respondents might not treat the given probabilities as given to 
them, suggesting that stated willingness to pay would not be proportional to the amount
68 To generate confidence intervals o f VSL estimates the recommended procedure should be to estimate a 
number o f different mean and median WTP for different samples generated by using simulation 
techniques (e.g. Monte Carlo, bootstrap). This procedure would enable the estimation o f  standard errors 
and confidence intervals for the Weibull parameters and, consequently, WTP estimates. Alternatively, the 
95% confidence interval o f  the estimated parameters in the Weibull constant-only regressions was used to 
estimate 95% confidence intervals for mean and median WTP and VSL.
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of risk reduction given to respondents, but should be proportional to changes in 
perceived risk. Finally, it is possible that respondents might not value changes in risk 
levels in a manner that is consistent with expected utility theory.
5.7. Validity tests of parametric willingness-to-pay estimates
This section aims to test whether the respondents’ willingness-to-pay values 
were influenced by socio-economic and behavioural factors, and if these factors are in 
accordance with the economic theory. Following Bateman et al. (2002), a fully 
parameterised model should be estimated to establish the degree of non-randomness 
observed in the sample data. The variables that influenced the stated willingness-to-pay 
values must be identified. Typically, such variables include income, age, education, 
details of respondent’s attitudes towards the good or service being valued, and 
information on respondent’s current knowledge of the good or service. These variables 
were included as covariates in the willingness-to-pay model. This model does not 
necessarily have to make the same distributional assumptions as those used to estimate 
mean and median willingness to pay. However, the Weibull distribution was assumed 
again for ease of comparison with results presented in the recent literature (e.g. Alberini 
e ta l , 2001, 2004a).
Because the objective now is to establish the degree of randomness of 
willingness-to-pay responses, all available variables were tested regardless of whether 
they are considered to be endogenous or exogenous to the decision of stating the 
willingness-to-pay values69. This is possible because the parameters themselves are not 
of interest, but their significance is important to establish the explanatory power of the 
model. The resultant statistical model is:
log WTPi = Xi./3 + £ , (105)
where (x) is a vector of individual characteristics and risk variables, (fi) is a vector of 
parameters to be estimated and (e) is the error term. Table 40 and Table 41 show the 
statistical significant covariates and, eventually, those insignificant ones but essential 
for the analysis like income, gender, age and education.
69 Econometric theory states that parameter estimates are biased when endogenous variables are included 
in the willingness-to-pay model.
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Table 40: Validity test - willingness-to-pay for a 5-in-1000 immediate risk
reduction










Constant 8.93490(,) 2.19569 12.8802n 3.33478 7.06822n 2.32752
Gender 0.19891(" ) 0.10389 0.26377(¥¥) 0.13043 0.22420(¥+) 0.11129
Age -0.05234 0.69270 -0.18042 0.10374 0.01953 0.07462
Age square 0.00051 0.00061 0.00160(¥¥) 0.00090 -0.00017 0.00066
Years o f education 0.00869 0.01401 0.00690 0.01906 0.01024 0.01548
Income 0.00064 n 0.00015 0.00054(¥) 0.00016 0.00061(¥) 0.00015
If smoker -0.14350 0.11537 -0.24127 0.15753 -0.2128(¥¥) 0.12300
Degree o f faith in religion -0.02660 0.06650 0.01248 0.08566 -0.09962 0.08006
Has health insurance -0.27606r) 0.10651 -0.36658(¥) 0.13758 -0.2848 l r) 0.11081
If respondent is married 0.02361 0.13008 -0.03586 0.16651 -0.00066 0.14184
Children -0.03672 0.18126 -0.27138 0.27371 -0.09724 0.19957
Self-assessed 
comprehension of the 
concept o f probabilities
0.05096 0.04369 0.05299 0.06675 0.08665(¥¥; 0.04742
If  respondent considered 
his/her finances when 
stating WTP
0.21739 0.12536 0.21550 0.16707 0.14056 0.13384
Role limitation physical 
score
0 .0 0 3 6 5 ^ 0.00188 0.00509(¥¥) 0.00254 0.00583(¥) 0.00204
Energy vitality score -0.00688(¥¥) 0.00308 -0.00398 0.00362 -0.0076(¥¥) 0.00361
Subjective expected age o f 
death
-0.0691 (” } 0.02945 -0 .0 8 1 6 ^ 0.03480 -0.04719 0.03238
Scale parameter 0.7437524 0.7490718 0.7504294
N 240 172 213
Log likelihood -273.76743 -193.29854 -240.89826
Notes: (*) significant at 1%; (**) significant at 10%.
The most important results in Table 40 relate to the significance level and 
positive sign of the individual income variable. As would be expected from economic 
theory, willingness to pay for a reduction in risk of death has a positive relation with the 
respondents’ income, since reducing mortality risk is considered to be a normal good. 
The fact that income is the most statistically significant covariate -  for all sub-samples -  
is also in line with the contingent valuation literature, which states that willingness to 
pay is the maximum amount of money that the individuals are willing to pay for the 
provision of the good being valued.
It can also be observed that, apart from income, the statistical significant 
covariates are not the same across the sub-samples. It was an expected feature given the 
discussion in section 5.3, which investigated the possible determinants of inconsistent 
willingness-to-pay responses and wrong answers to both probability tests, exactly the 
occurrences considered to censor the sub-samples. Among the statistically significant 
regressors are (i) the self-assessed comprehension of the concept of probabilities, which
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ranged between one and five in an increasing scale of comprehension, (ii) a dummy 
variable indicating whether respondents considered their finances when stating 
willingness-to-pay values, (iii) the energy vitality score, (iv) the role limitation physical
70score , and (v) whether the respondent has any health insurance.
Important socio-economic variables that would be expected to explain 
willingness-to-pay estimates but were not found to be significant include gender, age, 
education and marital status. According to a correlation analysis performed in this 
study, these covariates were not significantly linearly correlated with income, which 
suggests that the importance of income in explaining willingness to pay did not affect 
the (low) importance of the other socio-economic covariates in explaining the 
dependent variable. Surprisingly, perhaps, whether a respondent smoked or not was not 
significant in determining willingness-to-pay values, which would be expected to be 
significant since smokers already take greater mortality risks and since health risks 
associated with smoking, such as respiratory diseases and cancer, are well established 
and advertised71. Furthermore, the variable representing whether respondents have 
children, which might be interpreted to indicate that respondents may have more 
concern about their future health and capacity for providing support, was also not 
statistically significant.
Very similar results were obtained when the same analysis was performed for 
the 1-in-1000 risk reduction willingness-to-pay estimates (Table 41). The most 
important differences were that additional to income and other behavioural variables, 
respondents smoking or not, and the degree of religious faith were then statistically 
significant for some sub-samples. It is difficult to establish the reason why these 
behavioural attitudes are important in explaining willingness to pay for a smaller risk 
reduction while they are not significant to determine willingness to pay for a 5-in-1000 
risk reduction. The negative sign of the coefficient relating to the degree of religious 
faith indicates that the more (subjective) religious the respondents are the less the 
willingness to pay. This might be expected on the basis that the greater the faith the
70 Role physical limitation score “measures the extent o f disability in everyday activities due to physical 
problems. Low score indicates problems with work or other daily activities resulting from physical health; 
high score indicates no problems with work or other daily activities as a result o f  physical health”. Energy 
vitality health score is a “bipolar scale measuring energy level and fatigue; mid-range score indicates that 
the respondent does not report feeling tired or worn out; score=100 indicates that in addition, respondent 
feels fhll o f pep and energy all o f the time” (Alberini et a l ,  2004b). Both scales range from zero to 100.
71 This result is in line with Viscusi and Hersch (2001), which state that cigarette smokers assume more 
job risk than non-smokers.
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more the respondents transfer responsibility to the entities they believe in to protect 
them.
Table 41: Validity test - willingness-to-pay for a l-in-1000 immediate risk
reduction










Constant 10.2731(¥J 2.47587 12.0843(¥) 3.71081 8.81256(¥) 2.88181
Gender 0.19715(¥¥) 0.11656 0.26035 0.16336 0.31512(¥¥) 0.12579
Age -0.09329 0.07338 -0.16256 0.10754 -0.05701 0.08447
Age square 0.00075 0.00063 0.00141 0.00091 0.00048 0.00073
Years of education 0.00366 0.01727 0.02342 0.02556 0.01275 0.01888
Income 0.00059r) 0.00018 0.00041C” J 0.00021 0.00057^ 0.00019
If smoker -0.2478(” ^ 0.12924 -0.4732(¥¥) 0.17977 -0.34844(*) 0.13227
Degree o f faith in religion -0 .1 7 9 4 ^ 0.07693 -0.1863(¥¥J 0.10629 -0 .2 0 1 1 ^ 0.09297
Has health insurance -0.18347 0.12773 -0.12177 0.17869 -0.11376 0.13996
If respondent is married 0.03287 0.14478 0.05071 0.20140 0.03951 0.17250
Children -0.03503 0.20502 -0.14032 0.31015 -0.07871 0.23896
Self-assessed 
comprehension of the 
concept o f probabilities
0.04297 0.04815 0.10556 0.06817 0.11322(*¥) 0.05491
If respondent considered 
his/her finances when 
stating WTP
0.23274(¥¥) 0.12711 0.14878 0.16813 0.13930 0.13740
Scale parameter 0.8630446 0.9168229 0.869929
N 245 185 215
Log likelihood -319.76955 -236.92525 -281.3393
Notes: (*) significant at 1%; (**) significant at 10%.
• Pooled data (pilot plus final samples)
In order to confirm the validity tests performed on the final sample, the same 
model was executed with the pooled data, that is, appending the pilot sample to the final 
sample . This makes it possible to investigate whether the willingness-to-pay estimates 
are random or, instead, can be explained by some socio-economic and behavioural 
variables, regardless of the sample. That is, it is intended to test whether the observed 
statistically significant variables remain significant when a different sample is 
considered. Adding the pilot sample in the analysis includes extra 309 respondents. 
Table 42 shows the results for the 5-in-1000 immediate risk reduction while Table 43 
presents the figures relating to the l-in-1000 risk reduction.
72 Thanks to Ana Alberini and other participants o f the 14th Annual Congress o f Environmental 
Economists for this suggestion. T-tests o f equality o f mean values between the pilot and the final samples 
are presented in Annex 10.2.
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Table 42: Validity test - willingness-to-pay for a 5-in-1000 immediate risk
reduction (Pooled data)










Constant 7.60572r) 1.46501 8.15273n 1.71996 7.27616^ 1.54770
Gender 0.04738 0.08703 0.11196 0.09601 0.03350 0.09103
Age -0.02011 0.04815 -0.04022 0.05648 -0.00487 0.05116
Age square 0.00022 0.00042 0.00039 0.00049 0.00008 0.00045
Years o f education 0.04674r) 0.01078 0.04835r j 0.01291 0.04827r) 0.01153
Income 0.00045n 0.00005 0.00043(¥) 0.00005 0.00044n 0.00005
If  smoker 0.07816 0.10088 0.05872 0.11371 0.07056 0.10522
Degree o f faith in religion -0.07504 0.05235 -0.08014 0.06330 -0.12001" ’ 0.06020
Has health insurance -0.46210r) 0.09442 -0.4883 l r) 0.11755 -0.46035r j 0.10101
If  respondent is married -0.02329 0.09154 0.00008 0.10121 0.00048 0.09711
Children -0.16754 0.15821 -0.09648 0.19019 -0.19222 0.17313
Self-assessed 
comprehension o f the 
concept o f probabilities
0.06903(" } 0.03915 0.04164 0.04837 0.07062 0.04398
If  respondent considered 
his/her finances when 
stating WTP
0.31939n 0.10294 0.38360n 0.12005 0.2641 l (” j 0.10595
Role limitation physical 
score
0.00133 0.00133 0.00050 0.00161 0.00185 0.00147
Energy vitality score 0.00032 0.00275 0.00175 0.00314 0.00007 0.00300
Subjective expected age o f 
death
-0.01542 0.02613 -0.00675 0.03203 -0.00652 0.02926
Scale parameter 1.077121 1.088961 1.094792
N 545 426 499
Log likelihood -926.86317 -773.14112 -856.33379
Notes: (*) significant at 1%; (**) significant at 10%.
As can be seen in Table 42, almost the same set of variables that were significant 
in explaining the willingness to pay for a 5-in-1000 immediate risk reduction in the final 
sample (income, health insurance and if the responded considered his or her budget 
constraint) are important in determining the willingness to pay for this risk reduction 
using the pooled data. The main difference relates to the education variable, which is 
now statistically significant. The reason seems to be the higher education level observed 
in the pilot survey, one third of which consisted of students of Universities of the Third 
Age and highly qualified employees of a private bank.
Table 43 shows similar results for the l-in-1000 risk reduction. In general terms, 
the same set of regressors was important in explaining differences in willingness-to-pay 
values using the pooled data, except that the education variable is now significant. The 
variable relating to smoking is now not significant, possibly because of the effect of the 
education variable.
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Table 43: Validity test - willingness-to-pay for a l-in-1000 immediate risk
reduction (Pooled data)













Constant 9.86537(¥) 1.84726 9.11027(*J 2.31734 9.44585 1.96584
Gender 0.06009 0.10804 0.15830 0.13195 0.09026 0.11562
Age -0.0996(¥¥) 0.05978 -0.08236 0.07336 -0.08473 0.06350
Age square 0.00086(*+) 0.00052 0.00074 0.00063 0.00075 0.00055
Years o f education 0.02291(¥¥) 0.01335 0.03713(**} 0.01614 0.02094 0.01439
Income 0.00040(¥) 0.00005 0.00037^ 0.00005 0.00040(¥) 0.00005
If  smoker 0.05286 0.12800 0.02608 0.14335 0.02928 0.13539
Degree o f faith in religion -0 .1 3 9 1 ^ 0.06872 -0.23788n 0.08253 -0.1552(¥¥) 0.07960
Has health insurance -0.41845(¥) 0.11171 -0 .3 0 7 1 ^ 0.14044 -0.40657w 0.12002
If  respondent is married 0.04406 0.11945 0.05072 0.14465 0.05187 0.13029
Children -0.04268 0.21058 -0.16414 0.24303 -0.08431 0.24012
Self-assessed 
comprehension o f the 
concept o f probabilities
0.09101(¥¥) 0.04607 0.12872(¥¥) 0.05847 0.10556r ) 0.05261
If  respondent considered 
his/her finances when 
stating WTP
0.23209(*¥) 0.11747 0.15839 0.13860 0.16569 0.12293
Scale parameter 1.350752 1.416372 1.375685
N 551 440 501
Log likelihood -1049.2796 -857.13581 -962.63673
Notes: (*) significant at 1%; (**) significant at 10%.
From these results, it can be concluded that the willingness-to-pay estimates to 
reduce immediate probabilities of death in Sao Paulo seem to be robust, not sample- 
dependant, and not assigned randomly.
5.8. The value of a statistical life and the value of a statistical life year
The corresponding values of a statistical life were estimated using both median 
willingness-to-pay estimates (conservative estimates) and mean willingness-to-pay 
values. They were obtained by dividing the willingness-to-pay figures by the 
corresponding annual risk reduction being valued. It was assumed that respondents 
implicitly considered the risk reduction evenly over the ten-year period, which makes it 
possible to avoid discounting the respondents’ annual payments. Table 44 shows the 
results.
As can be seen in Table 44, the values of a statistical life estimated from l-in- 
1000 risk reductions are much higher than those estimated using the 5-in-1000 risk 
reduction, as expected since the willingness to pay is divided by a smaller risk variation. 
This is purely due to the lack of proportionality between the willingness-to-pay 
estimates regarding the differences in the size of risk reductions (Table 39). The
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estimates of the value of a statistical life reflect only differences in risk variation (almost 
five times bigger). In fact, these estimates of value of a statistical life, derived from 
willingness-to-pay estimates for different risk reductions, would be similar to each other 
if the mean and median willingness-to-pay estimates were proportional to the difference 
in risk variation. It is suggested that the value of a statistical life estimates derived from 
mean and median willingness-to-pay estimates for a 5-in-1000 risk reduction are of 
greater policy relevance since they represent more conservative estimates than those 
estimated using willingness to pay estimates for l-in-1000 risk reduction73. Thus, for 
policy assessments in Sao Paulo conservative values of a statistical life ranging between 
USS 0.77 -  1.31 million74 are suggested.
Table 44: Value of a statistical life using parametric estimation of mean and
median annual willingness to pay (US$ 2003) -  Weibull distribution (95%
__________C l)__________________________________ _____________________________________
5-in -l000 risk reduction over 10 years 
starting now





















(1,038,495 -  
1,667,161)
6,099,858 
(4,903,276 -  
7,668,017)
5,729,545 
(4,448,499 -  
7,490,598)
6,290,223 
(4,959,711 -  
8,071,165)
Median 767,187 
(675,649 -  
868,349)
809,587 
(692,728 -  
942,062)
753,159 
(655,851 -  
861,846)
3,458,245 
(3,034,213 -  
3,929,572)
3,244,472 





US$ 1 = R$ 3.40 during the survey period (March/2003).
When compared with European and North American estimates these values 
seem to be higher than expected. Given the close link between willingness-to-pay 
estimates and the population income, lower willingness-to-pay values for developing 
countries might be expected. A possible reason for the high willingness-to-pay and 
value of a statistical life estimates found in the current study might have been the 
‘cooperative’ behaviour observed in many of the respondents. A possible bias might 
have been introduced by the use of an incentive payment (R$25 or approximately 
US$7.5) to each respondent for his or her participation in the survey. Evidence for such 
a bias arose from a number of comments made by respondents to the effect that they 
were keen to take part in this survey and other such surveys, since the cash incentive
73 In this survey, the 1-in-1000-risk reduction question is asked after the 5-in-l000-risk reduction 
question. Prior testing in the North American context indicated that answers to the second question tend 
to be less reliable than those to the first question. It is also likely to be an easier size o f risk change to 
effectively comprehend.
74 The results using cleaned sub-samples were not substantially different from the results using the total 
sample. Therefore, it is suggested the latter set o f results for policy analysis in Brazil.
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was important to them (minimum wage in Brazil was R$240 per month). It is possible 
that those respondents tried to be ‘cooperative’ or helpful by saying ‘yes’ to every 
question. This ‘yeah-saying’ behaviour has been observed in several contingent 
valuation studies using the dichotomous choice format for the willingness-to-pay 
questions (e.g. Ready et al., 1986)75. It is believed that the relatively high figures in this 
valuation exercise may be partly due to this bias. This caveat can be regarded as a 
possible improvement for future contingent valuation studies in Brazil. On the other 
hand, as observed in Chesnut et a l (1997) for a study in Bangkok, in general health is 
seen as a basic necessity (like food or shelter) and those with lower incomes may be 
willing to pay a higher share of their income to protect their health (Chesnut et al., 
1997).
In order to test the hypothesis of ‘yeah-saying’ responses, the mean and median 
willingness to pay were estimated using a sub-sample where the ‘yeah-say’ respondents 
were excluded. A ‘yeah-say’ respondent was considered to be the individual who 
accepted all bid-values offered in both immediate (5 in 1000 and 1 in 1000) risk 
reductions. Table 45 shows the results, which, however, cannot be claimed as better 
results than those presented in Table 44 since it is not possible to distinguish genuine 
‘yes’ responses (those obtained after an implicit utility maximising process constrained 
by income) from ‘yeah-say’ respondents. In other words, the procedure adopted here 
may have excluded some genuine ‘yes’ responses from the sample.
Table 45: Value of a statistical life using parametric estimation of mean and
median annual willingness to pay (US$ 2003) -  Weibull distribution (95% 
________ Cl) -  excluding possible ‘yeah-say* responses_________________________
5-in-1000 risk reduction over 10 years 
starting now





















(395,384 -  
560,497)
2,412,626 
(2,018,173 -  
2,906,148)
2,436,371 
(1,991,195 -  
3,005,512)
2,319,842 
(1,912,481 -  
2,838,622)
Median 415,831 
(369,841 -  
465,793)
416,643














US$ 1 = R$ 3.40 during the survey period (March/2003).
The income-elasticity of willingness to pay was estimated by regressing a 
double-log model with income as the explanatory variable of willingness-to-pay
75 In fact, this conclusion is based on qualitative analysis o f respondents’ comments after attending the 
survey. Quantitatively, however, the percentages o f  ‘yeah-saying’ respondents were similar
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responses. The results suggest the income-elasticity of willingness to pay equal to 
0.9087 (5-in-1000 risk reduction) and 0.8331 (l-in-1000 risk reduction). Table 46 
shows the results for all sub-samples of interest. The results excluding ‘yeah-saying’ 
respondents were not statistically significant at the usual level, which undermines the 
validity of these figures.
Table 46: Income elasticity of willingness to pay -  double-log model -  Weibull
distribution
Risk Sample including ‘yeah-saying’ respondents
Reduction Total sample FlagO Flag4
5-in-1000 0.9087 0.9020 0.9276
l-in-1000 0.8331 0.7430 0.8760
Sample excluding ‘yeah-saying’ respondents
5-in-l 000 0.0515 0.0470 0.0821
l-in-1000 0.0126 0.0047 0.0386
US$ 1 = R$ 3.40 during the survey period (March/2003).
• The value of a life year lost (VLYL)
This empirical study is devoted to estimate the willingness to pay for small 
reductions in risks of death in Sao Paulo. As discussed in the literature review, another 
metric has been discussed among environmental economists in the context of air 
pollution. This is the value of a statistical life year (VSLY), which arguably has a 
number of advantages over the value of a statistical life (e.g. Markandya et al., 2003; 
Alberini et a l , 2004a). Rabl (2003) proposed a key argument in this debate. He shows 
that the number of deaths that can be attributed to this cause is only observable in 
mortality statistics when the exposure-death effect is sufficiently instantaneous that the 
initial increase in death rate is not obscured by the subsequent depletion of the 
population who would otherwise die later. Rabl argues that the usual case is that the 
impact of air pollution is not instantaneous but the cumulative result after years of 
exposure, so that the number of deaths is not observable76. As a result, it is impossible 
to tell whether a given exposure has resulted in a small number of people losing a large 
amount of life expectancy or a large number of people losing a small amount of life 
expectancy. In this case only the average number of years of life lost are calculable and
(approximately 50%) for all income-level groups, except the highest two out o f eight groups (class A).
76 In this case, for example, affected individuals may die over a period o f  30 years following exposure. 
Some individuals may die in the second year o f this period who would have died anyway in year 20. But 
individuals may die in year 20 from the exposure. Any change in the observable mortality rate in year 20 
therefore understates the true mortality rate that can be attributable to air pollution.
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so this makes a strong case for the use of VSLY in the context of air pollution 
(Markandya et al., 2003).
In order to compute the value of a statistical life year it is necessary to convert 
the probability changes of 1 in 1000 and 5 in 1000 into changes in life expectancy. For 
Europe, Rabl (2001) derived the changes in remaining life expectancy associated with 
the 5-in-1000 risk change over the next 10 years based on empirical life tables. 
According to his calculations, the extension in life expectancy ranges from 0.64 to 2.02 
months, depending on the person’s age and gender, and averages 1.23 months (37 days) 
for a European sample (Alberini et al., 2004a). Similar figures were estimated for Brazil 
following Rabl (2001). The extension in life expectancy ranged between 0.12 and 1.92 
for individuals aged between 40 and 70 years old. For an average individual in our 
sample (56 years old) this figure is equal to 0.96 months or approximately 29 days.
Table 47: Weibull accelerated failure-time model: willingness to pay for one month
of life extension













5-in-l000 immec iate risk reduction
Constant 8.0512r) 0.1125 8.1120n 0.1380 7.9572n 0.1174
Ancillary 
parameter (p) 0.6213 0.0387 0.6014 0.0422 0.6335 0.0479
Log
likelihood -467.9662 -340.2666 -408.7986
N 240 172 213
Notes: FlagO = Inconsistent maximum willingness-to-pay responses for both immediate risk reductions.
Flag4 = Wrong answer to both probability tests.
To estimate the value of a life-expectancy extension of a month, the 
respondent’s willingness to pay was divided by that respondent’s life expectancy 
extension and re-estimated using the Weibull double-bound constant-only model (Table 
47). The resulting mean willingness to pay equates to US$1,329 per year for each month 
of additional life expectancy (total sample). Median willingness to pay by the same 
method is US$512 for a month of life expectancy gain. Because in our survey the 
payments would be made every year for ten years, the total willingness-to-pay figures 
for a life expectancy gain of one month are US$13,288 and US$5,116 respectively. The 
implied values of a statistical life year (VSLY) are US$159,456 and US$61,392, 
respectively. Similar figures obtained when excluding ‘yeah-saying’ respondents 
correspond to VSLY equal to US$62,944 and US$34,729. Table 48 shows the results 
obtained using all sub-samples.
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Table 48: Value of a statistical life year (VSLY) -  5-in-1000 immediate risk
reduction -  Weibull distribution
Sample including ‘yeah-saying’ respondents
Total sample FlagO Flag4
Mean 159,456 176,515 141,811
Median 61,392 63,979 56,522
Sample excluding ‘yeah-saying’ respondents
Mean 62,944 62,396 55,961
Median 34,729 34,404 32,954
US$ 1 = R$ 3.40 during the survey period (March/2003).
5.9. Conclusions
This study used a methodology recently developed in North America, and 
applied a contingent valuation survey instrument that was designed to estimate the 
willingness to pay for reducing an individual’s risk of death. This instrument was 
adapted to the particularities of the Brazilian context and used to estimate the 
willingness to pay for different reductions in probabilities of death, regardless of the 
context in which the risks are analysed. The results suggest a value of a statistical life 
ranging between US$0.77 and 6.1 million, while it is suggested for policy analyses in 
Brazil that conservative values ranging between US$0.77 and US$1.31 million be used. 
The suggested value of a statistical life year ranged between US$ 61,392 and US$ 
159,456.
However, a number of problems seem to suggest that these figures are higher 
than would be expected for a middle-income country like Brazil. The most important 
problem that could be identified in this study refers to the ‘yeah-saying’ behaviour 
observed in some of the respondents. The results using a sub-sample that does not 
include potential ‘yeah-saying’ respondents suggest a value of a statistical life ranging 
between US$415,831 and US$489,752, and the value of a statistical life year ranging 
between US$34,729 and US$62,944.
As in the studies for industrialised countries, there are problems in eliciting the 
willingness to pay for risks of the kind experienced through air pollution. The issues 
that need most attention are (a) determining the survey design that minimises the 
possibility of ‘yeah-saying’ behaviour among the respondents (b) getting the idea of 
probabilities across to a wider section of the population and (c) understanding why 
willingness to pay for different risk levels does not behave consistently in line with 
expectations (proportionality). Finally, the analysis of the results and problems faced
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during this valuation exercise can be helpful for future developments of contingent 
valuation studies in developing countries.
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6. Research questions
The literature review of epidemiologic studies suggested that the mortality 
impact of air pollution tends to be more significant among the elderly and/or those 
individuals in poor health (the harvesting effect). When analysing the benefits of 
policies that aim to reduce air pollution, economists should consider that the willingness 
to pay for a reduction in the risk of dying might differ between young and old 
individuals, and between healthy and impaired groups. The theoretical literature review 
showed that these issues are inconclusive from a theoretical perspective (discussed 
below), and have to be solved empirically.
One aim of this research has been to estimate what adults in Brazil are willing to 
pay to reduce their risk of dying, through a contingent valuation survey described in 
Chapter 4, and to compare the results with related studies conducted in developed 
countries, which is discussed in Chapter 3. In addition, the main research questions 
involve examining the impact -  if any -  of age and current health status on willingness- 
to-pay estimates for small risk reductions in Brazil; and investigating whether 
willingness to pay for reduced future risks to death in Sao Paulo corresponds to 
expectation and theory.
This chapter discusses the research questions described above and is organised 
as follows. Section 6.1 investigates the impact of age on willingness-to-pay estimates, 
while section 6.2 explores the impact of health status. Section 6.3 presents the 
willingness-to-pay estimates for a future mortality risk reduction -  chronic mortality -  
and section 6.4 discusses differences between results obtained in Brazil and those 
obtained in European and North American studies. All the tests are performed using 
both final and pilot samples in order to test whether the results are sample-independent 
(robust). In addition, all the sub-samples are tested; that is, the sample where 
respondents who failed the probability tests are excluded (flag4), the sample where 
respondents who provided inconsistent willingness-to-pay responses are excluded 
(flagO), and the total sample. Finally, all the tests were also performed on a sample that 
does not include the ‘yeah-saying’ respondents, a bias identified in the results discussed 
in the last chapter.
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6.1. The impact of age on willingness-to-pay estimates
Theory is inconclusive about the role of age in the willingness to pay for small 
reductions in probabilities of death and the value of a statistical life, as demonstrated in 
the theoretical literature review. Initially, it can be expected that willingness to pay will 
increase with the probability of dying during the following year (baseline risk), which 
increases with age. However, willingness to pay also depends on the marginal utility of 
future consumption, and it is not clear whether and how this can be influenced by age 
(Alberini et al., 2004b). For plausible parameter values, however, Shepard and 
Zeckhauser (1982) concluded that willingness to pay would follow an inverted-U shape 
with regard to age, when assuming a very specific functional form for the utility 
function. Krupnick et al., (2002) showed that willingness-to-pay estimates did not 
change with age in Canada, although estimates for individuals older than 70 years were 
lower than for the rest of the sample (but not statistically significant). Alberini et al., 
(2004b) found no age effects on the willingness-to-pay estimates for reductions in risk 
of death in the US.
In this section an analysis is developed to investigate the impact of respondents’ 
age on willingness-to-pay estimates in Brazil. Initially, different models were developed 
in order to identify the significance of age variables when explaining willingness to pay. 
That is, willingness to pay is regressed in models where age (model 1), age-square 
(model 2), and age-category dummies (model 3) are the only regressors. These models, 
suggested by Krupnick et al., (2002), show the effect that marginal changes on the 
regressors have (<ceteris paribus) on willingness to pay. Model 1 imposes a linear 
relationship between age and willingness to pay, while model 2 includes the quadratic 
functional form. Model 3 specifies dummy variables per age category, which enables 
the investigation of the shape of the willingness-to-pay curve against respondents’ age. 
In mathematical form:
Model 1 log WTPi = a  + p.agei + £i
Model 2 log WTPt = a  + fluagei  +  fh .(a g e i)2 +  s> (106)
Model 3 XogWTPi = a  + p i.dummy5059# + pi.dummy6069/ + pi.dummyl015i + s /
6.1.1. Final sample
The total sample (without excluding any inconsistencies) and sub-samples 
excluding individuals with poor understanding of the concept of probabilities (Flag4)
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and those who stated inconsistent willingness-to-pay responses (FlagO) were used. 
These analyses used only the responses for the 5-in-1000 immediate risk reduction 
because it was the first question presented to respondents, and arguably, the one they 
answered with more attention and accuracy77.
As can be seen in Table 49, none of the coefficients of the age variable, which is
7fta continuous variable ranging from 40 to 75, was statistically significant . The results 
confirm the findings of the validity tests of willingness-to-pay estimates performed in 
Chapter 5 (the age variable was not significant as well). During the validity tests, the 
lack of significance of coefficients of the age variable might have been influenced by 
the inclusion of other socio-economic and attitudinal variables, especially the 
respondents’ income. By specifying age as the only regressor to explain willingness to 
pay, it is possible to analyse the effect of age on willingness to pay without the 
influence of other variables.
Table 49: Impact of age on willingness-to-pay for a 5-in-1000 immediate risk
reduction - final sample -  Mode 11










Constant 7.38382r) 0.55744 7.57496(,) 0.66273 7.63937(,) 0.63847
Age 0.00407 0.00993 0.00184 0.01183 -0.00070 0.0116
Scale parameter 1.194233 1.229878 1.216734
N 240 172 213
Log likelihood -404.43428 -295.57934 -361.84045
Excluding yeah-saying* respondents
Constant 6.91551n 0.37336 7.03440(,) 0.41638 7.14553n 0.40168
Age -0.00170 0.00631 -0.00360 0.00712 -0.00654 0.00680
Scale parameter 0.7043396 0.7283336 0.6971915
N 101 87 89
Log likelihood -124.3297 -109.89914 -108.28223
Notes: (*) significant at 1%; (**) significant at 10%.
The same non-significant results are obtained when a specification including the 
quadratic form of the age variable is used (Table 50). However, the coefficients are all 
statistically significant at the 10% level when respondents that expressed inconsistent 
willingness-to-pay answers are excluded from the sample (FlagO). It can be interpreted 
from the signs of the age variables’ coefficients (negative for age and positive for age
77 The 1-in-1000-risk reduction question is asked after the 5-in-1000-risk reduction question. Prior testing 
in the North American context indicated that answers to the second question tend to be less reliable than 
those to the first question. It is also likely to be an easier size o f risk change to effectively comprehend.
78 The same results were obtained when model 1 was specified using age square only.
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square) that for this group of respondents, willingness to pay decreases with age but the
70slope of this relationship increases at higher ages .
Table 50: Impact of age on willingness-to-pay for a 5-in-1000 immediate risk
reduction - Inal sample -  Mode 2










Constant 10.7317n 2.95846 13.9206(,) 3.66949 10.0997n 3.58184
Age -0.11740 0.10767 -0.2268(¥i) 0.13191 -0.09070 0.13333
Age square 0.00107 0.00096 0.00201" ’ 0.00117 0.00080 0.00122
Scale parameter 1.188735 1.214908 1.212641
N 240 172 213
Log likelihood -403.76362 -294.03514 -361.55688
Excluding \yeah-saying* respondents
Constant 8.9792 l n 2.05523 8.96120r) 2.27127 7.31402r) 2.20197
Age -0.07654 0.07386 -0.07309 0.081124 -0.01264 0.07866
Age square 0.00066 0.00065 0.00061 0.00071 0.00005 0.00068
Scale parameter 0.7030674 0.727204 0.6973341
N 101 87 89
Log likelihood -123.956 -109.6372 -108.28014
Notes: (*) significant at 1%; (**) significant at 10%.
Table 51: Impact of age on willingness-to-pay for a 5-in-1000 immediate risk
reduction - Inal sample -  Mode 3










Constant 7.73582r) 0.17290 7.90024n 0.20315 7.77143n 0.17434
Age 50-59 -0.31009 0.22105 -0.4337(*¥) 0.25801 -0.35847 0.22969
Age 60-69 -0.16486 0.23917 -0.39622 0.28792 -0.23252 0.24946
Age 70-75 0.19189 0.37543 0.29302 0.42406 0.09430 0.49614
Scale parameter 1.176243 1.193981 1.196425
N 240 172 213
Log likelihood -402.34981 -291.79582 -359.89993
Excluding yeah-saying* respondents
Constant 6.78902r) 0.13488 6.81217(,) 0.15354 6.78243(¥) 0.13962
Age 50-59 0.15795 0.17441 0.17003 0.19034 0.19899 0.17997
Age 60-69 -0.15217 0.17175 -0.20616 0.19814 -0.24073 0.18217
Age 70-75 0.28613 0.18684 0.25628 0.21142 0.13264 0.20489
Scale parameter 0.6873942 0.7088493 0.6752485
N 101 87 89
Log likelihood -121.93827 -107.4906 -105.55861
Notes: (*) significant at 1%; (**) significant at 10%.
Table 51 shows the results of the third specification model used to investigate 
the pattern of willingness to pay in regard to respondents’ age. The coefficients of the
79 The significant parameters obtained in Table 50 (model 2 and sub-sample FlagO) were used to 
estimate willingness to pay per age resulting in decreasing WTP (minimum value at age 56), and
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dummy variables indicating age groups were in general statistically insignificant. An 
exception was the coefficient for the group 50 to 59 years old respondents when 
individuals that reported inconsistent willingness-to-pay responses were excluded 
(FlagO). The results suggest that willingness to pay decreases with age but increases in 
older ages -  the negative sign of coefficients for age groups 50-59 and 60-69 indicates 
that individuals in these age groups pay less than respondents aged 40-49, the excluded 
dummy. This result, however, is undermined by the low significance of the coefficients.
6.1.2. Pilot sample
The same analyses/models were developed using the pilot sample to investigate 
whether the results are confirmed when a different sample is used. That is, it is intended 
to investigate whether the impact of age on willingness-to-pay estimates remain the 
same when another sample of residents of Sao Paulo is used. As demonstrated in 
Chapter 5, these samples differ in terms of education and income levels. The pilot 
sample has a considerable share of its respondents composed of high-level employees of 
a bank, and students of a University for the Third Age in Sao Paulo. Table 52, Table 53 
and Table 54 show the results.
Table 52: Impact of age on willingness-to-pay for a 5-in-1000 immediate risk
reduction - pilot sample -  Mode 1










Constant 8.64332r) 0.51778 9.00147n 0.53433 8.56147^ 0.53086
Age 0.00003 0.00873 -0.00328 0.00893 0.00153 0.00897
Scale parameter 1.708479 1.653056 1.708488
N 305 254 286
Log likelihood .644.37448 -532.57102 -604.32827
Excluding ‘yeah-saying’ respondents
Constant 5.65513n 0.34681 5.66358r) 0.37771 5.63225r) 0.36750
Age -0.00825 0.00594 -0.00857 0.00649 -0.00860 0.00647
Scale parameter 0.5477003 0.5658422 0.5791783
N 65 54 59
Log likelihood -66.456553 -57.057667 -62.843895
Notes: (*) significant at 1%; (**) significant at 10%.
In terms of statistical significance of the coefficients of model 1, the results are 
identical between the pilot and final survey (Table 52 and Table 49), that is, all 
coefficients are insignificant. The difference is the inverted sign of variable age when
increasing WTP at higher ages (U-shape).
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the cleaned sub-samples are considered, although the lack of significance of the 
coefficients makes the analysis of their signs not relevant.
Table 53: Impact of age on willingness-to-pay for a 5-in-1000 immediate risk
reduction - pilot sample -  Mode 12










Constant 4.57486 2.96735 5.32429(" ) 3.03639 4.71422 3.05159
Age 0.14570 0.10325 0.12799 0.10525 0.13980 0.10656
Age square -0.00126 0.00087 -0.00113 0.00089 -0.00120 0.00090
Scale parameter 1.700634 1.646506 1.701412
N 305 254 286
Log likelihood -643.51614 -531.94023 -603.60593
Excluding ‘yeah-saying’ respondents
Constant 3.62538("> 1.77772 3.40768(” } 2.01424 4.36592(*¥) 1.98380
Age 0.06535 0.06245 0.07286 0.07020 0.03753 0.07052
Age square -0.00064 0.00054 -0.00071 0.00060 -0.00040 0.00061
Scale parameter 0.5430748 0.5592438 0.5772879
N 65 54 59
Log likelihood -65.962099 -56.543749 -62.690994
Notes: (*) significant at 1%; (**) significant at 10%.
Again, the results of the pilot sample are insignificant as they were with the final 
sample, but the signs of the coefficients in the model are inverted. The signs of the 
coefficients in Table 53 indicate that the coefficient of variables age are positive and the 
squared age terms are negative, suggesting that willingness to pay increases with age 
but the slope of this relationship decreases at higher ages. This may be a consequence of 
the differences in education and income levels in the pilot sample, although the signs of 
coefficients have to be analysed with care given the lack of statistical significance.
Table 54 shows that the coefficients of the dummy variables indicating age 
groups continue to be statistically insignificant using the pilot sample. Again the signs 
are inverted when compared with the signs obtained in the final sample. The signs of the 
coefficients in Table 54 suggest that willingness to pay increases with age, although the 
result is the opposite when the ‘yeah-saying’ respondents are excluded from the pilot 
sample.
In summary, the results of this analysis of the effect of the respondents’ age on 
the willingness to pay for a small reduction in risk of death confirm the results obtained 
in the validity tests of the willingness-to-pay estimates undertaken in Chapter 5, which 
suggests that the respondents’ age was not important in determining the willingness-to- 
pay responses. This result is in line with other recent contingent valuation studies
193
developed in Europe and North America (e.g. Alberini et a l , 2002; Markandya et a l ,
2003).
Table 54: Impact of age on willingness-to-pay for a 5-in-1000 immediate risk
reduction - pilot sample -  Mode 13










Constant 8.50534r) 0.17544 8.71871(¥) 0.18537 8.4983\ n 0.17831
Age 50-59 0.26772 0.25837 0.24647 0.26555 0.27343 0.26963
Age 60-69 0.18567 0.24408 0.06069 0.24926 0.20594 0.24875
Age 70-75 0.09242 0.24926 0.04779 0.25349 0.12794 0.25718
Scale parameter 1.702197 1.647841 1.702295
N 305 254 286
Log likelihood -643.79974 -532.16748 -603.76607
Excluding ‘yeah-saying' respondents
Constant 5.25186(¥) 0.11629 5.24684(¥) 0.12151 5.23786(,) 0.11779
Age 50-59 0.02104 0.13772 0.01519 0.15425 -0.04465 0.15433
Age 60-69 -0.14648 0.15307 -0.14951 0.17129 -0.17879 0.17226
Age 70-75 -0.31769 0.21084 -0.31701 0.21286 -0.28820 0.23238
Scale parameter 0.5435866 0.5604402 0.577837
N 65 54 59
Log likelihood -66.026004 -56.708836 -62.750088
Notes: (*) significant at 1%; (**) significant at 10%.
6.1.3. Willingness-to-pay estimates per age-group
The results in Brazil suggest that age is not statistically significant in explaining 
willingness to pay for an immediate 5-in-1000 risk reduction. Although not significant, 
the coefficients for categorical dummy variables (model 3, both pilot and final samples) 
do not suggest an inverted-U-shape of the willingness-to-pay curve as proposed by 
Shepherd and Zeckhauser (1982). However, the results using the final sample suggest 
that individuals aged 70 or more tend to pay more compared to individuals aged 40 to 
50 (the dummy excluded from model 3), while the results using the pilot sample 
indicate willingness to pay increasing with age80.
In order to further investigate that, it is proposed to estimate mean and median 
willingness to pay for different sub-samples according to age groups. This approach is 
not affected by the poor statistical performance of the age variable since the constant- 
only approach (Weibull distribution) is used, that is, willingness to pay is modelled with 
no regressor. These estimates can provide further evidence of how willingness to pay
80 Based on the positive signs o f  the coefficients o f variable age at models 1, 2 and 3 (Table 52 and Table 
53).
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varies with age. Mean and median willingness to pay are estimated using the final 
sample and the pilot sample.
As can be seen in Table 55 and Figure 2, both mean and median willingness-to- 
pay estimates follow a U-shape trend when the final sample is used. Mean willingness 
to pay initially decreases with age but then increases steadily to a level higher than the 
willingness to pay expressed by the youngest group. Median willingness-to-pay 
estimates vary less according to age than mean values, but the pattern is similar -  
initially decreasing and then increasing.
Table 55: Mean and median annual willingness to pay per age group (US$ 2003) -







4 0 - 4 9 734.59 875.45 769.08 401.92 477.41 429.25
5 0 - 5 9 531.50 557.16 528.84 370.69 383.74 369.95
6 0 - 6 9 621.85 588.28 609.54 362.21 324.25 342.80
7 0 - 7 5 891.21 1,176.95 843.47 453.95 614.45 353.10
4 0 - 6 4 612.32 655.02 629.49 374.47 394.54 383.21
6 5 - 7 5 796.99 918.29 744.06 419.10 445.92 354.05
US$ 1 = R$ 3.40 during the survey period (March/2003).
Figure 2: Mean and median willingness-to-pay estimates by age groups -  final 
sample
M ean WTP by age group - final sample
60-6940-49 50-59 70-75
tota l flagO flag4
Median WTP by age groups - final sample
50-59 60-69 70-7540-49
total flagO flag4
Mean W TP per age group - final 
sample excluding 'yeah-saying'
40-49 50-59 60-6 9 70-75
flag4
Median W TP per age group - final 
sample excluding 'yeah-saying'
40-49 50-59 60-69 70-75
flag4
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The same analysis was performed using the pilot sample in an attempt to 
confirm whether the pattern of willingness-to-pay estimates by age groups remains the 
same. Although the values of both sets of estimates cannot be compared -  the bid values 
offered in the pilot sample were different (lower) than those used in the final sample -  
the willingness-to-pay curve can be identified in relation to the respondents’ age using 
the pilot sample and compared to the same curve originated from the final sample.
Figure 3: Mean and median willingness-to-pay estimates by age groups -  pilot 
sample
Median WTP by age group - pilot sample
40-49 50-59 60-69 70-75
flag4tota l flagO
Mean WTP by age group - pilot sample
40-49 50-59 60-69 70-75
total flagO flag4
Median WTP per age group - pilot 
sample excluding 'yeah-saying*
40-49 50-59 60-69 70-75
flag4total —« —  flagO
Mean WTP per age group - pilot 
sample excluding'yeah-saying'
40-49 50-59 60-69 70-75
total flagO flag4
As can be seen in Figure 3, mean willingness to pay has the inverted-U shape 
proposed by Shepherd and Zeckhauser (1982), the opposite obtained when using the 
final sample. Median willingness to pay also differs from the pattern presented with the 
final sample. These facts suggest that in the Brazilian case, the effect of age on 
willingness-to-pay estimates is sample-dependent, and has no identifiable pattern.
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6.1.4. Final comments
It can be concluded that no clear age effect on the willingness to pay for small 
risk reductions in Brazil can be identified from the samples available. The lack of 
statistical significance of coefficients of the age variable in models explaining the 
willingness-to-pay responses undermines any conclusion about the effect of age on 
willingness to pay. In addition, mean and median willingness to pay for different age 
groups, which were estimated using the constant-only approach, had no consistent 
pattern between both samples, which reinforces the conclusion that no effect can be 
identified.
6.2. The impact of health status on willingness-to-pay estimates
Theoretically, health status has a similar approach as age with regard to mixed 
influences on willingness to pay. Initially, it can be expected that individuals in poor 
health tend to pay more for a given reduction in their mortality risk since those 
individuals have lower chances of surviving the current period (higher baseline risk). 
On the other hand, these individuals have a lower life expectancy, which may imply 
lower willingness to pay for reductions in the risk of death, depending on the influence 
of health status on the utility of future consumption. Thus, the effect of respondents’ 
and/or their relatives’ health statuses on the value of a statistical life cannot be 
determined according to theory. Empirically, Alberini et al. (2004b) found that 
willingness to pay for reductions in risks of death are significantly greater for 
individuals with high blood pressure in the US, and that chronic respiratory illness and 
heart disease have no significant effect on willingness to pay both in Canada and the 
US.
The validity tests of willingness to pay performed in Chapter 5 showed that only
o  1
two SF36 indices were statistically significant in explaining willingness-to-pay 
responses, while other expected factors were not (e.g. having visited an emergency- 
room in the last five years and having cases of cancer in the family). These results might 
have been affected by the influence of other covariates used in the validity test of 
willingness-to-pay estimates. As in the analysis of the impact of age on willingness to 
pay for reductions in the risk of death, three different models were specified including
81 Short Form 36, or SF-36. Ware, J.E.Jr., Kosinski, M. and Keller, S. (1997). SF-36 Physical and Mental 
Health Summary Scales: a user’s guide manual. Lincoln: RI Quality Metric.
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the most important variables available in the dataset. Those variables represent the 
respondents’ own health status and the occurrence of some important diseases in the 
respondents’ relatives. Model 1 includes dummy variables reflecting the occurrence of 
the main diseases associated with air pollution -  respiratory and cardiac diseases and 
cancer -  either for the respondent and/or his or her family. Model 2 tests if the fact of 
having visited an emergency room or having a hospital admission in the previous five 
years has an influence on the willingness to pay for reductions in the probability of 
death. Finally, model 3 investigates the SF36 health indices. In mathematical form: 
Model 1 log WTPi = a  + fix.cardiaa + P 2.respiratoryi + (h .canceri + £ i
Model 2 log WTPi = a  + P\.selftiealth + pi.ERi + e t (107)
, ,  t „ log WTPi = a  + P\.mhsi + Pi.pfsi + Pi.rlpst + pA.pst +
Model 3 ,
+ ps.ghsi + P^.evsi + ps.sfsi + P%.rlesi + p9.chst + £ i
where,
mhs mental health score;
pfs physical function score;
rips role limitation score;
ps  pain score;
ghs general health perception score;
evs energy vitality score;
sfs social functioning score;
rles role limitation emotional score;
chs change in health score82.
6.2.1. Final sample
Table 56 shows the results obtained with model 1. As can be seen, none of the 
coefficients are statistically significant in most of the sub-samples tested -  except the 
cancer variable when ‘yeah-saying’ and inconsistent respondents are excluded. This 
result suggests that the occurrence of these health diseases in the respondents’ families 
or for themselves does not affect their willingness to pay for a reduction in their 
probability of death. In addition, it confirms the results of the validity tests of the 
willingness-to-pay estimates in Chapter 5, that is, other regressors in the validity tests 
did not affect these health indictors. The negative signs of coefficients relating to cancer
82 For a full description o f  the health status indices the reader may refer to Krupnick et al. (2002), annex.
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and respiratory diseases indicate that respondents (or their families) who experienced 
these diseases tend to express lower willingness to pay. The positive sign for cardiac 
diseases suggests the opposite. Both results cannot be claimed as relevant given their 
poor statistical significance.
Model 2 is presented in Table 57, demonstrating a similar lack of statistical 
significance of the coefficients obtained in model 1. No willingness-to-pay effect can be 
identified in relation to the visit to an emergency room, hospitalisation or the self­
assessed current health status.
Table 56: Impact of health status on willingness-to-pay for a 5-in-1000 immediate
risk reduction -  final sample -  Model 1













Constant 7.62652r) 0.16094 7.61263r j 0.19063 7.62346n 0.17310
Occurrence o f cardiac 
disease (own and/or family) 0.10949 0.19512 0.20253 0.23506 0.13436 0.20436
Occurrence o f respiratory 
disease (own and/or family) -0.21946 0.19846 -0.06622 0.23316 -0.33921 0.21466
Occurrence o f cancer (own 
and/or family) -0.05555 0.19028 -0.13794 0.23828 -0.01026 0.20979
Scale parameter 1.190826 1.225911 1.207066
N 240 172 213
Log likelihood -403.73177 -294.95051 -360.23016
Excluding ‘yeah-saying* respondents
Constant 6.87884r) 0.11639 6.88231(' } 0.12148 6.841 \9 n 0.12561
Occurrence o f cardiac 
disease (own and/or family) -0.05107 0.13985 -0.03695 0.15152 -0.00367 0.14318
Occurrence o f respiratory 
disease (own and/or family) 0.09196 0.14135 0.15790 0.15958 0.00285 0.15159
Occurrence o f cancer (own 
and/or family) -0.20592 0.14529 -0.276 r ) 0.16210 -0.25127 0.16107
Scale parameter 0.6958 0.7153746 0.6915032
N 101 87 89
Log likelihood -123.32829 -108.57904 -107.5456
Notes: (*) significant at 1%; (**) significant at 10%.
As can be seen in Table 58, only a few health indices were statistically 
significant when explaining willingness-to-pay responses, among them the physical 
function score and the role limitation score. The result is not consistent among all sub­
samples. The positive sign of the parameters suggests that the healthier the respondent 
feels (physically) the more this respondent would like to pay for a reduction in his or her 
risk of dying. The same interpretation can be obtained from the positive sign of the role 
limitation physical score. This result is in contrast with the result in model 2, where the 
self-assessed health status of the individual was not significant in explaining variations
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in willingness-to-pay responses. Perhaps individuals tend to value extensions in life 
expectancy more if they believe they are in good health; as if it was not worth paying 
for an increase in risk of surviving if the individual is not in good health. However, the 
result of the subjective health status (self-assessed) was not significant, while some 
health indices were significant. The health indices are constructed from individuals’ 
responses to questions about their daily activities. In this sense, the health indices can be 
considered a subjective measure of health quality as well.
Table 57: Impact of health status on willingness-to-pay for a 5-in-1000 immediate
risk reduction -  final sample -  Model 2













Constant 7.66659n 0.20486 7.65733n 0.27844 7.61255(*) 0.22630
Self-assessed health 
status -0.00902 0.10309 0.03017 0.14109 0.01185 0.11526
Has visited an 
emergency room or 
hospital during the last 
five years
-0.20758 0.19849 -0.18753 0.23719 -0.18647 0.22161
Scale parameter 1.190384 1.226333 1.212699
N 240 172 213
Log likelihood -404.02199 -295.28819 -361.49529
Excluding *yeah-saying* respondents
Constant 6.943 80r) 0.15689 6.93623n 0.18381 6.91936n 0.16733
Self-assessed health 
status -0.07893 0.07438 -0.07007 0.09339 -0.08659 0.07908
Has visited an 
emergency room or 
hospital during the last 
five years
0.08760 0.15899 0.08844 0.20470 0.06303 0.18695
Scale parameter 0.6999923 0.7261699 0.695082
N 101 87 89
Log likelihood -123.85413 -109.68437 -108.15056
Notes: (*) significant at 1%; (**) significant at 10%.
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Table 58: Impact of health status on willingness-to-pay for a 5-in-1000 immediate
_________risk reduction -  final sample -  Model 3__________ __________________













Constant 7.24430(’-) 0.53509 7.19303n 0.64744 6.97240r) 0.59985
Mental health score 0.00215 0.00694 0.00728 0.00839 0.00016 0.00711
Physical function 
score 0.00707(*} 0.00251 G .00858^ 0.00337 0.00697(*} 0.00266
Role limitation 
physical score 0.00724(*) 0.00233 0.00617(" } 0.00307 G.00982^ 0.00242
Pain score -0.00168 0.00546 0.00371 0.00680 0.00067 0.00595
General health 
perception score -0.00371 0.00612 -0.00807 0.00725 -0.00555 0.00654
Energy vitality score -0.00993 0.00646 -0.01167 0.00752 -0.00871 0.00722
Social functioning 
score 0.00041 0.00647 -0.00007 0.00903 0.00115 0.00704
Role limitation 
emotional score 0.00009 0.00247 -0.00190 0.00308 0.00036 0.00249
Change in health score 0.00182 0.00372 -0.00091 0.00501 0.00086 0.00445
Scale parameter 1.148338 1.188389 1.156018
N 240 172 213
Log likelihood -395.56777 -289.70854 -351.67216
Excluding \yeah-saying* respondents
Constant 6.59323r) 0.37088 6.59697n 0.44115 6.26763(’} 0.38270
Mental health score -0.00055 0.00423 0.00140 0.00535 0.00352 0.00368
Physical function 
score 0.00859^ 0.00276 0.00865^ 0.00295 0.01033^ 0.00236
Role limitation 
physical score 0.00162 0.00249 0.00119 0.00295 0.00166 0.00252
Pain score -0.00745(" ) 0.00395 -0.00693 0.00466 -0.00579 0.00384
General health 
perception score 0.00786 0.00483 0.00956(" ) 0.00547 0.01046(**} 0.00435
Energy vitality score -0.00102 0.00532 -0.00062 0.00630 -0.00537 0.00528
Social functioning 
score 0.00125 0.00392 -0.00326 0.00574 0.00164 0.00403
Role limitation 
emotional score -0.00346 0.00247 -0.00207 0.00281 -0.00341 0.00231
Change in health score -0.00383 0.00361 -0.00492 0.00418 -0.0074("'> 0.00414
Scale parameter 0.6597953 0.6834068 0.6159109
N 101 87 89
Log likelihood -117.41214 -104.02463 -98.454183
Notes: (*) significant at 1%; (**) significant at 10%.
6.2.2. Pilot sample
The aim of using the pilot sample to test the models above is to investigate if the 
results obtained using the final sample are robust, that is, not dependent on the sample. 
The most interesting result in Table 59 is the marginal significance of the coefficients 
associated with cases of cancer and cardiac diseases, although this result is not 
consistent among all sub-samples, neither in accordance with the results using the final
201
sample. The results suggest that respondents who have had cancer or have had a case of 
cancer in their family pay more to reduce their risk of dying. This result is not 
confirmed when ‘yeah-saying’ respondents are excluded from the analysis.
Table 59: Impact of health status on willingness-to-pay for a 5-in-1000 immediate
risk reduction -  pilot sample -  Model 1













Constant 8.37705^ 0.18256 8.51486r) 0.19485 8.31107n 0.19093
Occurrence o f cardiac 
disease (own and/or 
family)
0.23343 0.19841 0.29683 0.20721 0.35370r ) 0.20764
Occurrence o f 
respiratory disease 
(own and/or family)
-0.09766 0.19312 -0.02012 0.19904 -0.09918 0.19859
Occurrence o f cancer 
(own and/or family) 0 .4 1 1 4 0 ^ 0.19735 0.28203 0.19922 0.38889(**)
0.20563
Scale parameter 1.689512 1.64072 1.685224
N 305 254 286
Log likelihood -641.39637 -530.55249 -600.80028
Excluding *yeah-saying’ respondents
Constant 5.25485n 0.10505 5.28855r) 0.12523 5.24688r) 0.11723
Occurrence o f cardiac 
disease (own and/or 
family)
0.03270 0.11625 -0.03302 0.13969 -0.00626 0.12952
Occurrence o f 
respiratory disease 
(own and/or family)
-0.03712 0.14043 -0.09082 0.17322 -0.01573 0.14718
Occurrence o f cancer 
(own and/or family) -0.2499(**) 0.13746 -0.21592 0.14535 -0.27989(**) 0.15081
Scale parameter 0.5460691 0.5672721 0.5744472
N 65 54 59
Log likelihood -65.783115 -56.803394 -62.121039
Notes: (*) significant at 1%; (**) significant at 10%.
Table 60 shows that the results of model 2 using the pilot are similar to those 
obtained using the final sample -  non-significant coefficients for all covariates among 
all sub-samples. It is interesting to observe that the negative impact of having visited an 
emergency room or hospital admission is consistent with the previous result (Table 57), 
and this result is statistically significant when ‘yeah-saying’ respondents are excluded 
from the sample.
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Table 60: Impact of health status on willingness-to-pay for a 5-in-1000 immediate
risk reduction -  pilot sample -  Model 2













Constant 8.54827r) 0.22627 8.74137C¥} 0.22971 8.51029r ; 0.23036
Self-assessed health 
status 0.06662 0.11532 0.05328 0.11697
0.08084 0.11748
Has visited an 
emergency room or 
hospital during the last 
five years
-0.16297 0.23623 -0.16848 0.24713 -0.06382 0.23869
Scale parameter 1.704696 1.65069 1.705007
N 305 254 286
Log likelihood -644.09835 -532.40731 -604.12266
Excluding 4yeah-saying* respondents
Constant 5.29333(¥) 0.11063 5.16331(¥) 0.11544 5.21208(¥) 0.11067
Self-assessed health 
status -0.03138 0.05211 0.04595 0.04679
0.00224 0.05001
Has visited an 
emergency room or 
hospital during the last 
five years
-0 .6 3 3 1 ^ 0.27090 -1.0645(*} 0.23586 - i .o io ss^ 0.25179
Scale parameter 0.5356427 0.5181527 0.5400849
N 65 54 59
Log likelihood -64.374915 -52.489327 -58.860414
Notes: (*) significant at 1%; (**) significant at 10%.
Table 61 shows that a number of health indices are statistically significant in 
explaining variances in the willingness to pay when using the pilot sample, and this 
result is consistent across all sub-samples. These are the mental health, the physical 
function, the general health perception, and the social functioning scores. Compared to 
the final sample results, it confirms that the physical function score has a positive 
impact on willingness-to-pay estimates, that is, individuals with a higher physical score 
tend to pay more for reductions in their risk of death. On the other hand, the role- 
limitation physical score is not significant. When ‘yeah-saying’ respondents are 
excluded from the analysis the most interesting results refer to the significant and 
negative impact of the physical function score on the willingness-to-pay responses.
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Table 61: Impact of health status on willingness-to-pay for a 5-in-1000 immediate
risk reduction -  pilot sample -  Model 3













Constant 8.16863^ 0.67300 8.22114n 0.71904 8.45110(¥) 0.67794
Mental health score 0.01722t" ) 0.00738 0 .0 1 6 7 6 ^ 0.00793 0.01539rT) 0.00766
Physical function score 0.01667n 0.00413 0.01359r) 0.00462 0.0161 l n 0.00419
Role limitation 
physical score 0.00057 0.00330 -0.00391 0.00372 0.00078 0.00345
Pain score -0.00258 0.00550 0.00193 0.00568 -0.00357 0.00555
General health 
perception score -0.0144(M) 0.00760
oo■ 0.00797 -0.0170(M) 0.00754
Energy vitality score 0.00209 0.00791 0.00525 0.00839 0.00283 0.00790
Social functioning 
score -G .0165^ 0.00755 -0.0188(**} 0.00832 -0.0166(**) 0.00763
Role limitation 
emotional score 0.00405 0.00428 0.00666 0.00457 0.00553 0.00422
Change in health score -0.00102 0.00451 0.00189 0.00475 -0.00136 0.00465
Scale parameter 1.621445 1.590087 1.622024
N 305 254 286
Log likelihood -630.40866 -523.50916 -591.30871
Excluding ‘yeah-saying * respondents
Constant 5.03422(¥) 0.55029 4.64613(T) 0.79351 5.25249n 0.62382
Mental health score 0.00879(" } 0.00447 0.00388 0.00654 0.00931 0.00574
Physical function score -0.00895n 0.00347 -0.01138n 0.00423 -0.01046r ’J 0.00429
Role limitation 
physical score -0.00060 0.00192 -0.00305 0.00217 -0.00097 0.00198
Pain score -0.00403 0.00619 -0.00489 0.00779 -0.00529 0.00730
General health 
perception score 0.00238 0.00535 0.00120 0.00602 0.00041 0.00615
Energy vitality score 0.00409 0.00457 0.00860(” } 0.00514 0.00422 0.00550
Social functioning 
score 0.00018 0.00469 0,01081 0.01144 -0.00016 0.00478
Role limitation 
emotional score 0.00467(" ) 0.00236 o.ooes^ 0.00292 0.00589(" } 0.00244
Change in health score -0.00306 0.00259 -0.00340 0.00361 -0.00210 0.00301
Scale parameter 0.5023896 0.5166939 0.5226475
N 65 54 59
Log likelihood -60.215361 -50.89318 -57.04763
Notes: (*) significant at 1%; (**) significant at 10%.
6.2.3. Willingness-to-pay estimates per health occurrence
In order to investigate further whether particular health conditions affect 
willingness to pay for small risk reductions, mean and median willingness to pay are 
estimated using the constant-only Weibull distribution model83 with the final sample. 
Sub-samples separated by health characteristics (e.g. cancer and non-cancer) are used
83 The Weibull distribution was adopted in order to facilitate the comparison o f  results with the 
willingness-to-pay estimates shown in the last chapter, which were generated assuming the Weibull 
distribution.
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and the willingness-to-pay estimates compared, providing more confidence in 
determining the role of specific health conditions in willingness-to-pay estimates.
Table 62: Mean and median annual willingness to pay per health groups (US$
Disease Total sample FlagO Flag4
Yes No Yes No Yes No

















































MEDIAN 384 405 377
Cancer 379.36 385.67 368.49 420.47 375.98 376.84
Respiratory 339.46 405.28 407.27 403.86 307.55 412.48
Cardiac 388.34 375.49 431.57 366.37 381.16 369.31
ER 366.09 388.76 392.77 408.54 362.75 380.59
Excluding ‘yeah-saying' respondents

















































MEDIAN 208 208 199
Cancer 184.86 217.93 179.32 221.92 169.16 211.65
Respiratory 217.77 203.44 223.46 202.09 197.00 200.50
Cardiac 201.37 220.23 198.92 223.46 195.28 206.14
ER 231.55 203.28 220.66 206.41 207.90 197.62
US$ 1 = R$ 3.40 during the survey period (March/2003). Sample sizes are in parenthesis.
The results in Table 62 confirm the signs of corresponding coefficients observed 
in Table 56 and Table 57. For example, a case of cancer observed in the respondent or 
his/her family is associated with lower willingness-to-pay estimates, the same being true 
for respiratory diseases and emergency-room visits and hospital admissions. Opposite 
results are associated with cardiovascular diseases. However, this result should be 
treated with care since none of these variables was statistically significant in regressions 
using the final sample -  models 1 and 2.
6.2.4. Final comments
In summary, it can be concluded that no cancer, respiratory or cardiovascular 
disease effect can be identified in this study, given the lack of statistical significance of
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the coefficients in the regressions. However, the signs of the coefficients in regressions 
using the final sample (and the estimates in Table 62) suggest that the occurrence of 
respiratory (cardiac) diseases reduced (increased) the willingness to pay for a reduction 
in the probability of death, results confirmed by using the pilot sample. Cancer had 
mixed effects when comparing the results using the final (negative) and the pilot 
(positive) samples. Hospital admission and emergency-room visits had no significant 
effect on willingness to pay either, both results using final and pilot samples indicating a 
negative (but non significant) effect.
The only single relevant result regards the statistically significant effect of the 
physical function score (pfs) on the willingness to pay for a mortality risk reduction. 
This result has been consistently observed in all sub-samples both using the final and 
the pilot sample. The positive sign of the parameter suggests that the healthier the 
respondent feels (physically) the more this respondent would be prepared to pay for a 
reduction in the risk of dying.
6.3. Willingness-to-pay estimates for risk reductions happening in the future
The survey instrument proposed by Krupnick et a l, (1997,1999) includes the 
elicitation of the respondents’ willingness to pay for a risk reduction happening in the 
future, when the respondent is aged 70. This question was posed to all respondents aged 
between 40 and 60 years. This information is important given the latency period related 
to some health diseases associated with air pollution such as cancer. The willingness to 
pay for a risk reduction happening in the future is expected to be lower than the 
willingness to pay for an immediate risk reduction of the same size since there are 
uncertainties about the future, related both to individuals surviving to the period when 
they would enjoy the benefit, and to the individuals’ marginal utility of future 
consumption. This is theoretically demonstrated in models suggested by Cropper and 
Sussman (1990) and Alberini et al., (2002b). The former model was discussed in the 
theoretical literature review.
6.3.1. Non-parametric and parametric results
Initially, the same procedure described in Chapter 5 and adopted to estimate 
willingness to pay for two different immediate risk reductions was used to estimate the 
willingness-to-pay values for a 5-in-1000-risk reduction that happens in the future. First, 
the non-parametric willingness to pay was estimated using the responses to the initial
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bid question (Annex 10.3 presents the results using the responses to both initial and the 
follow-up questions), followed by a parametric estimation using the constant-only bid 
function and the Weibull parametric model. The validity test was performed for the final 
sample and the pooled data as well.
Table 63: Non-parametric (lower-bound) Turnbull estimation of mean annual
5-in-1000 risk reduction over 10 years
Total sample Without FlagO =1 Without Flag4 =1
Starting at age 70 461.77 99.33(a) 493.66
Starting immediately 522.09 464.74 524.93
Estimates are distribution-free and conservative (lower bound). US$ 1 = R$ 3.40 during the survey perioc 
(March/2003).
(a) The low figure is due to lack o f monotonicity o f the empirical density function in the highest bids, i.e. 
the percentage o f ‘yes’ responses did not decrease as bid values increased.
Table 63 shows the non-parametric willingness-to-pay estimates. A small 
reduction is observed in the lower-bound figures relating to the 5-in-1000 immediate 
and future risk reduction presented in Chapter 5 and re-introduced in Table 63. This 
suggests a preference for immediate consumption over future consumption of the same 
good, and indicates an implicit positive discount rate. However, this result is not 
confirmed when the parametric results are estimated (Table 65). The confidence 
intervals were calculated using the confidence interval of the estimated parameters 
(Table 64) of the constant-only regression model assuming the Weibull distribution.
Table 64: Weibull accelerated failure-time model -  risk reduction in the future










5-in-1000 future risk reduction
Constant 7.62290n 0.10795 7.55288(,) 0.12746 7.67650r) 0.11436
Ancillary
parameter 0.80461 0.04208 0.79237 0.04906 0.80572 0.04377
Log likelihood -266.02575 -198.73985 -236.58234
N 154 114 137
Excluding 'yeah-saying* respondents
Constant 6 .65608^ 0.12785 6.69794(¥J 0.14000 6.64923n 0.13712
Ancillary
parameter 086318 0.05985 0.87980 0.0693 0.86171 0.06556
Log likelihood -74.918476 -66.192932 -65.005162
N 53 46 46
Notes: FlagO = Inconsistent maximum willingness-to-pay responses for both immediate risk reductions. 
Flag4 = Wrong answer to both probability tests.
(*) significant at 1%; (**) significant at 10%.
The parametric willingness to pay for a 5-in-1000 risk reduction that happens in 
the future is very similar to those estimates referring to the 5-in-1000 immediate risk
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reduction. In fact, with the exception of the sub-sample where the inconsistent responses 
were excluded (FlagO), the willingness-to-pay estimates for the risk reduction in the 
future are higher than those for an immediate risk reduction, suggesting negative 
discount rate . This is an unexpected result since it is supposed that a developing 
country, presenting great inequality regarding income distribution, and a significant 
share of poor people should present a positive and relatively high social discount rate. 
The expected result, however, is observed when individuals who stated inconsistent 
willingness-to-pay responses are excluded from the analysis (FlagO), which suggests 
that inconsistent respondents did have an impact on the willingness-to-pay estimates for 
a risk reduction that happens in the future. More attention will be given to this specific 
sub-sample during the coming analyses in this section.
Table 65: Parametric estimation of mean and median annual willingness to pay 
________ i US$ 2003) -  risk reduction in the future -  Weibull distribution (95% Cl)
5-in-1000 risk reduction over 10 years starting a t age 70
Total sample FlagO Flag4
Mean 678 639 715
(5 1 4 -9 0 9 ) (461 -9 0 2 ) (534 -  973)
Median 381 353 402
(3 2 2 -4 4 8 ) (2 8 9 -4 2 8 ) (3 3 6 -4 7 8 )
5-in-1000 risk reduction over 10 years -  starting immediately
Mean 653 712 653
(5 2 8 -8 1 7 ) (549 -  936) (5 1 9 -8 3 3 )
Median 383 404 376
(3 3 7 -4 3 4 ) (3 4 6 -4 7 1 ) (3 2 7 -4 3 0 )
5-in-1000 risk reduction over 10 years -  starting immediately -  age 40 to 60 years
Mean 619 687 637
(4 7 7 -8 1 7 ) (5 0 3 -9 6 1 ) (486 -  852)
Median 375 409 387
(3 2 2 -4 3 6 ) (3 3 9 -4 8 9 ) (3 2 9 -4 5 4 )
US$ 1 = R$ 3.40 during the survey period (March/2003).
One possible reason for the unexpected result shown in Table 65 -  the 
parametric willingness to pay for a risk reduction in the future being higher than the 
willingness to pay for an immediate risk reduction of the same size -  might have been 
the observed behaviour of part of the respondents in ‘agreeing’ with all proposed bid 
values. As already explained in Chapter 5, this ‘cooperative behaviour’ was a problem 
observed during the survey that might be related to the sampling and format of the 
interviews (paying individuals to attend the interview), which can be in part responsible 
for the high percentages of ‘yes’ responses for all bid values.
84 The same result was observed when comparing the willingness-to-pay estimates for a risk-reduction in 
the future with the figures for an immediate risk reduction estimated for the same age group (40 to 60 
years old individuals).
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The mean and median willingness to pay is now estimated using a sub-sample 
where the ‘yeah-say’ respondents are excluded. The sample was reduced to 53 
respondents and the sub-samples (FlagO and Flag4) had 46 individuals only. Table 66 
shows that the mean and median estimates obtained with the sample excluding ‘yeah- 
say’ respondents are in accordance with the expected results, that is, willingness to pay 
for a risk reduction in the future being smaller than for an immediate risk reduction.
Table 66: Mean and median annual willingness to pay (US$ 2003) -  Weibull
distribution (95% Cl) -  risk reduction in the future -  without ‘yeah-say’ 
________ respondents_____________________________________________________
5-in-1000 risk reduction over 10 years starting at age 70
Total sample FlagO Flag4
Mean 217 227 215
(1 6 3 -2 9 2 ) (1 6 6 -3 1 6 ) (1 5 9 -2 9 7 )
Median 166 172 165
(1 3 5 -2 0 4 ) (1 3 7 -2 1 5 ) (1 3 2 -2 0 5 )
5-in-1000 risk reduction over 10 years -  starting immediately
Mean 244 254 247
(1 9 2 -3 1 5 ) (1 9 5 -3 3 6 ) (1 9 2 -3 2 3 )
Median 201 208 205
(1 6 8 -2 3 9 ) (1 7 1 -2 5 1 ) (1 7 0 -2 4 6 )
US$ 1 = R$ 3.40 during the survey period (March/2003).
The exercise presented above has the objective to highlight the impact of ‘yeah- 
saying’ behaviour on willingness-to-pay estimates in this study. It cannot be claimed 
that the sub-sample obtained when excluding the ‘yeah-say’ respondents can be 
considered any better than the original sample because some of the respondents may 
genuinely have accepted the bid-values offered to them. In other words, it is not 
possible to distinguish the true ‘yes’ response from the ‘cooperative approach’.
6.3.2. Validity tests of willingness-to-pay estimates
The validity test of willingness-to-pay estimates (Table 67) included the same 
set of covariates considered in the validity tests of the willingness to pay for the 
immediate risk reductions (Chapter 5) plus the subjective measures of how likely the 
respondent would survive to age 70 (0 -  100%) and how the respondent consider that 
his or her health would be at the age of 75 compared with his or her actual health status 
(scale from 1 -  much better -  to 5 -  much worse).
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Table 67: Validity tesi - willingness-to-pay for a 5-in-1000 future risk redaction













Constant 15.1731(¥) 5.20817 12.6340(¥¥) 7.64139 16.8361n 5.41379
Gender 0.13015 0.12639 0.24243 0.19098 0.11919 0.14951
Age -0.27402 0.20377 -0.22785 0.29941 -0.3949(M) 0.21810
Age square 0.00262 0.00207 0.00227 0.00305 0.00404(¥¥) 0.00223
Years o f education -0.00505 0.01857 -0.00366 0.03001 0.00880 0.02154
Income (individual) 0.00062n 0.00020 0.00052(¥¥J 0.00029 0.00063^ 0.00022
If  respondent smokes -0.20028 0.14844 -0.4318(¥¥) 0.25812 -0.3057(¥¥) 0.15978
Degree o f  faith in religion -0.10816 0.07747 0.09954 0.11353 -0.04053 0.10576
Health insurance -0.3439(” } 0.14841 -0.23393 0.22055 -0.3877(¥¥) 0.15211
If  respondent is married 0.33022(¥¥) 0.15371 0.47829(¥¥) 0.24544 0.55891n 0.18580
Has children 0.10437 0.21120 0.33824 0.30361 0.09410 0.21876
Self-assessed 
comprehension o f the 
concept o f probabilities
0.00076 0.05413 0.11749 0.07943 0.02584 0.05877
If  respondent considered 
his/her finances when 
stating WTP
0.19979 0.14853 0.34629 0.23201 0.13981 0.17163
Role limitation physical 
score 0.00103 0.00206 0.00430 0.00299 0.00347 0.00216
Energy vitality score -0.00616 0.00393 -0.00580 0.00574 -0.00478 0.00421
Subjective expected age o f 
death -0.03476 0.03635 -0.1097(*¥) 0.05872 -0.06872 0.04550
Subjective health status at 
age 75 -0.06846 0.06532 -0.2096(*¥) 0.11952 -0.01788 0.07323
Subjective chances o f  
surviving to age 75 0.00233 0.00202 0.00477 0.00366 0.00409 0.00274
Scale parameter (1/p) 0.758366 0.9322109 0.8438793
N 154 114 137
Log likelihood -184.96289 -174.9646 -199.37907
Notes: (*) significant at 1%; (**) significant at 10%.
As can be seen in Table 67, income is the most relevant determinant of 
willingness to pay for a risk reduction that takes place in the future, as it is for the 
immediate risk reduction. Respondents’ marital status is now a relevant determinant of 
the willingness to pay for risk reductions in the future, the positive sign of the 
coefficient suggesting that married people are more concerned about their future and 
longevity. Health insurance is again an important factor to determine the willingness to 
pay, and the negative sign suggests that those individuals with no health insurance tend 
to pay more for a risk reduction in the future. Other covariates were significant but not 
consistent among the different sub-samples. For example, the subjective possible age of 
death was significant when the sub-samples excluding inconsistent responses and 
individuals who gave wrong answers to the probability tests were used. The negative 
sign of the coefficient suggests that the longer the respondent expected to live, the lower 
this respondent would like to pay to reduce his or her probability of death in the future.
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The expected age of death is possibly correlated with the other two variables indicating 
subjective future expectations, and this fact may have lowered the significance of these 
other covariates. This is confirmed by the fact that the only sub-sample where the 
expected age of death is not significant had the subjective chances of surviving to age 
70 significant.
Table 68: Validity test - willingness-to-pay for a 5-in-1000 future risk reduction
(Pooled data)










Constant 7.06575 4.88111 4.00525 6.21500 5.82631 5.17680
Gender 0.03365 0.13095 0.13879 0.15883 0.04238 0.13974
Age 0.03210 0.19862 0.12862 0.24985 0.08334 0.21161
Age square -0.00037 0.00200 -0.00124 0.00251 -0.00083 0.00213
Years of education 0.02674 0.01805 0.04899(" } 0.02409 0.03086 0.01903
Income (individual) 0.00044r) 0.00005 0.00041(¥J 0.00005 0.00042(,J 0.00005
If  respondent smokes -0.08933 0.15183 -0.11438 0.17738 -0.13635 0.17089
Degree o f  faith in religion -0.1687l” } 0.07767 -0.1898(" J 0.10002 -0.2260(” ) 0.08829
Health insurance -0.52609n 0.14025 ■ © u> o ©
4 «
0.19421 -0.56132(*} 0.15379
If  respondent is married 0.11269 0.15436 0.09629 0.19628 0.28158^^ 0.17148
Has children 0.16758 0.21315 0.16278 0.26657 0.26603 0.22384
Self-assessed 
comprehension o f the 
concept o f probabilities
0.00783 0.06457 0.05528 0.09163 -0.006340 0.06887
If  respondent considered 
his/her finances when 
stating WTP
0.28720(" ) 0.14507 0.32392(**) 0.18545 0.22172 0.15132
Role limitation physical 
score 0.00047 0.00220 0.00041 0.00287 0.00081 0.00244
Energy vitality score 0.00031 0.00451 0.00183 0.00551 0.00078 0.00486
Subjective expected age o f 
death -0.00627 0.03419 -0.03232 0.04485 -0.02154 0.03823
Subjective health status at 
age 75 -0.10188 0.08632 -0.11955 0.11403 -0.10942 0.09324
Subjective chances o f 
surviving to age 75 0.00286 0.00255 0.00078 0.00332 0.00270 0.00283
Scale parameter (1/p) 1.311171 1.361024 1.328394
N 342 272 314
Log likelihood -643.93139 -520.69366 -595.40321
Notes: (*) significant at 1%; (**) significant at 10%.
When the pooled data are used for the validity test in order to confirm or not the 
determinants of willingness-to-pay responses (Table 68), a similar result obtained for 
immediate risk reduction is also observed for the risk reduction in the future. Income is 
still the most significant determinant of willingness-to-pay responses, with health 
insurance and religion being other important determinants that are consistent across the 
sub-samples. Financial constraint and education have now an important role in some
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sub-samples, seeming to be the influence of the more educated individuals in the pilot 
sample. From the results of the validity tests it can be concluded that the willingness-to- 
pay responses are robust in regard to different samples, that is, the same significant 
factors (education and health insurance) are consistent across different samples, with 
education, religion and marital status demonstrating importance in different sub­
samples.
6.4. Summary and comparison of results
A final research question in this study regards the identification of possible 
differences in attitudes and preferences towards mortality risks between a developing 
country (Brazil) and developed countries, where the number of studies aiming to 
estimate the value of a statistical life is significantly larger than in the developing world. 
In other to facilitate the comparison of results and the attempt to identify possible 
cultural and attitudinal differences between the populations of Brazil and other 
developed countries the focus of the comparative analysis is on the studies that used the 
same methodology and survey instrument as this study in Brazil. The rationale for 
limiting the analysis to those studies is that by doing so potential differences in results 
due to differences in the studies’ design -  the valuation method, survey design and 
statistical methods used -  can be eliminated.
For example, it is difficult to compare the value of a statistical life estimates 
generated in revealed preference methods such as the ‘compensating-wages’ studies 
with the results of stated preference methods such as the contingent valuation. As shown 
in the empirical literature review, the willingness-to-pay and value of a statistical life 
estimates can be very sensitive to the method and data used in the valuation exercise. In 
addition, there are different designs of contingent valuation surveys that may affect the 
produced estimates. For example, a contingent valuation study using an open-ended 
willingness-to-pay question may present results significantly different from a similar 
contingent valuation study using the dichotomous choice format (e.g. McFadden, 1994). 
Thus, eventual differences in results can be more directly attributed to observed 
differences between the samples if those results are generated under the same 
methodology, set of assumptions and statistical models. Also, if the samples are 
assumed as representative of the respective populations then differences in results can 
be considered as reflecting different attitudes towards risk.
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This section discusses potential cultural and/or attitudinal differences between 
developed and developing countries in regard to the valuation of small risk reductions in 
the probability of death. The studies undertaken in the US, Canada, the UK, France and 
Italy are compared with the Brazilian study in terms of sample characteristics and main 
results. The studies undertaken in Chile, Japan and China were not considered given the 
small sample size observed in the Chilean and Japanese studies (actually pilot surveys) 
and the different age group observed in the Chinese study -  95% of respondents were 
younger than 45 years old. It starts with a comparison of the samples used in the 
selected studies (Table 69).
Table 69: Comparison of mortality valuation studies -  sample characteristics
Sample characteristics US C anada UK France Italy Brazil
Sample size 1200 930 330 299 292 283
Age 54.4 54.2 58.0 55.3 57.0 56
Male 47% 46% 49% 47% 48% 45%
Years o f education 13 13.7 14.1 11.0 12.9 7.6
Income (S 2000) ($ 2000) ($ 2002) ($ 2002) (S 2002) ($ 2003)
Mean 53,000 46,800 43,677 35,061 43,698 2,982
Median 55,000 50,000 42,146 34,872 27,233 2,647
Married 72% NA 82% 65.5% NA 65%
Baseline risk of dying 187 123 199 109 50 220
Has health insurance 6% 69% 34% 89.9% NA 43.8%
Heart disease 21% 9.6% 8% 12% 12% 23%
High blood pressure NA 20.2% 28% 21% 21% 34.6%
Cancer 11% 3.4% 6% 6% 7% 9.5%
Asthma 10% 10.3% 13.6% 10.4% NA
Bronchitis, emphysema 
or chronic cough
16% 14.0% 15.4% 14.4% 12.7% 16.2%
As can be seen in Table 69, the samples used in the analysis are very similar in 
terms of their composition, especially regarding mean age of respondents and gender 
shares. The North American samples are three to four times bigger than the samples 
used in the European countries and Brazil, although none of the samples can be claimed 
to be fully representative of the respective population. The most significant difference 
between the Brazilian sample and other samples regards the income and education 
levels of individuals. The median annual income in the Brazilian sample corresponded 
to one-tenth of the Italian median income and one-twentieth of the US income. Also, the 
average number of years in school in the Brazilian sample was four years smaller than 
the French sample and roughly half of the observed in the UK. The health status of 
individuals in the Brazilian sample was very similar to the US respondents, both 
presenting higher figures than in the other developed countries. These higher figures 
correspond to individuals with a hystory of heart disease, cancer and respiratory
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diseases. The percentage of respondents with high blood pressure is higher in the 
Brazilian sample than in any other country. It can be concluded that most of the 
differences observed in the willingness-to-pay results can be attributed to differences in 
preferences among Brazilian respondents, which can be related to differences in socio­
economic characteristics, mainly income and education.
Table 70: Comparison of mortality valuation studies -  main results
Results US C anada UK F rance Italy Brazil
($ 2000) ($ 2000) ($ 2002) ($ 2002) ($ 2002) ($ 2003)
WTP (1-in-1000 now)
Mean 483 370 360 — 760 610(241)
Median 111 131 96 — 336 346(197)
WTP (5-in-1000 now) 
Mean 770 466 802 1,577 653 (245)
Median 350 253 422 522 788 384 (208)
WTP (5-in-1000
future) 727 265 256 650 453 639(217)
Mean 385 55 100 254 177 353 (166)
Median
VSL (5-in-1000 now) 
Mean 1,540,000 933,000 1,604,000 3,154,000 1,306,941
Median 700,00 506.000 844,000 1,043,573 1,576,000 (489,752)
767,187
(415,831)
VSL (l-in-1000 now) 
Mean 4,830,000 3,704,000 3,600,000 7,600,000 6,099,858
Median 1,110,000 1,312,000 960,000 3,360,000 (2,412,626)
3,458,245
(1,971,617)











Impact o f age No effect Negative 
after 70
No effect No effect Negative 
after 70
No effect
Impact o f health status Positive Positive for
for high 
blood
No effect Positive for ER visit or hospitalisation physical 
health score
pressure
Note: Figures obtained when excluding ‘yeah-saying’ respondents are in parenthesis.
Table 70 shows the comparison of the main results of the selected studies. The 
willingness-to-pay and value of a statistical life estimates in Brazil are as high as those 
observed in developed countries -  and in some cases higher. For example, the 
willingness to pay for a 1-in-1000 risk reduction in Brazil was almost twice the same 
estimate for Canada and the UK (mean values) and almost three times bigger when the 
median values are considered. The figures (mean and median) corresponding to the 5- 
in-1000 contemporaneous risk reduction -  the first willingness-to-pay question posed in
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the Brazilian study -  are similar to those observed in the US and the UK, higher than 
those observed in Canada but less than half of the Italian estimates. This result is 
difficult to justify via differences in income and education levels since the figures do not 
observe any proportionality in regard to income differentials85. Interestingly, income is 
the most influential variable in all validity tests of willingness-to-pay responses in all 
studies, which suggests that income differences between countries should be reflected in 
willingness-to-pay estimates.









1,000,000 -  \
The best explanation for the relatively high estimates found in the Brazilian 
study relies on the ‘cooperative’ behaviour identified among the Brazilian respondents. 
The ‘yeah-saying’ behaviour, identified in other contingent valuation studies (e.g. 
Ready et a l, 1986), seems to have had a significant impact on the willingness-to-pay 
estimates, and consequently, the value of a statistical life in Brazil. As shown in Chapter 
5 and Table 46, when supposed ‘yeah-saying’ respondents are excluded from the 
analysis, the willingness-to-pay results are much smaller, implying value of a statistical 
life US$489,752 (mean) and US$415,831 (median) for a 5-in-1000 immediate risk 
reduction. The mean estimate, for example, corresponds to approximately half the 
estimate for Canada, one-fifth of the US and the UK figures, and almost one-sixth of the 
Italian result. The same is observed regarding the value of a statistical life in Brazil 
using the median willingness-to-pay estimate. The results obtained when excluding 
potential ‘yeah-saying’ respondents do not follow strict proportionality to income 
differentials between the countries , a result that was pointed out by Chesnut et a l,
85 In addition, no cultural differences could have been observed during the initial phases o f the research 
and using the debriefing questions available in the questionnaire.
86 Income elasticity o f willingness-to-pay estimates are shown in Chapter 5. Income elasticity o f the value 
o f a statistical life using the 5-in-1000 risk reduction mean values were estimated as
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(1997). General health is seen as a basic necessity and those with lower incomes may be 
willing to pay a higher share of their income to protect their health. However, as 
explained before, the sub-sample excluding ‘yeah-saying’ respondents cannot be 
claimed as producing more reliable estimates than the full sample since it is not possible 
to distinguish true ‘yes’ responses (obtained in a utility maximising process constrained 
by income) from the ‘yeah-saying’ responses.
Regarding the impact of age and health status on the willingness-to-pay 
responses, the Brazilian results suggest no significant effect of age. The absence of an 
age effect in the Brazilian study was similar to the US, France and UK results, whilst 
the positive health status effect on willingness to pay was similar to the US and 
European studies, although for different health aspects.
6.5. Conclusions
This chapter investigated the impact that age and respondents’ health status had 
on the willingness to pay responses. In addition, the mean and median willingness to 
pay for a risk reduction in the future was estimated, and a comparative analysis of 
results was undertaken with studies carried out in developed countries using the same 
methodology as the one used in this study.
There was no age effect on the willingness to pay for small risk reductions in 
Brazil in the samples and sub-samples available. The coefficients of the age variable in 
different models explaining the willingness-to-pay responses were always not 
significant. Mean and median willingness to pay for different age groups were estimated 
using the constant-only approach, and presented no consistent pattern between samples 
and sub-samples, which reinforces the conclusion that no significant age effect could be 
identified.
No cancer, respiratory or cardiovascular disease effect on willingness-to-pay 
responses could be spotted in this study, given the lack of statistical significance of the 
coefficients in the regressions. However, when relaxing for a moment the statistical 
significance of the parameters, the signs of the coefficients in regressions using the final 
sample suggest that the occurrence of respiratory (cardiac) diseases reduces (increases) 
the willingness to pay for a reduction in the probability of death, a result confirmed by
TJ = ---------------------------------------. The results suggest an income elasticity o f VSL equal to 0.72 (US);
%change mean income
0.51 (Canada); 0.74 (UK), 0.91 (Italy), and 0.76 (France -  median values).
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using the pilot sample. Cancer had mixed effects when comparing the results using the 
final (negative) and the pilot (positive) samples. Hospital admission and emergency- 
room visit had no significant effect on willingness to pay, both results using final and 
pilot samples indicating a negative (but non significant) effect. A relevant result regards 
the statistically significant effect of the physical function score on the willingness to pay 
for a mortality risk reduction; a consistent result observed in all sub-samples both using 
the final and the pilot sample. The positive sign of the parameter suggests that the 
healthier the respondent feels (physically) the more this respondent would like to pay 
for a reduction in his or her risk of dying.
Willingness-to-pay estimates for a reduction in risk of dying in the future were 
not consistent with theory when the total sample and one sub-sample (Flag4) were used. 
However, when individuals who inconsistently answered the willingness-to-pay 
question were removed from the sample the results were in accordance with theory. It 
has been shown that the ‘cooperative behaviour’ demonstrated by a significant share of 
respondents had an impact on the willingness to pay for a risk reduction in the future. 
When the ‘yeah-say’ respondents were removed from the sample the results were all in 
accordance with the theory.
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7. Policy analysis
As can be seen in the previous chapters, the estimation of the value of a 
statistical life and the value of a statistical life year involves a number of uncertainties, 
both methodological and empirical. The willingness-to-pay-based measures can be 
estimated using revealed preference methods such as the ‘compensating-wage’, the 
hedonic price and averting behaviour methods; or stated preference methods, for 
example, the contingent valuation. Each method has specific advantages and 
disadvantages that are reflected in form of uncertainties about the resulting value of a 
statistical life (year) estimates. As shown in the empirical literature review, the 
estimates can vary substantially, depending on a number of characteristics of the 
studies.
This Chapter aims to discuss the relevance of the empirical results obtained in 
this study in terms of policy analysis in Brazil. It starts, in section 7.1, with a discussion 
of alternative approaches that can provide non-willingness-to-pay measures of the value 
of a statistical life (year), and their usefulness for establishing parameters for 
comparison of the results presented in this study. In addition, the Brazilian studies 
available are reviewed and the proxies for the value of a statistical life in Brazil are 
compared with the estimates presented in this study. Section 7.2 discusses the benefit 
transfer procedures that are, in general, the procedure adopted in developing countries in 
the absence of original revealed and/or stated preference studies. Some benefit transfer 
validity tests are performed to estimate potential ‘errors’ of benefit transfer estimates 
when compared with willingness-to-pay estimates generated in this study. Finally, 
section 7.3 presents previous studies undertaken in Brazil and explores the implications 
for policy analysis of using benefit transfer estimates or the results provided in this 
study.
7.1. The value of a statistical life implicit in life-saving interventions in Brazil
Although the willingness-to-pay approach is perhaps the most suitable method 
for estimating the value of mortality risk reductions, it is useful to compare these 
willingness-to-pay-based estimates with other estimates derived from different life- 
saving interventions in Brazil. The rationale for this comparison is that other approaches 
may generate approximate values that can be regarded as boundaries for the true value
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of a statistical life (year), and help reducing the uncertainties when using such estimates 
for policymaking. For example, Rabl (2004) considers it relevant to investigate the 
value of a statistical life (or life year) implicit in life-saving public decisions because 
consistency requires using the same value for all mortality risks that involve the same 
attributes, such as involuntariness and amount of suffering. In other words, “if people 
face continuous safety choices in a variety of contexts, the same individual should 
exhibit the same risk-money trade-off across different contexts, provided the character 
of the risks is the same” (Viscusi and Aldy, 2003). In this circumstance, it is possible to 
analyse data on actual expenditures for risk reductions in different sectors in the 
economy and estimate the implicit value of a statistical life. Finally, Ramsberg and 
Sjoberg (1997) argues that an implied value of a statistical life is simply the cost- 
effectiveness of a life-saving intervention, measured as cost per life saved.
Different types of life-saving interventions can be used for the purpose of 
investigating the cost per statistical life saved. These interventions can be grouped as 
medical or health-related interventions or non-medical interventions. The former group 
includes clinical tests aiming to screen for the presence of specific diseases and the 
effectiveness of medical interventions for the treatment of these diseases (e.g. cancer, 
heart disease), and public health (large scale) interventions such as influenza 
vaccination, malaria control, and AIDS prevention programmes. Non-medical life- 
saving interventions can include activities aiming to reduce risks of fatal accidents in 
the transport sector (e.g. regulation on seat belts, helmet use; road improvements); risk 
mitigating measures in the energy supply chain (e.g. emission control in coal-fired 
power plants, radiation control in nuclear power plants); occupational interventions such 
as toxin control in the working environment (e.g. benzene exposure control, asbestos 
ban in certain products); measures for reducing risks of fatal residential accidents (e.g. 
use of smoke detectors; compliance with safety standards in construction); and 
environment-related interventions such as air and water pollution control (e.g. emission 
control from mobile sources, pesticide use control).
The cost-effectiveness literature can provide some evidence of the costs per life 
saved and/or cost per year of life saved. In general terms, cost-effectiveness analysis 
describes an intervention or measure in terms of incremental costs per unit of 
incremental benefit, such as health effects (Garber and Phelps, 1997). It aims to promote 
economic efficiency in the allocation of resources by identifying those alternatives that 
costs less to achieve one unit of a given benefit. Some authors (e.g. Krupnick, 2004)
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consider the cost-effectiveness analysis a particular form of cost-benefit analysis, where 
the benefits are not monetised but rather, expressed in terms of a non-monetised unit. 
Net cost-effectiveness analysis is a particular type of cost-effectiveness analysis where a 
part of the benefits is monetised and included in the numerator of the cost-effectiveness 
ratio (CER)87 -  costs minus monetised benefits divided by non-monetised benefits 
(Krupnick, 2004).
Cost-effectiveness studies in general use two different metrics to express the 
benefits of alternative interventions or measures -  physical effects or health indices. The 
former metric, physical effects, involves expressing the benefits of interventions in 
terms of lives saved, life-years saved or life expectancy variations. In general, it is the 
simplest way to estimate the cost-effectiveness ratio since most epidemiologic studies 
already present outcomes in terms of physical effects. However, the disadvantage of 
using the physical effect metric is that only one effectiveness measure can be assessed. 
For instance, when morbidity effects represent an important role in total physical effects 
the analysis using only one health effect -  mortality -  can be misleading (Krupnick,
2004). An alternative metric used in cost-effectiveness analysis, very popular in the 
medical literature, is given in terms of health indices, such as the quality-adjusted life 
years (QALY), which has already been discussed in the empirical literature review. 
Health indices are calculated by weighting the amount of time an individual will spend 
in each future health state by an index or score that measures the health-related quality 
of life in that state, which allows the analyst to combine morbidity and mortality effects 
in the same analysis. This type of analysis is often found in the medical literature to 
compare the cost-effectiveness of different types of treatments or medical interventions, 
given that the use of new medicines, therapies or treatments should include economic 
justification in addition to clinical efficacy.
Two pertinent questions can be posed if  cost-effectiveness estimates are to be 
compared to the Brazilian value of a statistical life and value of a statistical life-year: (i) 
how are cost-effective measures comparable with willingness-to-pay-based measures?
(ii) Is cost-effectiveness a sound approach from an economic perspective? Regarding 
the first question, it seems that the comparability of measures is possible when cost- 
effectiveness ratios are estimated in studies with a number of desired characteristics. For
87 CER is the ratio o f  the incremental cost relative to incremental benefit associated with competing 
measures.
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88example, “when effectiveness is measured in terms of life expectancy, the optimal 
cost-effectiveness ratio represents the same concept as the (marginal) willingness to pay 
-  the amount an individual would pay to reduce a risk of death” (Graber and Phelps, 
1997). That is, when cost-effectiveness is conducted in a societal perspective,
O Q
accounting for all costs of the measure -  direct and indirect -  and benefits are 
measured in terms of life expectancy, the cost-effectiveness ratio represents the upper 
limit of what society is willing to pay for an additional unit of benefit. Another desirable 
characteristic refers to the alternatives under analysis in cost-effectiveness studies. In 
the medical literature most studies compare a new intervention to the current practice or 
the established intervention to deal with the disease, which may not represent the total 
benefit of the new intervention. For a complete economic value estimate new 
interventions should be compared with the no-intervention alternative.
On the other hand, Kuchler and Golan (1999) examined different approaches 
that economists and health policy analysts have developed to evaluate policies affecting 
health and safety, including the willingness-to-pay approach and cost-effectiveness 
analysis. The authors concluded that these approaches are not comparable on the basis 
that cost-effectiveness analysis measures costs in terms of ex-post damages while the 
willingness-to-pay approach measures costs in terms of ex-ante risk perception. In other 
words, “willingness to pay reflects expectations rather than realised damages” (Kuchler 
and Golan, 1999). Ramsberg and Sjoberg (1997) noted that although an implied value 
of life is the cost-effectiveness of a life-saving intervention, this latter estimate is an 
implied value of a statistical life only under the following conditions: (i) the 
intervention is implemented; (ii) the unique purpose of the intervention is life-saving; 
and (iii) the intervention can be continuously implemented up to infinity90.
Regarding the second question, whether cost-effectiveness is a sound approach 
from an economic perspective, Garber and Phelps (1997) used a Neumann-Morgenstem 
(expected) utility framework to show how a cost-effectiveness criterion can be derived 
to guide resource allocation decisions regarding medical interventions. It was intended
88 A cost-effectiveness ratio is optimal when it equals the sum of future individuals’ expected utility 
normalised by the marginal utility o f income at the present.
89 Cost-effectiveness ratios often include only resource costs (direct medical and non-medical costs) but 
lack some measure o f the opportunity and disutility costs (e.g. lost productivity, dread and suffering 
before death).
90 For example, reducing or eliminating lead from gasoline is an intervention that once implemented it is 
possibly maintained forever (continuously to infinity). This type o f intervention tends to be more 
expensive and generate higher cost-effectiveness ratios than non-continuous or temporary interventions 
such as campaigns against smoking.
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to establish some foundations for cost-effectiveness analysis based on economic theory, 
and to provide some theoretical justification for the cost-effectiveness technique use. 
The authors assumed that cost-effectiveness analysis is applied to maximise an 
aggregate of individual utilities with similar health prospects and preferences. The 
conclusions were that when applied to a heterogeneous population level (groups of 
people whose preferences or health status vary greatly) the cost-effectiveness criterion 
is unlikely to yield Pareto-optimal resource allocations. Also, that cost-effectiveness is 
internally consistent for selecting health interventions, that is, the optimal cost- 
effectiveness cut-off point91 is the same for all interventions, regardless of when 
(present or future) the interventions exert their effects. However, these conclusions hold 
only within the framework of standard Von Neumann-Morgenstem utility 
maximisation, which includes some restrictive assumptions such as additive 
separability, risk neutrality over lifetime, and constant rate of time preference.
The limitations of cost-effectiveness analysis include the fact that it cannot 
measure variations in social welfare and that it does not take into account social 
concerns, such as priority for the sick, reducing social inequalities in health, or 
wellbeing of future generations (Murray et a l , 2000). In addition, it measures only one 
impact, which means that it is not appropriate to evaluate interventions in areas that 
involve significant other impacts simultaneously. Also, cost-effectiveness results are in 
general context-specific and cannot be used to inform policy debate in another 
population (transferability). Other issues in cost-effectiveness analysis include 
discounting -  costs are incurred over a period of time and have to be converted into a 
present value -  which poses a problem to the analyst regarding which discount rate to 
use. In general, sensitivity analysis is performed to account for uncertainties regarding 
the social discount rate chosen.
In summary, most cost-effectiveness analyses compare treatments or measures 
related to the common practice to deal with the disease, intending to assess the benefits 
of new techniques in contrast to established usual treatments. However, the economic 
measure that would represent the total benefit of the new technique would be obtained 
by assessing the incremental benefit when compared to the ‘no-treatment’ alternative 
(Murray et a l , 2000). In other words, “ ...inferring the cost-effectiveness ratios of 
common practices provides little guidance regarding the optimal cost-effectiveness ratio
91 Cut-off point is the assumed willingness to pay for an additional unit o f  benefit (Murray et al., 2000).
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-  that is, the willingness to pay for a health effect” (Garber and Phelps, 1997). This fact 
has to be kept in mind when comparing the value of a statistical life and the value of a 
statistical life year estimated in this study with those costs per life saved obtained in the 
cost-effectiveness literature. Cost-effectiveness ratios when obtained comparing 
alternative medical treatments can be regarded as lower bound estimates of those figures 
presented in this study, which are based on the willingness-to-pay approach.
7.1.1. Health-related (medical) interventions
Cost-effectiveness studies of medical interventions in Brazil that used the 
physical effect metric -  the one of interest for the purposes of this study -  are not many. 
These studies, both clinical and public health programmes were investigated in 
specialised medical databases, such as the PubMed. The paucity of references obtained 
in these databases confirms that this type of analysis is not common in Brazil, resulting 
in only four studies being identified: Akhavan et a l (1999) on the cost-effectiveness of 
a public health programme (malaria control) undertaken in the Brazilian Amazon 
region; a cost-effectiveness analysis comparing four treatments of end-stage renal 
disease in Brazil (Sesso et a l , 1990); and the results of a clinical experiment involving 
the effectiveness of alternative methods for controlling heart disease (Vieira et al., 
2001). Another identified cost-effectiveness study in Brazil was not obtained (Akhavan, 
2000) and could not be included in this section. This study presented a cost- 
effectiveness analysis of Chagas disease control in Brazil.
• Health programme (Malaria control)
Akhavan et a l  (1999) presented results of a cost-effectiveness analysis of a 
malaria control programme (PCMAN) undertook in the Brazilian Amazon basin 
between 1989 and 1996. The malaria control programme arguably produced health 
benefits partly by preventing new cases of malaria (vector control), some of which 
would have ended in death, and by treating existing cases, particularly by preventing
07deaths from P.falciparum infection.
The authors estimated the health benefits from vector control by obtaining the 
projected incidence of cases of malaria and the expected severity (share of falciparum in
92 Plasmodium falciparum -  mosquitoes most likely to transmit malaria, which causes nearly all deaths in 
the Brazilian Amazon basin. Other malarial parasite is known as Plasmodium Vivax, but unlike 
Plasmodium falciparum  is rarely fatal.
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total cases) and lethality (case fatality rate) to derive the losses in deaths that would 
have occurred in the absence of the programme. For the period 1989-1996 a coefficient 
of incidence growth of malaria (new cases per 100,000 population) was assumed to be 
equal to the coefficient observed between 1980 and 1988, resulting in predicted 5.5% of 
the population suffering an attack of malaria per year. The number of prevented cases of 
malaria due to the control programme was estimated by applying the difference between 
observed and predicted incidence to the population of the Amazon basin. The observed 
severity, or share of malaria cases due to falciparum, was between 53-55% from 1984 to 
1987. Furthermore, in the absence of the control programme severity it was assumed 
that it would remain at that level between 1989 and 1996. Finally, it was assumed that 
10% of those sick with falciparum die within a short period of time if not treated, which 
is a conservative assumption, the authors argue, based on expert consultations. The 
average age at death from malaria during the period of analysis was 14 years, age at 
which life expectancy was 66 years. The future was discounted at a constant annual rate 
of 3% to estimate the number of discounted years lost to premature mortality. The total 
number of years of life lost per fatal case of malaria after age weighting and discounting 
was estimated to equal to 36.27 years/life lost and the total number of deaths avoided by 
preventing new cases of malaria amounted to 100,687.
Akhavan et a l (1999) also estimated the gains from treating observed cases 
during 1989-1996, arguably a simpler estimation given that only the observed incidence 
and severity matter. Lethality without treatment was assumed 10%, while lethality with 
treatment declined from 0.72% to 0.40% between 1980 and 1988. It was observed that 
overall mortality statistics are substantially under-reported: some people die without 
getting treatment and some die even after receiving ambulatory treatment, and these 
deaths may not be registered. To compensate the under-reported statistics, the authors 
assumed that on average throughout the period, 0.78% of treated falciparum cases 
would have died. Lives saved by treatment were the number of people sick with 
falciparum, discounted to present value, times the difference between untreated and 
treated lethality. The total number of lives saved by malaria treatment under the control 
programme was estimated to equal 129,897.
The estimated costs of prevention and treatment were initially reported in 
Brazilian currency, converted to US dollars in the current year using the average of the 
official buying and selling rates for the dollar in that year, adjusted to 1996 US$ by the 
US GDP deflator for the current year, and discounted to 1996 present value at 3% per
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year. This procedure expressed all values in constant US dollars of 1996 purchasing 
power. The costs of prevention or vector control included capital investment and non­
salary recurrent expenditures (e.g. insecticides, travel costs), plus working costs 
estimated from the number and type of personnel needed for vector control operations 
and salaries for each level of worker. The costs of treatment included the hospitalisation 
costs, ambulatory care and costs of diagnosis. The overall cost-effectiveness of saving 
lives under the malaria control programme ranged between US$ 2,492 and US$ 2,672 
per life saved. Table 71 summarises the results.
Table 71: Cost-effectiveness of saving lives from malaria in Brazil- 1989-1996
(US$ 1996)
Concept Prevention Treatment Total
Based on total cost 5,220 697 2,672
Based on net cost 4,808 697 2,492
Source: Adapted from Akhavan etal. (1999).
The estimates of cost per life saved by the malaria control programme in the 
Amazon basin seem to be very low when compared to other estimates of similar 
programmes elsewhere, according to the authors. They argue that previous estimates 
have been made mostly in Africa and Asia and have shown a wide range of costs per 
disability-adjusted life-year (DALY), which depend strongly on the case-fatality rate in 
each country. The cost estimation performed by Akhavan et al. (1999) considered only 
direct medical costs associated with the intervention, ignoring direct non-medical costs 
such as loss of productivity of those affected by malaria, as well as indirect costs related 
to the disutility of pain and suffering. It may be the main reason why the cost per 
statistical life saved estimated in this study is much lower than the willingness-to-pay 
based estimates shown is Chapter 5. Another characteristic of this cost-effectiveness 
analysis, that life saving was not the unique purpose of the malaria control programme, 
reinforces the inappropriateness of its results in terms of comparison with willingness- 
to-pay estimates.
• Clinical trial (Statins to control cholesterol)
Vieira et a l (2001) conducted a cost exercise of the use of statins, a drug used to 
lower cholesterol levels that, consequently, reduces the incidence of ischemic heart 
disease and its mortality effects. The study aimed to call attention to the need of 
carrying out a nationwide cost-effectiveness study concerning the use of statins in
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primary and secondary heart disease prevention93 in Brazil. The authors argued that, 
given the high costs of the drug, the socio-economic situation in Brazil sometimes 
prevents the correct use of statins, even when the cardiologists are absolutely sure about 
its indication.
The authors performed a cost analysis of these drugs in Brazil, in relation to the 
benefits statins bring, based on international randomised clinical trials of primary and 
secondary prevention. Specifically, results (benefits) were used from studies on primary 
prevention: ‘West of Scotland Coronary Prevention Study’ (WOSCOPS) and ‘Air 
Force/Texas Coronary Arteriosclerosis Prevention Study’ (AFCAPS/TexCAPS); and 
secondary prevention: ‘Scandinavian Simvastatin Survival Study’ (4S), ‘Cholesterol 
and Recurrent Events Trial’ (CARE), and ‘Long-term Intervention with Pravastatin in 
Ischaemic Disease Study’ (LIPID).
The procedure adopted in the descriptive cost analysis was as follows: reported 
benefits of statins use in the WOSCOPS study show that the absolute reduction of total 
mortality was 0.9% in five years, that is, given the number of patients in the study, it 
corresponds to an absolute reduction of two deaths per one thousand treated patients per 
year, corresponding to 556 patients that would need to be treated during one year to 
prevent one death. According to the observed costs of this specific intervention (40mg 
of pravastatin/day) in the Brazilian market (cheapest commercial product available), one 
prevented death would cost about US$351,832. According to the results of the same 
study, one prevented death from a coronary artery disease would cost about 
US$633,508, while to prevent one death from any cardiovascular cause would cost 
US$452,356. The same procedure was undertaken for all international clinical studies. 
Table 72 summarises the findings.
Vieira et al. (2001) highlighted that the drug doses used to obtain the benefits 
reported in the different studies were considerably higher than those that are usual in 
Brazil for routine care. However, from the perspective of an evidence-based medical 
practice, the same reported doses should be used to obtain the same health benefits. 
Also, the authors define their cost-effectiveness analysis as partial because it considered 
only the evaluation of the drug costs, as compared with the prevented outcomes. “A 
complete cost-effectiveness analysis should encompass the entire amount of expenses, 
including the increase in medical visits and laboratory tests required by the treatment,
93 Primary prevention refers to patients with no history o f  heart disease; secondary prevention refers to 
patients that already have had an occurrence o f a heart disease.
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along with the decrease in hospitalisation and procedure expenses associated with the 
benefits of the treatment... only a complete Brazilian cost-effectiveness study could help 
us evaluate, from which risk level for coronary artery disease does the treatment with 
statins become cost-effective within our reality” (Vieira et al., 2001).
Table 72: Costs per prevented death in Brazil (US$ 2000)








disease or acute 
myocardial infarct
WOSCOPS 351,832 633,508 452,356 —
AFCAPS/T exCAPS — 1,694,241 1,270,681 —
4S 78,534 — — —
CARE 405,236 287,958 — —
LIPID 124,607 203,665 — 107,330
Source: Adapted from Vieira et al. (2001).
In terms of comparability of results with willingness-to-pay estimates, this study 
has a number of positive characteristics. The medical intervention has the unique 
purpose of reducing the probability of death by heart diseases; the intervention can be 
continuously implemented (Ramsberg and Sjoberg, 1997); and it has benefits measured 
in physical effects (number of deaths), although there is no reference to the remaining 
years of life saved. The most important limitation of this study refers to the use of 
clinical results obtained in European populations, which are likely to present different 
health-related characteristics when compared to the Brazilian population. That is, the 
effect of drugs on the Brazilian population may differ from the effects observed in 
European countries due to differences in physical characteristics, health background, or 
even environmental characteristics such as air pollution concentration.
• Clinical trial (renal disease treatments)
Sesso et al. (1990) performed a cost-effectiveness analysis comparing four 
treatments of end-stage renal disease in Brazil and provided different estimates of costs 
per year of life saved. The authors investigated the following treatments: continuous 
ambulatory peritoneal dialysis (CAPD), in-centre haemodialysis (HD), cadaver donor 
transplantation (CD-Tx), and living related donor transplantation (LR-Tx). They used 
121 records of patients (between 15 and 50 years old) who initiated treatment for end- 
stage renal disease in a large care centre in Sao Paulo from September 1983 to 
December 1985. All patients included in this cost-effectiveness study were clear of
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diabetes, chronic pulmonary disease, cardiovascular disease, liver disease, and chronic 
infection.
The measure of effectiveness used was the physical impact -  life years of 
survival. In order to estimate the patient survival, the date on which the specific 
treatment started was defined as the beginning of the time period, and the end of the 
period of analysis (end of the follow-up period) was end of December, if the patient was 
alive. In case of death during the treatment, the date of death was the end of the time 
period relevant for estimating the surviving period. The number of years of survival was 
calculated by dividing the number of months of survival in the cohort by 12 and 24. The 
authors claim that determining costs and outcomes after one and two years was 
necessary because of the high initial costs of some services during the first year of 
treatment, for some treatments (e.g. transplantation surgery).
Sesso et al., (1990) estimated immediate direct costs and induced indirect costs 
incurred by the Brazilian National Institute for Medical Assistance (INAMPS) to 
provide the treatments involved in the end-stage renal disease treatment programme. 
Direct costs included labour costs, the purchase of equipments and supplies, transplant 
and surgery fees, physician and hospital fees, and medications. Indirect costs were 
considered those costs borne as a consequence of the treatment instituted, its side 
effects. For example, costs induced by rejection episodes in case of transplants. There 
was no attempt to measure indirect non-medical costs such as lost earnings from 
decreased productivity. Table 73 shows the estimates of costs per life (year) saved that 
can be expected for each initial treatment strategy.
Table 73: Costs per life saved with end-stage renal disease treatments in Brazil
(US$ 1985)
Renal disease treatment CAPD HD CD-Tx LR-Tx
Number o f patients 21 47 10 33
Total costs 527,814 911,913 143,040 196,112
Cost per life year saved 12,134 10,065 6,978 3,022
Cost per life saved (a) 25,134 19,402 14,304 5,943
(a) Total costs divided by the number o f patients alive at the end o f the two-years programme.
Source: Adapted from Sesso e ta l. (1990).
The cost-effectiveness study undertaken by Sesso et al., (1990) produced costs 
per life (year) saved per specific medical treatments for end-stage renal disease in 
Brazil. These results, however, are not suitable for a comparison with the value of a 
statistical life (year) estimated within the contingent valuation survey carried out in this 
study. The main reason relates to the costs measured in Sesso et a l , (1990), which
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considered only part of the total costs associated with the treatments -  the direct and 
indirect medical costs. It can be regarded, at best, as a lower bound of the value of a 
statistical life year in Brazil.
7.1.2. Non-medical interventions and other approaches
• Non-medical interventions
An extensive library and Internet search was undertaken in an attempt to identify 
cost-effectiveness studies of non-medical interventions in Brazil that could provide 
approximations of the value of a statistical life (year). No suitable study could have 
been identified in areas such as the transport, energy and environmental sectors. A few 
studies used benefit transfer of European or the US unit values to express mortality 
impacts of energy policies in Brazil in monetary terms (e.g. Molnary et a l,  available at 
http://www.ipen.br/cen/cent/publicacao/enfir2000_l.html). In addition, an unsuccessful 
search was undertaken for other sources/studies of estimates of the value of a statistical 
life (year) in Brazil that used other willingness-to-pay methods, such as the 
‘compensating-wage’ and hedonic-price model. The paucity of original (locally derived) 
unit values for mortality effects reinforces the relevance of the results obtained in this 
study for Brazil.
• Other (GDP-based) approaches
Alternative approaches to estimate approximations of the value of a statistical 
life (year) in monetary terms were presented in Rabl (2004) and Heck (2004). Both 
authors argue that it is worth exploring complementary approaches to derive the value 
of a life-year lost given the uncertainties involved with the willingness-to-pay approach, 
and specifically with contingent valuation studies. For example, Rabl (2004) claims that 
in view of the lack of reliable and generally accepted guidelines for the value of a 
statistical life year (VSLY or VOLY), as derived from the value of a statistical life 
estimated by different methods, it is interesting to have another perspective, by asking 
how much a rational individual is willing to pay for an extra year of life, assuming life­
time expected utility maximisation of rational individuals. In addition, analysts should 
examine data on actual expenditures for risk reductions in different sectors, and explore
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non-willingness-to-pay approaches in order to obtain further sources of guidelines on 
the VSLY.
Heck (2004) proposed the following method for comparing costs and benefits of 
different risk-reducing measures: to convert the economic costs of these measures into 
losses of life expectancy and compare with the benefits in terms of gains of life 
expectancy due to the measures. From these estimates it is possible to generate 
analytical approximations of years of life lost per dollar lost, and the ‘formal’ value of a 
life year lost (FVLYL), as described below. The basic idea of the proposed method was 
to use the biological measure life expectancy as a basic indicator, comparing life-saving 
measures according to their direct and indirect effects on life expectancy. The indirect 
effects include mainly the loss of options related to the loss of money. That is, “if an 
amount of money is spent on a certain risk-reduction measure like air pollution control, 
it may lack for alternative measures -  e.g. for medical services -  which have an 
influence on life expectancy as well” (Heck, 2004).
The author claims that given the strong correlation between wealth/income and 
life expectancy, a loss of money due to a certain expense causes a marginal decrease in 
life expectancy, which can be directly compared to the mortality benefit of the expense. 
It was formally shown that the change of life expectancy on the individual level due to 
changes in income could be approximately extracted from the global curve of average 
life expectancy depending on average incomes. Numerical FVLYL values were derived 
using the global relationship between national income per capita (GNI per capita and 
PPP adjusted GNI per capita) and life expectancy. Different fits of the global 
relationship curve were estimated and their parameters used to predict country-specific 
FVLYL94. Heck (2004) claims that more important than the numerical values presented 
in his paper is the general trend of the slope of the global curve, which suggests that 
economic mortality risks due to the loss of an amount of money tend to be bigger in 
poor countries than in rich countries. Table 74 presents the results for Brazil.
Table 74: GDP-based values of a statistical life year in IIrazil (US$ 2001)
Author Minimum Maximum
Heck (2004) 34,127 69,539
Based on Rabl (2004) 3,680 14,720
94 The author stresses that these numerical estimates should be used carefully given the uncertainties 
involving country-specific data generated from the global relationship between GNI per capita and 
average life expectancy.
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Rabl (2004) derived results for a collective value of a life-year lost for Europe 
and the ratio of VSLY per GDP per capita that are arguably suitable for policymaking 
while avoiding ethical dilemmas of assigning lower VSLY for poorer individuals. It is 
argued that the shift from individual willingness to pay to a representative collective 
VSLY for an entire country avoids the unethical issue of different VSLY according to 
income levels, and represents the actual need of policymakers for rational choices 
(estimates based on individual willingness to pay are summed-up for the entire 
population as well). The estimation proposed by Rabl (2004) is calculated for the 
average income and by averaging over the distribution of ages of concern for a policy 
decision.
The author used GDP per capita and survival data representative for Europe to 
estimate collective VSLY based on utility maximisation by rational well-informed 
individuals. The results suggest that VSLY equals to GDP per capita times a factor 
ranging between 0.5 and 2, depending on age, discount rate and variation of quality of 
life with age. Table 74 shows estimates derived for Brazil when using Brazilian GDP 
per capita equal to PPP US$7,360 in 200195. However, these are crude approximations 
since Rabl (2004) indicates that for application in developing countries the estimates 
would have to be recalculated with the appropriate (local) survival probabilities. Finally, 
the author claims that the same approach could also be used to determine the value of a 
statistical life but it would not be appropriate for accidental deaths or related to air 
pollution because it does not consider risk aversion of an early death and it does not 
account for the loss of life expectancy, respectively.
Dowrick et a l (1998) proposed a method to estimate the value of life using 
cross-country data on consumption of specific goods and services to explain variations 
in life expectancy between countries. The authors found that health care and nutrition 
consumption are important in determining life expectancy. Also, education is strongly 
associated with life expectancy since better schooling increases individuals’ knowledge 
about health-promoting behaviour. The cost function for life expectancy in terms of per 
capita consumption of health care, food and education was used to estimate the marginal 
cost of an increment in life expectancy for a representative consumer in each country. 
The cost of a reduction in age-specific mortality rates sufficient to save the life of one 
person is then estimated for each country, assuming that in each country health
95 http://www.undp.org/hdr2003/indicator/cty_f_BRA.html
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resources are allocated in order to maximise life expectancy. The marginal cost of 
saving one life in Brazil equalled US$120,544 (US$ 1980).
7.1.3. Summary
It was difficult to find cost-effectiveness studies of both medical and non­
medical life-saving interventions in Brazil with the necessary characteristics to allow 
the comparison of results with our willingness-to-pay-based estimates. These 
characteristics include, according to the brief review of the cost-effectiveness literature, 
the use of the physical impact metric (life-expectancy, years of life or lives lost); the 
real implementation of the intervention (continuously); the inclusion of all costs of the 
intervention (societal perspective); and having the main purpose of the intervention as to 
save lives (no joint benefit). It can be concluded that the (few) Brazilian cost- 
effectiveness studies do not provide suitable results in terms of the comparability with 
willingness-to-pay-based results, each of them failing to present some of the desired 
characteristics. The cost-effectiveness results can, at best, be considered as a lower 
bound for the willingness-to-pay estimates. As can be seen in Figure 5 and Figure 6, the 
estimates vary significantly, the willingness-to-pay estimates being of an order of 
magnitude higher, except the results of Vieira et al., (2001).
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The comparison above reinforces our preference for suggesting the value of a 
statistical life estimated using the 5-in-1000 immediate risk reduction estimates for 
policy analysis in Brazil. They are more conservative values than those using the 1-in- 
1000 risk reduction; they seem to be more reliable estimates because this was the first 
question posed to the respondents; and they are in line with the cost per life saved 
obtained in cost-effectiveness studies of life-saving intervention in Brazil when 
compared with the 1-in-1000 risk reduction estimates. Table 75 summarises the 
findings.
Table 75: Comparison of VSL and VSLY estimates in Brazil
Study Higher value Lower value
Value o f a statistical life or cost per life saved
This study: 5-in-1000 1,306,941 767,187
This study: 5-in-1000 - No 'yeah-say' 489,752 415,381
Vieira etal. (2001) 1,694,241 78,534
Dowrick et al. (1998) 120,544 120,544
Sesso etal. (1990) 25,134 5,943
Akhavan et al. (1999) 2,492 2,672
Value o f a statistical life year or cost per life-year saved
This study: 5-in-1000 159,456 61,392
This study: 5-in-1000 - No 'yeah-say' 34,729 62,944
Heck (2004) 69,539 34,127
Rabl (2004) 14,720 3,680
Sesso etal. (1990) 12,134 3,022
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7.2. Benefit transfer as an alternative to this study’s empirical results
In the absence of original stated preference studies in Brazil to estimate the 
willingness to pay for mortality risk reductions in Brazil, policymaking would have to 
rely on benefit transfer techniques or the human capital approach to provide estimates of 
the value of a statistical life. Benefit transfer is the most used technique to generate the 
value of a statistical life when proper valuation exercises are not possible in developing 
countries. This section aims to explore the benefit transfer techniques used so far in the 
environmental economics literature, to generate transferred willingness-to-pay estimates 
for Brazil, and to examine whether these estimate differ from the estimates produced in 
this study. The differences between transferred estimates and locally derived estimates 
using original stated preference studies are known in the literature as benefit transfer 
errors (Navrud, 2004; Ready et al., 2004). This procedure aims to provide some basis to 
discuss how important this study’s empirical results are for policymaking in Brazil.
7.2.1. Benefit transfer: concepts and conditions
According to Rosenberger and Loomis (2001), benefit transfer is defined as the 
adaptation and use of existing economic information derived to specific site under 
certain resource and policy conditions to new contexts or sites with similar resources 
and conditions. Brouwer (1998) defines it as a technique where the results of monetary 
(environmental or health) valuation studies, estimated through market based or non- 
market based economic valuation techniques, are applied to a new policy context. Some 
authors (e.g. Navrud, 2004) prefer the term ‘value transfer’, since in many cases damage 
estimates can also be transferred from previous studies (termed study sites) to new 
evaluation contexts (policy sites).
When the relevant economic values of different policy alternatives and the 
required resources are not available for developing new valuation studies to support 
decision-making, then economic measures estimated in similar contexts and sites can 
provide a proxy for the estimates necessary for the decision-making. In other words, 
benefit transfer is an alternative to fill in gaps in the availability of information on the 
preferences of individuals in a country or region. "Applying previous research findings 
to similar decision situations is a very attractive alternative to expensive and time 
consuming original research to quickly inform decision makers" (Brouwer, 1998).
• Alternative benefit transfer methods
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Navrud (2004) defines a typology of the most usual benefit transfer methods, 
identifying two main approaches: (i) the unit value transfer approach, which involves 
the methods known as simple unit transfer (also known as single-point estimate or 
average-value transfer -  Rosenberger and Loomis, 2001) and unit transfer with income 
adjustment; and (ii) the function transfer approach that uses the benefit function transfer 
method and meta-analysis (or meta regression analysis).
o Unit value transfer -  simple unit transfer
This is the simplest method of transferring economic estimates from one site or 
context to another, based on using an estimate from a single relevant study site or a 
range of point estimates if more than one study is considered relevant (average-value 
transfer). According to Navrud (2004), it assumes that the well being experienced by an 
average individual at the original study site will be equivalent to the well being 
experienced by the average individual in the policy site. Once this assumption holds, 
analysts can directly transfer the economic benefit or damage from the study site to the 
policy site. An alternative procedure, average-value transfer, is based on using a 
measure of central tendency of relevant studies as the transfer estimate for a given 
policy site. Rosenberger and Loomis (2001) argue that average value estimates, 
however, are no better than the data they are based on, that is, all of the eventual 
problems related to the credibility of any single estimate are also relevant for an average 
value based on that estimates. The authors claim that the primary steps to perform a 
single point estimate transfer (simple unit transfer) include identifying and quantifying 
the policy-induced changes, and locating and transferring a unit value (single estimate 
or average) representing the individuals’ welfare measure.
An immediate limitation of this method is that individuals in the policy site may 
differ from individuals at the study site(s) in terms of socio-economic characteristics -  
income, education, religion, for example -  that can affect their preferences. Therefore, 
Navrud (2004) concludes that the simple unit transfer approach should not be used for 
benefit transfer between countries with different income levels and costs of living.
o Unit value transfer -  unit transfer with income adjustment
The unit transfer with income adjustment method has been the most used 
practice for policy analysis in developing countries since most of the environmental
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valuation studies were conducted in developed countries (Navrud, 2004). This method 
assumes that the benefit value in the policy site can be estimated by adjusting the 
benefit value in the study site(s) by the ratio between income levels in both sites and the 
income elasticity of demand for the good. Formally:
where (Bp) is the adjusted policy-site benefit; (Bs) is the original benefit estimate in the 
study site; (Yp) and (7y) are the income levels; and (fi) is the income elasticity of demand 
for the analysed good.
However, it is argued that most studies assume GDP per capita as proxies for 
income in international benefit transfers, and income elasticity of demand equal to one. 
These common assumptions do not necessarily hold. Navrud (2004) argues that it is 
appropriate to use PPP estimates of per capita GDP, instead of GDP per capita, since 
these estimates are adjusted to reflect a comparable amount of goods and services that 
could be purchased with the per capita GDP in other country. Also, the author claims 
that there is no evidence that welfare measures associated with environmental goods 
vary proportionally with income, and sensitivity analyses should assume different levels 
of income elasticity of demand. Using an income elasticity equal to one would change 
the willingness-to-pay measure in the policy site proportionally to the relative per capita 
income differential across the two areas of study, whilst income elasticity equal to zero 
would mean that no adjustment is considered for income differentials (Davis et a l , 
1999).
Benefit-function transfer involves the use of a willingness-to-pay function, 
derived in a study site preferably using stated or revealed preference techniques, which 
relates willingness to pay to a set of characteristics of the study-site population and the 
environmental good. That is, benefit function transfers use a model that statistically 
relates benefit measures with study factors such as characteristics of the user population 
and the resource being evaluated. The transfer process involves adapting the benefit 
function to the characteristics and conditions of the policy site, forecasting a benefit 
measure based on this adaptation of the function, and use of the forecast measure for 
policy analysis (Rosenberg and Loomis, 2001).
/■  \  u
BP = B,. —
u .
(108)
o Function transfer -  benefit function transfer
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The advantage of benefit function transfer, in contrast with unit value transfer, is 
that more information can be taken into account in the transfer process. When 
transferring a unit value estimate from a study site to a policy site, it is assumed that the 
two sites are identical across the various factors that determine the level of benefits 
derived in both sites. However, Rosenberger and Loomis (2001) argue that this is not 
always the case, their argument being based on different validity and reliability 
assessments of unit value transfers. The invariance involving the transfer of benefit 
measures alone makes these transfers insensitive or less robust to significant differences 
between the study site and the policy site. Therefore, the main advantage of transferring 
an entire benefit function to a policy site is the apparently increased precision of 
tailoring a benefit measure to fit the characteristics of the policy site.
Disadvantages of this method are primarily due to data collection and model 
specification in the original study. Navrud (2004) claims that the main problem with the 
benefit function approach relates to the exclusion of relevant variables in the 
willingness-to-pay function estimated in a single study. For example, when the 
estimation is based on observations from a single environmental good, the lack of 
variation in some of the independent variables avoids the inclusion of these variables in 
the model, and in another policy site these variables may be important. Indeed, 
Rosenberg and Loomis (2001) report that factors in the benefit function may be relevant 
to the study site but not to the policy site. These factors can have distinct effects on the 
tailored benefit measures at a policy site.
o Function transfer -  meta-analysis
Meta-analysis is used when the results of many valuation studies, developed in 
different study sites, are used for estimating a single benefit transfer function. It is 
defined as the statistical summary of relationships between benefit estimates and 
quantifiable characteristics of studies. In meta-analysis, several studies are analysed as a 
group and each result of these studies is one observation in a regression analysis. The 
data for a meta-analysis is typically summary statistics from study-site reports and 
includes quantified characteristics of the user population, study site’s environmental 
resources, and valuation methodology used.
Navrud (2004) claims that meta-analysis allows analysts to evaluate the 
influence of a wider range of population and environmental good characteristics, as well
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as the modelling assumptions. The resulting regression equations can then be used to 
predict an adjusted unit value for the policy site, given the availability of data on the 
independent variables for the policy site. The meta-analysis regression has the welfare 
measure as dependent variable, the environmental good and population characteristics 
as independent variables (similar as the benefit function transfer), but also includes 
characteristics of the original studies in the study sites. These characteristics include 
methodological variables, such as elicitation format, payment vehicle, and response 
rates in case of studies applying stated preference methods. However, the author argues 
that methodological variables are not particularly useful in predicting welfare estimates 
for environmental goods, especially in international benefit transfer, if we assume cross­
country heterogeneity in preferences for environmental goods. The author concludes 
that to increase the applicability of meta-analysis for benefit transfer, analysts should 
select original studies that are methodologically very similar to each other, isolating the 
effects of site and population characteristics on the estimates.
• Validity and reliability of benefit transfer
Several factors were identified that can affect the reliability and validity of 
benefit transfers (Rosenberger and Loomis, 2001). One group of factors that affects the 
validity of benefit transfers includes (i) the quality of the original study greatly affects 
the quality of the benefit transfer process; (ii) the limited number of studies 
investigating a specific environmental good, thus restricting the pool of estimates and 
studies from which to draw information; and (iii) the documentation of data collected 
and reported can be a limitation.
A second group of factors is related to methodological issues. For example (i) 
different research methods may have been used across study sites, including what 
question(s) was asked, how it was asked, what was affected by the management or 
policy action, how the environmental impacts were measured, and how these impacts 
affect recreation use; (ii) different statistical methods for estimating models can lead to 
large differences in values estimated, including issues such as the overall impact of 
model misspecification and choice of functional form; and (iii) there are different types 
of values that may have been measured in primary research, including use values and/or 
passive- or non-use values.
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A third group of factors affecting the validity of benefit transfers regards the 
correspondence between the study site and the policy site, which arises because (i) some 
of the existing studies may be based on valuing activities at unique sites and under 
unique conditions; (ii) characteristics of the study site and the policy site may be 
substantially different, leading to quite distinct values.
A fourth validity factor is the issue of temporality or stability of data over time. 
If the existing studies occurred at different points in time, relevant differences between 
then and now may not be identifiable nor measurable based on the available data. The 
fifth factor is the spatial dimension between the study site and the policy site. This 
includes the extent of the implied market, both for the extent and comparability of the 
affected populations and the resources impacted between the study site and the policy 
site. All these factors can lead to bias or error in the benefit transfer process, reducing its 
robustness. The objective of the benefit transfer process is to minimize mean square 
error between the true value and the predicted or transferred value of impacts at the 
policy site. However, Rosenberger and Loomis (2001) claim that the original or true 
values are themselves approximations and are subject to error. Therefore, any 
information transferred from a study site to a policy site is accomplished with varying 
degrees of confidence in the applicability and precision of the information.
• Conditions and limitations of benefit transfer
Rosenberger and Loomis (2001) argue that some general conditions should be 
met to perform benefit transfers. First, the policy context should be carefully defined, 
identifying (i) the extent, magnitude, and quantification of expected impacts from the 
proposed action; (ii) the population that will be affected by the expected impacts; and
(iii) the data needs, including the type of measure (unit, average, marginal value) and 
the degree of certainty surrounding the transferred data. Second, the study-site data 
should also meet certain conditions, such as (i) studies transferred must be based on 
adequate data, valid economic method, and correct empirical technique; (ii) contain 
information on the statistical relationship between benefits and socio-economic 
characteristics of the affected population; and (iii) contain information on the statistical 
relationship between the benefits and physical/ environmental characteristics of the 
study site.
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Finally, the correspondence between the study site and the policy site should 
ideally have specific characteristics such as (i) the environmental resource and the 
change in the quality or quantity of the resource at the study site and the resource and 
expected change at the policy site should be similar; and (ii) the markets for the study 
site and the policy site are similar, unless there is enough usable information provided 
by the study on own and substitute prices -  other characteristics should be considered, 
including similarity of demographic profiles between the two populations and their 
cultural aspects.
7.2.2. Benefit transfer validity tests
Studies have tested the validity and reliability of different benefit transfer 
methods and results have shown that the uncertainty in spatial and temporal benefit 
transfer can be large (e.g. Ready et al., 2004; Kristoferson and Navrud, 2005). Although 
no standard protocol or guidelines for conducting benefit transfer is available, some 
studies compare benefit transfer estimates with contingent valuation studies of the same 
site to test the validity of benefit transfer. For example, Bergland et a l (1995), cited in 
Navrud (2004), conducted contingent valuation surveys for increasing water quality in 
two different lakes in Norway, generated benefit functions for each of them, transferred 
the benefit function to each other, and then compared the transferred values with the 
original contingent valuation estimates. The authors also transferred and compared the 
mean (unit) values, since the lakes were rather similar in size and type of pollution 
problem. Several tests for transferability were conducted but transferred and original 
estimates were statistically different at the 5% level. However, the transfer error96 varied 
between 20% and 40%, with predicted values being lower in one case (for one of the 
lakes) and higher for the other lake. Finally, Navrud (2004) cites examples of validity 
tests performed in-country, cross-countries, and between developed and developing 
countries, and concluded that the results from these studies show that the uncertainty in 
value transfer can be large. The general indication is that benefit transfer cannot replace 
original studies, especially when the costs of being wrong are high.
Ready et al. (2004) measured the benefits for specific health impacts related to 
air and water pollution in five European countries using similar contingent valuation 
surveys. The authors tested different benefit transfer methods against original
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contingent valuation estimates, finding an average error of 38%. They concluded 
“accounting for measurable differences among countries in health status, income and 
other demographic measures, either through ad hoc adjustments to the transferred values 
or through value transfer function transfer, did not improve transfer performance” 
(Ready et a l, 2004). It suggests that cultural and attitudinal factors seem to be important 
in explaining differences in valuation across countries. Finally, Ready et a l, (2004) 
claimed that some of the differences between predicted and original estimates might be 
due to some amount of sampling error in the target country estimate, and proposed the 
use of Monte Carlo techniques to simulate what would occur if the same survey was 
undertaken many times in the country. This procedure can arguably produce more 
accurate error estimates.
As seen before, the usual benefit transfer methods are (i) unit (mean and median) 
value transfer (UVT), (ii) unit value transfer with income adjustments (UVTA), and (iii) 
willingness-to-pay or benefit function transfer (BFT), in which predicted willingness to 
pay in the policy site are estimated using the willingness-to-pay function estimated in 
study sites and individuals’ characteristics set equal to the average from the policy site 
sample. The transfer of benefit functions is, initially, preferred to the transfer of average 
unit values since more information about the willingness-to-pay estimates can be used 
in the estimation of transferred values (e.g. Brower and Spaninks, 1999). However, 
some authors (e.g. Bergland et a l, 1995) advocate that both willingness-to-pay 
functions and unit values should be transferred and tested. For example, Muthke and 
Holm-Mueller (2004) analysed the forecasting quality of benefit transfer by comparing 
results of two German contingent valuation studies with two Norwegian studies that 
applied a similar methodology. They concluded that there was no clear increase in 
accuracy when applying the benefit transfer function method to their samples, 
suggesting that adjusting the primary study with the income ratio is more advantageous 
than transferring a complete benefit function.
Brower and Spaninks (1999) summarised the different validity tests in the 
international literature (Table 76). The first set of validity tests is appropriate to the unit 
value and income-adjusted unit value transfer methods. The mean and median 
willingness-to-pay estimates at the policy and study sites can be tested using parametric 
(e.g. t, Wald) and non-parametric (e.g. Mann-Whitney) tests. Equality of the distribution
96 Usually defined as the difference between transferred mean WTP and observed mean WTP, as a 
percentage o f the observed mean WTP (Navrud, 2004; Ready et al., 2004)
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of individual willingness-to-pay values at the policy (WTPp>i) and study sites (WTPSii) 
can be tested using the Kolmogorov-Smimov test. The second and third groups of 
hypothesis refer to the benefit function transfer. Brower and Spaninks (1999) claim that 
for a valid benefit function transfer the estimated coefficients of the willingness-to-pay 
function should be equal in policy and study sites (flp = fis). “If the coefficients of 
explanatory variables are not the same at different sites, their impact will be different at 
these sites and hence the model estimated at one site cannot be used to predict 
willingness to pay at another site” (Brower and Spaninks, 1999). The second group of 
hypothesis compare the coefficients directly whereas the third hypothesis compares the 
coefficients with the pooled model using both samples. According to Muthke and 
Holm-Mueller (2004) this test is weaker than comparing the coefficients directly since 
the pooled parameter (fip+s) already comprehend information of the policy and study 
sites.
Table 7<5: Validity tests for benefit transfer
Transfer Null hypothesis Test
UVT7
UVTA
I -  Average WTP at policy site = average WTP at study site 
I -  Distribution W TPdj = Distribution WTP s i
t-test / Mann-Whitney test 
Kolmogorov-Smimov test
II -  B p = B s
II -  a  0 = a 2* (explained variance at policy and study sites)
Lagrange multiplier /  Wald test 
Chow /  Likelihood ratio test
BFT
III -  Bp + s = B p= B s 
III -  o  o+s = <J2d = 02s
Lagrange multiplier /  Wald test 
Chow /  Likelihood ratio test
IV -  W TPpp = f  (B , ,  X p ) = WTPp
IV -  Distribution WTP pp j = Distribution WTP p j
IV -  WTP ss = f  (B p , X s ) = WTP s
IV -  Distribution WTP ssj = Distribution WTP s i
t-test /  Mann-Whitney test 
Kolmogorov-Smimov test 
t-test / Mann-Whitney test 
Kolmogorov-Smimov test
Source: Adapted from Brower and Spaninks (1999) and Muthke and Holm-Mueller (2004)
A fourth group of hypothesis involves using the estimated willingness-to-pay 
function in the study site (fis) and the explanatory variables of the policy site (Xp) to 
predict mean and median willingness to pay in the policy site (WTPpp) and compare it 
with the observed actual average willingness-to-pay estimate in the policy site (WTPp). 
The same procedure can be undertaken using the benefit function of the policy site to 
predict estimates in the study site (WTPsp) and compare it with the observed estimate in 
the study site (WTPS). Also, the test of equal distribution of the observed willingness-to- 
pay values can be performed.
Finally, Kristoferson and Navrud (2005) suggested the use of equivalence tests 
as a more appropriate hypothesis test of benefit-fimction transfer. The authors claim that 
the usual validity tests state a null hypothesis of no difference between an original study
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result and a benefit transfer estimate. Rejection of this hypothesis is interpreted as 
evidence against the validity of benefit transfer, and non-rejection as evidence for 
validity. They argue that the heterogeneity of environmental goods does not support the 
usual equality test since willingness to pay for an environmental good would be 
expected to be equal in different sites only if the functional form of the indirect utility 
functions in two populations are the same, and the vector of prices and the vectors 
describing environmental quality are identical. In equivalent tests the null hypothesis is 
that values are different, and only through rejection of the null hypothesis it can be 
concluded that the values are equivalent. It demands the definition of an interval within 
which estimates are regarded equivalent, also known as ‘limit of tolerance’ -  the level 
of benefit transfer error that the researcher is willing to accept (Muthke and Holm- 
Mueller, 2004).
• Benefit transfer errors
The approach used to test the validity of transferred willingness-to-pay estimates 
to Brazil is to compare these estimates with those obtained in the contingent valuation 
survey in Brazil and estimate the magnitude of the benefit-transfer ‘errors’. A UK 
benefit function is used to estimate adjusted willingness-to-pay estimates for Brazil 
according to the socio-economic differences between Brazil and the UK. The UK 
estimates and willingness-to-pay functions are used in this analysis because (i) the 
survey instrument is identical in Brazil and in the UK, (ii) the good evaluated is the 
same in both studies (small risk reductions in probabilities of death), (iii) the statistical 
models used to generate mean and median estimates are identical, and (iv) the sample 
sizes are similar. These characteristics seem to guarantee that potential differences 
between estimates can be attributed to differences in respondents’ preferences, 
minimising differences due to methodological divergences.
The UK mean and median willingness-to-pay estimates for immediate risk 
reductions were transferred to Brazil using the unit value transfer (direct transfer) and 
the income-adjusted unit value transfer assuming different income elasticity of 
willingness to pay (e):
f  • \ Er  ,  r i T T i n  l17C017J6br s irk rwtransferred WTP -  WTPuk. -----------  (109)
I incomeuk J
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The parameters used to transfer the UK unit values were the income elasticity of 
willingness to pay equal to one and equal to 0.4 {e=l and 6=0.4, Alberini et al., 1997) 
and the USS 2003 GDP per capita adjusted by PPP equal to US$27,700 in the UK and 
US$7,600 in Brazil97. The adjusted transferred values are shown in Table 78.
The UK willingness-to-pay functions used to estimate transferred values to 
Brazil considered individuals characteristics that were statistically significant in the 
validity tests in the UK (income and education), and in Brazil (mainly income). The 
benefit transfer functions were estimated as follows98:
Model 1: W T P u k i  = /  {income, education) (110)
Model 2: WTPu k i  = / {income)
Table 77: the UK Willingness-to-pay for immediate risk reductions -  Weibull
distribution
S-in-1000 Model 1 Model 2
Regressors Coefficient Standard error Coefficient Standard error
Constant 7.4324 n 0.5795 5.8402r) 0.1792
Income (thousand) 0.0205("> 0.0122 0.0114 0.0119
Years o f  schooling -0.1248r) 0.0420 — —
Scale parameter 1.2549 1.2864
N 313 318
Log likelihood -392.8674422 -402.8587966
1-in-1000
Constant 6.6125 n 0.7320 5.0457r) 0.2135
Income (thousand) -0.0151 0.0135 -0.0234(" J 0.0129
Years o f schooling -0.1234r ’} 0.0537 — —
Scale parameter 1.9342 1.9406
N 313 318
Log likelihood -365.317992 -377.7138731
Notes: (*) significant at 1%; (**) significant at 10%.
Table 77 shows the models’ estimated coefficients that were combined with the 
Brazilian sample’s averages (annual income and years of education), which are similar 
to the Sao Paulo population figures99, to produce the benefit-function transferred values, 
shown in Table 78. Wald tests of equality between the coefficients in Table 77 and the 
corresponding coefficients using the Brazilian sample (test II in Table 76) resulted in
97 http://www.worldfactsandfigures.com/gdp_country_desc.php
98 These UK willingness-to-pay models were estimated using SAS 8.0, in contrast with all other models 
in this work that were estimated using STATA 6.0. The reason is that STATA deals with interval data 
with no upper limit (missing value) differently than SAS. The Brazilian study considered the willingness- 
to-pay intervals bounded by individuals income (Chapter 4), while the UK study did not bound these 
intervals. SAS was used in order to obtain the same results as presented in the literature (Alberini et al., 
2004a).
99 For example, the average annual individual income in the sample equalled R$10.137,81 while the 
figure relative to Sao Paulo’s population is R$12.665,00.
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null hypothesis of equality being rejected for all models and risk reductions. The benefit 
transfer errors were estimated as defined by equations (111), and represent the 
percentage deviations between the transferred values and the locally estimated 
willingness to pay in Brazil.
I transferred WTP -  WTPbi\
Benefit transfer error I  =  ---------------------------------
W T P br
\transferred WTP -  WTPbr no' yeah - saying'
Benefit transfer error II  =  -----------------------------------------------  (HI )
WTPbR no' yeah - saying1
Table 78: Benefit transfer values and errors -  WTP for immediate risk reduction
Risk reduction 5-in-1000 1-in-1000 Avg
transfer









Brazil - excluding 'yeah-saying' 245(208 - 290)
208







UK unit value transfer 802 422 360 96 —
Benefit transfer error I 22.8 9.9 41.0 72.3 36.5
Benefit transfer error II 227.3 102.9 49.4 51.3 107.7
Income-adjusted UK transfer (e=l) 220 116 99 26 —
Benefit transfer error I 66.3 69.8 83.8 92.4 78.1
Benefit transfer error II 10.2 44.3 59.0 86.6 50.0
Income-adjusted UK transfer (e=0.4) 478 252 215 57 —
Benefit transfer error I 26.8 34.5 64.8 83.5 52.4
Benefit transfer error II 95.1 20.9 11.0 71.0 49.5
UK benefit function transfer 1 268 149 138 36 —
Benefit transfer error I 59.0 61.2 77.4 89.6 71.8
Benefit transfer error II 9.3 28.5 42.8 81.7 40.6
UK benefit function transfer 2 131 71 68 18 —
Benefit transfer error I 79.9 81.6 88.8 94.9 86.3
Benefit transfer error II 46.4 65.9 71.7 91.0 68.7
Notes: Benefit transfer values in USS (95% confidence interval); benefit transfer errors in percentage.
As can be seen in Table 78, while the benefit transfer estimates can be 
significantly different from the locally derived Brazilian willingness-to-pay estimate, 
quite a few transferred estimates were inside the 95% confidence interval of the 
corresponding Brazilian estimate. When transferred values were compared with the full 
sample estimates only the UK unit value transfer -  both mean and median willingness to 
pay for a 5-in-1000 risk reduction -  fell inside the 95% confidence interval of the 
Brazilian estimates. When the sample without ‘yeah-saying’ respondents is considered 
the following transferred estimates ranged between the corresponding 95% confidence 
interval: income-adjusted (e=l) mean value for a 5-in-1000 risk reduction; income- 
adjusted (e=0.4) mean values for the 1-in-1000 risk reduction; and the transferred mean
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value (5-in-1000 risk reduction) using the benefit function 1 (income and education as 
explanatory variables). These results are expected, given the peculiarities of the 
Brazilian figures, such as the lack of proportionality between estimates for different risk 
reductions and the unexpectedly high willingness-to-pay values presented, which make 
the Brazilian results appear similar to developed countries’ estimates. In this 
circumstance, it is expected that the transferred unit values for the 5-in-1000 risk 
reduction range between the 95% confidence interval of the Brazilian estimates, while 
the same is not true for the smallest risk reduction. When the estimates excluding ‘yeah- 
saying’ respondents are compared with transferred estimates other income-adjusted 
transferred values are within the corresponding 95% confidence interval, but still not 
consistently.
Due to the peculiar characteristics of the Brazilian estimates referred above, it is 
not surprising that the direct transfer of the UK unit values outperformed other transfer 
methods when transferred values were compared with values estimated using the full 
sample (benefit transfer error I), presenting the lowest average benefit transfer error of 
36.5%. When ‘yeah-saying’ respondents were excluded the mean and median values 
were smaller than the figures of the full sample. In this case, transfer methods that 
adjust estimates according to the policy-site population characteristics presented better 
results (benefit transfer error II) than the direct unit value transfer. The average benefit 
transfer error of the characteristics-adjusting transfer methods was approximately 52%, 
with the best performance presented by the willingness-to-pay function with education 
and income as explanatory variables (40.6%). Surprisingly, the worst performance 
among these adjusting transfer methods related to the other benefit transfer function 
tested, which included only income as regressor (68.7%).
The results of this benefit transfer exercise suggest that if the willingness-to-pay 
function is available and its specification follows the statistical significance criteria then 
it can be the preferred alternative to undertaking original stated preference studies in the 
policy site. That is, if the benefit function can be specified with the significant 
explanatory variables in the study site then the transfer results can outperform other 
transfer methods results, whereas a misspecification of the benefit function, as 
apparently is the case with the benefit transfer function 2, can result in higher transfer 
errors. In any case, it seems that the income-adjusted unit value transfer can be an 
interesting alternative to original stated preference studies in developing countries since
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its average transfer errors -  approximately 50% - lie between the range of errors 
produced by different benefit transfer functions.
Notwithstanding all the problems, however, it is important to note that the 
average benefit transfer results are in line with Ready et al., (2004). Their benefit 
transfer tests in five European countries showed overestimations as high as 230% and 
underestimations as high as 77% while the majority of transfers resulted in errors less 
than 50% (average error 38%). Alberini et a l , (1997) found benefit transfer errors 
ranging between 29% and 54% when testing willingness to pay for health occurrences 
in the US and in Taiwan.
7.2.3. Summary
In the absence of the value of statistical life estimates locally derived in Brazil 
using stated- or revealed preference techniques, policy analyses would have to rely on 
benefit transfer to estimate the benefits of air pollution control policies in Brazil. It is 
acknowledged that the willingness-to-pay estimates generated using the contingent 
valuation survey in Brazil have a number of uncertainties regarding the assumptions 
adopted, for example, the assumed distribution of willingness to pay, parametric versus 
non-parametric results, value of a statistical life derived from mean versus median 
willingness to pay; value of a statistical life derived from 1-in-1000 or 5-in-1000 risk 
reduction. However, these results can be compared with estimates generated under 
equivalent assumptions in different countries, a major advantage of having used the 
same methodology as in other countries.
The UK results were used to estimate the percentage difference between 
transferred estimates to Brazil and locally derived estimates (benefit transfer errors) 
using different benefit transfer methods. The transferred estimates when compared with 
the results obtained using the full sample in Brazil (with potential ‘yeah-saying’ 
respondents) presented average transfer errors equal to 69%, the direct unit value 
transfer outperforming other transfer methods with the smallest average benefit transfer 
error (36.5%). This result can be explained by the unexpected high values observed in 
this study most likely because of the cooperative behaviour of part of respondents. 
When the same analysis is undertaken excluding the cooperative respondents, the 
average benefit transfer error equals 63% - this average falls to 52% if only the income- 
adjusting transfer methods are considered.
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The results of this benefit transfer exercise do not allow us to conclude which 
benefit transfer method would be preferable in case an original valuation study would 
not be possible in developing countries. Indeed, it shows that benefit transfer errors may 
be as high as 200% in some cases. It can be an alternative method to generate estimates 
of the value of a statistical life when the resources for an original valuation study are not 
available and the accuracy of the estimates are not relevant for policy analysis. This is 
not, however, true in the case of policy analysis relating to air pollution, for which the 
mortality effect is the main impact and, therefore, requires estimates of the value of a 
statistical life to be as accurate as possible for policy evaluation.
7.3. Study cases
Chapter 5 described the survey instrument and statistical methods used to obtain 
the value of a statistical life in Brazil, while Chapter 6 (section 4) compared the 
Brazilian results with similar estimates of the value of a statistical life in other countries 
using the same valuation methodology. Previously, Chapter 4 reviewed the international 
literature that presented estimates of the value of a statistical life obtained with other 
valuation techniques and meta-analyses in different countries. The previous sections in 
this Chapter were devoted to the comparison of the estimates of the value of a statistical 
life (and life year) obtained in this study with other estimates for Brazil obtained with 
non-valuation methods (e.g. alternative national income-based approaches), cost- 
effectiveness analysis, and benefit transfer methods.
This section aims to evaluate the impact that our estimates could have in policy 
analysis in Brazil by comparing the results of two cost-benefit analyses that relied on 
benefit transfer methods with the cost-benefit results using the estimates provided by 
this study. It aims to highlight the importance of our results in reducing the uncertainties 
of policy analyses that include the reduction of mortality among their main effects. It 
starts with a brief description of the regulatory framework regarding air pollution in Sao 
Paulo, Brazil (sub-section 7.3.1), followed by an analysis of a national programme to 
control vehicle emissions in Brazil -  Proconve (sub-section 7.3.2), and the analysis of a 
local programme to improve urban transportation in Sao Paulo aiming to reduce air 
pollution -  PITU (sub-section 7.3.3).
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7.3.1. The regulatory framework regarding air pollution in Sao Paulo
The institutions responsible for environmental policies in Sao Paulo are the 
federal government, state authorities, and municipal government agencies (Omarsal and 
Ganton, 1997)100. At federal level decisions are made regarding general policy 
guidelines, laws, standards, and budget, mainly through the National Environmental 
Council (CONAMA101 -  “Conselho National do Meio Ambiente”, created in 1981), the 
Ministry of the Environment, and the Brazilian Institute of the Environment and 
Renewable Natural Resources (IBAMA). At the state level the Environmental 
Sanitation Technology Company (CETESB), part of the state Secretariat of the 
Environment, is the environmental protection institution responsible for monitoring air 
pollution in Sao Paulo. CETESB is in charge of licensing new industrial installations, 
monitoring air quality, and enforcing state pollution control legislation. The 
municipality of Sao Paulo is responsible for traffic managing, licensing taxis and 
operating bus lines through the Municipal Public Bus Company (CMTC).
Omarsal and Ganton (1997) reported that with regard to vehicular air pollution, 
CETESB has supported federal environmental agencies in reducing vehicular air 
pollution. For example, CETESB helped to prepare the CONAMA Resolution that 
established the Programme to Control Air Pollution from Motor Vehicles 
(PROCONVE) at the national level, the first case study analysed below. CETESB also 
prepared the CONAMA resolution that established emission limits for used cars and 
associated testing procedures. CETESB also designed a programme to control air 
pollution from motor vehicles in the State of Sao Paulo. The objective of this 
programme was to integrate the air pollution control efforts of CETESB with other 
institutions involved in the public transport sector (e.g. the Sao Paulo Metro Company 
and municipalities within the Sao Paulo metropolitan region -  SPMR). The PITU 
programme, our second case study, is among the results of this initiative of CETESB.
100 A complete description o f the development o f the regulatory framework regarding environmental 
issues in Brazil is available at the World Bank, http://www.worldbank.org/nipr/brazil/braz-over.htm
101 CONAMA is the consultation and deliberating organism o f the National Environmental System 
(SISNAMA). It is composed by technical chambers and working groups, representing all sectors o f the 
Brazilian society interested in environmental issues. The president o f CONAMA is the Ministry o f the 
Environment, and its executive secretary is the Ministry’s Executive Secretary. The council’s meetings 
are open to the general public (http://www.mma.gov.br/port/conama/index.cfm).
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7.3.2. PROCONVE -  Programme for control of air pollution from mobile 
sources
Motor vehicles are the main source of air pollution in the Sao Paulo 
metropolitan region, where private cars were responsible for 75% of carbon monoxide 
(CO), 73% of hydrocarbons (HC), 23% of nitrogen oxides (NOx) and 10% of particulate 
matter (PM) emissions in 1997 in Sao Paulo (Ferraz and Seroa da Motta, 2001). In 1995 
the region’s automotive fleet consisted of about 5.16 million vehicles that were 
responsible for 96% of CO, 90% of HC, 97% of NOx, 86% of S02, 42% of PM 
emissions, whereas industry contributed 46% of all PM emitted in Sao Paulo MR in 
1995 (Omarsal and Ganton, 1997). In addition, given its geographic characteristics, Sao 
Paulo is subject to thermal inversions that can lead to increasing accumulation of 
atmospheric pollutants (Saldiva et a l, 1995).
In order to reduce air pollution levels in Brazilian urban areas, the government 
implemented in 1986 the PROCONVE programme102, establishing emission standards 
for new vehicles produced in or imported to Brazil. PROCONVE, which was based on 
the international experience (mainly the US) on emission standards, also aimed to 
promote and develop technology for sampling and analysing pollutants; to create 
vehicles inspection and maintenance programmes; to promote public awareness of the 
vehicular air pollution problem; and to establish a criterion for evaluation of the 
programme’s results. The programme considered automotive vehicles in three
1 fttsegments and for each group, a specific adjustment schedule was established. 
According to Ferraz and Seroa da Motta (2001), the adjustment schedule considered 
three phases. Phase one was implemented gradually between 1988 and 1991 with 
specific adjustment schedules for some car models that were allowed a six-month period 
of adjustment. Phase two started with the limits imposed for 1992 until 1997. The third 
phase started in 1997 aiming to induce manufacturers to apply the best technology 
available for emission control. The PROCONVE protocol was successfully 
implemented from 1988 to 1997 and the average emission levels decreased 
considerably, as can be seen in Table 79.
As a consequence of the induced emission levels reduction observed between 
1988-1997 it is believed that the Proconve programme contributed to the avoidance of a
102 CONAMA Resolution 18/86 established PROCONVE and was subsequently complemented by nine 
other resolutions and Federal Law 8723 o f October 1993 (Omarsal and Ganton, 1997).
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considerable number of disease occurrences and deaths in Sao Paulo during that period 
and later. The epidemiologic literature suggests that the reduced exposure to pollutants 
should have reduced the number of respiratory and cardiovascular deaths, hospital 
admissions and other health outcomes. Pinheiro et al (2004) analysed health impacts of 
the PROCONVE program in Sao Paulo during two periods in the nineties -  1991/1994 
and 1997/2000, concluding that the PROCONVE programme contributed to avoiding 
up to 4,500 deaths. To analyse the health impacts of PROCONVE, the authors used air 
quality data (PM io, SO2, CO, O3), minimum temperature, and relative humidity from 
1991 to 2000; mortality data for young children (<2 years) and the elderly (>64 years) -  
total deaths, respiratory deaths and cardiovascular deaths; and a number of 
epidemiologic studies undertaken in Sao Paulo with the respective age groups. In 
addition, that study assumed that most of the benefits from improvement in air quality 
in Sao Paulo during the nineties resulted from the PROCONVE programme.
Table 79: Average emission level for new automobiles in Brazil
Year Fuel type CO (g/km) HC (g/km) NOx (g/km)
Prior to 1980 Gasoline 54 4.7 1.2
1 9 8 6 - 1987 Gasoline 22 2.0 1.9
Ethanol 16 1.6 1.8
1988 Gasoline 18.5 1.7 1.8
Ethanol 13.3 1.7 1.4
1992 Gasoline 6.2 (-78%) 0.6 (-75%) 0.6 (-63%)
Ethanol 3.6 (-79%) 0.6 (-63%) 0.5 (-58%)
1997 Gasoline 1.2 (-96%) 0.2 (-92%) 0.3 (-81%)
Ethanol 0.9 (-95%) 0.3 (-84%) 0.3 (-75%)
2000 Gasoline 0.73 (-97%) 0.13 (-95%) 0.21 (-87%)
Ethanol 0.63 (-96%) 0.18 (-89%) 0.21 (-83%)
2003 Gasoline 0.40 (-98%) 0.11 (-95%) 0.12 (-93%)
Ethanol 0.77 (-95%) 0.16 (-90%) 0.09 (-93%)
Note: (%) refers to t le decrease o f emissions when compared with 1985 vehicles.
Source: Adapted from Ferraz and Seroa da Motta (2001) and IBAMA (2004), “PROCONVE/PROMOT”, 
2nd edition, Brasilia: Colecao Meio Ambiente. Serie Diretrizes -  Gestao Ambiental, 2.
The dose-response functions used to estimate the mortality effect of the 
PROCONVE programme are shown in Table 80. Pinheiro et al. (2004) describes the 
time-series analyses that were carried out, fitting generalized linear Poisson regression 
models for each one of the outcomes and controlling for long-term trend, temperature 
and humidity. The authors adopted a semi-parametric smooth function due to the non­
linear dependence of the adopted endpoints on those covariates. When necessary,
103 Light vehicles for passenger use, light vehicles for commercial use and heavy vehicles.
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autoregressive terms were included in the models to minimize the autocorrelation of the 
residuals. The 95% confidence intervals were estimated assuming normality of the 
residuals.
Table 80: Association between mortality and air pollutants
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Note: 1 interquartile range; 2 (ig/m3.
Source: Adapted from Pinheiro et al. (2004)
The relative risk (RR) of a given endpoint (f) was estimated as the exponential 
of the regression coefficient (ft) of the air pollutant times air pollution concentration 
(MPol):
/UJ(K) = exp(/?*MPol) (112)
Pinheiro et a l (2004) showed that the relative risks of all outcomes decreased 
from the first to the second period, which is expected since air pollutant concentrations 
declined in the 1990s. Relative risks associated with SO2 exposure were those that 
presented the lower decrease reflecting the small change in the pollutant concentration. 
The number of deaths attributed to a given air pollution concentration at a given period 
(t) was given by:
E [Events (MPolt )]= [exp (j$ * (MPolt))-1]* Total Eventst , (113)
where (Total Events) refers to the total number of outcomes (deaths). It was assumed 
that the effects were linear, without thresholds. Table 81 presents the estimated deaths 
attributed to air pollution in the studied periods. SO2 was the pollutant that presented the 
smallest concentration decrease among all primary pollutants. On the other side, its 
concentrations have not reached the standards, neither the daily nor the annual 
standards, since the eighties. Since the number of deaths attributed to SO2 effects in the 
second period was greater than in the first period, there were not any avoided events. 
However, even though the number of events was greater, the percentage contribution of 
SO2 on total, respiratory, and cardiovascular deaths dropped from 1991-1994 to 1997- 
2000 (Pinheiro et a l, 2004).
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Table 81: Avoided mortality events due to the Proconve Programme in Sao Paulo
Total deaths Deaths attributable to air Avoided
pollution Events
1991-1994 1997-2000 1991-1994 1997-2000
Fetal 12,565 11,250
N 0 2 2,945 1,525 1,420
>64
Total 182,320 215,402
PM10 9,973 9,175 798
S 02 11,513 12,091 -578
CO 8,923 5,621 3,302
Respiratory 26,603 31,110
PM10 2,642 2,395 247
S02 1,575 1,638 -63
Cardiovascular 88,019 99,581
S 02 3,301 3,324 -23
CO 3,636 2,197 1,439
Source: Adapted from Pinheiro et al. (2004).
The avoided deaths due to the PROCONVE programme were multiplied by the 
value of a statistical life to produce the mortality benefit of the policy. The authors used 
benefit transfer to estimate the value of a statistical life in Brazil, based on an estimated 
value of a statistical life in the US equal to US$4,800,000 (1990) and income-adjusting 
(purchasing power parity) to Brazil (US$577,243 in 1999 values). Table 82 shows the 
mortality benefit estimates.
Table 82: Mortality values associated with the PROCONVE programme - Sao 
Paulo
Avoided deaths Benefit (US$ 1999)
0-2 years > 64 years 0-2 years > 64 years
N 02 1,420 — 819,685,516 —
PM10 — 798 — 460,640,170
S02 — -578 — -333,646,640
CO — 3,302 — 1,906,057,446
Totals 1,420 3,522 819,685,516 2,033,050,977
Source: Adapted from Pinheiro et al. (2004).
The total number of avoided deaths attributed to the PROCONVE programme in 
Sao Paulo was multiplied by our preferred estimates of the value of a statistical life and 
the corresponding estimates using ‘non-yeah-saying’ respondents, producing different 
estimates of the mortality benefit of the PROCONVE programme. Table 83 shows the 
mortality benefit estimates and the percentage variation of the benefit based on 
transferred estimates (Pinheiro et al. 2004) and the benefit figures using our estimates of 
the value of a statistical life, assuming that estimates based on original stated preference 
methods are preferable to benefit transfer estimates.
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Table 83: Impact of using different mortality values associated with the
PROCONVE programme in Sao Paulo
VSL (US$) Benefit valuation Difference
Pinheiro et al. (2004) 577,243 2,852,736,493 —
Preferable estimate w -  lower value 767,187 3,791,438,154 -24.8%
Preferable estimate -  upper value 1,306,941 6,458,902,422 -55.8%
No ‘yeah-say’ -  lower value 415,831 2,055,036,802 38.8%
No ‘yeah-say’ -  upper value 489,752 2,420,354,384 17.9%
(a) Mean and median estimates o f the WTP for a 5-in-1000 immediate risk reduction.
As can be seen in Table 83, the divergences between mortality benefit estimates 
can be significant. In this example, the observed variation in total benefit is the same 
variation observed in the value of a statistical life since no adjustments were undertaken 
in the value of a statistical life according to sub-groups of the affected population (e.g. 
different age groups).
The accuracy in estimating the health benefits, especially mortality benefits, of 
policies can be determinant in decision making when costs and benefits associated with 
the policy are of the same magnitude or similar to each other. This importance is 
decreased whether the costs and total benefits differ in order of magnitude, as it seems 
that it was the case of the PROCONVE programme in Brazil. Pinheiro et al. (2004) did 
not provide estimates of the implementation costs of the programme but it is unlikely 
that its costs have been measured in billions of dollars. In this case, inaccurate estimates 
of the health benefits would not have an impact in the decision about implementing the 
programme since the cost-benefit ratio is still lower than one (benefits higher than 
costs). However, if this inaccurate cost-benefit ratio of the PROCONVE programme 
had to be compared with the cost-benefit ratio of alternative policies (e.g. health or 
educational projects), the inaccurate benefit estimate could have been responsible for 
the rejection of the programme in favour of another project that presented a better cost- 
benefit ratio.
The PROCONVE programme analysis was ex-post, which means that no 
decision was made based on the results of a cost-benefit analysis. The impact of 
‘wrong’ benefit estimates can be more significant in ex-ante analyses when decisions 
are made whether undertaking the policy or not. Our next case study is an example of an 
ex-ante analysis.
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7.3.3. PITU -  Integrated urban transport programme -  Sao Paulo
Traffic jams are frequent in Sao Paulo during rush hours, contributing 
significantly to the worsening of air quality in the Sao Paulo metropolitan region. The 
economic and fuel loss due to traffic congestion is estimated at US$6.2 million a day 
(Omarsal and Ganton, 1997). Limited integration between the metro and suburban trains 
are also responsible for the traffic jams since it discourages rail-based trips in favour of 
trips by cars and buses. For example, in 1990 about 30 million trips a day were made in 
the metropolitan region of Sao Paulo (Table 84), 10 million of these were walking trips 
and the remaining 20 million trips consisted of cars (40%), buses (38%), metro (14%), 
and metropolitan train (6%,) (Omarsal and Ganton, 1997).
Table 84: Daily trip distribution in the Sao Paulo Metropolitan Region, li190
Mode Trips a day (million) Per cent
Individual motorised transport
Car 8.2 27






Non-motorised transport (on foot) 10.0 33
Total 30.4 100
Source: Omarsal and Ganton, 1997
The Integrated Urban Transport Program -  PITU -  was conceived to plan and 
administer the urban transport sector in the metropolitan region of Sao Paulo. It consists 
of an investment (long-term) plan of urban transportation strategies. Environmental 
issues were among the concerns of the PITU programme. It comprises ongoing 
infrastructure projects aiming to increase integration of the metro and railway systems 
with the road transportation. Also, studies are under way for planning the future in a 
broader scenario -  to the year 2020.
Pinheiro et al. (2004) presented results of the analysis of alternative air quality 
scenarios resulting from emissions projections to 2020 in Sao Paulo, as part of the 
Integrated Environmental Strategies (IES) project in Brazil104. The total implementation 
of the PITU programme comprised one of the scenarios studied. The authors obtained 
the energy and emission inventory for year 2000, the baseline year, including data and 
parameters regarding energy use, population, and economic activities. The analysis
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assumed population growth, increased mobility per capita and the share of public 
transportation, constant economic growth, improved income distribution and efficiency 
in energy use. Using air quality models that combine the emission inventory with 
meteorological data, the authors estimated ambient air quality concentrations under each 
scenario for years 2005, 2010, 2015, and 2020. Finally, the anticipated health impacts 
were estimated using locally derived dose-response functions for each mortality impact 
(total, cardiovascular and respiratory)/pollutant/scenario, as described before in the 
PROCONVE case study.
Table 85: Avoided mortality events attributed to air pollution exposure with full 
implementation of PITU in the metropolitan region of Sao Paulo
(US$1000)
Event Avoideddeaths Lower bound valuation Upper bound valuation
CRM-PMio 116 66,960 92,830
CRM-S02 10 5,772 8,003
CRM-CO 175 101,018 140,045
ETM-PM10 1,625 938,518 1,301,110
e t m -s o 2 162 93,407 129,495
ETM-CO 1,134 655,041 908,113
ERM-PM,o 459 264,348 366,477
ERM-SO2 23 13,123 18,193
ECVDM-SO2 44 24,995 34,652
ECVDM-CO 435 251,173 348,212
Notes: CRM = child respiratory mortality; ETM = elderly total mortality; ERM = elderly respiratory
mortality; ECVDM = elderly cardiovascular mortality.
Source: Adapted from Pinheiro et a l ,  (2004).
Table 85 shows the results for the scenario involving the full implementation of 
the PITU programme in Sao Paulo. The avoided deaths from air pollution related effects 
in the metropolitan region of Sao Paulo from 2000 to 2020 were estimated to equal 
1,800 (the sum of maximum values of child mortality and total elderly mortality). As 
can be seen in Table 85, PM io presented the strongest association with respiratory 
mortality among children and among the elderly, and the elderly total mortality, 
whereas for cardiovascular disease CO was associated with the highest mortality among 
the elderly. The economic valuation used transferred values of a statistical life from the 
US (US$577,243) and Europe -  ExtemE Project (US$800,258). Table 86 shows the 
economic valuation of the mortality impact associated with the PITU programme using 
the estimates of the value of a statistical life generated in the contingent valuation study 
undertaken in Sao Paulo.
104 http://www.epa.gov/ies/brazil.htm
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Table 86: Impact of using different mortality values associated with the full 
_________implementation of the PITU programme in Sao Paulo (2000-2020)
VSL (US$) Benefit valuation (US$ 1000)
CRM-CO
Pinheiro et al. (2004) 
Preferable estimate (a) 
Excluding ‘yeah-saying’





72 ,770 -85 ,707  (52.1%)
ETM-PM jo
Pinheiro et al. (2004) 
Preferable estimate (a) 
Excluding ‘yeah-saying’
577,243 -  800,258 
767,187- 1,306,941 
415,831 -489 ,752
9 3 8 ,5 1 8 - 1,301,110 
1,246,679-2,123,779 (-33.6%) 
675,725 -  795,847 (52.2%)
(a) Mean anc median estimates o f the WTP for a 5-in-1000 immediate risk reduction.
As can be seen in Table 86, the difference on total benefit estimate can be 
significant. When considering the mid-point of the intervals, the total mortality benefit 
estimate reported by Pinheiro et a l (2004) was 33.6% lower than the corresponding 
figure using our preferred set of estimates of the value of a statistical life. On the other 
hand, the estimates used by Pinheiro et a l (2004) in their analysis are 52.1% higher than 
the estimates obtained using the sample where the ‘yeah-saying’ respondents are 
excluded.
Again, Pinheiro et a l (2004) did not provide estimates of the costs involved in 
the analysed projects. In order to provide some basis of comparison, Table 87 shows the 
estimated costs of past and ongoing projects in the Brazilian urban transport sector. 
There were no details on which projects comprise the costs associated with the PITU 
programme, the smallest figure among the projects in Table 87.







Sao Paulo Metro Transport Decentralization (1992) 281.0
Urban Transport Rail II (1980) 312.8
Third Urban Transport (1981) 257.0
Fourth Urban Transport (1987) 468.2
Ongoing
Projects
Sao Paulo Integrated Urban Transport -  PITU (1998) 95.1
Rio Transport Decentralization (1993) 272.0
Rio Mass Transit (1997) 373.0
Belo Horizonte Metropolitan Transport Decentralization (1995) 197.3
Recife Metropolitan Transport Decentralization (1995) 203.8
Salvador Urban Transport (1999) 308.0
(a) US$ millions
Source: Adapted from Kojima and Lovei (2001)
7.4. Conclusions
This Chapter aimed to discuss the relevance of the empirical results obtained in 
this study in terms of policy analysis in Brazil by investigating alternative approaches to 
undertake policy analysis in the absence of estimates of the value of a statistical life 
originally generated in Brazil. The alternative approaches that can provide proxies of
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the value of a statistical life (year) in Brazil and that were investigated were the studies 
of cost-effectiveness of medical interventions, some GDP-based approaches, and the 
benefit transfer methods. In every case the available estimates were compared with our 
results and two study cases highlighted potential divergences among the results when 
different estimates of the value of a statistical life are used.
A limited number of cost-effectiveness studies in Brazil did provide estimates of 
cost per life saved, but the available estimates could not be regarded as fully comparable 
with willingness-to-pay measures, each of them failing to present some of the desired 
characteristics of cost-effectiveness ratios in order to represent willingness to pay. The 
cost-effectiveness results can, at best, be considered as a lower bound for the 
willingness-to-pay estimates. Benefit transfer methods were tested using the UK results 
of an identical contingent valuation survey, which minimised differences in the results 
in terms of study design and statistical methods. The transferred estimates presented 
average transfer errors equal to 69% (full sample) and 63% when the same analysis is 
undertaken excluding the cooperative respondents (No ‘yeah-say’ respondents).
The case studies aimed to compare the results of two recent analyses in Brazil 
that relied on benefit transfer methods with the results using the estimates provided by 
this study, given that it is understood that the accuracy in (ex-ante) estimation of the 
mortality benefits of certain policies can be a determinant of the decision to undertake 
or not the specified policies. The divergences in measuring the mortality benefits of the 
specific projects were significant when our values of a statistical life were used, ranging 
between 24% and 55% in the case of PROCONVE and between 33% and 55% in the 
PITU case study. The divergence between transferred estimates of the value of a 
statistical life (or other similar proxy such as the cost per life saved) and locally derived 
estimates using original studies can be substantially increased when the number of 
fatalities associated with the analysed policies increase. It can be concluded that the 
variance between ‘true’ values of a statistical life and their proxies can be decisive in 
rejecting a ‘good’ policy and/or accepting a ‘bad’ policy, which reinforces the need of 
original stated preference studies and, by extension, the relevance of this study for 
policy making in Brazil in the context of air pollution.
258
8. Conclusion and discussion
Epidemiologic studies suggest that short-term and long-term exposure to 
different levels of air pollutants are positively associated with various health effects, 
including mortality. The adverse health effects of air pollution are currently widely 
accepted among researchers. Recent studies developed in Brazil associating air 
pollution with mortality trends confirm that mortality risks increase when pollutant 
levels increase in Sao Paulo. In order to undertake policy analysis and formulate 
policies that aim to reduce air pollution, policy makers should know how much the 
society evaluates the mortality risk reduction associated with the proposed policies. This 
study has aimed to estimate such benefit in Sao Paulo and provided estimates of the 
value of a statistical life in Brazil. In addition, the effects of respondents’ age and health 
status on the willingness-to-pay estimates were investigated, along with the willingness 
to pay for a risk reduction happening in the future.
This study has explored the different perspectives to establish appropriate 
economic values for changes in risk of death and reviewed the main characteristics, 
advantages and disadvantages of each approach and valuation method. It has used the 
willingness-to-pay approach and the contingent valuation method to elicit the 
population’s willingness to pay for small mortality risk reductions. The study included a 
contingent valuation survey undertaken in Sao Paulo between October 2002 (pilot 
survey) and March 2003 (final survey) that used a survey instrument (questionnaire) 
especially designed to estimate the willingness to pay for reducing an individual’s risk 
of death (Krupnick et a l,  1998, 1999). The survey instrument has been adapted to the 
Brazilian context, allowing the estimation of individuals’ willingness to pay for 
different reductions in probabilities of death. The survey has targeted individuals 
resident in Sao Paulo, aged 40-75 (percentages per age intervals reflecting the city 
population profile), and belonging to A, B and C social classes -  rich and middle class.
The results suggest that the value of a statistical life in Brazil ranges between 
US$0.77 and 6.1 million. The preferred estimates for policy analyses in Brazil range 
between US$0.77 and US$1.31 million. The corresponding value of a statistical life 
year ranged between US$ 61,392 and US$ 159,456. If these numbers were compared 
with similar estimates in other developed countries it seems that these figures are higher 
than would be expected for a middle-income country like Brazil. For example, the 
international literature review of empirical studies, focused on the main willingness-to-
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pay-based methods used to estimate the value of a statistical life, presented values of a 
statistical life ranging between US$0.5 and US$20.8 million in the US based on a meta­
analysis study of ‘compensating-wage’ studies. The review of contingent valuation 
studies using the Krupnick et a l (1998, 1999) methodology resulted in estimates 
ranging between US$0.5 (Canada) and US$7.6 (Italy) million. Averting behaviour 
studies also presented a wide range of estimates -  US$0.77 and US$4.3 million, and 
meta-analyses of studies estimating the value of a statistical life ranged between US$1.5 
and US$5.6 million. From the literature review of international values of a statistical life 
it can be concluded that, although these estimates can be very sensitive to the valuation 
method used, to the dataset used, to the assumptions and statistical methods used in the 
valuation exercise, the Brazilian figures are not so different from those observed in 
developed countries. Given the income differentials between Brazil and industrialised 
countries, it would be expected that our estimates of the value of a statistical life should 
be lower than those estimates in the developed world, even observing that other studies 
in developing countries (e.g. Chesnut et a l , 1997) found that health can be seen as a 
basic necessity so that individuals with lower incomes may be willing to pay a higher 
share of their income to protect their health.
The best explanation for the unexpected high results obtained in Brazil refers to 
the ‘cooperative’ or ‘yeah-saying’ behaviour observed in part of the respondents since a 
bias might have been introduced by the use of an incentive payment to each respondent 
for his or her participation in the survey. Several comments made by respondents to the 
effect that they were keen to take part in the survey and other such surveys provided the 
evidence of the ‘yeah-say’ bias. It is possible that respondents might have tried to be 
‘cooperative’ or helpful by saying ‘yes’ to every question. This ‘yeah-saying’ behaviour 
has been observed in several contingent valuation studies using the dichotomous choice 
format of the willingness-to-pay questions (e.g. Ready et al., 1986).
Estimates using a sub-sample where the ‘yeah-say’ respondents were excluded 
showed that the willingness-to-pay results are much smaller than those using the full 
sample, implying a value of a statistical life equal to US$0.49 million (mean) and 
US$0.41 million (median) for a 5-in-1000 immediate risk reduction (full range between 
US$0.41 and US$2.41 million). The value of a statistical life year ranged between 
US$34,729 and US$62,944. The mean value of a statistical life estimate, for example, 
corresponds to approximately half the estimate for Canada, one-fifth of the US and the 
UK figures, and almost one-sixth of the Italian result. The Brazilian ‘no yeah-say’
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figures are, therefore, more in line with the results that would be expected from 
mortality risk valuation exercises undertaken in developing country.
However, these results must be taken carefully since it was not possible to 
distinguish genuine ‘yes’ responses (those obtained after an implicit utility maximising 
process constrained by income) from ‘yeah-say’ respondents. As a result, it cannot be 
claimed with certainty that the ‘no yeah-say’ figures are more representative of the 
Brazilian society’s preferences than those using the full sample, although the 
comparison of results between developed and developing countries may suggest it. The 
exclusion of possible ‘yeah-saying’ respondents aimed to highlight the impact that this 
type of bias can have on the value of a statistical life. This caveat can be regarded as a 
possible improvement for future contingent valuation studies in Brazil and other 
developing countries, in order to test whether this behaviour can be generalised and 
regarded as a typical middle and low-income country phenomenon.
No age effect on the willingness-to-pay estimates for small risk reductions in 
Brazil could have been identified from the samples and sub-samples available in this 
study. The coefficients of the age variable in different models explaining the 
willingness-to-pay responses were always not statistically significant at the usual levels. 
Mean and median willingness to pay for different age groups were estimated using the 
constant-only approach, which in theory is not affected by regressors, presented no 
consistent pattern between samples and sub-samples. The result reinforces the 
conclusion that no significant age effect exists in the Brazilian estimates, which is a 
similar result than those observed in the US, France and the UK.
No significant cancer, respiratory or cardiovascular disease effect on 
willingness-to-pay responses could be identified in the Brazilian results given the lack 
of statistical significance of the coefficients in several regressions. Also, hospital 
admission and emergency-room visit had no significant effect on willingness to pay. A 
relevant result regards the statistically significant effect of the physical function on the 
willingness to pay for mortality risk reduction; a consistent result observed in all sub­
samples both using the final and the pilot sample. The positive sign of the parameter 
suggests that the healthier the respondent feels (physically) the more this respondent 
would like to pay for a reduction in his or her risk of dying. The positive health status 
effect on willingness to pay was similar to the impact observed in the US and European 
studies, although for different health aspects.
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Willingness-to-pay estimates for a reduction in risk of dying that happens in the 
future were not consistent with theory when some sub-samples were used, that is, 
results were not smaller than the corresponding willingness to pay for a risk reduction of 
the same magnitude that occurs immediately. However, when individuals who 
inconsistently answered the willingness-to-pay questions were removed from the 
sample the results were in accordance with theory. It has been shown that the 
‘cooperative behaviour’ demonstrated by a significant share of respondents has had an 
impact on the willingness to pay for a risk reduction that happens in the future. When 
the ‘yeah-say’ respondents were removed from the sample (‘no yeah-say’ sample) all 
the results were in accordance with theory.
The relevance of the empirical results obtained in this study in terms of policy 
analysis in Brazil was investigated by examining alternative approaches to undertake 
policy analysis in the absence of estimates of the value of a statistical life originally 
generated using the established valuation methods. These alternative approaches 
investigated were the cost-effectiveness of medical interventions, some GDP-based 
approaches, and the benefit transfer method. Few appropriate cost-effectiveness studies 
were available in Brazil and the provided estimates could not be regarded as fully 
comparable with willingness-to-pay measures. Benefit transfer methods, which are the 
most used techniques in developing countries as an alternative to undertaken proper 
valuation exercises, presented average transfer errors equal to 69% (full sample) and 
63% when the same analysis is undertaken excluding the cooperative respondents. The 
difference is significant if it is considered that similar exercise undertaken within 
European countries presented an average transfer error equal to 38% (Ready et a l, 
2004). No benefit transfer method could have been identified as preferable in case an 
original valuation study would not be possible in Brazil.
Two recent Brazilian case studies compared the results obtained by using benefit 
transfer methods with the results using the estimates obtained in the contingent 
valuation exercise undertaken in this study, highlighting potential divergences arising 
when different estimates -  transferred and locally derived estimates -  of the value of a 
statistical life are used. The divergences in measuring the mortality benefits of the 
specific projects were significant when our values of a statistical life were used, ranging 
between 24% and 55% in one case study and between 33% and 55% in another. It 
suggests that the benefit transfer errors of the value of a statistical life can have a 
substantial impact in the cost-benefit analysis if the number of fatalities associated with
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the analysed policy is high. Given that the mortality effects of policies that aim to 
reduce air pollution correspond to a significant share of the total effects, the impact of 
benefit transfer errors can result in inaccurate policy analysis and mistaken decisions 
whether implementing or not these policies.
In summary, the main contribution of this research to the literature relates to the 
usefulness of its findings for future designing and implementation of valuation exercises 
undertaken in Brazil and other developing countries in the context of mortality risks 
associated with air pollution. First, it seems that paying respondents in cash as an 
incentive for their participation in the survey can be associated with their ‘cooperative’ 
behaviour. Further research is necessary to formally test the existence of such bias in 
Brazil and other developing countries, and determine better survey designs that can 
minimise the possibility of ‘yeah-saying’ behaviour among the respondents. Second, it 
seems that it was rather difficult for respondents in Sao Paulo to understand the concept 
of probability and distinguish between different small risk reductions given the high 
percentage of wrong answers to the probability tests undertaken in the survey. In the 
future other procedures must be tested in order to better explain and test the concept of 
risks, especially for the share of the population with lower education levels. Third, it is 
important to understand why willingness-to-pay values for different risk levels do not 
observe the desirable characteristic of non-strict proportionality between risk sizes and, 
consequently, not behaving consistently with expectations. It may be related either to 
the misunderstanding of the concept of risk reduction or to the ‘yeah-saying’ behaviour 
in Brazil. However, it seems that this is a wider problem since the lack of 
proportionality between willingness-to-pay estimates has also been observed in all 
contingent valuation studies in the context of air pollution in developed countries.
Finally, it is pertinent to discuss how the literature on mortality risk valuation in 
the context of air pollution has moved on since the beginning of this research and in 
which direction it possibly will go. At the beginning of this research (2001), the 
methodology developed by Krupnick et a l (1999, 2001) and used in this research could 
be regarded as the state-of-the-art methodology to estimate individuals’ willingness to 
pay for a mortality risk reduction similar to those observed in the air pollution context. 
The authors aimed to overcome problems associated with using estimates of the value 
of a statistical life generated in a context other than the air pollution context, such as 
transport fatalities and work-place accidents. Examples of these problems are the 
average age of the mainly affected population in different contexts, the risk size
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experienced in those contexts and the latency problem associated with some pollutants. 
However, as technology developed and recent epidemiologic studies provided a better 
understanding of the physical effect of air pollution on the human health, an important 
discussion has dominated the literature: the usefulness of the value of a statistical life as 
the most appropriate metric for evaluating deaths associated with exposure to air 
pollutants when compared with the more recent concept of the value of a statistical life 
year (VSLY). This discussion has motivated a number of seminars, expert meetings105 
and studies to elaborate recommendations for policy analysis in the context of air 
pollution106.
It seems that there is a trend in the recent literature to accept the value of a 
statistical life year as the most important metric for policy making in the context of air 
pollution, although there is still no consensus among researchers, especially between 
European and North American researchers. The main argument underlying this 
discussion is the claim that the relevant health impacts that can be associated with air 
pollution increase (the chronic effects) are primarily expressed in changes in life 
expectancy or years of life lost instead of the number of deaths. In addition, the acute or 
short-term mortality effects of air pollution are deaths of the elderly, which have fewer 
life years lost at the moment of their deaths than younger individuals. In this sense, the 
value of a statistical life year is claimed to be more appropriate for policy analysis in the 
context of air pollution than the value of a statistical life, a statistic that refers to all 
individuals in the society, independently of age groups.
However, as shown in the empirical literature review, most of the values of a 
statistical life year available in the literature have been derived from existing estimates 
of the value of a statistical life. Alternatively, as undertaken in this study, these 
estimates have been derived from respondents’ willingness-to-pay values for a small 
risk reduction, which is different from asking respondents to explicitly state their 
willingness to pay for an increase in their life expectancy. It seems that future research 
on mortality in the context of air pollution will go in the direction of an increasing 
number of studies investigating the value of a statistical life year directly using stated 
preference methods.
105 For example, the UK Health Valuation Workshop held by DEFRA in June 2004.
106 E.g. the UK government’s Interdepartmental Group on Costs and Benefits (IGCB) report on the 
valuation o f health benefits associated with reductions in air pollution (2004).
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10. Annexes
10.1. General structure of the questionnaire
• Initial comments about the survey;
• Respondent’s age and gender;
• Occurrence of cancer, cardiac and respiratory diseases in the respondent’s 
family and his or her own;
• Illustrates the concept of probabilities;
• Presents baseline risks per age and gender;
• Examples of life-saving activities and associated costs;
• Probability tests of comprehension;
• Willingness-to-pay questions:
o WTP for a 5-in-1000 risk reduction in the next ten years, follow-up 
question and open-ended question to elicit the maximum WTP for the 
risk reduction;
o WTP for a 1-in-1000 risk reduction in the next ten years, follow-up 
question and open-ended question to elicit the maximum WTP for the 
risk reduction;
o WTP for a 5-in-1000 risk reduction in the future, follow-up question 
and open-ended question to elicit the maximum WTP for the risk 
reduction;
• Debriefing questions of the questionnaire and the good being valued;
• SF-36 questions (physical and mental health status);
• Socio-economic questions (e.g. income, marital status, education);
• Confirmation or update of WTP values.
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10.2. T-tests of equality of mean values between pilot and final samples
. use c:\MortalityBrazil\Pooleddata\Pooled592.dta;
. ttest sexe, by(sample); /* Gender: l=man 2=woman */;
Two-sample t test with equal variances
Group |
_____ -f-_









.4982489 1.492937 1.609537 
.497588 1.500935 1.612333
combined | 592 1.554054 .0204467 .4974899 1.513897 1.594211
diff | -.0053976 .040967 -.0858564 .0750613
Degrees o f freedom: 590
Ho: mean(fmal) - mean(pilot) = diff = 0 
Ha: d iff < 0 Ha: d iff ~= 0 Ha: diff > 0
t=  -0.1318 t=  -0.1318 t=  -0.1318
P < t =  0.4476 P > |t| = 0.8952 P > t =  0.5524
. ttest age, by(sample); /* Age of respondent */;
Two-sample t test with equal variances
Group | 
______




283 56.02827 .5624405 
309 57.33981 .5863732
9.461713 54.92115 57.13538 
10.3075 56.186 58.49361
combined | 592 56.71284 .4079373 9.925542 55.91165 57.51402
______
diff | -1.311537 .8155689 -2.913309 .2902342
Degrees o f freedom: 590
Ho: mean(fmal) - mean(pilot) = d iff = 0 
Ha: d iff < 0  H a :d iff~ = 0  Ha: diff > 0
t=  -1.6081 t=  -1.6081 t=  -1.6081
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P < t =  0.0542 P > |t |=  0.1083 P > t =  0.9458
. ttest educ, by (sample); /* Years of education */;
Two-sample t test with equal variances




283 7.64311 .2480648 
309 9.252427 .2593259
4.173096 7.154816 8.131403 
4.558534 8.742153 9.762702
____
combined | 592 8.483108 .18282 4.448204 8.124052 8.842164
_____
diff | -1.609318 .3602616 -2.316869 -.9017664
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = d iff = 0 
Ha: d iff < 0  Ha: d iff ~= 0 Ha: d iff > 0
t =  -4.4671 t =  -4.4671 t=  -4.4671
P < t =  0.0000 P > |t| = 0.0000 P > t =  1.0000
. ttest incomei, by(sample); I* Individual income */;
Two-sample t test with equal variances
Group | Obs Mean Std. Err. Std. Dev. [95% Conf. Interval]
 +---------------------------------------------------------------------
final | 283 844.8174 67.77983 1140.233 711.3988 978.236
pilot | 309 1902.697 135.9523 2389.824 1635.184 2170.21
 +---------------------------------------------------------------------
combined | 592 1396.988 80.92062 1968.884 1238.061 1555.915
 +---------------------------------------------------------------------
diff | -1057.879 156.1758 -1364.608 -751.1512
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = d iff = 0 
Ha: d iff < 0  H a :d iff~ = 0  H a:d iff > 0
t = -6.7736 t = -6.7736 t = -6.7736
P < t =  0.0000 P > Itl = 0.0000 P > t =  1.0000
. ttest fumeur, by(sample); /* If respondent smokes: l=yes 2=no */;
Two-sample t test with equal variances
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283 1.706714 .0271108 
309 1.805825 .0225394
.456075 1.653348 1.760079 
.3962057 1.761475 1.850176
combined | 592 1.758446 .0176066 .4283873 1.723867 1.793025
______
diff | -.0991115 .0350403 -.1679304 -.0302925
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = d iff= 0 
Ha: diff < 0 Ha: d iff ~= 0 Ha: diff > 0
t=  -2.8285 t=  -2.8285 t=  -2.8285
P < t =  0.0024 P > | t | =  0.0048 P > t =  0.9976
. ttest religion, by(sample); /* Religion: l=very religious...5=not at all */;
Two-sample t test with equal variances




283 1.971731 .0541228 
309 2.071197 .0451992
.9104863 1.865196 2.078267 
.7945301 1.982259 2.160136
combined | 592 2.023649 .0350439 .8526548 1.954823 2.092474
_____
diff | -.099466 .0700954 -.2371328 .0382009
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0 
Ha: diff < 0  Ha: d iff ~= 0 Ha: diff > 0
t=  -1.4190 t=  -1.4190 t=  -1.4190
P < t =  0.0782 P > | t | =  0.1564 P > t =  0.9218
. ttest mutuelle, by(sample); /* Health insurance: l=yes 2=no */;
Two-sample t test with equal variances
Group | Obs Mean Std. Err. Std. Dev. [95% Conf. Interval]
 +--------------------------------------------------------------------
final! 283 1.561837 .029546 .4970403 1.503679 1.619996
287
pilot | 309 1.33657 .0269253 .4733027 1.283589 1.38955
 +---------------------------------------------------------------------
combined | 592 1.444257 .020439 .4973032 1.404115 1.484399
 +--------------------------------------------------------------------
d iff | .2252679 .0398883 .1469276 .3036082
Degrees o f freedom: 590
Ho: mean(final) - mean(piiot) = d iff = 0 
Ha: d iff < 0  H a : d i f f ~ = 0  Ha: d iff > 0
t =  5.6475 t=  5.6475 t=  5.6475
P < t =  1.0000 P > | t | =  0.0000 P > t =  0.0000
. ttest marital, by(sample); /* Marital status: l=married 0=otherwise */;
Two-sample t test with equal variances




283 .6537102 .0283327 
309 .6569579 .02705
.4766297 .5979398 .7094807 
.4754954 .6037318 .7101841
___ ___
combined | 592 .6554054 .0195486 .4756378 .6170122 .6937986
_____
diff | -.0032477 .0391679 -.0801731 .0736777
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = d iff = 0 
Ha: d iff < 0  Ha: d iff~=  0 Ha: d iff > 0
t =  -0.0829 t=  -0.0829 t=  -0.0829
P < t =  0.4670 P > | t | =  0.9339 P > t =  0.5330
. ttest enfants, by(sample); /* Kids: l=yes 2=no */;
Two-sample t test with equal variances
Group | Obs Mean Std. Err. Std. Dev. [95% Conf. Interval]
 +---------------------------------------------------------------------
final | 283 1.102473 .0180595 .3038072 1.066925 1.138022
pilot | 309 1.067961 .0143408 .2520875 1.039743 1.096179
 +---------------------------------------------------------------------
combined | 592 1.084459 .0114385 .2783108 1.061994 1.106925
 + ---------------------------------------------------------------------------------
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diff | .0345123 .0228744 -.0104129 .0794375
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = d iff = 0 
Ha: diff < 0 Ha: d iff ~= 0 Ha: diff > 0
t=  1.5088 t=  1.5088 t=  1.5088
P < t =  0.9341 P > |t| = 0.1319 P > t =  0.0659
. ttest etatsant, by(sample); /* Subjective health status l=good...5=bad */;
Two-sample t test with equal variances
Group | Obs Mean Std. Err. Std. Dev. [95% Conf. Interval]
final | 
pilot |
283 1.819788 .0505352 
309 1.831715 .0459846
.8501339 1.720314 1.919262 
.8083356 1.741231 1.922199
_____
combined | 592 1.826014 .0340264 .827897 1.759186 1.892841
diff | -.0119272 .0681744 -.1458212 .1219668
Degrees o f freedom: 590
Ho: mean(fmal) - mean(pilot) = diff = 0 
Ha: diff < 0 Ha: d iff ~= 0 Ha: diff > 0
t =  -0.1750 t=  -0.1750 t=  -0.1750
P < t =  0.4306 P > | t | =  0.8612 P > t =  0.5694
. ttest cancerh, by(sample); /* History of cancer: l=yes 0=no */;
Two-sample t test with equal variances




283 .3286219 .027971 
309 .3559871 .0272828
.4705443 .2735636 .3836803 
.479588 .3023028 .4096713
combined 
_____ « . + —
| 592 .3429054 .0195257 .4750816 .3045571 .3812537
diff | -.0273651 .0391061 -.1041692 .0494389
Degrees o f freedom: 590
Ho: mean(fmal) - mean(pilot) = diff = 0
289
Ha: d iff < 0 Ha: d iff ~= 0 Ha: d iff > 0
t=  -0.6998 t=  -0.6998 t=  -0.6998
P < t =  0.2422 P > |t| = 0.4843 P > t =  0.7578
. ttest respirat, by(sample); /* Respiratory diseases: l=yes 0=no */;
Two-sample t test with equal variances













| 592 .3310811 .019358 .4710001 .2930623 .3690999
diff | -.0250209 .0387725 -.1011698 .0511281
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = d iff = 0 
Ha: d iff < 0  H a : d i f f ~ = 0  Ha: d iff > 0
t =  -0.6453 t=  -0.6453 t=  -0.6453
P < t =  0.2595 P > | t | =  0.5190 P > t =  0.7405
. ttest cardiac, by(sample); /* Cardiovascular diseases: l=yes 0=no */;
Two-sample t test with equal variances




283 .6360424 .0286513 
309 .6245955 .0275914
.481989 .5796449 .6924399 
.4850126 .570304 .678887
combined | 592 .6300676 .0198592 .4831944 .5910644 .6690707
diff | .0114469 .0397876 -.0666956 .0895895
Degrees o f  freedom: 590
Ho: mean(final) - mean(pilot) = d iff = 0 
Ha: d iff < 0 Ha: d iff ~= 0 Ha: d iff > 0
t=  0.2877 t=  0.2877 t=  0.2877
P < t =  0.6132 P > | t | =  0.7737 P > t =  0.3868
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. ttest erhosp, by(sample); /* Emergency room or hospital admission */;
Two-sample t test with equal variances




283 .204947 .0240378 
309 .1585761 .0208138





| 592 .1807432 .0158288 .3851307 .1496558 .2118307
diff | .0463709 .0316575 -.0158041 .108546
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0 
Ha: diff < 0 Ha: d iff ~= 0 Ha: d iff>  0
t =  1.4648 t =  1.4648 t=  1.4648
P < t =  0.9282 P > | t | =  0.1435 P > t =  0.0718
. ttest agedcs, by(sample); /* Subjective age of death: l=sooner...9=later */;
Two-sample t test with equal variances
Group | 
______




283 5.491166 .1138663 
309 5.601942 .0990667




| 592 5.548986 .0750486 1.82601 5.401592 5.696381
diff | -.1107757 .1503002 -.4059642 .1844128
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0 
Ha: diff < 0 Ha: d iff ~= 0 Ha: d iff > 0
t =  -0.7370 t =  -0.7370 t=  -0.7370
P < t =  0.2307 P > |t| = 0.4614 P > t =  0.7693
. ttest comprhen, by(sample); /* Subjective comprehension of probability */;
Two-sample t test with equal variances






283 4 .0764144 1.285489 3.849585 4.150415 
309 4.236246 .0641582 1.127798 4.110002 4.36249
combined | 592 4.123311 .0497512 1.2105 4.0256 4.221022
_____
diff [ -.236246 .0992073 -.4310884 -.0414035
Degrees o f  freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0 
Ha: d iff < 0 Ha: d iff ~= 0 Ha: diff > 0
t=  -2.3813 t=  -2.3813 t=  -2.3813
P < t =  0.0088 P > | t | =  0.0176 P > t =  0.9912
. ttest croyance, by(sample); /* If accepted baseline risk as his/her own */;
Two-sample t test with equal variances
Group | Obs Mean Std. Err. Std. Dev. [95% Conf. Interval]
 +---------------------------------------------------------------------
final | 283 1.222615 .0247725 .4167387 1.173852 1.271377
pilot | 309 1.187702 .0222493 .3911076 1.143922 1.231482
 +---------------------------------------------------------------------
combined | 592 1.204392 .0165878 .4035976 1.171814 1.23697
 +---------------------------------------------------------------------
diff | .0349126 .0332046 -.030301 .1001262
Degrees o f freedom: 590
Ho: mean(fmal) - mean(pilot) = diff = 0 
Ha: d iff < 0 Ha: d iff ~= 0 Ha: d iff > 0
t=  1.0514 t=  1.0514 t=  1.0514
P < t =  0.8533 P > |t| = 0.2935 P > t =  0.1467
. ttest fdoutes, by(sample); /* Doubts about efficacy of proposed good */;
Two-sample t test with equal variances
Group |
_____-f-_
















combined | 592 .3699324 .0198592 .4831944 .3309293 .4089356
 +--------------------------------------------------------------------
diff | -.0114469 .0397876 -.0895895 .0666956
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0 
Ha: diff < 0  H a : d i f f ~ = 0  Ha: diff > 0
t=  -0.2877 t =  -0.2877 t=  -0.2877
P < t =  0.3868 P > |t| = 0.7737 P > t =  0.6132
. ttest feffets, by (sample); /* If considered side effects */;
Two-sample t test with equal variances
Group | Obs Mean Std. Err. Std. Dev. [95% Conf. Interval]
final | 
pilot |
283 .360424 .0285909 
309 .3398058 .0269883
.480974 .3041453 .4167028 
.4744114 .286701 .3929106
_____
combined | 592 .3496622 .0196155 .4772665 .3111375 .3881868
diff) .0206182 .0392931 -.0565531 .0977895
Degrees o f  freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0
Ha: diff < 0 Ha: d iff ~= 0 Ha: diff > 0
t=  0.5247 t=  0.5247 t=  0.5247
P < t =  0.7000 P > | t | =  0.6000 P > t =  0.3000
. ttest ffinance, by(sample); /* If considered his/her finances */
Two-sample t test with equal variances
Group | Obs Mean Std. Err. Std. Dev. [95% Conf. Interval]
 +--------------------------------------------------------------------
final | 283 .7137809 .0269158 .4527937 .6607996 .7667623
pilot | 309 .7572816 .0244289 .4294217 .7092128 .8053503
 +--------------------------------------------------------------------
combined | 592 .7364865 .0181213 .440911 .7008964 .7720765
 +--------------------------------------------------------------------
diff I -.0435006 .0362642 -.1147233 .027722
293
Degrees o f freedom: 590
Ho: mean(fmal) - mean(pilot) = d iff = 0 
Ha: d iff < 0 Ha: d iff ~= 0 Ha: d iff > 0
t =  -1.1995 t =  -1.1995 t=  -1.1995
P < t =  0.1154 P > | t | =  0.2308 P > t =  0.8846
. ttest fautres, by(sample); /* If benefited other members of family */;
Two-sample t test with equal variances




283 .4840989 .0297595 
309 .4822006 .0284721
.5006324 .42552 .5426779 
.5004936 .4261762 .5382251
_____
combined | 592 .4831081 .0205555 .5001372 .4427374 .5234788
_____
diff | .0018983 .0411855 -.0789898 .0827863
Degrees o f  freedom: 590
Ho: mean(final) - mean(pilot) = d iff = 0 
Ha: d iff < 0 Ha: d iff ~= 0 Ha: d iff > 0
t =  0.0461 t =  0.0461 t=  0.0461
P < t =  0.5184 P > |t| = 0.9633 P > t =  0.4816
. ttest mhs, by(sample); /* Mental health score: 0-100 */;
Two-sample t test with equal variances
Group |
___________ - j - _ .







17.54324 63.79886 67.90432 
18.61903 65.73459 69.90295
combined | 592 66.87838 .7448994 18.12418 65.41541 68.34135
diff | -1.96718 1.490302 -4.894122 .9597621
Degrees o f  freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0 
Ha: d iff < 0  H a : d i f f ~ = 0  Ha: d iff > 0
t =  -1.3200 t =  -1.3200 t=  -1.3200
294
P < t =  0.0937 P > |t| = 0.1874 P > t =  0.9063
. ttest pfs, by(sample); /* Physical function score: 0-100 */;
Two-sample t test with equal variances
Group |
______












| 592 75.28716 1.096169 26.67093 73.1343 77.44002
diff [ -5.830617 2.183157 -10.11832 -1.542913
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0
Ha: diff < 0 Ha: d iff ~= 0 Ha: diff > 0
t=  -2.6707 t=  -2.6707 t=  -2.6707
P < t =  0.0039 P > | t | =  0.0078 P > t =  0.9961
. ttest rps, by(sample); /* Role limitation physical score: 0-100 */;
Two-sample t test with equal variances
Group | Obs Mean Std. Err. Std. Dev. [95% Conf. Interval]
 +--------------------------------------------------------------------
final | 283 77.0318 2.198421 36.98316 72.7044 81.3592
pilot | 309 81.39159 1.99951 35.14818 77.45716 85.32601
 +--------------------------------------------------------------------
combined | 592 79.30743 1.482563 36.07231 76.3957 82.21917
 +--------------------------------------------------------------------
diff | -4.359784 2.965076 -10.18317 1.463604
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0 
Ha: d iff < 0 Ha: d iff ~= 0 Ha: diff > 0
t=  -1.4704 t=  -1.4704 t=  -1.4704
P < t =  0.0710 P > | t | =  0.1420 P > t =  0.9290
. ttest ps, by(sample); /* Pain score: 0-100 */;
















| 592 83.10811 .819182 19.93156 81.49925 84.71697
diff | -1.561835 1.640076 -4.782932 1.659262
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0 
Ha: d iff < 0 Ha: d iff ~= 0 Ha: d iff > 0
t =  -0.9523 t=  -0.9523 t=  -0.9523
P < t =  0.1707 P > |t| = 0.3413 P > t =  0.8293
. ttest ghps, by(sample); /* General health perception score: 0-100 */;
Two-sample t test with equal variances
Group | 
_____








15.91959 65.68142 69.40692 
15.55511 68.48532 71.96775
combined | 592 68.94426 .6483142 15.77417 67.67098 70.21754
_____
diff | -2.682368 1.294278 -5.224319 -.1404158
Degrees o f  freedom: 590
Ho: mean(fmal) - mean(pilot) = d iff = 0 
Ha: d if f< 0  H a : d i f f ~ = 0  H a : d i f f > 0
t =  -2.0725 t=  -2.0725 t=  -2.0725
P < t =  0.0193 P > | t | =  0.0387 P > t =  0.9807
. ttest evs, by(sample); /* Energy vitality score: 0-100 */;
Two-sample t test with equal variances
Group | Obs Mean Std. Err. Std. Dev. [95% Conf. Interval]
 +---------------------------------------------------------------------
final! 283 62.61484 .9369854 15.76253 60.77047 64.45921
296
pilot | 309 63.33333 .9140595 16.0677 61.53474 65.13192
----------------------+ —
combined | 592 62.98986 .6540264 15.91315 61.70537 64.27436
diff | -.7184923 1.310091 -3.291502 1.854518
Degrees of freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0 
Ha: diff < 0 Ha: d iff ~= 0 Ha: diff > 0
t=  -0.5484 t=  -0.5484 t=  -0.5484
P < t =  0.2918 P > | t | =  0.5836 P > t =  0.7082
. ttest sfs, by(sample); /* Social functioning score: 0-100 */;
Two-sample t test with equal variances







17.59245 72.6176 76.73458 
15.68233 74.54803 78.05894
_____
combined | 592 75.52552 .6834294 16.62856 74.18328 76.86777
diff | -1.627398 1.367698 -4.313547 1.058751
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = diff = 0 
Ha: diff < 0 Ha: d iff ~= 0 Ha: diff > 0
t=  -1.1899 t=  -1.1899 t=  -1.1899
P < t =  0.1173 P > | t | =  0.2346 P > t =  0.8827
. ttest res, by(sample); /* Role limitation emotional score: 0-100 */;
Two-sample t test with equal variances
Group | Obs Mean Std. Err. Std. Dev. [95% Conf. Interval]
 +--------------------------------------------------------------------
final | 283 76.32509 2.037718 34.27973 72.31402 80.33616
pilot | 309 81.5534 1.841193 32.36521 77.93049 85.1763
 +--------------------------------------------------------------------
combined | 592 79.05405 1.371432 33.36838 76.36058 81.74753
 +--------------------------------------------------------------------
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diff |  -5.22831 2.739395 -10.60846 .1518424
Degrees o f freedom: 590
Ho: mean(final) - mean(pilot) = d iff = 0 
Ha: d iff < 0  H a :d i f f ~ = 0  Ha: diff > 0
t=  -1.9086 t=  -1.9086 t=  -1.9086
P < t =  0.0284 P > | t | =  0.0568 P > t =  0.9716
. ttest chs, by(sample); /* Change in health score: 0-100 */;
Two-sample t test with equal variances
Group | 
+ .












| 592 58.57264 .9273294 22.5629 56.75137 60.3939
diff | -2.715073 1.854657 -6.357607 .9274607
Degrees o f freedom: 590
Ho: mean(fmal) - mean(pilot) = diff = 0 
Ha: d iff < 0  Ha: d iff ~= 0 Ha: diff > 0
t=  -1.4639 t =  -1.4639 t=  -1.4639
P < t =  0.0719 P > |t| = 0.1437 P > t =  0.9281
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10.3. Non-parametric estimation of WTP using the responses to the 
follow-up questions
This section is based on Carson et a l (2003) and Terawaki (2003), which 
describe the procedure to estimate the non-parametric Turnbull estimator using 
the answers to the double-bound dichotomous choice questions. The initial task 
involves estimating the frequency of each possible combination of responses for 
all bid values107. Table 88, Table 89 and Table 90 present the results in 
percentages, as proposed in Carson et al. (2003).
Table 88: Percentage of responses per type of response -  5-in-1000 immediate risk 
reduction
Bid Yes -Yes Yes - No No -  Yes N o - N o Total
Total sample
240 56.94 20.83 5.56 16.67
oo
600 53.03 15.15 6.06 25.76 100
1,800 54.79 12.33 5.48 27.40 100
2,700 45.83 13.89 9.72 30.56 100
FlagO = 0
240 57.41 18.52 5.56 18.52 100
600 44.19 18.60 2.33 34.88 100
1,800 53.85 5.77 3.85 36.54 100
2,700 41.67 8.33 4.17 45.83 100
Flag4 = 0
240 56.25 21.88 3.13 18.75 100
600 53.45 13.79 6.90 25.86 100
1,800 53.13 12.50 6.25 28.13 100
2,700 49.23 13.85 10.77 26.15 100
Table 89: Percentage of responses per type of response -  l-in-1000 immediate risk 
reduction
Bid Yes -Y es Yes - No N o - Y e s  N o - N o Total
Total sample
240 58.33 12.50 12.50 16.67 100
600 37.88 13.64 13.64 34.85 100
1,800 36.99 6.85 12.33 43.84 100
2,700 44.44 9.72 4.17 41.67 100
FlagO = 0
240 51.85 14.81 12.96 20.37 100
600 23.26 11.63 16.28 48.84 100
1,800 25.00 1.92 13.46 59.62 100
2,700 35.42 4.17 0.00 60.42 100
Flag4 = 0
240 56.25 12.50 14.06 17.19 100
600 43.10 10.34 13.79 32.76 100
1,800 40.63 4.69 14.06 40.63 100
2,700 47.69 10.77 4.62 36.92 100
107 The complete structure and sequence o f the bid values used was presented in Table 29.
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Table 90: Percentage of responses per type of response -  5-in-1000 risk reduction 
in the future
Bid Yes -Y es Yes - No N o - Y e s N o - N o Total
Total sample
240 57.78 13.33 11.11 17.78 100
600 51.22 9.76 9.76 29.27 100
1,800 47.62 9.52 2.38 40.48 100
2,700 47.06 7.84 7.84 37.25 100
FlagO = 0
240 54.29 11.43 14.29 20.00 100
600 33.33 8.33 16.67 41.67 100
1,800 41.38 6.90 3.45 48.28 100
2,700 45.95 8.11 8.11 37.84 100
Flag4 = 0
240 60.00 12.50 12.50 15.00 100
600 56.76 8.11 8.11 27.03 100
1,800 51.35 10.81 2.70 35.14
oo
2,700 50.00 8.33 8.33 33.33 100
Table 91, Table 92 and Table 93 present the results of the Turnbull estimation of 
the probability that the underlying willingness-to-pay value is greater than the upper 
bound value of each interval, and the corresponding change in the density function.
Table 91: Turnbull estimation results -  5-in-1000 immediate risk reduction
Interval Total sample FlagO = 0 Flag4 = 0
A B A B A B
0-120 0.833 0.167 0.815 0.185 0.813 0.188
120-240 0.761 0.072 0.711 0.103 0.762 0.050
240-600 0.659 0.102 0.611 0.101 0.651 0.112
600-1800 0.635 0.024 0.531 0.079 0.647 0.003
1800-2700 0.572 0.063 0.520 0.011 0.581 0.066
2700-3600 0.458 0.114 0.417 0.103 0.492 0.089
3600-infinite 0.000 0.458 0.000 0.417 0.000 0.492
Notes: A = Probabi ity o f WTP being greater than upper bound o f interval; B = Change in density
Table 92: Turn mil estimation results -  l-in-1000 immediate risk reduction
Interval Total sample FlagO = 0 Flag4 = 0
A B A B A B
0-120 0.833 0.167 0.796 0.204 0.828 0.172
120-240 0.681 0.152 0.598 0.198 0.680 0.148
240-600 0.555 0.127 0.430 0.168 0.565 0.116
600-1800 0.469 0.085 0.301 0.129 0.508 0.056
1800-2700 0.455 0.014 0.320 -0.019 0.496 0.012
2700-3600 0.444 0.011 0.354 -0.034 0.477 0.019
3600-infinite 0.000 0.444 0.000 0.354 0.000 0.477
Notes: A = Probabi ity o f WTP being greater than upper bound o f interval; B = Change in density
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Table 93: Turnbull estimation results -  5-in-1000 risk reduction in the future
Interval Total sample FlagO = 0 Flag4 = 0
A B A B A B
0-120 0.822 0.178 0.800 0.200 0.850 0.150
120-240 0.709 0.113 0.627 0.173 0.727 0.123
240-600 0.594 0.116 0.500 0.127 0.632 0.096
600-1800 0.575 0.019 0.500 0.000 0.623 0.009
1800-2700 0.516 0.058 0.485 0.015 0.553 0.070
2700-3600 0.471 0.046 0.459 0.025 0.500 0.053
3600-infinite 0.000 0.471 0.000 0.459 0.000 0.500
Notes: A = Probability o f WTP being greater than upper bound o f interval; B = Change in density
The change in density of each interval is then multiplied by the lower bound 
value of each interval and summed-up to produce the non-parametric Turnbull mean 
value of annual willingness to pay, shown in Table 94.
Table 94: Non-parametric (lower-bound) Turnbull estimation of mean annual













Immediate 623.01 554.05 637.05 515.90 379.27 549.88
Future 580.92 529.74 621.13 — — —
Estimates are distribution-free and conservative.
US$ 1 = R$ 3.40 during the survey period (March/2003).
